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ABSTRACT
Saccharomyces cerevisiae (budding yeast) cells defective for the PS02/SNM1 gene are 
uniquely sensitive to agents that produce DNA interstrand cross-links (ICLs), but not 
other forms of DNA damage. In the absence of Pso2, repair is stalled after the initial 
incision of ICLs, resulting in an accumulation of DNA double strand breaks (DSBs). 
The Pso2 protein is a member of the (3-CASP metallo-P-lactamase family of hydrolytic 
enzymes, that include the mRNA processing enzyme CPSF, and Artemis, a human 
V(D)J recombination factor demonstrating single-strand DNA specific 5’-to-3’ 
exonuclease and a hairpin endonuclease activity. Given the genetic epistasis of PS02 
with the nucleotide excision repair pathway (NER) confirmed here in an isogenic 
background, it is probable that Pso2 is involved in the processing of ICL-repair 
intermediates arising from NER. Consequently, the genetic interactions between PS02 
and yeast nucleases implicated in DNA repair and recombination have been 
characterised. PS02 demonstrates a striking synergistic relationship with the 5’-to-3’ 
exonuclease EXOl. Double disruptant pso2 exol yeast cells are significantly more 
sensitive to the cross-linking drug nitrogen mustard, relative to the single mutants, and 
accumulate a higher proportion of DSBs, which fail to be repaired. Furthermore, loss of 
both pso2 and exol results in a moderate sensitivity to ionising radiation, and a 
deficiency in spontaneous homologous recombination at a chromosomal inverted-repeat 
substrate. EXOl is known to interact, both genetically and physically, with the 
mismatch repair factor MSH2. In this study, it has been established that pso2 msh2 
double disruptants phenocopy pso2 exol, consistent with an overlap of activity of Pso2 
with the Exol-Msh2 complex. This relationship involves a requirement for both MutS 
complexes (Msh2-Msh3 and Msh2-Msh6), but does not extend to spontaneous 
mismatch correction. It is proposed that Pso2 plays a role in the processing of repair 
intermediates for downstream recombination events, that is functionally redundant with 
Exol-MutS during spontaneous recombination and double-strand break repair. As a 
conclusion to this study, FLAG-tagged Pso2 protein has been successfully purified from 
budding yeast. Western blotting shows this protein to be larger than expected, and 
cross-reactivity of purified Pso2 with a human polyclonal aSUMO antibody suggests a 
role for sumoylation in the regulation of Pso2 activity.
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CHAPTER 1 INTRODUCTION
Cancer is a complex disease arising from genetic mutations that confer a selective 
advantage for disregulated cell growth and development. Yet DNA is also the target for 
many of the current cancer therapies, as critical DNA damage can cause cell death. 
Hence, genomic integrity represents a crucial determinant in cancer progression, and 
therefore our understanding of normal DNA metabolism and repair is central to the 
development of successful treatments for this disease.
1.1 DNA damaging agents
The DNA of any organism is under constant assault from both the environment and 
reactive species generated within the cell (reviewed in Friedberg et al., 1995). 
Spontaneous damage occurs frequently during normal DNA metabolism and may result 
in strand breakage, mismatches, or alterations in the chemistry of DNA bases (e.g. 
tautomeric shifts, deamination, depurination, depyrimidination). Environmental stress 
may be chemical (e.g. alkylating agents, benzo(a) pyrenes, aflatoxins) or physical (e.g. 
ultraviolet light, ionising radiation), and can inflict a similarly diverse range of DNA 
lesions. Examples include: covalent linkage of adjacent pyrimidines (cyclobutane 
pyrimidine dimers and 6-4 photoproducts) resulting from UV exposure; ionising 
radiation-induced strand breaks; and DNA base adducts formed by aflatoxin and 
alkylating agents. Furthermore, reactive oxygen species arising both endogenously and 
exogenously cause a variety of DNA damage including fragmentation and base loss.
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Many clinically relevant chemicals, including many common chemotherapeutic agents, 
cause damage to DNA through the formation of cross-links. For example, nitrogen 
mustards, platinum drugs, photoactivated psoralens, and the natural compound 
mitomycin C (Metzler, 1986). Cross-links are produced when a monoadduct that is 
covalently attached to DNA undergoes a second reaction with the same DNA strand 
(intrastrand), the complementary DNA strand (interstrand), or in some cases with a 
protein (Fig. 1.1). These lesions can be highly cytotoxic as a result of the inhibition of 
essential cellular processes such as transcription and replication, particularly the 
interstrand cross-link (ICL), as it prevents separation of the two DNA strands. 
Furthermore, if allowed to persist, cross-links can cause further damage, such as the 
formation of DNA strand breaks (reviewed in Hartley, 2001).
1.1.1 Alkylating agents
Alkylating agents are electrophilic compounds that can substitute a proton with an alkyl 
group to form covalent adducts with DNA, RNA, or protein. The alkylation reaction 
may occur either by first (SN1) or second (SN2) order nucleophilic substitution. The rate 
of SNlreactions is limited by the formation of a highly reactive positively charged 
intermediate, whereas the SN2 mechanism involves bimolecular nucleophilic
displacement. Some alkylating drugs act preferentially by one mechanism (SNj for 
nitrogen mustards, SN2 for the alkylalkanesulphonate, busulfan), whereas others appear 
to utilise both (Hartley, 2001). In the case of nitrogen mustards, loss of chloride results 
in the formation of a highly electrophilic aziridinium ion intermediate, which reacts 
covalently with DNA (Fig. 1.2). This can be repeated with the other chloroethyl group
17
m onoadduct in terstrand  
cross-link  (ICL) DNA-protein
cross-link
minor groovemajor groove
in trastrand
cross-link
Figure 1.1 Types o f DNA adduct formed by cross-linking agents. A 
covalent attachment to a single strand of DNA results in a monoadduct. 
Bifunctional compounds have the ability to react a second time, either with 
the same DNA strand (intrastrand cross-link), the complementary strand 
(interstrand, ICL), or with a protein. (Adapted from McHugh et al., 2001)
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A. Mechlorethamine (HN2)
CH3  N
CH2CH2CI
c h 2c h 2ci
B. Reactive aziridinium ion intermediate
CH.
CH2
l+ \
N ------ CK
CH2CH2CI
Figure 1.2 Structure o f nitrogen mustard. A. The simple nitrogen mustard 
(mechlorethamine, HN2). The non-alkylating methyl group is substituted 
in mustard analogues. B. Loss of a chloride ion produces the electrophilic 
aziridinium ion intermediate, which can react with DNA to form 
monoadducts. An analogous reaction at the other chloroethyl group results 
in a DNA cross-link.
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and a second nucleophile, resulting in the formation of a cross-link (Fig. 1.1). Such 
compounds are known as bifunctional alkylating agents, as a result of their ability to 
form two alkylation reactions (Hartley, 2001).
DNA contains a number of nucleophilic centres, although some sites, particularly the 
ring nitrogens of the bases, are more susceptible to alkylation. The preferential site of 
attack is the N7 position of guanine in the major groove, producing a 7-alkylguanine 
adduct (Hartley, 2001) (Fig. 1.3). However, this is a relatively harmless lesion that does 
not alter normal base pairing, and is slowly hydrolysed to leave an apurinic site, which 
can be readily repaired. The other frequently occurring monoadducts, 3-alkyladenine, 
are formed at the N3 position of adenine in the minor groove, and cause a greater 
obstruction to the progression of DNA polymerase, so are more toxic (Hartley, 2001). 
A further adduct is 06-alkyl guanine, an enol-tautomeric base that is highly mutagenic 
as a result of erroneous DNA synthesis (Hartley, 2001) (Fig. 1.3).
The preference for particular nucleophilic sites largely reflects their molecular 
electrostatic potential, with the N7 position of guanine being the most negative site 
within the bases of DNA. However, not all guanines will be alkylated to the same 
extent, because the electrostatic potential of any one site is affected by its flanking 
bases. Two adjacent guanine bases constitute the greatest electrostatic potential, and as 
such, alkylation by simple agents such as mechlorethamine occurs predominantly in 
guanine-rich regions of DNA.
20
<<\ajor groove H
minor gro°
Thymine Adenine
rtxajor groove
Cytosine
H
h° r groove
Guanine
Figure 1.3 Alkylation sites o f DNA bases. The reactive sites of adenine (Nj 
and N3) and guanine (0 6 and N7) are highlighted with a red outline. The 
different atoms within the bases are colour coded: carbon in pale blue, nitrogen 
in orange, and oxygen in green. The C{ site of deoxyribose is depicted in dark 
blue. (Adapted from Hartley, 2001)
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1.1.1,1 Nitrogen mustards
The alkylating agent mechlorethamine (nitrogen mustard, HN2; Fig. 1.2) was the first 
antitumour drug to be administered, more than fifty years ago, following observations 
that the related compound, di(2-chloroethyl)sulphide (sulphur mustard, used as a war 
gas) was toxic to the haematopoetic system (Jacobson et al., 1946; Goodman et al., 
1946). Today, the clinical application of HN2 is restricted largely to the treatment of 
Hodgkin’s lymphoma as a result of its high systemic toxicity. However, a range of 
bifunctional nitrogen mustard derivatives including melphalan, chlorambucil, 
cyclophosphamide, and ifosfamide are widely used. In these compounds, the simple 
methyl group is substituted with alternative organic chains and rings. Even small 
changes in these non-alkylating regions can significantly affect biological properties, 
such as compound stability, metabolic bioactivation, cellular uptake, sequence 
specificity, and cross-resistance. This facilitates the use of different alkylating agents in 
combination chemotherapy to more effectively treat a range of tumours (reviewed in 
Hartley, 2001).
The production of cross-links first requires the formation of a monoadduct. The second 
alkylation event is slow, and not all monoadducts will react to form cross-links. The 
ratio of monoadducts to cross-links is usually in the region of 20:1 (Hartley, 2001), and 
for HN2, ICLs only account for 1-4 % of the total adducts formed (Dronkert and 
Kanaar, 2001). Bifunctional mustard compounds form DNA intra- and interstrand 
cross-links between guanine N7 residues, most often at the recognition sequence 5’- 
GNC-3’/3’-CNG-5’ (Ojwang et al., 1989). The ICL is generally regarded to be the 
critical cytotoxic lesion for members of the nitrogen mustard class, as the extent of 
interstrand cross-linking correlates well with cytotoxicity (O’Connor and Kohn, 1990;
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Sunters et al.y 1992). Furthermore, there is growing evidence that clinically-acquired 
drug resistance may specifically be the result of increased repair of these lesions 
(Chaney and Sancar, 1996; Spanswick et al., 2002).
1.1.2 Platinum-based compounds
Platinum complexes are DNA cross-linking agents that have a similar mechanism of 
action to the alkylating agents. The biological activity of platinum compounds was 
discovered fortuitously forty years ago by Rosenberg, who observed that platinum salts 
produced during electrolysis caused filamentation in E. coli (due to the inhibition of cell 
division) (Rosenberg et al., 1967). Depending on the oxidation state of the platinum 
ion, complexes may have either four (Pt(II) complex) or six (Pt(IV)) coordination sites. 
These coordination complexes are fixed, giving rise to distinct cis (cisplatin) and trans 
(transplatin) isomers (Fig. 1.4 A). Transplatin has a much lower cytotoxicity compared 
to cisplatin, and has no anti-tumour activity (Jakupec et al., 2003). There are a number 
of reasons that have been demonstrated to account for this crucial difference, including 
less inhibition of DNA replication and transcription by transplatin adducts, a slower rate 
of monoadduct to cross-link conversion, and the inability of transplatin to produce 1,2- 
intrastrand cross-links (Jakupec et al., 2003). The anti-cancer agent cis- 
diamminedichloroplatinum(II) (cis-DDP, cisplatin) possesses two chloride ions, which 
can be displaced in aqueous solution to form a reactive electrophilic species (Fig. 1.4 A) 
(Jakupec et al., 2003). Activated cisplatin will efficiently attack any cellular 
nucleophile, including DNA, RNA, and protein, and the sequential displacement of both
23
H3N NH.
\  /
Pt
/  \Cl Cl
Cisplatin
H3N Cl
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I
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1,3-intrastrand d(GpXpG) interstrand (ICL)
Figure 1.4 Structures o f platinum compounds. A. Structures of cis- and 
trans-platin. In an aqueous solution, the chloride ions can be displaced to 
leave an electrophilic aquated species, which is the reactive form of these 
compounds. B. Schematic of the different bifunctional adducts formed by 
cisplatin on DNA.
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chloride groups will result in a bifunctional agent, capable of forming covalent cross­
links (Fig. 1.1) (Jakupec et al., 2003).
Cisplatin primarily reacts with the N7 atom of purine bases in the DNA major groove 
resulting in the formation of l,2-d(GpG), l,2-d(ApG), and l,3-d(GpNpG) intrastrand 
cross-links, and interstrand cross-links between guanines in the complementary DNA 
strands (Fig 1.4 B) (Pinto and Lippard, 1985; Comess and Lippard, 1993). The 
l,2cisplatin intrastrand adducts (d(GpG) and d(ApG)) account for around 90 % of the 
DNA damage (Fichtinger-Schepman et al., 1985), and are less well recognised by the 
mammalian Nucleotide Excision Repair (NER) apparatus than the rarer (approximately 
6 %) 1,3-intrastrand cross-links, probably as a result of the smaller degree of helical 
distortion induced (Zamble et al., 1996; Moggs et al., 1997). The cisplatin ICLs and 
monoadducts are even more rare, occurring only at a frequency of around 1-2 % 
(Fichtinger-Schepman etal., 1985).
It is clear that the clinical effectiveness of cisplatin is a result of the DNA, rather than 
RNA and protein lesions (Jakupec et al., 2003). The critical cytotoxic lesion is likely to 
be the predominant 1,2-intrastrand cross-links (Fichtinger-Schepman et al., 1995), 
although evidence has also been presented regarding the cytotoxicity of ICLs (Zwelling 
et al., 1979). An ELISA-based quantitation of the level of intrastrand adducts has 
shown a correlation with clinical response in testicular and ovarian cancer cells (Reed et 
al., 1986). Furthermore, all components of the NER machinery are required for the 
unhooking of cisplatin ICL in vivo, yet in some mutants this results in only a modest 
increase in sensitivity (De Silva et al., 2002).
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Cisplatin was approved for clinical use in anti-cancer therapy in 1979 (Loehrer and 
Einhom, 1984), and it remains one of the most utilised agents. It is an effective 
component of several different combination drug protocols used to treat a variety of 
solid tumours, including testicular, ovarian, and bladder cancers. However, acquired 
resistance is frequently observed, and some tumours, such as liver and colon, appear to 
be intrinsically resistant to cisplatin chemotherapy (reviewed in Ho et al., 2003). A 
number of factors are thought to contribute to resistance, including increased DNA 
repair, and tolerance due the binding of cellular proteins to platinum adducts. Hence, 
research is being conducted to identify new compounds with distinct chemical and 
biological properties. Platinum (II) complexes essentially have two stable carrier 
ligands (the amine groups in cisplatin), and two anionic leaving groups (cisplatin 
chloride ions). It is thought that the carrier group determines the structure of the adduct 
bound to DNA, whereas the reactivity of the leaving group affects drug toxicity, and 
can also influence tissue and intracellular distribution (reviewed in Ho et al., 2003). A 
number of cisplatin analogues are now in clinical use, including carboplatin and 
oxaliplatin. Carboplatin has been found to exhibit reduced side effects compared to 
cisplatin, probably as a result of the less labile cyclobutanedicarboxyl leaving group 
(Ho et al., 2003). Oxaliplatin demonstrates enhanced activity and a lack of cross- 
resistance to cisplatin, which may be due to the inhibition of DNA repair by the bulky 
diaminocyclohexane carrier ligand (Ho et al., 2003).
1.1.3 Psoralens
DNA cross-links can also be formed as a result of the photoaddition of bifunctional 
psoralens to pyrimidine bases. Psoralens are planar tricyclic furocoumarins (Fig. 1.5 A)
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Figure 1.5 Structures o f  other cross-linking compounds. A. Psoralen and its 
derivative 8-methoxypsoralen. B. Mitomycin C.
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that can intercalate with DNA, and become covalently bound to pyrimidine bases after 
photoactivation by UVA radiation. The principal site of attack is the 5,6 double bond of 
thymine, and two sequential UV absorption events will result in the formation of a 
stable interstrand cross-link between thymines above and below the plane of the 
psoralen molecule (Friedberg et al., 1995). These ICLs cause significant distortion to 
the helix, as well as inducing the unwinding of DNA. Three times as many 
monoadducts are produced compared to ICLs, yet, as for other classes of compound, the 
cross-link has been shown to be the crucial determinant of cellular toxicity (Brendel and 
Ruhland, 1984). Due to the planar structure of psoralens, intrastrand cross-links cannot 
be formed in DNA, but photoreactivation with proteins has been observed after 
prolonged exposure to UVA (Brendel and Ruhland, 1984).
The inhibition of DNA replication by psoralen in combination with high-intensity UVA 
radiation is widely utilised in the treatment of psoriasis and other skin diseases, which 
are characterised by a marked proliferation of certain skin epithelial cells (Friedberg et 
al., 1995). More recently, psoralens have been found to act as effective 
chemoprotective agents against non-melanoma skin cancers (Pathak and Fitzpatrick, 
1992).
1.1.4 Mitomycin C
Mitomycin C is a natural antibiotic compound (Fig. 1.5 B), isolated from Streptomyces 
caespitosus, that is used to treat a wide spectrum of tumours including breast, gastric, 
oesophageal, and bladder cancer (reviewed in Hartley, 2001). It requires bioactivation 
by reduction of the quinone moiety, in order to function as an alkylating agent (Hartley, 
2001). All monoalkylation and cross-linking occurs in the minor groove of DNA.
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Activated mitomycin C forms monoadducts at the N7 and N2 positions of guanine, with 
a preference for the DNA sequence 5’-CGN-3’ (where N is C>T>G>A), compared to 
5’-GGN-3’ (Kumar et al., 1992). Intrastrand cross-links are formed between guanine 
N2 residues at d(GpG) sites, whereas ICLs occur at d(CpG) sequences (Tomasz, 1995). 
Unlike the cross-links produced by nitrogen mustards and platinum compounds, 
mitomycin C-induced ICL cause relatively little DNA distortion (Tomasz, 1995). 
Monoadducts are also formed without significantly affecting DNA conformation, 
however, the intrastrand cross-link has been shown to result in bending of the DNA 
(Rink et al., 1996). Mitomycin C monoadducts react slowly to form cross-links, and 
ICLs are believed to constitute 5-13 % of the total adducts (Dronkert and Kanaar, 
2001). However, the ICL has been shown to be the critical determinant of cytotoxicity 
(Palom et al., 2002).
1.1.5 DNA strand breaks
Single (SSBs) and double (DSBs) strand breaks occur frequently in DNA, as a result of
both endogenous and exogenous assault (Friedberg et al., 1995; Paques and Haber,
1999). SSBs occur during replication and repair, for example, by the action of type I
topoisomerases, or where a replication fork encounters an unrepaired adduct, and they
are also one of the lesions induced by UV and ionizing radiation. DSBs are a
consequence of ionizing radiation, radiomimetic drugs such as bleomycin, mechanical
stress, and endonuclease digestion. These lesions are also produced as a consequence
of oxidative damage or unrepaired nicks occurring during normal metabolic processes,
and are thought to arise at stalled replication forks (Cox et al., 2000). Of particular
significance to this study, DSBs are known to occur during the repair of DNA ICL
(Section 1.3). Strand breaks, especially DSBs, have the potential to cause considerable
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cytotoxicity as a result of increased genomic instability and the inhibition of cellular 
processes such as replication.
The exact nature of a strand break can vary, depending on the causative agent. Endo- 
and exonucleases, such as those employed in DNA recombination and repair pathways 
(Section 1.2), hydrolyse the phosphodiester linkages in DNA, causing a range of 
discrete nicks and longer digested regions, often with a complementary single strand 
overhang. In contrast, ionizing radiation-induced DSBs exhibit additional damage (e.g. 
fragmentation, loss) to the terminal bases and sugars of the DNA helix, and the anti­
cancer drug bleomycin produces breaks with phosphoglycolate-modified 3’-termini. 
These differences can have major implications for the mechanism of repair employed 
by the cell, as the damage may not be completely restored by simple end joining.
1.2 DNA repair
As already described, the DNA in any organism is constantly subject to many different 
types of damage. It follows that cells have evolved a complex system of repair 
pathways to counteract this assault. Many of the factors involved in these mechanisms 
were identified by the analysis of genetic mutants, both in model organisms such as E. 
coli and Saccharomyces cerevisiae, and more recently, higher eukaryotes. Classically, 
these repair factors have been allocated into independent genetic epistasis groups, for 
example the /?AD3/nucleotide excision repair and /MD52/homologous recombination 
pathways of budding yeast. However, research now suggests that these well- 
characterized pathways also form part of a composite system in which repair proteins 
interact with multiple partners to process different types of lesion. The co-operation of
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various factors and pathways is exemplified by the case of DNA interstrand cross-link 
repair (Section 1.3).
1.2.1 Nucleotide Excision Repair (NER)
The nucleotide excision repair pathway is proficient in the repair of a variety of DNA 
lesions, particularly those that are bulky and distort the DNA helix, such as UV-induced 
dipyrimidine photoproducts (Prakash and Prakash, 2000). NER is also likely to be the 
major determinant of cellular sensitivity to bifunctional chemotherapeutic agents, such 
as cisplatin, that predominantly produce intrastrand cross-links as opposed to ICL 
(Section 1.1.2). The NER pathway was initially deciphered in E. coli, and identification 
of NER genes in both yeast and mammalian cells has relied upon the identification of 
UV-sensitive mutants, such as those isolated from Xeroderma pigmentosum (XP) 
patients. The genes involved in yeast repair are designated RAD as a result of these 
studies into radiation sensitivity, and those that are associated with UV sensitivity form 
the RAD3 group. A combination of genetic and biochemical analyses has identified 
specific interactions between these factors to form functional complexes. Physical 
associations between more diverse members of the NER group have also been 
suggested, as a result of the co-purification of large protein complexes from yeast. 
These complexes have been designated ‘nucleotide excision repair factors’ (NEF; 
Guzder et al., 1996).
In S. cerevisiae, global genome NER (GGR, Fig. 1.6), the initial recognition of a DNA 
lesion is probably mediated by the Rad4-Rad23 (NEF2) and Rad7-Radl6 (NEF4) 
complexes. It has been suggested that these complexes interact in the presence of ATP, 
enhancing binding to the damaged site (Guzder et al., 1999). Recent research has
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shown that binding of Rad7-Radl6 to DNA also generates helical torsion that is 
essential for the excision reaction to proceed (Yu S. et al., 2004). The single-stranded 
DNA-binding protein, RPA, is thought to be involved in both damage binding and the 
subsequent incision step (Huang et al., 1998; Prakash and Prakash, 2000). The 
remaining NER proteins are probably recruited to the lesion through the interaction of 
Rad23 with the transcription factor TFIIH (NEF3) and Rad 14 (NEF1) (Prakash and 
Prakash, 2000). The helicases Rad3 and Rad25 (part of the NEF3 complex) unwind the 
DNA at the damaged site by translocating along ssDNA in the 5’-3’ and 3’-5’ 
directions, respectively, creating an open “bubble” around the lesion (Sung et al., 1996). 
This provides access to the single-strand/double-strand DNA junctions that are 
substrates for the dual endonuclease incisions, made 5’ to the lesion by the Radl-RadlO 
heterodimer (NEF1) and 3’ to the lesion by the Rad2 protein (NEF3) (Bardwell et al., 
1994; Habraken et al., 1995). An oligonucleotide of 24-32 nt containing the damaged 
region is released (Guzder et al., 1995), leaving a gap, which is restored by DNA 
synthesis, performed by DNA polymerase 6 and e, and ligation by DNA ligase I (Cdc9) 
(Prakash and Prakash, 2000).
NER operates in essentially the same manner in mammalian cells as in yeast, and 
human homologues of most of the yeast NER factors have been identified (Table 1.1), 
particularly from studies in Xeroderma pigmentosum (XP) patients, who display an
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Figure 1.6 Mechanism o f  NER in yeast. Following damage recognition by 
Rad4-Rad23 and/or Rad7-Radl6 (1), the double helix is unwound around the 
lesion by the helicases Rad3 and Rad25, and components of the TFIIH 
complex are recruited (2). The resulting bubble structure provides the 
substrate for the structure-specific endonucleases Rad2 (cleaving first, 3 ’ to 
the lesion) and Radi-Rad 10 (subsequently cleaves 5 ’ to the lesion) (3). A 
lesion-containing oligomer is released, and the remaining gap reconstituted 
by DNA synthesis (DNA polymerase e/6 and PCNA) and ligation (DNA 
ligase), using the undamaged strand as a template (4). (Adapted from 
McHugh et a l ., 2001)
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Table 1.1 Conservation of NER genes between yeast and humans
S. cerevisiae Human Function
Rad4-Rad23 XPC-hHR23B Lesion recognition
Rad7-Radl6 None identified Lesion recognition
Rad 14 XPA Lesion recognition
Rad3, Rad25 XPD, XPB DNA unwinding
Radi-Rad 10 XPF-ERCC1 Lesion excision
Rad2 XPG Lesion excision
Rad26, Rad28 CSB, CSA TCR
extreme sensitivity to sunlight and a predisposition to skin cancer. Recognition of DNA 
lesions is thought to require the XPC-hHR23B complex, possibly assisted by XPA in 
combination with RPA (replication protein A) (Batty and Wood, 2000). However, 
studies using immunofluorescent labelling to determine the assembly of NER proteins 
in UV-irradiated human cells indicate a later role for XPA, promoting the recruitment 
and activation of the nucleolytic factors XPF-ERCC1 and XPG (Yolker et al., 2001). 
As in S. cerevisiae, the helicases XPD and XPB are believed to associate at the 
damaged site as part of a complex with TFIIH, leading to the local unwinding of 10-20 
nt in an ATP-dependent fashion (Evans et al., 1997). This enables the release of a 
damage-containing oligonucleotide by sequential asymmetric incision reactions, first 3’ 
(XPG) and then 5’ (XPF-ERCC1) to the lesion (Sancar, 1996). It has even been 
suggested that XPG is involved in the recruitment of XPF-ERCC1 (Wakasugi and 
Sancar, 1998). Repair is completed by the activities of PCNA, DNA polymerases 6 and 
e, and DNA ligase.
Recognition of damaged sites in actively transcribed regions of DNA is specifically 
achieved by the interaction of the Rad26-Rad28 complex with stalled RNA polymerase
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II (Transcription Coupled Repair, TCR) (van Gool et al., 1994; Bhatia et al., 1996). In 
humans, Cockayne’s syndrome is associated with a deficiency in TCR, and two of the 
associated gene disruptants correlate with Rad26 (CSB) and Rad28 (CSA). These 
factors may stimulate the removal of the RNA pol II complex in order to facilitate 
binding of the downstream NER factors (Balajee and Bohr, 2000).
1.2.2 Mismatch Repair
The identification and repair of single nucleotide mismatches and small 
insertion/deletion loops (IDLs) of DNA is achieved through the combined activity of 
the Mismatch repair (MMR) family of proteins (Hansen and Kelley, 2000; 
Hoeijmakers, 2001). This pathway was originally characterized in E. coli, which has 
served as the model for elucidation of eukaryotic systems (such as yeast, shown in Fig. 
1.7). In E. coli, a homodimer of MutS protein binds non-specifically to DNA, and scans 
the DNA until it encounters a mismatch, stimulating a conformational change into the 
recognition complex (Wang et al., 2003). In the presence of ATP, MutS translocates 
along the DNA, forming a loop structure with the mismatch at its apex. The 
recruitment of MutL and MutH into the MutS-DNA complex activates the endonuclease 
activity of MutH, which nicks the newly-replicated unmethylated DNA strand (MutH 
recognises hemi-methylated dam sites that exist transiently after replication). This nick 
may occur on either side of the mismatch, and so the single-strand exonuclease 
responsible for further degradation is specific to this polarity: Exol, ExoX, or ExoVII if
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Figure 1.7 Mechanism o f MMR in yeast. The mismatched DNA base or 
insertion/deletion loop is recognised by either Msh2-Msh6 or Msh2-Msh3, 
respectively (1). The M lhl-Pm sl heterodimer is then recruited, resulting in 
the formation of a 5 ’ or 3 ’ nick (2). The exonuclease activities of Exol and 
DNA pol 6/e leads to the creation of a 100-1000 nt gap (3), which is repaired 
by DNA synthesis and ligation (4).
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the nick occurs 3’ to the mismatch, and either ExoVII or RecJ for 5’ nicks. MutL 
recruits helicase II, which unwinds a repair patch up to 1 kb long, and DNA polymerase 
III replicates across the gap resulting from exonuclease digestion. The remaining nick 
is sealed by DNA ligase (reviewed in Marti et al., 2002).
Eukaryotic MMR proteins have been classified by analogy to their bacterial 
counterparts MutS and MutL. Six MutS (Mshl-6) and four MutL (Mlhl-3, Pmsl) 
homologues have been identified in S. cerevisiae, some of which are specific to meiotic 
recombination (Msh4, Msh5) and mitochondrial repair (Mshl) (Hollingsworth et al., 
1995; Ross-Macdonald and Roeder, 1994; Reenen and Kolodner, 1992). Mitotic 
mismatch repair is governed by Msh2, which functions as a heterodimer with Msh3 or 
Msh6 to specify recognition of either IDLs, or base substitutions and 1-2 nt loops, 
respectively. These complexes are known as MutSp (Msh2-Msh3) and MutSa (Msh2- 
Msh6), and have also been identified in mammalian cells (Genschel et al. 1998). The 
function of bacterial MutL is primarily accomplished by a heterodimer of Mlhl and 
Pmsl in yeast (Prolla et al., 1994). However, Mlhl may also complex with Mlh2 or 
Mlh3, possibly to repair certain intermediates arising from the activity of MutSa. It has 
also been suggested that different Mlhl heterodimers may exist at distinct stages of the 
cell cycle (reviewed in Harfe and Jinks-Robinson, 2000). No eukaryotic homologues of 
MutH have been identified, despite extensive screening. However, the sliding clamp 
protein, PCNA (proliferating cell nuclear antigen), has been shown to physically 
interact with Msh2 and Mlhl, and it has been suggested that through its interaction with 
the replication machinery could provide the means to discriminate between the newly 
synthesized and template DNA strands (Harfe and Jinks-Robinson, 2000). Nick- 
directed mismatch processing is believed to occur in the 5’-3’ direction by means of the
exonuclease Exol, and 3’-5’ through exonuclease activities associated with the 
replicative DNA polymerases e and 5 (Harfe and Jinks-Robinson, 2000).
The yeast MMR factors have also been implicated in recombination events, some of 
which also involve interactions with members of the NER family. MutS(5 in 
combination with the Radl-RadlO complex, has been shown to be involved in the 
removal of 3’ non-homologous tails arising during gene conversion and single-strand 
annealing (described in more detail in Section 1.2.3.1.1) (Sugawara et al., 1997). It has 
been suggested that Msh2-Msh3 bind and stabilise single-strand/double-strand DNA 
junctions, enabling nicking by Radl-RadlO. The NER endonuclease Radi is also 
required for the Msh3-dependent repair of a 95 nt loop between direct repeats during 
DNA replication, as well as the Msh2-dependent removal of a 26 nt loop during meiotic 
recombination (Harfe and Jinks-Robinson, 2000). It is believed that Msh2-Msh3 and 
Radl-RadlO may form a novel complex that is responsible for the excision of 
heterologies larger than a few nucleotides. In addition, one report has shown that 
MutSa may bind and influence the resolution of Holliday junctions in vitro, analogous 
to the role of Msh4 and Msh5 in meiosis (Marsischky et al., 1999).
An additional responsibility of some of the MMR proteins is the suppression of 
homeologous recombination (between diverged sequences). Recent research suggests 
that Msh2 and Msh6 are required to prevent single-strand annealing between 
moderately divergent sequences, whereas the full complement of MMR factors are 
utilised in the correction of mismatches in the heteroduplex intermediate (Sugawara et 
al., 2004). However, Msh3 and Pmsl have also been implicated in rejecting other
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homeologous recombination events (Paques and Haber, 1999). Msh2 may be especially 
important in the regulation of homeologous recombination in mammalian cells, due to 
the large fraction of the genome that is comprised of repetitive elements (Abuin et al., 
2000).
Defective MMR results in both an accumulation of replication errors and inappropriate 
recombination events, hence is highly mutagenic. In humans, MMR deficiency, 
particularly due to mutated MSH2 or MLH1 alleles, is associated with a large proportion 
of hereditary non-polyposis colorectal cancer (HNPCC) (Muller and Fischel, 2002). 
MMR defects have also been detected in a number of sporadic tumours (Hoeijmakers, 
2001), with hypermethylation silencing of the MLH1 promoter occurring at high 
frequency. This hypermethylation has also been observed in cisplatin resistant ovarian 
tumour cell lines (Strathdee et al., 1999). An MMR deficiency has been shown to 
correlate with resistance to a number of anti-tumour agents including cisplatin, 
carboplatin, busulphan, temozolomide, etoposide, and doxorubicin (Fink et al., 1998). 
Furthermore, Msh2 expression is elevated in both testicular and ovarian tissue, 
corresponding with the tumour types most successfully treated by cisplatin (Mello et al., 
1996). In the same report, analysis of hMsh2 binding to cisplatin-modified DNA has 
shown an affinity for 1,2-intrastrand cross-links (although recognition of the interstrand 
adduct was solely excluded on the basis of its infrequent occurrence). The authors 
suggest that Msh2 mediates cisplatin toxicity either by initiating futile MMR resulting 
in lethal DNA-strand breaks, or by preventing the recognition of cisplatin adducts by 
appropriate NER factors. However, Moggs et al. have shown that mismatched 1,2- 
intrastrand cross-links are in fact repaired more effectively by NER in vitro, and that
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this increased repair is not dependent upon MMR factors, as the same NER preference 
is observed in extracts from cells deficient for hMutSa (Moggs et al., 1997).
1.2.3 Double Strand Break Repair Pathways
Double strand breaks (DSBs) are formed on exposure to agents such as ionising 
radiation and free radicals, but can also occur naturally in a cell as intermediate 
structures during meiotic and V(D)J (mammalian immunoglobulin class switching) 
recombination events. Furthermore, DSBs may arise during the repair of other DNA 
damage and as a result of replication fork collapse at lesions, single strand breaks or 
gaps (Paques and Haber, 1999; Cox et a l  2000). Unrepaired DSBs lead to gene 
disruption and chromosomal rearrangements, ultimately increasing the risk of tumour 
progression. Indeed, human cancer-prone syndromes such as Nijmegen breakage 
syndrome and ataxia-telangiectasia-like disorder are associated with defects in DSB 
repair (Karran, 2000).
The two primary pathways for DSB repair are homologous recombination (HR) and 
nonhomologous end joining (NHEJ), which, as suggested by the nomenclature, are 
concerned with regions of long (hundreds of base pairs) near-perfect homology, and 
little or no sequence homology, respectively. In S. cerevisiae, HR is the predominant 
mechanism, although NHEJ can efficiently repair certain classes of DSB, such as those 
induced by endonuclease digestion retaining complementary single-strand DNA 
overhangs. In contrast, chemically modified DSB ends (e.g. arising from ionising 
radiation) are poor substrates for NHEJ (Lewis and Resnick, 2000). In higher 
eukaryotes, pathway preference may be cell cycle-dependent, with NHEJ favoured 
during Gl/early S phase, and HR in late S-G2 (Takata et al., 1998). Furthermore, the
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conceived boundaries between these pathways may prove to be flexible, as cooperation 
between NHEJ and homology-driven processes has been observed in the repair of DSBs 
in murine cells (Richardson and Jasin, 2000).
1.2.3.1 Homologous recombination
Many of the genes involved in HR were originally identified from S. cerevisiae mutants 
displaying a hypersensitive phenotype to ionising radiation, and are collectively known 
as the RAD52 epistasis group. To date, the known HR factors are Rad50, Rad51, 
Rad52, Rad54, Rad55, Rad57, Rad59, M rell (originally Rad58), and Xrs2, of which 
rad51, rad52 and rad54 mutants are associated with the most severe deficiencies in 
recombination and DSB repair (reviewed in Pastink and Lohman, 1999). Rad52 is the 
central recombination factor, and is required in all known mechanisms of HR in 
budding yeast. Rad52 forms ring structures that interact with ssDNA, promoting the 
efficient annealing of complementary strands (Shinohara et al., 1998). Rad51, Rad55 
and Rad57 are homologues of the E. coli recombination factor, RecA, which catalyses 
the pairing of ssDNA with complementary dsDNA. Rad51 polymerizes on DNA to 
form nucleoprotein filaments, which initiate pairing between single-strand DNA and 
duplex DNA to catalyze strand exchange (Sung, 1994). This polymerisation is 
regulated by the Rad55-Rad57 heterodimer and Rad52, which suppress the inhibitory 
effects of RPA (Sugawara et al., 2003). A further protein required for efficient strand 
exchange is Rad54, a DNA-dependent ATPase thought to be involved in chromatin 
remodelling to ‘open up’ the DNA helix (Petukhova et al., 1999).
The final three members of the RAD52 epistasis group, Rad50, M rell, and Xrs2, 
function as a complex (MRX), as determined by genetic and protein assays (reviewed in
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Haber, 1998). The M rell protein alone displays a 3’-5’ exonuclease and an 
endonuclease activity, which is enhanced by binding of the Rad50 and Xrs2 cofactors. 
Despite this polarity, yeast cells deficient for any of these factors demonstrate a 
considerably reduced 5’-3’ exonuclease activity (Ivanov et al., 1994; Tsubouchi and 
Ogawa, 1998). One explanation for this apparent contradiction is that the complex may 
endonucleolytically remove ssDNA tails unwound by an associated helicase, analogous 
to the activity of the RecBCD complex in E. coli (Eggleston and West, 1996). Recent 
research suggests Xrs2 to be important in the recruitment of the complex to DSB ends 
(Trujillo et al., 2003), whilst Rad50 is a member of the ‘structural maintenance of 
chromosomes’ family of proteins and hence presents a number of DNA binding motifs 
(de Jager et al., 2001). Rad50 has been shown to bind ATP, causing a conformational 
change in the MRX complex that appears to regulate the specificity of binding to DNA 
(de Jager et al., 2002). Furthermore, it has been suggested that Rad50 dimerises upon 
binding of ATP, and this may be important for the juxtaposition of DSB ends (de Jager 
et al., 2001; Hopfner et a l,  2002; Moncalian et al., 2004). In addition to HR, the MRX 
complex is involved in a range of other DNA repair and maintenance processes 
including NHEJ and telomere conservation (Section 1.2.3.2; reviewed in Haber, 1998). 
Recently, it has been proposed that the MRX complex may perform an important role in 
the early stages of DSB detection and signalling, acting to co-ordinate repair attempts 
by the HR and NHEJ pathways (Lisby and Rothstein, 2004).
The key features of HR appear to be conserved in higher eukaryotes, and a number of 
homologues of the RAD52 family have been identified, both by sequence analysis and 
from studies in defective cell lines, such as the X-ray repair cross complementation 
(XRCC) analysis in rodent cells. Multiple paralogues of the yeast RAD51 gene have
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been discovered, including XRCC2, XRCC3, HsRADSl, HsRAD51B, HsRADSIC, 
HsRAD51Dy and HsDMCl, yet it remains to be determined whether any of these 
additional factors are functionally equivalent to the Rad55-Rad57 heterodimer (Pastink 
and Lohman, 1999). Sequence homologues of RAD52, RAD54, RAD50, and MRE11 
have also been found, yet only a functional analogue, NBS1 (Nijmegen Breakage 
Syndrome factor), has been detected for XRS2 (Pastink and Lohman, 1999). 
Discrepancies in mutant phenotypes (for example null lethality and sensitivity to X- 
irradiation) have been observed between mammalian and yeast recombination factors, 
although these are probably due to a combination of functional redundancy and an 
increased repair burden in higher eukaryotic genomes (reviewed in Paques and Haber, 
1999; Pastink and Lohman, 1999).
1.2.3.1.1 Models o f  homologous DSB repair
There are three main models of homologous recombination that are used to explain the 
repair of chromosomal DSBs in mitotic yeast cells: gene conversion, break-induced 
replication, and single-strand annealing. Moreover, two models have been proposed to 
account for gene conversion events (DSB repair, and synthesis-dependent strand- 
annealing models), and given the substantial supporting experimental data, it is likely 
that they both represent functional subpathways of repair. Some key features are shared 
between these mechanisms, namely, resection of the DSB ends, strand invasion, 
removal of non-homologous tails, and gap repair by DNA synthesis.
1.2.3.1.1.1 Gene conversion
The original mechanism proposed for HR, referred to as the DSB repair or Szostak 
model (Szostak et al., 1983; although an earlier model was suggested by Resnick,
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1976), involves strand exchanges between sister chromatids or homologues (Fig. 1.8 A). 
This process is initiated by a DSB, the ends of which are first resected to yield 3’ single­
stranded tails. The Rad51 protein forms a protective filament on the ssDNA, and 
facilitates the invasion of the homologous duplex by both of the 3’ tails, priming DNA 
synthesis to replace the degraded region. Ligation leads to the formation of a double 
Holliday Junction (dHJ) structure, which when resolved causes an exchange of genetic 
material between the damaged and homologous duplexes in the newly-synthesised 
patches. Depending on the resolution orientation, these products may also exhibit a 
‘crossover’, where the region of genetic exchange extends from the break site along the 
entire length of the chromosome (Symington, 2002). It is thought that most gene 
conversion events, where DNA is exchanged in a non-reciprocal manner, occur as a 
result of mismatch repair activity upon the long heteroduplex tracts that form between 
the invading and donor sequences (Weng and Nickoloff, 1998).
The second model, synthesis-dependent strand-annealing (SDSA), was proposed to 
account for DSB gene conversion events that occurred with low levels of associated 
crossovers, such as HO endonuclease-mediated mating-type switching in yeast 
(reviewed in Paques and Haber, 1999). In SDSA, only one of the 3’ tails resulting from 
the resected DSB invades the homologous duplex to prime DNA synthesis, resulting in 
the formation of a displacement (D-) loop (Fig. 1.8 B). Displacement of this nascent 
strand from the donor duplex provides a template for DNA synthesis from the other 3’
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Figure 1.8 Models o f DSB repair by homologous recombination in yeast. A. 
Szostak model of gene conversion by Holliday junction formation. B. 
Synthesis-dependent strand-annealing. C. Break-induced replication, 
(homologous chromosomes depicted in black and green, with newly 
synthesised DNA in red). D. Single-strand annealing (homologous region 
depicted in orange). (Adapted from Haber et al., 2004)
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tail, in order to complete repair across the DSB. It follows that only the broken DNA 
molecule is modified with genetic material from the homologous duplex, whilst the 
donor remains intact (Symington, 2002). SDSA is also thought to be responsible for the 
occurrence of a dHJ on one side of a DSB, rather than flanking it, as seen in the Szostak 
model (Haber et al., 2004). SDSA is thought to be promoted by the helicase, Srs2, 
possibly by regulation of Rad51 during strand exchange (Ira et al., 2003).
Recent research has shown that the incidence of crossovers is tightly regulated. 
Crossovers are promoted during meiosis, but are suppressed during mitosis (Allers and 
Lichten, 2001). Loss of the Sgsl helicase (homologue of human BLM/WRN) 
significantly increases the frequency of crossovers (Ira et al., 2003). Hence it was 
proposed that Sgsl, in combination with its associated topoisomerase Top3, acts to 
eliminate dHJ intermediates to reduce the crossover occurrence, by a mechanism 
distinct from SDSA. This hypothesis was corroborated in human cells, where BLM and 
hTOPOIIIa act to dissolve dHJs arising from the homologous recombination-dependent 
repair of replicative strand gaps (Wu and Hickson, 2003). This prevents a high 
frequency of sister chromatid exchange, which is characteristic of Bloom’s syndrome 
cells (BLM deficiency). Crossovers are thought to occur by RuvC-like resolution of 
dHJs, yet to date no formal HJ resolvase has been identified in eukaryotes. The most 
likely resolvase candidate is thought to be Xrcc3-Rad51C in human cells (and by 
analogy, Rad55-Rad57 in yeast, as these are the most conserved paralogues) (Liu et al., 
2004).
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1.2.3.1.1.2 Break-induced replication
A further mechanism is that of break-induced replication (BIR, Fig. 1.8 C). This results 
from the synthesis of both leading and lagging strands by the invasion of just one end of 
a processed DSB. In contrast to gene conversion events, where the second DSB tail 
eventually engages either the replication fork or the displaced nascent strand, BIR 
continues to the end of the donor chromosome (Maikova et al., 1996). It has been 
suggested that BIR provides the means to maintain telomeres in the absence of the 
dedicated telomerase enzyme (Le et al., 1999). Genetic analysis has revealed two 
independent branches of BIR in both telomere maintenance and DSB repair in diploid 
cells (Maikova et al., 1996; Signon et al., 2001). Both demonstrate an absolute 
requirement for Rad52, however one mechanism involves Rad50-Mrell-Xrs2 and 
Rad59, whilst the other depends on Rad51, Rad54, Rad55 and Rad57. It has been 
suggested that Rad51 is inhibitory to recombination in cases where homology is limited, 
whereas the Rad50-dependent pathway remains efficient, even with only 30 bp of 
homology on each side of the break (Ira and Haber, 2002).
1.2.3.1.1.3 Single-strand annealing
The subpathway of homology-dependent recombination known as single-strand 
annealing (SSA), is specific to DSBs occurring between direct repeat sequences (Fig. 
1.8 D). Such events have been identified in yeast using artificial repeat substrates 
(Fishman-Lobell et al., 1992), but may potentially be an important mechanism in higher 
eukaryotic genomes that contain a high proportion of repeated DNA regions (such as 
Alu repeats) (Symington, 2002). In SSA, the DSB ends are resected to generate 3’ 
single-stranded regions with sufficient homology to be annealed. The non- 
complementary ssDNA overhangs are then removed endonucleolytically, and the
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resulting gaps are filled in by DNA synthesis and ligation (Sugawara and Haber, 1992). 
This mechanism of homologous repair is mutagenic, as it results in the deletion of one 
of the repeat sequences. Rad52, but not Rad51 (nor Rad54, Rad55, and Rad57), has 
been found to be necessary for SSA (Ivanov et al., 1996). As in gene conversion, the 
initial step requires resection of the DSB ends to facilitate annealing in the regions of 
homology. The overhanging 3’ tails are then cleaved from the intermediate repair 
structure by the NER endonuclease complex Radl-RadlO (Bardwell et al., 1994). This 
role is performed by the equivalent heterodimer XPF-ERCC1 in mammalian cells. 
Furthermore, the mismatch repair complex Msh2-Msh3 has been shown to bind to the 
branched DNA intermediate and promote cleavage by Radl-RadlO, especially where 
the flanking homologous regions are short (Sugawara et al., 1997). It is not yet known 
whether the role of Msh2-Msh3 is to stabilise the branched structure and facilitate 
cleavage, or to directly recruit the endonuclease complex.
1,23,2 Nonhomologous end-joining (NHEJ)
NHEJ is a lower fidelity repair pathway than HR due to the reduced requirement for 
homology between DNA ends, and as a consequence of the loss of a few bases at some 
types of repaired site. However, it is still an important pathway for maintaining 
genomic integrity, and is utilised more often than HR in higher eukaryotes (Jeggo, 
1998). Furthermore, NHEJ is the preferred pathway of DSB in S. cerevisiae in cases 
where the DSB has short (4 bp) complementary ends (Haber, 2000). Most of the repair 
factors employed in NHEJ are distinct from the protein complement utilised in HR, with 
only Rad50, M rell, and Xrs2 required in both processes (reviewed in Paques and 
Haber, 1999).
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In S. cerevisiae, the DSB ends are identified and bound by a heterodimer of Yku70 and 
Yku80, which migrates along the DNA to allow further Ku molecules to be loaded onto 
the break site (Fig. 1.9). To date, no yeast homologue of the mammalian catalytic 
subunit of DNA-dependent protein kinase (DNA-PKcs) has been identified, suggesting 
that the complete DNA-PK complex (regulatory Ku70/Ku80 and DNA-PKcs) performs 
an additional role in higher eukaryotic NHEJ. The functions of the Yku70/Yku80 
complex are believed to include protecting broken DNA ends from cellular nucleases, 
promoting the association of compatible DNA ends, and recruiting other NHEJ factors 
for the processing and ligation of the damaged site. The Ku heterodimer has been 
shown to associate with DNA break sites in vivo (Martin et al., 1999). Accurate and 
efficient end joining also requires the recruitment of downstream factors, namely the 
DNA ligase, Dnl4, and its cofactor Lifl. Loss of DNA ligase IV in higher eukaryotes 
has been shown to result in significant sensitivity to ionising radiation (Adachi et al., 
2001; Karanjawala et al., 2002). Furthermore, the human homologues, DNA ligase IV 
and XRCC4 have been found to form a tetramer which is thought to act as a bridge 
between the DSB ends to facilitate ligation (Lee et al., 2000). Two regulatory factors, 
Nejl and Lif2, have also been identified, which repress NHEJ during mating-type 
switching in yeast diploids (Valencia et al., 2001; Frank-Vaillant and Marcand, 2001).
A further protein complex involved in NHEJ is the MRX (Mrell-Rad50-Xrs2) 
nuclease, which is considered to be particularly important in the repair of DSBs with 
damaged termini, such as those arising from ionising radiation. The human XRS2
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Figure 1.9 Mechanism o f Non-Homologous End Joining in yeast. The 
Ku70-Ku80 heterodimer binds to the DNA ends of a DSB, and migrates 
along the DNA to allow loading of further Ku molecules (1). A complex of 
ligase IV (Lig4) and its co-factor Lifl is recruited to the DSB, and possibly 
acts as a bridge to facilitate ligation of the ends (2). The Mrel 1-Rad50-Xrs2 
complex is also required for the efficient association and rejoining of the 
DSB ends.
homologue, NBS1 (associated with the disorder Nijmegen breakage syndrome), has 
been shown to be responsible for the localisation of the other subunits to sites of 
radiation-induced damage (Kobayashi et al., 2004). Plasmid repair assays (which 
monitor the end-joining of compatible break termini produced by restriction nucleases) 
have shown that in contrast to a loss of Ku, Dnl4, or Lifl, absence of the MRX complex 
results in inefficient but predominantly accurate repair. It has been suggested that the 
MRX complex is involved in the stabilisation of interactions between short homologous 
sequences, and also the resection of ssDNA overhangs, during NHEJ (Pauli and Gellert, 
1998).
In mammalian cells, V(D)J recombination at the immunoglobulin locus is a specialised 
system of NHEJ reaction in developing B and T lymphocytes that is partially 
responsible for antibody diversity. The process is initiated by the formation of ssDNA 
nicks that result in DSBs between variable (V), diversity (D), and joining (J) sub-exon 
segments of the immunoglobulin genes, and proceeds through a number of intermediate 
structures, including DNA hairpins (O’Driscoll and Jeggo, 2002). The full complement 
of NHEJ factors, namely both Ku proteins, DNA-PKcs, and DNA ligase IV, are 
essential for efficient rejoining of the V(D)J segments to produce the complete variable 
domain exon. Some of the evidence establishing this link between NHEJ and V(D)J 
recombination has resulted from studies in SCID (severe combined immunodeficiency) 
mice, which were found to be deficient in DNA-PKcs or one of the Ku genes 
(O’Driscoll and Jeggo, 2002).
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1.2.4 Post-replication repair
DNA post-replication repair (PRR) is a tolerance pathway, through which single-strand 
gaps in the nascent DNA can be filled in without removal of the replication-blocking 
lesion (Fig. 1.10). PRR is known to counter replication obstruction arising from many 
different types of damage, particularly bulky lesions such as UV photoproducts and 
alkylation, but also irradiation. In S. cerevisiae, the Rad6-Radl8 heterodimer is central 
to this pathway, with many of the other factors identified as members of the RAD6 
epistasis group through genetic studies for mutagenesis-defective mutant phenotypes 
(Broomfield et al., 2001). Rad6 is an E2 ubiquitin-conjugating enzyme, which is 
thought to be targeted to the gaps formed at stalled replication forks by the ssDNA 
binding capacity of Radl8 (Bailly et al., 1994). Protein modification by ubiquitin (a 
small peptide) is emerging as an important signal for various cellular processes, 
including regulated proteolysis, protein localization, DNA repair and regulation of 
chromatin structure. Binding of Rad6-Radl8 to DNA initiates lesion bypass via one of 
a number of downstream sub-pathways, which can be error-free or error-prone 
(mutagenic). Ultimately, all pathways result in the bypass of unrepaired DNA lesions 
(Johnson et al., 1999).
A subset of the error prone pathway is performed by the translesion polymerase X> (a 
heterodimer of Rev3 and Rev7) (Nelson et al., 1996 A), in conjunction with the 
deoxycitidyl transferase Revl, which promotes the incorporation of cytosine opposite 
an abasic site or UV photoproducts (Nelson et al., 1996 B). An alternative mutagenic
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Fig. 1.10 Schematic o f  Post-replication repair. Initial recognition and binding 
to DNA damage requires the Rad6-Radl8 heterodimer. Downstream of 
damage recognition, the pathway divides into error-free and error-prone 
(mutagenic) branches of repair. The translesion polymerase Polq is involved 
in both error-free and error-prone mechanisms of repair.
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pathway is represented by the repair of N-methyl-N’-nitro-N-nitrosoguanidine 
(MNNG)-induced lesions, which have been shown to require polymerase r\ (Haracska 
et al., 2000). However, the major role of polymerase r\ is in the error free bypass of 
UV-induced cyclobutane pyrimidine dimers (CPDs), where it can accurately insert two 
complementary adenine bases during DNA replication (Masutani et al., 1999; Johnson 
et al., 1999). Correspondingly, loss of the human gene (RAD30) has been implicated in 
a variant form of Xeroderma pigmentosum, which is associated with an increased 
incidence of mutations as a result of compensatory use of error-prone polymerases 
(Johnson et al., 1999; Woodgate, 1999). Hence branches of error free and error prone 
PRR are not necessarily exclusive, and may depend upon the type of DNA damage.
Another error free pathway requires the ubiquitin conjugating enzymes Ubcl3 and 
Mms2, before further subdivision into branches dependent on either Rad5, a ssDNA 
ATPase, or the replicative DNA polymerase 6 in combination with PCNA (proliferating 
cell nuclear antigen, a DNA ‘sliding clamp’ likely to function as a docking platform for 
replication and repair proteins) (Torres-Ramos et al. 2002). Rad5 has been shown to 
physically interact with both the Ubcl3-Mms2 complex and Radl8, and may act to 
coordinate ubiquitin conjugation (Ulrich and Jentsch, 2000). It is thought that 
ubiquitination of Rad5 by Ubcl3-Mms2 facilitates strand-switching by DNA 
polymerase 6, in order to replicate past lesions in the original template strand (Torres 
Ramos et al., 2002). Recent research suggests that ubiquitination of PCNA by Rad6- 
Radl8 and Ubcl3-Mms2 also leads to the activation of translesion synthesis by DNA 
polymerases £ and r\ (Stelter and Ulrich, 2003). Furthermore, the specificity of the 
various PRR subpathways may be regulated by differential modification of PCNA by
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ubiquitin and the ubiquitin-like peptide SUMO (Stelter and Ulrich, 2003; Haracska et 
a l , 2004).
PRR is clearly one of the less well-defined pathways of DNA repair, and much is still to 
be elucidated. Studies performed in higher eukaryotes have identified homologues to 
the yeast PRR factors, suggesting that a similar system exists. Moreover, a number of 
additional translesion polymerases have been discovered, and these are believed to be 
responsible for the majority of mutations induced by bulky DNA damaging agents 
(Christmann et al., 2003).
In addition to the translesion synthesis mechanism for resolving stalled replication 
forks, there is also evidence to suggest a role for sister chromatid exchange 
recombination events to facilitate replication past the DNA lesion. This may be through 
strand invasion and the formation of a Holliday junction, or by template switching to 
provide a ‘copy choice’ mode of DNA synthesis (Broomfield et al., 2001). In either 
case, PRR by sister chromatid exchange is considered to be dependent upon Rad52. It 
is likely that the preference for translesion synthesis or recombination is tightly 
regulated, potentially through the modification of regulatory factors by ubiquitin and 
SUMO (Broomfield et al., 2001). The error free branches of PRR appear to be linked 
to recombination by the helicase Srs2 (Broomfield and Xiao, 2002). Studies of the 
mutant srs2 phenotype have revealed that Srs2 acts upon replication-blocking lesions to 
create a DNA intermediate structure that diverts repair from recombination into the 
Mms2-dependent branch of error-free PRR (Broomfield and Xiao, 2002).
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1.2.5 Other Repair Pathways
Other pathways of DNA repair that have been identified are of less relevance to this 
study, and so are only reviewed here in brief. Base excision repair (BER) is concerned 
with the correction of modified DNA base structures arising from endogenous 
metabolites (such as reactive oxygen species, methylation, deamination) as well as 
damage produced by ionising radiation and alkylating agents. Recognition of the 
damaged base is achieved by one of a range of structure-specific DNA glycosylases, 
which in many cases ‘flip’ the altered base out of the helix (reviewed in Friedberg et a/., 
1995). The abasic site is cleaved by either a hydrolytic AP endonuclease (e.g. Apnl) or 
N-glycosylase associated AP lyases (e.g. Ntgl, Ntg2), and the resulting gap is processed 
by DNA polymerase p (Memisoglu and Samson, 2000) An alternative ‘long patch’ 
gap repair process exists in mammalian cells (particularly at AP sites produced by X- 
irradiation or chemical agents), in which 2-10 nt are excised and replaced by the 
combined activity of DNA polymerase, PCNA, replication factor C, and the flap 
endonuclease FEN1. Corresponding proteins have been identified in yeast, but to date, 
long patch BER has not been observed (Memisoglu and Samson, 2000). Interestingly, 
some overlap has been shown between BER, NER recombination, and translesion 
synthesis pathways for the repair of abasic sites, alkylation, endogenous, and exogenous 
oxidative damage (Xiao and Chow, 1998; Doetsch et al., 2001).
A number of specific types of DNA damage, either involving abnormal chemical bonds 
between bases or inappropriate base modifications, can be corrected by direct damage 
reversal. This repair process requires specialized enzymes to recognise and eliminate 
the lesion. Examples include the photoreactivation of cyclobutane pyrimidine dimers 
by DNA photolyase, and the selective removal of methyl groups from the O6 position of
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guanine bases by 0 6-methylguanine DNA methyltransferase (MGMT) (Friedberg et al., 
1995). Such reactions differ from excision repair pathways in that the modification is 
repaired without the need to replace the damaged DNA base.
1.3 Repair of DNA interstrand cross-links
The primary process by which DNA interstrand cross-links (ICLs) are repaired, requires 
the coordinated efforts of factors from the main cellular repair pathways, most notably 
NER and homologous recombination. An alternative pathway of ICL repair is thought 
to depend upon the activities of the RAD6Ipost replication repair group. Hence, the 
elucidation of ICL repair has depended to some extent on the current awareness of these 
other mechanisms, and as such is less well defined. Studies of ICL repair have also 
been hampered by the fact that cross-links form only a small fraction of the total DNA 
damage inflicted by most agents (photoactivated psoralens 30-40 %, cisplatin 5-8 %, 
nitrogen mustard (mechlorethamine, HN2) 1-5 %) (Dronkert and Kanaar, 2001), hence 
the cellular response is less easy to decipher. Approaches used to combat this issue 
include the comparison of repair pathways utilised in response to related bifunctional 
and monofunctional compounds, and also the production of plasmids with single site- 
specific ICL. A further caveat is that some of the techniques used to investigate ICL 
repair, such as alkaline sedimentation, alkaline elution, and gel electrophoresis, have a 
low sensitivity and require a relatively high concentration of cross-linking agent 
(reviewed in Hartley et al., 1993; Dronkert and Kanaar, 2001). Such a dose is often 
extremely toxic, especially considering that a single ICL is lethal to repair-deficient 
yeast cells (Magana-Schwencke et al., 1982).
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1.3.1 Escherichia coli
A model for the repair of ICLs in E. coli was first outlined by Cole (1973). Genetic and 
biochemical studies using photoactivated psoralens had shown that the NER factors 
UvrA, UvrB, UvrC, and UvrD, in conjunction with the recombinase RecA and the 
polymerase PolA, were required for the repair of ICLs. Cole proposed that repair was 
initiated by asymmetric dual incisions flanking the cross-link in one strand of the DNA, 
which ‘unhooks’ the lesion to leave an 11-base oligonucleotide-drug moiety covalently 
bound to the complementary strand. These incisions are performed by the UvrABC 
nuclease complex (Van Houten et a l, 1986). It has since been discovered that 
subsequent processing of the nick 3’ to the ICL by the 5’-exonuclease activity of DNA 
polymerase I (PolA) (Sladek et al., 1989), creates a ssDNA region through which RecA 
can initiate strand exchange with intact homologous DNA (Cole et a l, 1976). The 
sensitivity of different recombination-deficient bacterial strains to cisplatin suggest that 
in vivo, other factors, including RecFOR and RecBCD, are necessary for efficient 
recombination at the cross-link (Zdraveski et al., 2000). In normal recombination 
events, RecFOR promotes the formation of ssDNA-RecA nucleofilaments and 
stimulates strand invasion, especially in the absence of a DSB (Webb et al., 1997), 
whereas the RecBCD complex is required to resect DSBs to produce a 3’ ssDNA tail 
that is subsequently bound by RecA (Anderson and Kowalczykowski, 1997). However, 
the exact roles of these factors in ICL repair remains to be determined. During 
recombination at the ICL, a three-stranded intermediate structure is formed, in which 
the predominant base pairing is between the full-length DNA strands. This facilitates 
access of the UvrABC nuclease to cleave and release the lesion-containing 
oligonucleotide (Sladek et al., 1989). The resulting gap is repaired by DNA polymerase 
I, and ligation.
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A recombination-independent pathway has been identified in E. coli, which requires 
both the UvrABC nuclease complex, and DNA polymerase II (polB) (Berardini et al.,
1999). Repair is similarly initiated by UvrABC incision and unhooking of the cross­
link, however, instead of a recombination event, new DNA is subsequently synthesized 
across the gap by DNA polymerase II. The UvrABC nuclease completes repair by 
incising the cross-linked oligonucleotide from the complementary strand. The capacity 
of this pathway to repair ICL appears to vary between agents, with only 2 % of psoralen 
ICLs repaired in RecA-deficient cells, compared to 30 % of HN2 ICLs (Piette et al.y 
1988; Berardini et al., 1999). This may reflect differences in pathway preference, with 
possible variances in the requirement for individual repair factors for each type of ICL 
(Lage et al.y 2003). The reasons for such disparities are as yet unknown, but could 
conceivably result from restrictions on recognition and access to the various ICLs 
formed at different sites in the DNA. Furthermore, residual repair is seen in uvr 
mutants, suggesting that recombination or bypass of the ICL may still occur in the 
absence of cleavage by UvrABC, perhaps through the action of other nucleases such as 
the newly discovered NER factor Cho (Dronkert and Kanaar, 2001; Van Houten et al.y 
2002).
1.3.2 S. cerevisiae
The yeast S. cerevisiae was the first eukaryotic system of ICL repair to be investigated, 
although it is not yet characterised in as much detail as in E. coli. As in bacteria, the 
major pathway of yeast ICL repair requires elements from both the NER and 
recombination systems (Fig. 1.11). Genetic studies have shown that loss of genes 
belonging to either the RAD3 or RAD52 epistasis groups renders cells sensitive to cross­
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linking agents (Jachymczyk et al., 1981; McHugh et al., 2000). The unhooking of the 
cross-link from one strand of the DNA involves NER factors (Jachymczyk et al., 1981; 
Miller et al., 1982), however, the oligonucleotide-drug moiety that remains attached to 
the complementary strand after incision blocks the normal completion of NER by DNA 
synthesis and ligation. Furthermore, it has been suggested that the nature of an ICL 
may even prevent the unwinding of DNA to form a bubble prior to incision (Bessho et 
al., 1997).
It is well established that NER plays a key role in early ICL repair, since cross-linked 
DNA from cells deficient in radl, rad2, or rad3 cannot be denatured (Miller et al., 
1982; Meniel et al., 1995). This contrasts with the situation in both wild-type and 
recombination-deficient cells, which exhibit denatured DNA after an appropriate period 
of incubation for the initial incision events. However, little is known about the nature 
of these incisions, the resulting repair intermediates, or whether NER factors are also 
responsible for nuclease activity in the later stages of repair. Further evidence for the 
involvement of NER factors in ICL repair can be inferred from the observation that 
repair is faster in transcriptionally active regions, and as mutations induced by psoralen- 
ICLs are predominantly found in the non-transcribed strand (Meniel et al., 1995; Meniel 
et al., 1997; Barre et al., 1999 A). The involvement of the NER lesion recognition 
factors may vary between different types of ICL. Analysis of the sensitivity of mutant
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Figure 1.11 Model o f  ICL repair in yeast, developed from the known 
mechanism in E. coli. (1) Collapse of the replication fork due to torsional stress 
may result in the formation of a DSB. (2) NER-dependent dual incision 
reactions leads to the unhooking of the cross-link from one strand. (3) 5 ’-3’ 
nucleolyitc resection may provide a gap and ssDNA tail for recombination by 
strand invasion. (4) Homologous recombination. (5) Resolution of 
recombination. (6) A second incision reaction releases the damaged DNA. 
Repair is completed by DNA resynthesis across the gap and ligation.
strains to mitomycin C and cisplatin revealed an equal role for RAD4 and RAD14 in 
ICL repair compared to UV, yet an increased requirement for RAD7 and RAD 16, and a 
lesser involvement for RAD23 (Wu et al., 2004). Interestingly, loss of the TCR 
recognition factors RAD26 and RAD28 did not result in sensitivity to either cross- 
linking agent.
As in E. coli, it is believed that a recombination event occurs post-incision, providing a 
template to complete the repair process. Indeed, yeast cells deficient in homologous 
recombination pathways (e.g. radSl, rad52, rad54, m rell) are sensitive to agents such 
as nitrogen mustard and psoralen plus UVA (Henriques and Moustacchi, 1980, 1981), 
and exhibit a reduced capacity to recover high-molecular weight DNA (i.e. intact 
chromosomes) after ICL-associated DSB formation (Jachymczyk et al., 1981; Magana- 
Schwencke et al., 1982; McHugh et al., 2000). No evidence exists as to the exact 
recombination mechanism involved in ICL repair, and any of the known models 
(Holliday Junctions, BIR, SSA) could conceivably be utilised (Dronkert and Kanaar, 
2001). NHEJ is not thought to be required for ICL repair, as NHEJ mutants are not 
sensitive to ICL agents, and a ku70 rad52 double disruptant is only as sensitive as the 
rad52 alone (McHugh et al., 2000). Hence, even in the absence of homologous DNA 
during stationary phase, the NHEJ pathway does not appear able to compensate for loss 
of HR. One of the caveats of proposed ICL repair by sequential NER and 
recombination events (Fig. 1.11) is that synergism has been observed between 
representative factors of these pathways (Chanet et al., 1985; Magana-Schwencke and 
Averbeck, 1991). This does not exclude the possibility of cooperation in ICL repair, 
however these pathways are likely to be involved in other independent systems of 
repair.
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A further prominent limitation of the existing model for ICL repair in replicating yeast 
cells (Fig. 1.11) is that, if the replication fork disintegrates upstream of the cross-link, it 
precludes the production of a sister chromatid for homologous recombination bypass of 
the incised adduct. Given that DNA must be unwound a considerable distance ahead of 
the advancing fork during DNA replication, the resulting torsional stress exerted by an 
ICL renders fork collapse likely. Hence, in haploid cells that lack homologous 
chromosomes, some additional mechanism is required to facilitate repair and replication 
past the cross-link (discussed in more detail in Chapter 6).
The formation of DSBs was first identified during ICL repair in yeast by density 
gradient DNA sedimentation (Jachymczyk et al., 1981), and initially this was 
interpreted as evidence for dual incisions on each strand to release the cross-link from 
both DNA strands. However, it was subsequently suggested that, as in E. coli, such 
dual incisions on both strands do not occur (Dardalhon and Averbeck, 1995; McHugh et 
al., 2000). Nevertheless, the formation of DSBs is much more prominent in yeast than 
bacteria, and, as DSBs are potent initiators of recombination in eukaryotic cells they 
may be an important intermediate for the promotion of efficient post-incision repair 
events.
DSBs are believed to arise during ICL repair by different means. Firstly, they can occur 
as a direct result of nuclease activity. Indeed, the NER endonuclease Rad2 (in addition 
to Rad3) is involved in the production of DSBs during the repair of psoralen-induced 
cross-links (Jachymczyk et al., 1981; Magana-Schwencke et al., 1982). However, the 
DSBs observed in the presence of HN2-induced ICL do not depend on functional NER 
(McHugh et al., 2000). It is thought that these DSB intermediates may be the result of
collapsed replication forks due to the torsional stress encountered close to an ICL, as 
DSBs are observed at greatest frequency in rapidly dividing exponential phase cells 
(Dardalhon and Averbeck, 1995; McHugh et al., 2000). DSBs have also been observed 
in cisplatin treated cells using density gradients (Wilborn and Brendel, 1989). It 
remains to be determined whether DSBs occur on only one or both sides of the cross­
link. However, the unidirectional gene conversion tracts associated with 
recombinational repair of a psoralen ICL primarily occur upstream of the cross-link, 
suggesting an asymmetric bias in the early incision and strand breakage events 
(Greenberg et al., 2001).
In non-dividing haploid cells, where no sister chromatid or homologue is present, an 
alternative route for repair is provided by the PRR pathway. Cells deficient in PRR are 
sensitive to ICL-inducing agents, and this appears to be synergistic with both the NER 
and HR pathways (Chanet et al., 1985; McHugh et al., 2000). Most of the known PRR 
genes have a sensitive mutant phenotype to ICL agents, with the exception of rad30 
(Grossmann et al., 2001; Wu et al., 2004). The induction of DSBs occurs normally in 
these mutants, yet the reconstitution of higher molecular weight DNA is retarded 
(Chanet et al., 1985; Dardalhon and Averbeck, 1995). Interestingly, some factors 
(rad6, radl8) seem to be required in both growing and stationary cells, whereas others 
are only essential in stationary phase (rev3) (Henriques and Moustacchi, 1981; McHugh 
et al., 2000).
This ICL repair mechanism is less well defined than the NER/recombination system, 
but is believed to involve the activity of an error-prone DNA polymerase to fill in the 
gap resulting from incision (McHugh et al., 2000). However, the reduced sensitivity to
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ICL agents seen in the rev3 mutant compared to the rad6, suggests that error-free sub­
pathways of PRR are also utilised in ICL repair (Lawrence and Hinkle, 1996), It is not 
known whether translesion synthesis occurs in conjunction with sequential NER 
excision reactions, as suggested for E. coli. The fact that mutations associated with the 
repair of psoralen induced ICLs are found predominantly on the non-transcribed strand 
suggests a role for translesion synthesis after unhooking of the cross-link from the 
transcribed strand by NER. However, studies of psoralen ICL-associated muitagenesis 
have also revealed NER-independent roles of PRR in cross-link repair (Bairre et al., 
1999 B; Greenberg RB eta l., 2001).
1.3.3 Mammals (Higher eukaryotes)
The mechanism of ICL repair in mammalian cells in largely unknown, and muich of the 
available data have been determined from analyses of hamster cell lines sensitiwe to ICL 
agents, and comparisons of mammalian genes with their yeast homologues. It seems 
that, as in yeast and bacteria, the pathways of NER, recombination, and ?RIR are all 
involved in the response to ICL (reviewed in Dronkert and Kanaar, 2001). iHowever, 
some significant differences have been observed. Unlike in yeast, whae all NER 
mutants are equally sensitive to ICL inducing agents, most mammalian N1ER gene 
defects exhibit only a mild sensitivity, with the exception of mutations in elhesr XPF or 
ERCC1, which result in a severe phenotype (Collins, 1993; De Silva et al., !OCOO). This 
distinction is observed for most ICLs (HN2, cyclophosphamide, cisplatin, maitomycin 
C), but crucially not for UV-induced lesions. Interestingly, some stidlies have 
suggested that XPF and ERCC1 mutants are not hypersensitive to psordenn-induced 
ICLs, suggesting a degree of substrate specificity (Kaye et al., 1980; Vukannovic and 
Cleaver, 1987).
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A comprehensive explanation for this phenomenon has not yet been achieved, although 
there are two plausible rationales. One is that the incision reaction at the ICL is more 
dependent upon XPF-ERCC1 than the other NER factors. The evidence for this 
hypothesis appears conflicting, yet this may result from variances in the repair of 
different types of ICL. For example, a direct correlation is observed between sensitivity 
to HN2 and the ability to uncouple the cross-link, and psoralen-induced ICLs can be 
incised in vitro by XPF-ERCC1 alone (De Silva et al., 2000; Mu et al., 2000; Kuraoka 
et al., 2000). However, additional NER factors (including the XPG nuclease) are 
required to uncouple a cisplatin-induced ICL, despite not exhibiting a sensitive mutant 
phenotype (De Silva et al., 2002). The other possibility is that the dual roles of XPF 
and ERCC1 in NER and recombination may be more prominent in mammalian ICL 
repair, perhaps as a result of an increased preference for HR mechanisms involving 
XPF-ERCC1. Recent studies have suggested roles for XPF-ERCC1 in the recognition 
of ICL and initial incision reactions (5’ and to a lesser extent 3’ to the ICL), and also in 
the resolution of DSBs arising at cross-links, but not in the formation of the DSB 
(Kuraoka et al., 2000; Kumaresan et al., 2002; Rothfuss and Grompe, 2004; 
Niedernhofer et al., 2004). Reports have also been made of dual incisions solely on the 
5’ side of a psoralen ICL in vitro, which require the full complement of NER factors, 
and appear to result in futile cycles of DNA synthesis across the gap, rather than acting 
as a recombinogenic signal (Bessho et al., 1997; Bessho, 2003).
As in yeast, DSBs have been observed in mammalian cells following treatment with 
either HN2 or psoralen (De Silva et al., 2000; Akkari et al., 2000), but not cisplatin (De 
Silva et al., 2002). Consistent with DSB formation as a result of replication fork 
collapse, these DSBs occurred in dividing but not confluent CHO (Chinese Hamster
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Ovary) cells (De Silva et al., 2000). Furthermore, passage through S-phase of the cell 
cycle was a prerequisite for chromosome breakage in human fibroblasts exposed to sub- 
lethal doses of psoralen (Akkari et al., 2000). Indeed, the occurrence of DSBs at a 
single site-specific psoralen ICL has since been shown to correlate with the termination 
of DNA replication in vitro using a HeLa-cell extract (Bessho, 2003). Induction and 
repair of HN2-associated DSBs has been shown to be normal in all NER mutants, 
whilst cells deficient in the homologous recombination genes XRCC2 and XRCC3 are 
proficient in DSB induction, but severely impaired in DSB repair (De Silva et al., 
2000). Hence, as in yeast, DSBs are formed independently of ICL incision by NER 
factors. It has been suggested that DSBs may arise prior to unhooking of the cross-link, 
as the kinetics of DSB formation have been observed to be more rapid than incision in 
CHO cells (Damia et al., 1996).
Analyses of sensitivity to cross-linking agents in hamster and human cell lines have 
suggested a particular requirement for RAD57-homologues such as XRCC2 and XRCC3 
in ICL repair, but not genes associated with NHEJ (Jones et al., 1987; De Silva et al.,
2000). Cells deficient in one of the RAD51 paralogues are far more sensitive to ICLs 
than DSBs alone, implying that they may have an important role in the modulation of 
strand invasion for the complex intermediate DNA structures arising at an ICL (De 
Silva et al., 2000; Dronkert and Kanaar, 2001). A plasmid-based system has provided 
further evidence for the involvement of homologous recombination, as ICL repair by 
mammalian cell extracts was significantly stimulated in the presence of a homologous 
substrate (Li et al., 1999). This repair was dependent upon functional XPF, ERCC1, 
XRCC2, and XRCC3. An increase in sister chromatid exchange has been observed in
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response to cross-linking agents, but not mono-functional compounds, suggesting an 
important role for recombination in mammalian ICL repair (Bodell, 1990).
Treatment of mammalian cells with ICL agents, as with ionizing radiation, results in the 
formation of nuclear foci consisting of a number of repair factors including Rad51 and 
Brca2 (Bishop et al., 1998; Godthelp et al., 2002; Kraakman-van der Zwet et al., 2002). 
It is thought that these foci may represent centres of DNA repair, with proteins such as 
Brcal and Brca2 providing coordinated regulation of the damage response and cell 
cycle checkpoints. Other repair foci containing the Rad50-Mrell-Nbsl recombination 
complex are also observed after treatment with ICL agents, and the formation of these 
foci appears to occur independently of incision events (Pichierri et al., 2002). 
Interestingly, the uncoupling of cisplatin-induced, but not HN2-induced ICLs, appears 
to require XRCC2 and XRCC3 in addition to XPF-ERCC1 (De Silva et al., 2000, 2002).
Even less is currently known about the role of PRR in the repair of ICLs. RAD18 
deficient chicken DT40 cells have been reported to be extremely sensitive to cisplatin, 
with an associated increase in the occurrence of sister chromatid exchange events, 
perhaps to compensate for the absence of PRR (Dronkert and Kanaar, 2001). 
Furthermore, mitomycin C sensitivity can be increased by the expression of a RAD18 
mutant, defective in the Rad6 binding domain, in human cells (Tateishi et al., 2000). In 
contrast to yeast, human RAD30 mutant cells exhibit hypersensitivity to psoralen ICLs 
and reduced replication bypass (Misra and Vos, 1993). One study has reported the 
requirement for a NER-dependent, but recombination-independent, pathway of repair 
for a site-specific psoralen ICL in mammalian cells, and that this repair correlates with 
an increased rate of mutagenesis (Wang et al., 2001). This is strongly suggestive of a
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role for PRR, particularly the error-prone subpathways, in mammalian ICL repair. The 
relative contribution of translesion synthesis to ICL repair may depend on the nature of 
the cross-link, as the degree of mutagenesis appears to be variable (Dronkert and 
Kanaar, 2001).
A number of other factors have also been implicated in the repair of ICLs in higher 
eukaryotes. Fractionation of nuclear extracts from HeLa cells revealed that RPA is 
required for incisions at a psoralen ICL in vitro, as well as during subsequent DNA 
synthesis (Zhang and Legerski, 2003). Furthermore, PCNA was shown to be necessary 
for DNA synthesis during ICL repair, and can enhance the incision reaction possibly 
through improved lesion recognition by MutS(3 (Zhang N. et al., 2002). Another group 
of genes that confer hypersensitivity to cross-linking agents are those associated with 
Fanconi anaemia (FA), an autosomal recessive cancer-prone syndrome (Grompe and 
D Andrea, 2001). There are ten distinct FA complementation groups (FANCA, FANCC, 
FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG, FANCL, FANCI and FANCJ), 
eight of which of these have now been cloned (all except FANCI and FANCJ). In 
addition to FA, somatic inactivation of the FA/BRCA pathway has been shown to 
account for the chromosomal instability of other cancers, and FANCF inactivation is 
associated with cisplatin sensitivity in ovarian cancer (Taniguchi et al., 2003; DAndrea 
and Grompe, 2003). A “core” complex of six FA proteins (A, C, E, F G and L) 
localises to the nucleus, where it regulates the activation of FANCD2 by 
monoubiquitylation (Garcia-Higuera et al., 2001). The subunit responsible for the 
addition of ubiquitin moieties to substrate proteins, E3 ubiquitin ligase, has been shown 
to correspond to FANCL (Meetei et al.y 2003). Activated FANCD2 is then targeted to 
Rad51-BRCA1 nuclear foci, which are involved in the regulation of homologous
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recombination repair and cell cycle checkpoints (Meetei et al., 2003). FA cells are 
proficient in the incision reactions at an ICL, as well as the formation of DSBs 
(Rothfuss and Grompe, 2004). FANCC is required for the assembly of the RAD50- 
MRE11-NBS1 complex in response to DNA cross-links, and FANCD2 has also been 
shown to interact with NBS1 (Nakanishi etal., 2002; Pichierri et al., 2002).
1.4 PS02ISNM1
1.4.1 Identification as a gene involved in ICL repair
The S. cerevisiae PS02  or SNM1 gene was identified from two independent screens to 
isolate novel strains exhibiting sensitivity to ICLs produced by psoralen/UVA 
(Henriques and Moustacchi, 1980), and nitrogen mustard (mechlorethamine, HN2) 
(Ruhland et al., 1981 A), respectively (PS02 = psoralen sensitive, SNM1 = sensitivity 
to nitrogen mustard). Subsequent complementation studies and analysis of meiotic 
segregation proved the two genes to be allelic (Cassier-Chauvat and Moustacchi, 1988). 
S. cerevisiae cells defective for pso2 are uniquely sensitive to all ICL-forming agents 
tested to date, irrespective of the type of bases involved in ICL formation. A 
representative sample illustrating the breadth of pso2 sensitivity to ICL species 
comprises HN2 and derivatives such as chlorambucil, photoactivated psoralens, 
mitomycin C, triaziquone, diepoxyoctane, and platinum-based compounds including 
cisplatin (Fleer and Brendel, 1979; Pungartnik et al., 2002). However, pso2 strains 
demonstrate almost wild-type-like resistance to monofunctional alkylating agents and 
ionising radiation. Furthermore, pso2 mutant cells exhibit only mild sensitivity to 
UVC, possibly as a result of the minor ICL lesions produced (Rahn and Patrick, 1976; 
Ruhland and Brendel, 1979; Ruhland et al., 1981 B). This sensitivity results from a
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DNA repair defect as pso2 mutant cells are proficient in the uptake of drug (Ruhland et 
al., 1981 B).
1.4.2 Homology
The S. cerevisiae PS02 gene is located on chromosome XIII, and encodes a 76kDa 
protein with 29% identity to both Schizosaccharomyces pombe PS02  and Mus 
musculus SNM1A, and 28% identity to the human gene hSNMlA (Fig. 1.12). However, 
a region of 327 amino acids in hSNMl exhibiting the greatest similarity to ScPS02 is 
48% identical, and a further 14% of the residues are similar (Demuth and Digweed, 
1998). Multiple paralogues are found in both mouse and humans, including hELAC2, 
which is associated with an inherited susceptibility to prostate cancer (Tavtigian et al.,
2001). It is possible that these paralogues may have evolved distinct functions, as the 
extent of complementation is not yet known. Sequence analysis has shown that 
hSNMlB  may contain a mitochondrial localization sequence (P. McHugh, unpublished 
observations). Furthermore, the human paralogue Artemis/hSNMIC was identified as 
the mutant gene in RS-SCID (Radiation Sensitive Severe Combined Immune 
Deficiency), where the phenotype results from defects in V(D)J recombination and in 
the non-homologous end joining (NHEJ) of double strand breaks (DSBs) (Moshous et 
al., 2001). In addition, a unique nonsense mutation in Artemis that results in a truncated 
protein has been implicated as the cause of the autosomal recessive trait Athabascan 
SCID (Li et al., 2002). A further PS02  homologue, MUS322, which also confers 
mutant sensitivity to HN2, has recently been identified in Drosophila (Laurenconef al., 
2004).
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Pso2_Sc  MSRKSIVQIRRSEVKRKRSSTASSTSEGKTLHKNTHTSSKRQRTLTEFNIPTSSNLP
Pso2_Sp  MSKRK-SSSILDFFKKSNNGKNMWG------------
SnmlA_Hs — MLEDISEEDIWEYKSKRKPKRVDPNNGSKNILKSVEKATDGKYQSKRSRNRKRAAEAK
SnmlA_Mm — MLEDTWEEEIWEYKSKRKPKPVHPNNCSENISESVEKSTDGKHQSK— GNEKRASENP
Mus322_Dm MSNVGKIKIRSIADLQATVRVNVEPDPTPTIENRTPDKKRAGRTRAASTTKKVRPKTEAC
Pso2_Sc — VRSSSYSFSRFSCSTSNKNTEPVIINDDDHNSICLEDTAKVEITIDTDEE--------
Pso2_Sp  NEAVSVEKTDSTTKPSTVKNAISSSQIKNEKFSQEVLLQFNDP-------------
SnmlA_Hs -EVKDHEVPLGNAGCQTSVASSQNSSCGDGIQQTQDKETTPGKLCRTQKSQHVSPKIRPV
SnmlA_Mm GKTKDHKVCLAETDSQISAGSSQSSSCRDESQQSQNKETTPKKQHRTRRGKQVTPKVRPV
Mus322_Dm PIIASTAFKRSSKKTPLPGQMRIDSFFTSAVKNYKVKSSSSCRKVDPPLDKRKVSTK---
PS02_SC ---------- ELVSLHDNEVSAIENRTEDR-------------------------------
Pso2_Sp ---------- SFTSEVGESPQWQSFGDAN--------------------------------
SnmlA_Hs YDGYCPNCQMPFSSLIGQTPRWHVFECLDSPPRSETECPDGLLCTSTIPFHYKRYTHFLL
SnmlA_Mm YDGYCPSCQMPFSSLLGQTPQWHVFECLDSPPISDTECPEGLLCTSTIPSHYKKYTHILL
Mus322_Dm ------GRKRLFEESTTTSSAFTG-------------------------------------
Pso2_Sc --------------------------------------------------------------
Pso2_Sp --------------------------------------------------------------
SnmlA_Hs AQSRAGDHPFSSPSPASGGSFSETKSGVLCSLEERWSS-YQNQTDNSVSNDPLLMTQYFK
SnmlA_Mm AQSRDSKEPLGSPSDALAGLFAAAAPGSPCNLEERRSMTLKTENLRKVSDHSLLMMQYLE
Mus322_Dm --------------------------------------------------------------
Pso2_Sc --------------------------------------------------------------
Pso2_Sp --------------------------------------------------------------
SmtllA_Hs KS-PSLTEASEKISTHIQTSQQALQFTDFVENDKLVG-----VALRLANNSEHINLPLPE
SnrnlA_Mm TSQPSAEINRKNVSSPCSQTSPVPQCAEFVKKTQLVGGGSPLAEVALNSQSKSGYVALPE
Mus322_Dm --------------------------------------------------------------
Pso2_Sc --------------------------------------------------------------
SnmlA_Hs NDFSDCEISYSPLQSDEDTHDIDEKPHDSQEQLFFTESSKDGSLEEDDDSCGFFKKRHGP
SnmlA_Mm MTLT-AWSYSPLHSDEETYDIDPRADDSQQELFFTQSSKDSSLEED— CSAIFENLHGP
Mus322_Dm --------------------------------------------------------------
m nnnnE
Pso2_Sc ------------------------------IVTELEEQVN VKVSTEVIQCPICLENLS
Pso2_Sp--------- ------------------------------ ILEPLKNELVKNEESTMSELLLCPICGITLE
SnmlA_Hs LLKDQDESCPKVNSFLTRDKYDEGLYRFNSLNDLSQPISQNNESTLPYDLACTGGDFVLF
SnmlA_Mm SPKEGEGIRPTAKSLVPQARCSAPSEGS-TLSDSFLLLSYTSNRLSQEDLPHTDAAFHLL
Mus322_Dm ------------------------------ KLDAKPSEKRVQPSRRAKGKENASLSEVHVI
Ucjj-mu
Pso2_Sc HLELYER--------------------------------------------------------
Pso2_Sp SLTVDAN--------------------------------------------------------
SnmlA_Hs PPALAGKLAASVHQATKAKPDEPE-FHSAQSNKQKQVIEESSVYNQVSLPLVKSLMLKPF
SnmlA_Mm SPALAVGGAASNYQTSKAKLDEPEKFLSLASSHQQQKIETSAVGNQTSLPLLTRARSKPL
Mus322_Dm DLCSEDEQTIKRKPS--------------------------------------------- Al
Pso2_Sc ETHCDTCIGSDPSNMGTPK-------------------------------------------
Pso2_Sp -IHVNDCLDGRTTEAVSKKLKKD---------------------------------------
SnmlA_Hs ESQVEGYLSSQPTQNTIRKLSSENLNAKNNTNSACFCRKALEGVPVGKATILNTENLSST
SnmlA_Mm EKEGGKCLPLHPTQSQTRGSPRKGLGAPG ANCACR---------------NAQKRSSM
Mus322_Dm ASPCEKSSDVQATKFRTPETSMPEAKLSN--------------------------------
Pso2_Sc ---------- KNIRSFISNPSSPAKTKRDIATSKKPTR----------------------
Pso2_Sp ---------- SWKADPSNSSTFPISDSCKQALLPLPGKQIN------------------
SnmlA_Hs PAPKYLKILPSGLKYNARHPSTKVMKQMDIGVYFGLPPKRKEEKLLGESALEGINLNPVP
SnmlA_Mm PLDKPLRTSPSSPKCSPSQPSKKVMKQMDIGVFFGLPPKRQETSLR-ESASEGPNVSPW
Mus322_Dm -----S SLDLVEISPGPNKSPTNNFYRS SPAAITKE SPLGKNSKKG--------------
Pso2_Sc --------------------------------------------------------------
Pso2_Sp --------------------------------------------------------------
SnmlA_Hs SPNQKRSSQCKRKAEKSLSDLEFDASTLHESQLSVELSSERSQRQKKRCRKSNSLQEGAC
SnmlA_Mm SPNQKRPRLCKRKAQSSLSDLEFDAKNLNESQHSVGLSGEKRQHRRKRHKTSNSPREGPC
Mus322_Dm --------------------------------------------------------- -----
Pso2_Sc -------------------------------------------------VKLVLPSFlSlKF
Pso2_Sp -------------------------------------------------VRSWPFYKpMPY
57
24
58
56
60
107
67
117
116
117
127
86
177
176
135
236
236
290
296
350
353
155
117
410
412
166
162
124
469
472
183
181
146
529
515
212
209
178
589
574
253
649
634
222
191
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SnmlA_Hs 
SnmlA_Mm 
Mus322 Dm
Pso2_Sc 
Pso2_Sp 
SnmlA_Hs 
SnmlA_Mm 
Mus322 Dm
Pso2_Sc 
Pso2_Sp 
SnmlA_Hs 
SnmlA_Mm 
Mus322 Dm
Pso2_Sc 
Pso2_Sp 
SnmlA_Hs 
SnmlA_Mm 
Mus322 Dm
QKRSDHLINTESEAVNLSKVKVFTKSAHGGLQRGNKKIPESSNVGGSRKKTCPFYKKIPG 709 
QRRSGHLMNNP-ELGPVSLSKAFVRRTRGRTQRGNMNISESSGAGEVRR-TCPFYKRIPG 692 
 TVRKQRKPKPCPPYKfVEG 272
^ * K A S P H = i r a S ^ K TLYCSKITAIL 282
N—  IPFAVDkFAYGAID G C A Y F L lHFHSDhIgIlTPKWKHG------- PIYCSEVTGNL 242
 TgC ^ B fQYGWEGCTAYFiI hFHSDhIaIl SKHFTF-------- PVYCSEITGNL 758
 TGVT^K'QYGEIEgItA ^ H hFHSDhIaIlSKDFTR-------- PVYCSEITGNL 741
 Ts| H 1 fQfgeiegIth^ H hfhadhI iIl t k k f c h-------- PLYVSPISARL 321
. * * . *  . . * * * . * * * . * * *  * * .  . * . . .  *
VNLKFKIPMDEIQILPMNKRFWITDTISVVTLDANMPGAIIMLFQEFLANSYDKPIRQI 342
LINVMHVDEQYVKRLKLNQPYNIMG-ITVYVLDANhIpGSAMFVFETLQSN----QTRRV 297
l k n k l h v q e q y i h p l p l d t e c i v n g-v k w l l d a n h Ipg a v m i l f y l p n g------- TVI 810
l k k k l r v q e q y i r q l p m d t e c w d s -v k w f v d a n h Ip g a t m i l f q l p n g------- AVI 793
v r t f i k l d e t h i h e i d v d q t l d v d g-vqvtaleanh|p g a l m f f f k l s s g EC I 373
. . .  . . . . .  • . ; * . . * * * * * * .  . .  *
SNAKMIETIQKWLAETANET
SKDHVMHPV-----LREKTI
P-SMERSL-----LADQ
P-SMERSR-----LAGRK
SADMESLPIFWN HSN
MGYNFPSQHSVCETVADFTLR 402 
PKYTFPPQADWQACADKAIS 352 
PEYTFPSQQEVIRFAINTAFE 864 
PEYTFPSQQEVIQFAINTAFE 847 
KNYDFCHQSESVDRAVDLVRA 429
* *  * * *  * .
Pso2_Sc LIKHGKNKTFGDSQRNLFHFQRKKTLTTHRYRVLFLVGTYTIGKEKLAIKICEFLKTKLF 462
Pso2_Sp IKKS-------------------------- TDSRLLVWSTYSIGKEKVAVAIAKSLSSRIY 388
SnmlA_Hs AVT--------------------------- LNPHALWCGTYSIGKEKVFLAIADVLGSKVG 899
SnmlA_Mm AVT---------------------------LNPRALWCGTYCIGKEKVFLAIADVLGSKVG 882
Mus322_Dm FLEKN-------------------------AAKRILIVCGSYVIGKEKIWLALAKEFTMRVW 466• *****. . . t ( . ..
Pso2_Sc VMPNSVKFSMMLTVLQNNENQNDMWDESLLTSNLHESSVHLVPIRVLKSQETIEAYLKSL 522
Pso2_Sp WPRKMH11KQLENQDLID---------- LLTDDPTQASVHMVTMMGIH-------- PNSL 431
SnmlA_Hs MSQEKYKTLQCLNIPEINS---------- LITTDMCSSLVHLLPMMQIN-------- FKGL 942
SnmlA_Mm MSQEKYKTLQCLNIPEVSS---------- LITTDMCDSLVHLLPMMQIN-------- FKGL 925
Mus322_Dm TESNRSTAVRCLNWPDLDS---------- VLTEDRSGANLHVIAMGKIS-------- YPSL 509
* . *
Pso2_Sc KELETDYVKDIEDWGFIPTGWSHN----FGLKYQKKNDDDENEMSGNTEYCLELMKNDRD 579
Pso2_Sp LDYLEQYNSSFDKIIGYKVTGWTFQPLENRAQLSSSLDSIISRPPKFVEYDLRAIRGSTD 491
SnrnlA_Hs QSHLKKCGGKYNQILAFRPTGWTHS--------------------- NKFTRIADVIPQTKG 982
SnmlA_Mm QSHLKKCGGKYDQILAFRPTGWTHS--------------------- NNITSTADIIPQTRG 965
MUS322 Dm VDYFTEFEDQYDMLLGIRPSGWEKN---------------------------- SKPSYG— K 541
Pso2_Sc 
Pso2_Sp 
SnmlA_Hs 
SnmlA_Mm 
Mus322 Dm
n d d e n g f e i s s i l r q y k k y n k f q|fnIpH eh^ H nd|vk|gckH cseH p t v n l n-nl 638 
K-------------------- VA|FvlpHEH^nrDlTMlcLsHlGHHpTVNVG-SQ 530
n ---------------------------------------- i s | ygI p H eh^ h e I krI vqwH pqkH pt v n v g - tw 1021
N-------------------- I s | yg| p H eH ^ K jeI krI vQwH p QkH p TVNVG-SF 1004
r -------------------- ISTIgIeHbH^BkeIerIvRfPpKrMsTVPVGRDL 581
* * * * * * *  . .  * . .  . . * . * *  .
Pso2_Sc WKVRYMTNWFQCWENVRKTRAAK---------------------------------------661
Pso2_Sp RSREKMNVWLDRWAWRRKKQGLLSLENVDW------------------------------- 560
SnmlA_Hs KSRSTMEKYFREWKLEAGY------------------------------------------- 1040
SnmlA_Mm RSRNTMEKYFKEWRLEAGY------------------------------------------- 1023
MUS322 Dm YVTGEVPIRWYKYEGRASMLRTGFQPSISTFLATPKRAFAKFSADTEMFLSPVDENASKG 641
Figure 1.12 Multiple protein sequence alignment o f  members o f  the Pso2/Snml family, performed using 
ClustalW (www.ebi.ac.uk/clustalw) set to the default parameters. Protein sequences were obtained from 
the NCBI database, accession numbers: Pso2_Sc NP_013857, Pso2_Sp Q10264, Snm lA_Hs AAT09762, 
Snm lA_M m  NP_061301, Mus322_Dm NP_061301. Functional domains are highlighted above the 
sequence: putative bipartite nuclear localization signal (Prosite, www.expasy.org/prosite) putative zinc
finger j | (SWISS-PROT, www.ebi.ac.uk/swissprot/) . metallo-|3-lactamase motifs 1-3 |  (L. Aravind, 
1999), P-CASP motifs 4  and A-C Q (Callebaut et al., 2002). Conserved residues in the metallo-P- 
lactamase/p-CASP motifs are highlighted as follows: catalytic yellow, hydrophobic red, small turquoise, 
hydroxylic blue, tiny green, polar brown. Extent of residue conservation is shown below the sequence: 
(* )  identical residues, (:) conserved residue substitutions, (.) semiconserved residue substitutions 
(ClustalW).
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In apparent contrast to the yeast gene, mouse embryonic stem cells with a null 
phenotype for SNM1 solely demonstrate sensitivity to mitomycin C and not other ICL- 
inducing chemicals, although this may be explained by functional redundancy with the 
other murine homologue (Dronkert et al., 2000). Complementation of mitomycin C 
sensitivity in mSNMl'1' cells was achieved by transfection with hSNMlA cDNA, 
implying a certain degree of functional conservation of this gene (Dronkert et al., 2000). 
Furthermore, expression of hSNMlA from the galactose inducible vector pYES in S. 
cerevisiae pso2 cells results in partial complementation of HN2 sensitivity (A. Hazrati 
and P. McHugh, unpublished observations). Hence it appears that Pso2 function is to 
some extent conserved from yeast to humans, and so detailed genetic studies in model 
organisms such as S. cerevisiae will be a powerful means to further elucidate the role of 
the PS02/SNM1 family in DNA metabolism.
1.4.3 Transcription and Inducibility
In S. cerevisiae, constitutive transcription of PS02 is maintained at a steady state of
only 0.3 transcripts per cell as a consequence of an upstream silencer within the
adjacent GTP1 ORF (Richter et al., 1992). A four-fold induction of transcription is
seen within 4 hours following treatment with ICL-inducing drugs, but not by
monofunctional agents or the UV-mimetic agent 4-nitroquinoline-l-oxide (Wolter et
al., 1996). Inducibility was shown to require a 15 bp motif with homology to the DRE2
box found in the promoter of the damage-inducible repair gene RAD2. Additionally,
induction of PS02  is dependent upon the Dunl kinase, known to be required for the
transcription of a number of genes induced by DNA damage and replication checkpoint
pathways (Wolter et al., 1996). Interestingly, analysis of the promoter of the human
SNM1A homologue KIAA0086 revealed consensus sequences for the transcription
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activators NFkB and API, which respond to many factors including ionising radiation 
and mono/poly-functional alkylating agents (Demuth and Digweed, 1998). However, 
no change in either hSNMl transcript abundance or size has been observed in HeLa 
cells up to 22 hours after treatment with mitomycin C (Richie et al., 2002).
A recent study has shown that the hSNMl transcript has a long 5’ untranslated region 
and an internal ribosome entry site, which upregulates translation during mitosis, but 
maintains a suppressed state for the remainder of the cell cycle (Zhang X. et al., 2002). 
Studies in murine ES cells intimate that Snml is strictly maintained at a low level, even 
when under the control of the strong PGK promoter, which is also suggestive of post- 
transcriptional regulation. Furthermore, human cells over-expressing hSNMl exhibit 
morphological changes consistent with apoptosis (Dronkert et al., 2000). It is possible 
therefore, that Pso2/Snml may be toxic when present in large quantities.
1.4.4 Intracellular localisation
The Pso2 protein has a nuclear transport signal peptide and correspondingly, has been 
shown to localise to the nucleus by immunological staining (Henriques et al., 1997; 
Dronkert et al., 2000). Recent studies using human cell lines have observed that hSnml 
may be spread diffusely throughout the nucleus, sequestered in large nuclear bodies, or 
as multiple smaller foci (Richie et al., 2002). These foci appear to co-localise with 
other repair proteins including M rell, BRCA1, and 53BP1, and it has been suggested 
by Richie et al. that these smaller foci represent sites of recruitment to DNA double­
strand breaks.
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1.4.5 Metallo-p-lactamase superfamily
The Pso2 protein is a member of the metallo-|3-lactamase superfamily of enzymes that 
share a hydrolytic domain (Aravind, 1999). The metallo-(3-lactamase fold, first 
described for the Bacillus cereus (3-lactamase, consists of a four layered (3 sandwich 
with two mixed |3 sheets flanked by helices, and metal co-ordination sites located at 
one edge of the (3 sandwich (Carfi et a l , 1995). Of the five conserved sequence motifs, 
the HxHxDH motif is the most characteristic feature of the superfamily, with the first 
histidine and aspartate conserved in all active members (Fig. 1.12). It has been inferred 
from the crystal structure of |3-lactamases that the first two histidines are involved in 
zinc coordination, while the conserved aspartate projects close to the active site, 
participating in the hydrolysis reaction (Carfi et al., 1995). Interestingly, a 
thermoconditional pso2 mutant, deficient for ICL repair, results from a single amino 
acid change three residues downstream of the HxHxDH motif (Niegemann and Brendel, 
1994). This modification replaces a small glycine residue with arginine, which has a 
large, charged polar side chain. Hence it is likely that the thermosensitive phenotype is 
due to disrupted binding at the active site. Indeed, a recent paper has demonstrated that 
this (3-lactamase motif is essential for Pso2 function, as replacement of the highly 
conserved aspartate by site directed mutagenesis produces cells with a phenotype 
indistinguishable from the pso2 null mutant (Li and Moses, 2003). Given the nuclear 
localisation of Pso2 and its role in DNA repair, the most likely substrate for hydrolysis 
is DNA. Indeed, one of the five human paralogues, Artemis, exhibits a single strand- 
specific 5’ to 3’ exonuclease activity in vitro, but when complexed with DNA-PKcs it 
becomes phosphorylated, acquiring 5’ and 3’ overhang and hairpin endonuclease 
activity (Ma et al., 2002).
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A further subdivision of the metallo-fMactamase superfamily has led to the formation of 
the P-CASP group of proteins that act upon nucleic acid substrates. This group is 
named after the representative members: CPSF (a mRNA cleavage and polyadenylation 
specificity factor), Artemis, Snml, and Pso2 (Aravind, 1999; Callebaut et al., 2002). It 
had been noticed that the length between the fourth and fifth metallo-P-lactamase motifs 
could be extremely variable, to the extent that the catalytic histidine of motif 5 could not 
be convincingly identified in members of the P-CASP group (Aravind, 1999). 
However, the C-terminal region that encompasses motif 5 comprises a number of 
conserved sequences specific to this group, and constitutes a distinct globular domain, 
referred to as the P-CASP motif (Figs. 1.12, 1.13) (Callebaut et al., 2002). Detailed 
analysis of this motif has resulted in the confirmation that DNA, rather than RNA, is the 
likely substrate for the PS02ISNM1 family, as they have a valine residue in place of the 
conserved histidine observed in RNA-specific proteins (Callebaut et al., 2002).
In S. cerevisiae Pso2 and hSnml, the C-terminal metallo-P-lactamase/p-CASP domain 
is preceded by a large N-terminal region, which includes a single putative zinc finger 
motif. Such motifs are characteristic of proteins that bind to DNA. However, deletion 
of this zinc finger by targeted mutagenesis established it to be dispensable for repair 
activity (Henriques et al., 1997). Furthermore, a zinc finger motif has not been detected 
in other PS02  homologues, such as Artemis. In fact, the Artemis protein has a distinct 
configuration, with the metallo-p-lactamase/p-CASP domain at the N-terminus, 
followed by a large predominantly non-globular domain that does not share any 
detectable similarity with other proteins (Callebaut et al., 2002) (Fig. 1.13). 
Interestingly, an Arabidopsis SNM1 homologue also contains an additional domain, 
which is homologous to the eukaryotic DNA ligase I (Callebaut et al., 2002).
77
Pso2_Sc 
N —---------- - mm c
Pso2_Sp
SnmlA_Hs
Mus322_Dm
Artemis Hs
DNA ligase_At (putative)
 —
Figure 1.13 Graphical representation o f proteins o f the /3-CASP family 
(reproduced from the Pfam database, www.sanger.ac.uk/Software/Pfam). The 
green DRMBL domain represents the metallo-P-lactamase motif 5/p-CASP 
motif, specific to the metallo-p-lactamase superfamily members predicted to 
interact with nucleic acids. This simple schematic highlights the broad 
similarities and differences in protein architecture: the highly conserved Pso2_Sc, 
Pso2_Sp and SnmlA_Hs all contain the DRMBL domain at the C terminus, 
whereas the Artemis_Hs DRMBL domain is located more centrally, with an 
additional non-conserved C-terminal region. Furthermore, the putative DNA 
ligase_At comprises DRMBL plus additional domains.
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1.4.6 Epistasis and functional analysis
Although genetic studies in S. cerevisiae have assigned PS02 to the RAD3/NER 
epistasis group (Henriques and Moustacchi, 1981; Siede and Brendel, 1982), there are 
fundamental distinguishing features with respect to ICL repair. Density gradient 
centrifugation experiments, conducted by Magana-Schwencke et al. (1982), clearly 
demonstrated the formation and repair of single and double-strand DNA breaks in wild- 
type exponential phase yeast cells exposed to 8-methoxypsoralen photoaddition. In a 
rad3 mutant (defective in NER) the incision step was almost completely abrogated, 
contrasting with pso2 cells that produced both single and double strand breaks but were 
unable to subsequently reconstitute dsDNA. Hence pso2 mutants are proficient in the 
incision step of ICL repair, but are defective at some downstream processing event. 
Nevertheless, investigations into the genetic relationships of PS02 with other key repair 
genes have shown no epistasis with the RAD52/homologous recombination group 
(Siede and Brendel, 1982), whilst data regarding the interaction with RAD6/PRR is 
inconsistent (Henriques and Moustacchi, 1981).
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1.5 Objectives of this study
Despite more than 20 years of research since its identification from a mutant yeast strain 
exhibiting a specific sensitivity to DNA interstrand cross-links, little is known about the 
function of PS02. However, such knowledge could be crucial in further elucidating the 
intricate eukaryotic system of ICL repair. Furthermore, given the unique specificity for 
ICLs, human Pso2 may prove to be a suitable target for new strategies in the treatment 
of cancer. A future prospect might be to develop an agent that could be used in 
combination with existing anticancer therapeutics, to overcome the acquired resistance 
that is so frequently observed.
DNA ICLs are complex lesions that require the co-operation of a number of different 
repair pathways to facilitate their removal. Hence, in addition to the clinical 
considerations regarding cytotoxicity and potential therapeutic applications, ICLs 
provide an interesting illustration of the co-ordination of DNA replication and repair 
processes within the cell. It is hoped that a detailed study of the PS02 gene will aid the 
elucidation of the complete mechanism by which ICLs are repaired. It is anticipated 
that the initial genetic approaches will clarify the probable role of PS02 at an 
intermediate stage of ICL repair, and hence facilitate a more targeted biochemical 
characterisation of Pso2 protein function.
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CHAPTER 2 MATERIALS AND METHODS
2.1 Chemicals and enzymes
Analytical grade mechlorethamine (nitrogen mustard or HN2), 2-dimethyl- 
aminoethylchloride hydrochloride (half mustard, HN1), Benomyl, Hydroxyurea, 
Geneticin/G418 and L-canavanine were purchased from Sigma-Aldrich (Gillingham, 
UK). Vent DNA polymerase was purchased from New England Biolabs (NEB, 
Hertfordshire, UK), and Super Taq polymerase from HT Biotechnology (Cambridge, 
UK). All other enzymes were obtained from Promega (Southampton, UK).
2.2 Media and cell culture conditions
All media was sterilised by autoclaving, with the exception of galactose, which was 
filter sterilised to prevent isomerisation. Standard sterile techniques were employed.
2.2.1 Saccharomyces cerevisiae
Cells were grown on yeast extract-peptone-dextrose (1 %, 1 %, 2 % respectively) 
YEPD agar plates, or YEPD liquid media supplemented with adenine at 40 mg/1 to give 
YPAD. YPG media consists of yeast extract and peptone, but utilises 3 % v/v glycerol 
as the carbon source. All media components were purchased from Sigma, with the 
exception of mycological peptone (Lab M, Lancashire, UK). For analysis of 
intrachromosomal recombination, identification of gene disruptants, and for plasmid 
retention, cells were grown on Synthetic Complete (SC) medium (0.67 % yeast nitrogen
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base, 0.5 % ammonium sulphate and 2 % glucose) with appropriate amino acids omitted 
(BIO 101 supplied by Anachem, Luton, UK). Minimal media constituted SC media 
without amino acids. Induction media for the expression of genes from the GAL1 
promoter was SC medium with 2 % galactose and 1 % raffinose as the combined carbon 
source in place of glucose. All strains were grown at 28°C.
2.2,1.1 Alpha factor growth arrest
The yeast alpha mating factor was used to synchronise a culture of cells in the G1 phase 
of the cell cycle. 1 ml exponential phase cells at 2 x 107 cells/ml were treated with 10 
p<g alpha factor (Sigma) in pre-warmed YPAD for 1 h shaking at 28°C, and then a 
further 10 pg dose for a second 1 h incubation. Cells were sonicated for 30 s (Branson 
sonifier 250: output control 5, constant duty cycle) and observed microscopically to 
ensure that the culture had reached a 90 % proportion of shmooed and single cells.
2.2.2 Schizosaccharomyces pombe
Strains were maintained on standard YES (0.5 % yeast extract, 3 % glucose, 225 mg/1 
each of adenine, histidine, leucine, uracil, lysine hydrochloride) agar plates. Liquid 
cultures were sustained in YES media. All strains were grown at 28°C. Drug 
sensitivity assays were performed as for S . cerevisiae cells, with the exception that 
exponential phase cultures were sonicated for 1 min (Branson Sonifier 250: output 
control 5, constant duty cycle) prior to treatment.
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2.2.3 Escherichia coli
E. coli cells were utilised for the amplification of plasmids. Luria-Bertani (LB) liquid 
medium consisted of lx peptone, 0.5 x yeast extract, and 1 x NaCl. LB-agar plates 
were produced from pre-prepared pellets (Sigma), 10 per 500 ml as per manufacturers 
instructions. Plates and liquid media were supplemented with 100 mg/1, and 50 mg/1 
ampicillin (Sigma) respectively, to select for plasmid retention.
2.3 Production of yeast gene disruptants
The novel yeast strains used in this study are described in table 2.1, and were derived 
from B356-7C (a gift from Professor L. Symington, Columbia University, USA), 
DBY747 (a gift from Professor W. Xiao, University of Saskatchewan, Canada), or 
BY4741 (European Saccharomyces cerevisiae Archives for Functional Analysis 
(EUROSCARF) yeast deletion project) by Polymerase Chain Reaction (PCR)-based 
micro-homology targeted gene deletion (Manivasakam et al., 1995; Longtine et al., 
1998; Goldstein and McCusker, 1999). This method entails the production of a DNA 
cassette bearing a selectable marker gene flanked by short regions of homology to the 
gene intended for disruption (Fig. 3.1 A). The cassette is transformed into an 
appropriate yeast strain where it recombines with the terminal regions of homology in 
the endogenous DNA. Hence any yeast gene, or any specific region of a gene can be 
permanently disrupted by replacement with the alternative cassette DNA, and modified 
cells can be readily identified by virtue of the selectable marker.
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Table 2.1 S. cerevisiae strains used in this study.
Strain Genotype Source (ref.)
DBY747 MATa his3-Al leu2-3,-112 trpl-289 ura.3-52 Xiao et al., 1996
WXY9387 DBY747 with rad52::LEU2 Xiao etal., 1996
WXY9382 DBY747 with rev3::LEU2 Xiao et al., 1996
WXY9394 DBY747 with rad4::hisG-URA3-hisG Xiao et al., 1996
WXY9326 DBY747 with rad!8::TRPl Xiao etal., 1996
LBY1 DBY747 with pso2::kanMX4 This study
LBY2 DBY747 withpso2::kanMX4 rad4::hisG-URA3-hisG This study
LBY5 DBY747 with pso2::kanMX4 rev3::LEU2 This study
LBY7 DBY747 with pso2::kanMX4 radl8::TRPl This study
W303-1A MAT a his 3-11,15 leu2-3,112 ade2-l trpl-1 ura3-l canl-100 Lab Stock
B356-7C W303-1A with ade2::hisG his3::ade2-5’A -TRPl-ade2-n Bai, Symington, 
1996
B356-13D B356-7C with rad51::HIS3 Bai, Symington, 
1996
B356-11C B356-7C with rad52::TRPl Bai, Symington, 
1996
LBY9 B356-7C withpso2::kanMX4 This study
LBY17 B356-7C with rad4::kanMX4 This study
LBY25 B356-7C withpso2::his3 rad4::kanMX4 This study
LBY28 B356-7C with pso2::kanMX4 rad51::HIS3 This study
LBY51 B356-7C with pso2::kanMX4 rad52::HIS3 This study
LBY13 B356-7C with exol::kanMX4 This study
LBY11 B356-7C withpso2::kanMX4 exol::HIS3 This study
LBY15 B356-7C with mrel 1 ::kanMX4 This study
LBY12 B356-7C with pso2::kanMX4 mrell::HIS3 This study
LBY26 B356-7C with radl::kanMX4 This study
LBY50 B356-7C with pso2::kanMX4 radl::HIS3 This study
LBY45 B356-7C with rad27::HIS3 This study
LBY47 B356-7C with pso2::kanMX4 rad27::HIS3 This study
LBY21 B356-7C with rad4::kanMX4 exol::HIS3 This study
PJM37 B356-7C with rad4::kanMX4 rad52::HIS3 This study
LBY48 B356-7C with msh2::kanMX4 This study
LBY23 B356-7C withpso2::kanMX4 msh2::HIS3 This study
LBY29 B356-7C with exol::kanMX4 msh2::HIS3 This study
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Strain Genotype Source (ref.)
LBY73 B356-7C with pso2::kanMX4 exol::HIS3 msh2::URA3 This study
LBY97 B356-7C with msh3::kanMX4 This study
LBY101 B356-7C with pso2::kanMX4 msh3::HIS3 This study
LBY93 B356-7C with msh6::kanMX4 This study
LBY95 B356-7C with pso2::kanMX4 msh6::HIS3 This study
LBY103 B356-7C with mlhl::kanMX4 This study
PJM39 B356-7C with pso2::kanMX4 mlhl::HIS3 This study
LBY34 LBY9 with pDB20 This study
LBY37 LBY9 with pDB-EXOi This study
LBY109 LBY9 with pYES2 This study
LBY110 LBY9 with pYES-EXOl This study
LB Y107 LBY9 with pRS425 This study
LBY108 LBY9 with pRS-MSH2 This study
LBY116 LBY9 with pYES2 pRS425 This study
LBY115 LBY9 with pYES-£X07 pRS-MSH2 This study
LBY64 LBY13 with pYES2 This study
LBY67 LBY11 with pYES2 This study
LBY68 LBY11 with pYES-PS02 This study
LBY69 LBY11 with pYES-EXOl This study
LBY84 LBY48 with pYES2 This study
LBY89 LBY23 with pYES2 This study
LBY90 LBY23 with pYES-PS02 This study
LBY92 LBY23 with pRS-MSH2 This study
LBY88 LBY9 with pGAL-c-FLAG-P502 This study
BY4741 MAT a his3-l leu2-0 metl5-0 ura3-0 EUROSCARF
Y06743 BY4741 with pso2::kanMX4 EUROSCARF
Y01809 BY4741 with exol::kanMX4 EUROSCARF
Y06240 BY4741 with msh2::kanMX4 EUROSCARF
Y01781 BY4741 with Ug4::kanMX4 EUROSCARF
LBY74 BY4741 with pso2::kanMX4 exol::HIS3 This study
LBY78 BY4741 withpso2::kanMX4 msh2::HIS3 This study
LBY87 Y06743 with pGAL-c-FLAG-PS02 This study
JEL1 MATa leu2 trpl ura3-52 nprbl-1122 pep4-3AHis3::pGAL10- Lindsley, Wang,
GAL4 1993
LBY117 JEL1 with PGAL-C-FLAG-PS02 This study
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2.3.1 PCR-based production of the disruption cassette
Specific deletion primers bearing 40 bp homology to the gene of interest and 20-25 bp 
of overlap with the selective marker (adapter sequence) were designed to generate each 
cassette (Appendix). In all cases, the regions of homology between the primer 
sequences and the endogenous gene lay at the 5’ and 3’ ends of the coding sequence, to 
ensure complete disruption. The FI and R1 primer adapter sequences were used to 
amplify from either the KanMX4 or HIS3MX6 cassette templates (a gift from Professor 
M. Longtine, Universitat Basel, Switzerland) to give kanamycin or histidine selection, 
respectively. The URA5’ and URA3’ primer adapter sequences were designed to 
produce an URA3-based cassette from pYES2, providing an additional selective marker 
for the production of triple-disruptant yeast strains.
Reaction mixes were prepared in a total volume of 100 pi as follows: 100 ng (in 10 pi) 
of miniprepped plasmid template (prepared as described in Section 2.10.1.5); 1 x 
thermopol buffer (NEB); 100 mM magnesium sulphate; 2 mM dNTPs (Invitrogen, 
Paisley, UK); 250 pmol each primer (MWG Biotech., Milton Keynes, UK); and 2 units 
Vent polymerase. Vent polymerase was specifically used to reduce the incidence of 
replication errors. The optimised PCR conditions (regardless of gene or selective 
marker) were: 94°C 4 min; 94°C 1 min, 55°C 1 min, 72°C 2 min + 1 s/cycle, 30 cycles; 
72°C 5 min. PCRs were performed on a MJ thermocycler machine.
PCR products were phenol-chloroform extracted and ethanol-precipitated using 
standard procedures, to provide a clean, concentrated cassette preparation for 
transformation. Briefly, four identical PCR reactions were combined, and a 1:1 volume 
of phenol-chloroform was added. This was vortexed, and spun in a microcentrifuge for
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5 min at full speed. The upper aqueous layer was carefully transferred to a fresh 
eppendorf, and mixed with 2 volumes of 99 % ethanol and V,o volume sodium acetate. 
This was then incubated on dry ice for 20 min, before centrifuging for 5 min at full 
speed. The supernatant was poured off, and the pellet was washed in cold 70 % 
ethanol. After further centrifugation and drying, the DNA pellet was resuspended in 10 
pi sterile water. 0.5 pi was run in loading buffer (6 x bromophenol blue loading buffer, 
Sambrook et al., 1989) on a 1 % agarose gel in 0.5 x Tris-Borate-EDTA (TBE, 
Sambrook et al., 1989) buffer to confirm the quality of the cassette preparation. 
Cassettes were stored at -  20°C until required.
2.3.2 Transformation of 5. cerevisiae
Exponential phase yeast cells were transformed with a single cassette using the BIO 101 
Alkali-Cation Yeast Transformation Kit (Anachem), according to manufacturers 
instructions. Briefly, competent cells were produced from 2 x 107 Tris-EDTA (TE, 
Sambrook et al., 1989) -washed exponential phase cells by incubating in 100 mM 
lithium acetate for 30 min at 30°C. Cells were then resuspended in TE, and a V10 (100 
pi) aliquot was mixed with 10 pi salmon sperm DNA (sheared and boiled) and 10 pi 
histidine solution. To this suspension was added the 10 pi preparation of cassette DNA, 
which was mixed well by pipetting and incubated at room temperature for 15 min. 1 ml 
of a PEG/cation mix was then added to the transformation reaction, and incubated at 
30°C for 10 min. Reactions were heat-shocked in a water bath at 42°C for 10 min, 
resuspended in warm YEPD, and incubated for 3 h at 28°C to initiate expression of the 
selectable marker, before plating on selective media. Plates were incubated at 28°C for
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3 days. Transformants were identified by resistance to G418/Geneticin (300 mg/1) or 
the capacity to grow in the absence of histidine or uracil, as appropriate.
2.3.3 Confirmation of gene disruption
Integration of the cassette at the correct locus was confirmed by PCR across the gene 
using specific gene primers designed to flank the disrupted region, and template DNA 
derived from a single transformant colony. Two approaches were used, depending on a 
number of factors, including the number of transformants to be tested and the ease of 
PCR across the disrupted region (especially with respect to size of the intended PCR 
product). Either DNA was extracted from cultured transformant cells for use in PCR 
(Section 2.3.3.1), or PCR was performed directly on cells picked from a single colony 
(Section 2.3.3.2). In most cases, the size of the PCR product could distinguish between 
disrupted genes and false positive transformants (a higher frequency was observed 
when using the histidine and uracil-based cassettes as regions of homology remained in 
the disrupted endogenous HIS3 and URA3 genes). However, further verification of the 
gene disruption was always obtained from restriction enzyme digests performed on the 
PCR product. Two restriction enzymes were chosen per gene that would each yield a 
characteristic array of fragments to distinguish between the normal and disrupted genes, 
as visualised by agarose gel electrophoresis. Restriction digests were performed 
directly on 10 pi of the PCR reaction in a total volume of 20 pi, for 1 h in a 37°C 
hotblock, and the entire reaction was subsequently run on a 1 % agarose gel in 0.5 x 
TBE buffer.
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2.3.3.1 Isolation o f yeast genomic DNA
Genomic DNA was isolated from exponential phase cells using the Nucleon Yeast 
DNA Mini-prep kit (Tepnel Life Sciences, Manchester, UK) but with a modified 
protocol. Briefly, 2 ml of an overnight culture were pelleted by centrifugation for 5 min 
at 2000 rpm, and resuspended in 540 pi solution A plus 60 pi solution B (Mini-prep 
kit). This cell suspension was vortexed for 30 s and incubated in a 70°C heat block for 
20 min. A 1:1 volume of phenol-chloroform was then added instead of solution C, as 
this was found to result in an improved DNA yield. Samples were vortexed and spun 
for 5 min at full speed in a microcentrifuge. The upper aqueous layer was transferred 
by Gilson pipette to a fresh tube, and an equal volume of isopropanol was added. 
Samples were mixed by inversion and spun for a further 5 min. The supernatant was 
poured off, taking care not to dislodge the fragile pellet, which was then washed with 
100 pi cold 70 % ethanol. Pellets were dried at 70°C and resuspended in 100 pi sterile 
water. Subsequent PCR reactions to check the disrupted gene were in a total volume of 
30 pi as follows: 2 pi DNA preparation; 1 x Super Taq buffer (HT Biotech.); 2 mM 
dNTPs; 250 pmol each primer (MWG); and 2 units Super Taq polymerase. The PCR 
conditions were optimised to each gene, but in general resembled the following: 94°C 4 
min; 94°C 1 min, 42-58°C (depending on primer specificity) 1 min, 72°C 2-10 min 
(depending on product size), 35 cycles; 72°C 5 min. PCRs were performed on a MJ 
thermocycler machine.
2.33,2  Yeast Colony PCR
A master mix for the total number of PCR reactions was prepared according to the
following ratios, in order to give final reaction volumes of 30 pi: 1 x Super Taq buffer;
2 mM dNTPs; 250 pmol each primer (MWG); sterile water as appropriate. A small
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quantity (equivalent in volume to 0.5 pi water) of a single transformant colony was 
transferred to a sterile PCR tube using a Gilsen pipette tip. Tubes were microwaved at 
full power for 90 s, and immediately placed on ice. The PCR reaction mix was added to 
each tube, and vortexed briefly. Super Taq polymerase (2 units) was added to each 
reaction after a hot start. PCR conditions were as described in Section 2.3.3.1.
2.4 Analysis of growth rate and cell cycle phase
Exponential phase cells were used to inoculate a fresh YPAD culture at 2 x 106 cells/ml, 
and 1 ml samples were taken at hour intervals for 10 h. A sample was also taken at 0 h 
(point of inoculation). Spectrophotometer analysis of absorption at 600 nm was 
performed immediately for each sample, diluting in media where appropriate to ensure 
readings were in the linear range, and using 1 ml YPAD for the zero reading. Results 
were normalised to the 0 h timepoint for each strain.
To investigate the proportion of cells in different stages of the cell cycle, cells were 
observed by light microscopy at 40 x objective, and counted using a haemocytometer 
slide. Populations were classified as either single unbudded cells (Gl), small budded (S 
phase), or large budded (M phase), where the bud size constituted more than half of the 
volume of the mother cell.
2.5 Colony-based survival assays
In this study, colony-based survival assays were the routine approach for testing yeast 
sensitivity to various DNA damaging agents. This is a quantitative method, whereby
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treated cells are grown on agar plates to yield countable colonies. Each colony 
therefore represents one cell that was able to withstand treatment at the tested dose. 
Results are expressed as percentages of the number of colonies arising from an 
untreated control, to enable comparison between different strains and experiments.
In all cases, liquid YPAD medium was inoculated with a single colony picked from a 
freshly streaked YEPD stock plate, and grown overnight at 28°C with vigorous shaking. 
Cultures were counted microscopically and only those in mid-exponential phase (2-5 x 
107 cells/ml) were used.
2.5.1 Nitrogen mustard treatment
Exponential cells were resuspended in phosphate-buffered saline (PBS) at a density of 2 
x 107 cells/ml. 2 ml aliquots were treated with 0,1, 10, 100, or 1000 pM doses of HN2 
(freshly dissolved in cold sterile water, and serially diluted to give appropriate stock 
solutions) for 60 min shaking at 28°C. The cells were harvested, washed twice with 
PBS, and plated onto YEPD in duplicate at appropriate dilutions giving rise to 200 
colonies per plate in untreated controls. Plates were incubated at 28°C for 3 days, and 
then scored. Any experiments giving rise to more than 250 colonies per plate in 
untreated controls were discarded.
2.5.2 X-irradiation
Exponential cells were resuspended in sterile water at 2 x 105 cells/ml. 250 pi aliquots 
were exposed in microcentrifuge tubes to X-irradiation at a dose rate of 2.5 Gy/min 
(General Electric Corporation X-ray source). All treatments were performed on ice to
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minimise repair activity. Exposure times were as follows: 0, 20, 40, 80, and 120 min 
(giving doses of 0, 50, 100, 200, and 300 Gy). Samples were plated in duplicate at 
appropriate dilutions to give rise to 200 colonies in untreated controls. Plates were 
incubated at 28°C for 3 days and then scored.
2.5.3 UVC
Exponential phase cells were serially diluted in sterile water to a final concentration of 2 
x 103 cells/ml. 100 pi (~ 200 cells) of this suspension was plated onto 12 YEPD plates, 
to allow for 6 doses in duplicate. The UVC lamp used had been calibrated to emit 
radiation at a rate of 0.5 J/m2/s when positioned at a height of 280 mm. A plate outline 
was made at the epicentre of the light falling on the surface below, to ensure that all 
treatments were irradiated equally. All normal light sources in the vicinity of the hood 
used for UVC exposure were switched off for the duration of the treatments. Plates 
(with the lid removed) were then individually exposed to UVC, and immediately placed 
in a dark incubator following treatment. Exposure times were as follows: 0, 10, 20, 50, 
100, 200 s (giving doses of 0, 5, 10, 25, 50, and 100 J/m2). Plates were incubated at 
28 °C for 3 days and then scored.
2.5.4 Colony spotting assay
For the qualitative screening of drug sensitivities, a colony spotting assay was 
employed. Exponential cells were resuspended in sterile water at a concentration of 5 x 
107 cells/ml, and diluted in a ten-fold series to 500 cells/ml. 10 pi of each of the last 
four dilutions of the series were spotted onto square YEPD plates, using a grid layout: 
each line comprising a series of ‘spots’ of one strain, containing sequentially 5000,500,
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50, and 5 cells. Typically, 4 or 5 strains were spotted on any one plate, and plates were 
spotted in duplicate. Plates were incubated at 28°C for 3 days and then photographed.
Benomyl and hydroxyurea treatments were performed as above, using freshly prepared 
YEPD plates containing the drug. Drug doses were added in 2 ml aliquots per 200 ml 
media (4 plates), after autoclaving, and only once the media had cooled to 40-50°C. 
Benomyl was prepared in DMSO, and appropriate dilutions made to give final plate 
concentrations of 0, 10, 25, 50, and 100 pg/ml. DMSO was also added to YEPD plates 
in the same ratio (2ml per 200 ml), as a control for toxicity. Hydroxyurea (HU) was 
initially resuspended in sterile water, and appropriate dilutions were made to give final 
plate concentrations of 0, 2 .5 ,5 ,10,20 and 40 mM HU.
Colony spotting assays for the evaluation of sensitivity to 2-dimethyl- 
aminoethylchloride hydrochloride (half mustard, HN1) were performed slightly 
differently in that cells were treated in suspension, prior to serial dilution and spotting. 
Exponential phase cells were resuspended in PBS at a concentration of 2 x 107 cells/ml. 
2 ml aliquots were treated with 0, 10, 100, 1000, or 10000 pM doses of HN1 (freshly 
dissolved in cold sterile water, and serially diluted to give appropriate stock solutions) 
for 60 min shaking at 28°C. The cells were harvested, washed twice with PBS, and 
then serially diluted for spotting onto YEPD plates as described above.
2.6 Analysis of mutagenesis
The yeast CAN1 gene encodes arginine permease, a selective protein channel 
responsible for the transportation of both arginine and its toxic analogue canavanine,
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into the cell. Canavanine resistance therefore corresponds with mutations in CAN1 that 
abrogate protein function, hence providing a strong phenotypic selection for forward 
mutation. The incidence of forward mutations is a preferable approach to determining 
rates of mutation, as unlike systems based on specific reversion mutations, the measured 
phenotype can arise from a range of different types of mutation (e.g. frameshift, 
missense, deletion, insertion), and cannot be influenced by suppressor mutations in 
other genes. The CAN1 system can reveal a wide spectrum of mutations that has proved 
useful in characterising deficiencies in both DNA replication and repair (Tishkoff et a l , 
1997; Chen and Kolodner, 1999).
2.6.1 Spontaneous mutagenesis
Single yeast colonies were resuspended in sterile water at a concentration of 2 x 107 
cells/ml. 100 pi was plated in duplicate on SC-arginine plates containing 60 mg/1 L- 
canavanine (Sigma, added after autoclaving once media had cooled to ~50°C). Serial 
dilutions of the cell suspension were made to enable 200 cells to be plated on YEPD as 
controls for plating efficiency and to determine more accurately the number of cells in 
the original suspension. Plates were incubated at 28°C for 3 days and then scored. The 
rate of mutation was calculated as follows:
mean arg-can colonies x 108 = mutants /108 survivors 
(mean YEPD colonies) x 104
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2.6.2 HN2-Induced mutagenesis
Exponential phase cells were treated with 0, 1, 10, 100, and 1000 p,M doses of HN2 for 
1 h as described in Section 2.5.1. Cells were washed with PBS, and serially diluted in 
order to plate 2 x 106 cells on SC-arg plus canavanine, and 200 cells on YEPD. All 
plates were made in duplicate, and incubated for 3 days at 28°C before scoring. 
Calculations were performed for each dose as described in 2.6.1, to give the mutation 
rate per 108 survivors at a specific HN2 dose.
2.6.3 PCR-based analysis of mutagenesis
The PCR-based screen for large insertion-deletion alterations in the CAN1 gene was 
based that of Xie and co-workers (2001). Briefly, colony PCR (Section 2.3.3.2) was 
performed on 18 independent CanR colonies per strain, which had been obtained by 
growth on SC-arg plus canavanine plates. The complete open reading frame of the 
CAN1 gene (coordinates 50 to 1925 of the X03784 Genbank sequence) was amplified 
using the following primers: CAN1-5’ 5 ’-GTT CTT CAG ACT TCT TAA CTC CTG- 
3’, and CAN1-3’ 5’-GAG AAT GCG AAA TGG CGT GG-3’. The optimised PCR 
conditions were: 94°C 4 min; 94°C 1 min, 54°C 1 min, 72°C 2.5 min, 35 cycles; 72°C 
5 min. The PCR products were subsequently digested with 2.5 units Hph I for 2 h at 
37°C, and visualised on a 2 % agarose gel. The full length CAN1 gene, in the absence 
of large insertion-deletion mutations, yields the following characteristic set of Hph I 
digest fragments: 207, 249, 252, 271,411, and 480 bp.
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2.7 CHEF analysis of DSB repair
Pulsed-field gel electrophoresis (PFGE) was developed to facilitate the separation of 
larger DNA molecules than is possible by simple agarose electrophoresis. In PFGE, the 
direction of the electric field is altered at regular intervals, forcing DNA to reorient in 
the new field direction. Due to the resistance of the agarose matrix, smaller molecules 
are able to reorient more quickly than larger ones. Contour-clamped homogeneous field 
electrophoresis (CHEF) is one variation of PFGE in which the direction of the electrical 
field is changed electronically by altering the polarity of the electrode array (Chu and 
Gunderson, 1991). The practice of embedding cells in agarose plugs before enzymatic 
digestion to release the DNA is particularly appropriate for the study of DSB induction 
and repair, as it significantly reduces the incidence of background strand breaks arising 
from the handling of DNA. CHEF has been widely used in the study of DSBs, both in 
yeast and mammalian cells (Averbeck and Dardalhon, 1990; Averbeck et al., 1992; 
Dardalhon and Averbeck, 1995; De Silva et al., 2000).
2.7.1 HN2-induced DSBs
Cells were grown to exponential phase in YPAD, harvested, and resuspended in 20 ml 
PBS at a density of 2 x 107 cells/ml. This was split into two aliquots: 15 ml was treated 
with a dose of 50 or 100 HN2, and to the remaining 5 ml an equivalent volume of 
water was added as an untreated control. Cells were incubated at 28°C for 3 h with 
vigorous shaking, harvested, and resuspended in an equal volume of minimal media 
(MM). 5 ml samples were removed at 2, 4, and 24 h post-treatment at 28°C. The 
untreated control was incubated for 24 h. CHEF plugs were prepared from 3 x 107 cells 
for each sample using the Bio-Rad (Hemel Hempstead, UK) yeast CHEF genomic DNA
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plug kit as instructed by the manufacturer. Briefly, cells were embedded in an agarose 
plug and sequentially treated with lyticase for 1 h at 37°C, and proteinase K overnight at 
50°C. Plugs were washed thoroughly, and used whole. CHEF was performed with a 
1% agarose gel (Biorad, pulse field certified) in 0.25 x TBE buffer using a Biometra 
Rotaphor type V apparatus, run for 24 h at 14°C under the following parameters: 
interval 100-10 s, log scale; angle 120-110°, linear scale; voltage 200-150 V, log scale. 
On completion, gels were stained with 2 p-g/ml ethidium bromide for 30 min, destained 
for 1 h in distilled water, and photographed on a UV illuminator.
2.7.2 Irradiated cells
Exponential phase cells were exposed to 200 Gy X-rays (General Electric Corporation 
X-ray source, 2.5 Gy/min) in 4 x 1 ml aliquots of 6 x 107 cells/ml, on ice. After 
treatment, 3 of the aliquots were each resuspended in 3 ml MM and incubated, shaking 
at 28°C for 2, 4, and 24 h. The fourth treated aliquot was immediately washed in PBS, 
and maintained at 4°C as a cell pellet. An untreated aliquot of cells was also incubated 
in MM for 24 h as a control.
Exponential phase cells were exposed to 200 Gy y-irradiation (“ Co source, 9.1 Gy/min) 
in 4 x 4 ml aliquots of 1.5 x 107 cells/ml, and immediately placed on ice. Aliquots were 
subsequently resuspended in MM for repair timepoints, as described above for X- 
irradiation.
The same procedure described in Section 2.7.1 was followed for the preparation of 
agarose plugs and subsequent CHEF analysis of X- and y-irradiated cells.
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2.7.3 Quantification of results
Two approaches were used in an attempt to quantify the extent of DSB induction and 
repair, as illustrated by CHEF analysis. Semi-quantitative analysis of the DNA bands 
revealed by UV-illumination of the ethidium bromide-stained gel was performed with 
the computer software Gel Pro Analyser (Media Cybergenetics). However, in contrast 
to the straightforward use of this software to quantify mammalian DSBs, where only 
broken chromosomes are released from the agarose plug, it was difficult to accurately 
distinguish between the intact yeast chromosome bands, and the smear of degraded 
DNA. The second approach involved Southern blotting of the CHEF agarose gel.
2.7.3.1 Gel Pro Analyser
The Gel Pro Analyser software has been used successfully to quantify CHEF gels of 
mammalian DSB samples. However, under the parameters used for mammalian CHEF 
only broken DNA is released from the plug, whereas yeast CHEF also produces a 
characteristic ladder of bands representing the intact chromosomes. This complicates 
the use of this software, which can be used to measure the optical density (OD) of any 
highlighted band on the gel image. Obviously, yeast DSBs cannot be quantified as 
percentage release from the plug if intact chromosomes are sufficiently small to migrate 
through the agarose gel. It is relatively easy to measure the intensity of the largest 
chromosome bands, but the smaller chromosomes overlap with the smear of degraded 
DNA, making it almost impossible to determine whether the ethidium bromide has 
intercalated with intact or broken DNA molecules. The approach used here was to 
measure the OD of the largest chromosome bands, and express each as a fraction (q) of 
the same chromosome band in the untreated control sample. This provides a
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comparison of the number of intact chromosomes at different repair timepoints. It is 
only semi-quantitative as it assumes equal loading between the different plug samples, 
(which in practice is unlikely to be absolute). The number of DSBs (n) within a defined 
region can be determined by: n = -ln(q) (Geigl and Eckardt-Schupp, 1990). Using the 
Poisson distribution, the probability of at least one DSB occurring within that defined 
region can be calculated as P = 1 - e'n.
2.7 ,32  Southern blotting
Southern blots were carried out according to standard protocols (Sambrook et al., 1989; 
Hybond Protocol, Amersham Biosciences, Buckinghamshire, UK):
2.7 .32.1  Preparation o f  probes
Primers were designed to produce two different probes to target a small and a large 
yeast chromosome, respectively: a 950 bp probe at the MATa locus on chromosome III, 
and a 1 kb probe at the PHO80 gene on chromosome XV. Probe-specific template 
DNA was first prepared by PCR using the following reaction mix in a total volume of 
100 pi: 2 pi yeast genomic DNA preparation (Section 2.3.3.1); 1 x thermopol buffer; 
100 mM magnesium sulphate; 2 mM dNTPs; 250 pmol each primer, MATatop/bottom 
or PHO80CHK573’, as appropriate (MWG); and 2 units Vent polymerase. The 
optimised PCR conditions (for either primer pair) were: 94°C 4 min; 94°C 1 min, 53°C 
1 min, 72°C 4 min, 35 cycles; 72°C 5 min. PCRs were performed on a MJ 
thermocycler machine. PCR products were purified on a Qiaquick column (Qiagen), 
according to the manufacturers instructions, and eluted in 50 pi sterile water. Agarose
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gel electrophoresis was performed on 5 p,l each eluate to check the quality of the PCR 
products.
Radioactively-labelled probes were prepared from the above templates in a 50 pi 
reaction volume as follows: V10 DNA eluate; 50 pmol primer, MATatop or 
PHO80CHK5’, as appropriate; 1 x Super Taq buffer (HT Biotech.); 2 mM 
dATP/dTTP/dGTP dinucleotide mix; 2 units Super Taq; 50 p,Ci 32P dCTP (used with 
appropriate radioactivity precautions). The optimised PCR conditions (for either 
primer) were: 94°C 4 min; 94°C 1 min, 53°C 1 min, 72°C 1 min + 1 s/cycle, 35 cycles; 
72°C 5 min. The radioactive probe was isolated using a Probe Quant G-50 
microcolumn (Amersham) according to the manufacturers instructions, and stored at 
4°C if necessary. Immediately before use, probes were denatured at 100°C for 5 min, 
and held on ice for 2 min.
2.73 .2 .2  Southern blotting o f  CHEF agarose gel
After a photograph had been taken, excess gel was removed to leave a minimal border 
around the DNA bands, taking care to limit UV exposure to prevent the induction of 
further DNA strand breaks. The trimmed gel was depurinated in 0.125 M HC1 for 10 
•min, to aid the transfer of large (> 10 kb) DNA fragments, and then equilibrated in 0.4 
M NaOH for 15 min. The blot apparatus was set up as follows: i) a glass plate was 
suspended over a tray containing 0.4 M NaOH; ii) a filter paper wick was soaked in 0.4 
M NaOH and laid across the glass plate, with both ends immersed in the buffer below; 
iii) the equilibrated gel was laid on top of the filter paper; iv) a piece of Hybond 
membrane, cut exactly to the size of the gel, was laid over the gel and gently rolled with 
a sterile pipette to ensure absence of trapped air bubbles; v) saran wrap was carefully
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laid around the edges of the membrane (creating a 5 mm border) and over the tray of 
buffer, to help prevent a short circuit from the upper filter paper coming into contact 
with either the wick or buffer; vi) 3 sheets of filter paper cut exactly to the size of the 
gel (to prevent a short circuit), and briefly wetted in 0.4 M NaOH, were overlaid on the 
membrane; vii) a tall stack of paper towels, cut exactly to the size of the gel, were 
placed on top; viii) finally, a weight was placed at the top to facilitate absorption 
through the stack. The blot was left at room temperature overnight. After blotting, the 
membrane was washed briefly in 2 x SSC (1 M sorbitol, 0.1 M sodium citrate, 10 mM 
EDTA, pH 7.5).
2.7.3.2.3 Hybridisation
Hybridisation was carried out in a specialised oven (Techne Hybridiser HB-1D), with a 
rotating cylinder. The membrane was pre-hybridised for 1 h at 65°C in a solution of 5 x 
SSPE (3 M sodium chloride, 0.2 M sodium phosphate, 20 mM EDTA, pH 7.0), 5 x 
Denhardts solution, and 0.5 % w/v SDS, containing 20 p-g/ml salmon sperm DNA. The 
denatured probe was then added, and the hybridisation reaction was allowed to proceed 
overnight at 65°C. The membrane was washed with sequential buffers increasing in 
stringency as necessary, starting with 2 x SSPE, 0.1 % SDS at room temperature for 10 
min, up to 0.1 x SSPE, 0.1 % SDS at 65°C. Once the membrane count had been 
reduced to about 80 cpm, the membrane was rinsed in 0.2 x SSC at room temperature, 
wrapped in Saran, and exposed to photographic film.
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2.8 Recombination at an ADE2 inverted repeat construct
The B356-7C yeast strain was engineered to contain an integrated (HIS3 locus, chrom. 
XV) intrachromosomal inverted duplication of the ade2 gene separated by the TRP1 
gene (Fig. 4.9 A), as a substrate for the analysis of mitotic recombination events 
(Rattray and Symington, 1994). Both ade2 alleles are non-functional: one has a 
deletion of the 5’ coding region and upstream DNA extending beyond the region of 
homology, and the other full-length allele bears a 3’ frame-shift mutation at an Nde I 
site. The frequency of intrachromosomal recombination can be quantified by measuring 
reversion to ADfT prototrophy, in terms of the proportion of a population arising from a 
single cell that is able to grow in the absence of adenine. In addition, the nature of the 
recombination event (gene conversion and/or crossover) can be established through 
physical analysis of the ADE2 construct orientation in a single prototroph.
2.8.1 Determination of spontaneous mitotic recombination frequency
Single pink colonies were picked from strains grown on YEPD for 3 days at 28°C 
(growth for longer gives artificially high recombination rates as Ade+ cells continue to 
divide for longer than Ade' cells) and resuspended in 1 ml water. 200 cells were plated 
in duplicate on SC-trp medium to determine total cell number. Appropriate dilutions 
(typically 2 x 104 -  2 x 107 cells/ml) were plated in duplicate on SC-ade in order to 
determine the number of Ade+ prototrophs. Plates were incubated for 3 days at 28°C 
and then scored. Mean mitotic recombination frequencies were determined from the 
ratio of Ade+ prototrophs to the total cell number:
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0.4343 x (ADE+ cells / (TRP+ cells x 1001 )
l n ( N - N 0)
where: N = TRP+ cells in colony 
N0 = 1
2.8.2 Analysis of HN2-induced mitotic recombination frequency
Single pink colonies were picked from strains grown on YEPD for 3 days at 28°C and 
resuspended in 1 ml water. 200 cells were plated in duplicate on SC-trp medium to 
determine total cell number and 2 x 104 cells on SC-ade to calculate the number of Ade+ 
prototrophs in the inoculate. 25ml YPAD was inoculated with 2 x 106 cells, and grown 
overnight at 28°C with vigorous shaking. Cells were grown to mid-exponential phase, 
then resuspended at 2 x 107 cells/ml. 2 ml aliquots were treated with 0, 1,10, 100, 1000 
p,M HN2 (freshly dissolved in cold sterile water) for 60 min at 28°C with vigorous 
shaking. The cells were harvested, washed twice with PBS and plated in duplicate at 
appropriate dilutions to determine total cell number (200 cells on SC-trp) and the 
number of Ade+ prototrophs (2 x 104 -2 x 107 cells on SC-ade). Plates were incubated 
for 3 days at 28°C and then scored. Mean mitotic recombination frequencies were 
determined according to the formula:
0.4343 x (ADE+ cells / (TRP+ cells x 1001 1 
l n ( N - N 0)
where: N = TRP+ cells in end culture 
N0 = TRP+ cells in inoculum
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2.8.3 PCR-based analysis of recombination events
Investigation of the nature of the recombination events (cross-over, gene conversion, or 
both; Fig. 4.10 A) can be achieved through physical analysis of the ADE2 construct, 
originally performed using Southern blot (Rattray and Symington, 1994). A novel 
PCR-based method is presented here, which allows the differentiation between the 
Class I, II, and III recombination events. This PCR-based protocol utilises the residual 
fragments of vector sequence arising from molecular cloning within the ADE2 construct 
to provide unique primer sites (Rattray and Symington, 1994, and refs therein). The 
ADE2 alleles are flanked on the outside by DNA from the pBluescript II KS(-) plasmid, 
containing the recognition sequences for the T7 and T3 standard primers, upstream of 
the ade2-n and ade2-5’A alleles, respectively (Fig. 4.10 B). A short region of the 
pBluescript II KS(-) multiple cloning site sequence remains between the ade2-5’A and 
TRP1 genes, to which a novel primer, int, has been designed: 5’-GAT CTC GAA TTC 
CTG CAG CC-3’. PCR analysis of DNA extracted from single ADE+ prototrophs was 
carried out using all 3 primers in the same reaction (in a total volume of 30 pi): 2 pi 
DNA preparation (Section 2.3.3.1); 1 x Super Taq buffer (HT Biotech.); 2 mM dNTPs 
(Invitrogen); 250 pmol each primer (MWG); and 2 units ‘MOJO’ polymerase (a blend 
of Super Taq (HT Biotech.) and Pfu (Promega) polymerases, optimised for long PCR 
products by Dr. F. Ghadessy, personal communication). In the original orientation of 
the ADE2 construct, this int primer will only generate a DNA fragment with the T7 
primer (Class I), whereas an inversion of the intervening DNA results in a product from 
the int and T3 primer pair (Class II and III). The conditions of the PCR reaction were 
optimised to exclude the longer T7-T3 product: 94°C 4 min; 94°C 1 min, 54°C 1 min, 
72°C 10 min, 40 cycles; 72°C 5 min. Subsequent digestion of the PCR product with 20 
units Nde I for 2 h at 37°C identifies colonies that have undergone gene conversion (and
hence restored the Nde I frameshift mutation). The entire digested PCR reaction was 
then visualised by ethidium bromide-agarose gel electrophoresis. The expected DNA 
fragment patterns were as follows: Class I, 2.1, 1.7 kb; Class II, 3.6 and 2.1 kb; Class 
III, 2.1,1.2, and 1.0 kb.
2.9 NHEJ assay
The plasmid-based system used to investigate the efficiency of yeast NHEJ is based on 
the one developed by Professor S. Jackson using the plasmid pBTM116, which has 
been central to the discovery of many of the key factors involved in NHEJ (Boulton and 
Jackson, 1996). However, due to the restriction of available selectable markers an 
alternative plasmid, YEplacl81 (LEU2-based), was utilised. This plasmid was chosen 
for its unique restriction sites, which enabled use of the same endonucleases to generate 
strand breaks as in the Jackson assay. Linearised plasmids can be used to detect the 
capacity of different yeast strains for NHEJ, as they can only be propagated in yeast if it 
is re-circularised -  i.e. the DSB is repaired. Hence the number of colonies recovered on 
selective media corresponds with the proportion of plasmids that have been repaired. 
The assay can be conducted using restriction enzymes with different modes of action to 
investigate the repair of a variety of DSB termini. In this investigation, the repair of 
DSBs bearing 5’ overhangs (EcoR I), 3’ overhangs (JPst I), and incompatible ends 
{EcoR I and Pst I double digestion) were determined.
Miniprepped YEplacl81 (prepared as described in Section 2.10.1.5) was digested with 
1 unit restriction endonuclease per pg DNA (with appropriate buffer according to 
manufacturers instructions) in a 37°C hotblock for 24 h to ensure complete digestion.
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Enzymes were then heat inactivated by incubating at 65°C for 20 min. 1 \i\ of each 
digest was checked for the absence of intact plasmid on a 1 % agarose gel in 0.5 x TBE 
buffer. 5 p,g digested plasmid was used to transform 5 x 107 yeast cells, using the BIO 
101 Alkali-Cation Yeast Transformation Kit (Anachem) as described for cassette DNA 
in Section 2.3.2, with the exception that cells were only incubated in YPAD for 1 h 
following heat shock. A control transformation was performed simultaneously using 5 
p,g supercoiled plasmid. Transformants were plated on SC-leu media, incubated for 3 
days at 28°C and then scored. The NHEJ efficiency for each type of DSB was 
calculated as the number of transformants obtained using cut plasmid as a percentage of 
the control transformation.
2.10 Plasmids and Complementation Analysis
A number of different yeast expression vectors have been used in the course of this 
study. The ADH1 promoter-based, URA3 selective yeast expression vector pDB20 was 
used to provide high-level constitutive expression (Becker et al., 1991; Ammerer, 
1983). PDB-ScE (a gift from Professor B. Shen, City of Hope National Medical Center, 
California, USA) has an insertion of S. cerevisiae EXOl at the Hind III site of pDB20, 
and has been used successfully to complement yeast exol and rad27 mutants (Qiu et al., 
1999). To investigate overexpression in an inducible system, the S. cerevisiae genes 
PS02  and EXOl were cloned into the GAL1 promoter-based, URA3 selective yeast 
expression vector pYES2 (Invitrogen, Paisley, UK). The GAL1-MSH2 expression 
vectors pEAE127 {LEU2 based pRSY25 vector) and pAC12 (URA3 based Yepl95 
vector) were obtained from Professor E. Alani (Cornell University, USA) (Sokolsky 
and Alani, 2000) and Professor T. Kunkel (National Institute of Environmental Health
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Sciences, USA) (Clark et al., 1999), respectively. The galactose-inducible GAL1 
promoter provides a simple system for the overexpression of tightly regulated cellular 
proteins, such as nucleases, as it allows transient increases in transcription from the 
plasmid-based gene upon a change in the media carbon source from glucose (which 
represses the GAL1 promoter) to galactose.
Plasmids (1 pg of a miniprep, Section 2.10.1.5) were transformed into the appropriate 
yeast strain using the BIO 101 Alkali-Cation Yeast Transformation Kit (Anachem) as 
described for cassette DNA in Section 2.3.2, and selection was maintained using SC-ura 
or SC-leu media as appropriate.
2.10.1 Cloning of P S02  and EXOl into pYES2
The complete open reading frames (ORFs) of S. cerevisiae PS02 and EXOl were 
introduced into the yeast expression vector pYES2 using standard molecular cloning 
procedures (Sambrook et al., 1989).
2.10.1.1 Gene amplification
Primers were designed to amplify the complete ORF from upstream of the 5’ ATG to 
downstream of the 3’ termination sequence: PS02 131-2308 bp, EXOl 158-2720 bp 
(coordinates as per Genbank entries X64004 and U86134 respectively). The 5’ end of 
the primers were modified with unique restriction sites to facilitate orientation-specific 
cloning into pYES, and 10 bp of random sequence was incorporated at the termini to aid 
enzyme recognition and cleavage (Table 2.2).
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PCR reaction mixes were prepared in a total volume of 100 pi as follows: 2 pi yeast 
genomic DNA preparation (Section 2.3.3.1); 1 x thermopol buffer; 100 mM magnesium 
sulphate; 2 mM dNTPs; 250 pmol each primer (MWG); and 2 units Vent polymerase. 
Vent polymerase was utilised as its proofreading capacity would reduce the likelihood 
of incorporating a mutated form of the gene into the plasmid. The optimised PCR 
conditions (for both PS02  and EXO l) were: 94°C 4 min; 94°C 1 min, 55°C 1 min, 
72°C 2 min, 35 cycles; 72°C 5 min. PCRs were performed on a MJ thermocycler 
machine. Products were phenol-chloroform extracted and ethanol precipitated as 
already described (Section 2.3.1). DNA pellets were resuspended in 18 pi sterile water, 
and 2 pi was electrophoresed on a 1 % agarose gel in 0.5 x TBE buffer to confirm that a 
clean, single fragment had been obtained from the PCR.
Table 2.2 Prim ers used in the cloning of PS02  and EXOl. Random bp are 
shown in black, restriction sites are in red upper case, and gene-specific sequences are 
in blue. RE denotes the restriction enzyme.
Primer Sequence (5’-3’) RE
PS02-0/E-5’ get act gat cGG ATC Cac ctg cgt caa aac tea tgt BamH  I
PS02-0/E-3’ gca ctt cga cGC GGC CGC gga etc tga gta taa tac gat at Not I
EXOl-O/E-5’ get act gat cAA GCT Tgt tga eta eta cga get ata cga Hind III
EXOl-O/E-3* gca ctt cga cGC GGC CGC aat tct tgt ctt gag gca tt Not I
2.10.1.2 Restriction enzym e-based cloning o f  gene into pY E S2
Double restriction digests (PS02 : BamH I, Not I; EXO l: Hind III, Not I) were
performed for 2 h at 37°C on the remaining 16 pi of PCR product (as above) in a total
reaction volume of 20 pi, using the appropriate buffer as recommended by the
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manufacturer. Corresponding double restriction digests were performed on 2 pi of a 
pYES2 miniprep (prepared as described in Section 2.10.1.5). The digests were 
subsequently run on a 1 % agarose gel (0.5 x TBE) and the digested fragments were 
gel-extracted using the Qiaquick gel extraction kit (Qiagen), according to the 
manufacturers instructions. Bands were cut from the ethidium bromide-stained gel 
using a dark reader transilluminator (Clare Chemical Research Inc., Dolores, USA) to 
prevent incorporation of UV-induced mutations. The DNA was eluted in 30 pi EB, and 
2 pi was checked on a 1 % agarose gel in order to determine the relative yields of 
gene:vector. Ligation reactions were performed with a 3:2 ratio of gene:vector (as the 
vector is considerably longer than the gene insert), 1 x T4 ligase buffer, and 400 units 
T4 DNA ligase (NEB), in a final volume of 20 pi for 20 min at room temperature.
2.10.1.3 Transformation ofE.  coli
A 50 pi aliquot of XLIO-Gold ultracompetent E. coli cells (Stratagene, California, 
USA) was used per plasmid transformation. Cells were slowly thawed on ice and 
treated with p-mercaptoethanol, according to the manufacturers instructions. 5 pi of the 
ligation reaction (Section 2.10.1.2) was added, and mixed thoroughly by pipetting. The 
transformation mix was incubated on ice for 30 min, heat-shocked at 42°C for 30 s, and 
returned to ice for a further 2 min. 1 ml warm LB was then added, and the cells were 
incubated at 37°C for 1 hour. Subsequently, the cells were pelleted by pulsing in a 
microcentrifuge, and resuspended in 200 pi LB. A tenth of the transformant mix (20 pi) 
was plated on one LB-amp plate, and the remainder (180 pi) on another. Plated were 
incubated at 37°C overnight.
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2.10.1.4 Confirmation o f  gene cloning into pYES2
E. coli transformants were checked by colony PCR, using primers specific to the 
inserted gene (identical sequences to the primers used in the initial amplification of the 
gene, but without the terminal restriction site/random bp modifications to improve PCR 
efficiency). A master mix for the total number of PCRs was prepared according to the 
following ratios, in order to give final reaction volumes of 30 pi: 1 x Super Taq buffer; 
2 mM dNTPs; 250 pmol each primer (MWG); and 2 units Super Taq polymerase. A 
small quantity (equivalent in volume to 0.5 pi water) of a single transformant colony 
was transferred to a sterile PCR tube using a Gilson pipette tip, before the PCR mix was 
added and vortexed. The optimised PCR conditions were: 94°C 4 min; 94°C 1 min, 
55°C 1 min, 72°C 2 min, 25 cycles; 72°C 5 min. PCRs were performed on a MJ 
thermocycler machine. Products were checked on a 1 % agarose gel (0.5 x TBE buffer) 
to confirm the presence of the insert.
2.10.1.5 Isolation o f plasmid DNA
Single colonies isolated from an E. coli transformation were cultured in 1.5 ml liquid 
LB-amp media overnight. Plasmid DNA was isolated from pelleted cells using the 
Qiagen (Crawley, UK) miniprep kit according to the manufacturers instructions, and 
eluted in 50 pi sterile water. The integrity of the extracted DNA and the size of the 
plasmid (as an additional confirmation of gene insertion) was confirmed by running a 5 
pi aliquot on a 1 % agarose gel in 0.5 x TBE buffer.
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2.10.2 Complementation using a galactose-inducible system
For complementation analysis of genes regulated by the GAL1 promoter, transformed 
cells were grown to exponential phase in SC-ura/SC-leu (as appropriate) with 2% 
glucose, then resuspended at an OD of 0.4 in induction media (SC-ura/SC-leu 2% 
galactose/1 % raffinose) and incubated overnight at 28°C. Raffinose, which has no 
affect on expression from the GAL1 promoter, was provided as an additional carbon 
source to reduce metabolic stress. Subsequent analysis of HN2 sensitivity was 
performed as already described (Section 2.5.1).
2.10.3 Complementation using a constitutive expression system
For complementation analysis of genes under the constitutive expression of the ADH1 
promoter, transformed cells were cultured overnight at 28°C in SC-ura (2 % glucose) 
media to select for plasmid retention. Subsequent analysis of HN2 sensitivity was 
performed as already described (Section 2.5.1).
2.10.4 Confirmation of gene overexpression by RT-PCR
Reverse transcriptase-PCR (RT-PCR) is a widely used method to evaluate levels of 
gene expression. Briefly, cellular RNA is extracted and the mRNA quotient specifically 
amplified by means of primers that target the poly-adenine tail, and the viral enzyme 
reverse transcriptase, which produces DNA from an RNA template. This cDNA is then 
used in a PCR reaction with primers specific to the gene of interest.
RNA was extracted from 4 x 107 cells using the Qiagen RNeasy kit, according to the
manufacturers’ instructions. The RNA was eluted in 50 pi DEPC-treated water, and
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20 pi (in 3 ml DEPC water) was used to determine concentration by measurement of the 
absorbance at 260 nm using a spectrophotometer. 1 pg RNA was treated with 1 unit 
RQ1 RNase-free DNase (Promega) in 1 x RQ1 buffer and DEPC water, to a total 
volume of 10 pi. The digestion reaction was incubated at 37°C for 30 min before 
adding 1 pi of the provided stop solution and heating to 65°C for 10 min. The digested 
RNA was then diluted in DEPC water to give 1 pg/100 pi. Reverse transcription 
reactions were set up in a total volume of 20 pi as follows: 0.1 pg digested RNA; 1 x 
Sensiscript buffer (Qiagen); 0.5 mM dNTPs; 1 pM oligo dT (Invitrogen); 10 units 
RNasin (Promega); 1 pi Sensiscript RT (Qiagen); and DEPC water as necessary. RT 
was performed at 37°C for 60 min. The full RT reaction was subsequently used for 
PCR, in a total reaction volume of 100 pi: 20 pi RT reaction; lx  Taq buffer (Promega);
1.5 mM MgCl2; 2.5 mM dNTPs; 100 pmol each primer (2 x gene specific, 2 x ACT1 
control primers). The primers for this PCR reaction were designed to lie within the 
coding region and generate short products (500 bp gene specific, 300 bp ACT1 control) 
to maximise yield. Each PCR reaction contained 2 sets of primer pairs, one specific to 
the gene of interest, and another to the constitutively expressed ACT1 gene, as a loading 
control. 5 units Taq polymerase (Promega) was added after a hot start. The PCR 
conditions were as follows: 94°C 2 min; 94°C 1 min, 51°C 1 min, 72°C 1.5 min, 40 
cycles; 72°C 7 min. The entire PCR reaction was electrophoresed on a large 1.5 % 
agarose gel, in 0.5 x TBE buffer, and visualised by ethidium bromide staining and UV- 
exposure.
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2.11 Protein analysis
A plasmid (pGAL-C-FLAG-/55'02) expressing a C-terminal FLAG-tagged Pso2 
protein, under the control of the GAL1 promoter was obtained from M. Tyers (Samuel 
Lunenfeld Research Institute, Toronto). The small FLAG-tag (DYKDDDDL) was the 
peptide of choice for this study, as it is not thought to interfere with fusion protein 
expression, proteolytic maturation, or activity (Molloy et al., 1994; Lee and Altenberg, 
2003; Terpe, 2003).
2.11.1 Protein extraction and quantification
The pGAL-C-FLAG-PS02 plasmid was transformed (as described in Section 2.3.2) 
into the protease-deficient S. cerevisiae strain, JEL1 (Lindsley and Wang, 1993; gift of 
Professor Ian Hickson, Weatherall Institute of Molecular Medicine, Oxford, UK), to 
prevent degradation of the Pso2 protein, and hence facilitate efficient extraction. 
Selection was maintained on SC-leu media.
Cells were cultured to exponential phase in SC-leu with 2% glucose, then resuspended 
at an OD of 0.4 in induction media (SC-leu 2% galactose/1% raffinose) and incubated 
at 28°C. A preliminary analysis was carried out to optimise the duration of galactose- 
induction for increased protein yield. Subsequent cultures for protein extraction were 
induced for 24 h, before washing in sterile water and freezing cell pellets at -  70°C, 
until required.
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2.11.1.1 Whole-cell protein extraction
Cell pellets from 50 ml induced culture were resuspended in 1 ml RIPA buffer (50 mM 
Tris-HCl pH 7.5; 250 mM NaCl; 1 % deoxycholic acid; 1 % Triton-XlOO; 0.1 % SDS; 
protease inhibitor cocktail (1 complete EDTA-free tablet (Roche Diagnostics, Germany) 
per 50 ml buffer)) (P. Kaiser, University of California Irvine, USA: 
www.ucihs.uci.edu/biochem/faculty/Kaiser.html) and ground in liquid nitrogen, using a 
pestle and mortar. Disrupted cell solutions were microcentrifuged at top speed for 5 
min at 4°C. The supernatant was carefully transferred to a sterile eppendorf, and 
maintained on ice. Protein concentrations were determined (Section 2.11.1.4).
2.11.1.2 Immunoprecipitation
Small-scale immunoprecipitations were performed on 200 pg crude protein extract, 
made up to a final volume of 500 pi in RIPA buffer. 4 pg anti-FLAG polyclonal 
antibody (Sigma) was added to each sample, and incubated overnight at 4°C on a rotary 
wheel.
Protein A-sepharose (Sigma, 10 pi stock per immunoprecipitation reaction) was 
prepared by washing in PBS and resuspending in RIPA buffer as a 50 % suspension. 
This was then added to the antibody-protein samples, and incubated for 1 h at 4°C on 
the rotary wheel. Subsequently, the conjugates were washed 3 times in RIPA buffer 
(microcentrifuging for 2 min at 3000 rpm at 4°C) and resuspended in a final volume of 
30 pi RIPA buffer to enable loading of the entire sample on a PAGE gel. Samples were 
boiled in SDS-loading buffer prior to PAGE.
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2.11.1.3 Large scale Pso2 protein extraction
Cell pellets from 1-2 litres induced culture were resuspended in 5 ml CelLytic-Y buffer 
(Sigma) per gram of cells, and ground in liquid nitrogen, using a mortar and pestle. The 
CelLytic-Y buffer was freshly supplemented with a cocktail of protease inhibitors (1 
complete EDTA-free tablet (Roche Diagnostics, Germany) per 50 ml buffer). 
Disrupted cell samples were then spun in an ultracentrifuge at 30 000 rpm for 1.5 h at 
4°C. After checking the protein concentration (Section 2.11.1.4), the supernatant was 
recentrifuged for a further 45 min. A second calculation of the protein concentration 
was made. Extracts were maintained on ice at all times, and stored at -  70°C until 
required.
1 ml aliquots of the extract supernatant were added to Anti-FLAG M2-agarose affinity 
gel (Sigma, murine IgGx monoclonal antibody), prepared from 20 pi packed gel 
according to the manufacturers instructions. This immunoprecipitation reaction was 
incubated overnight on a rotary wheel at 4°C. Samples were then washed 3 times in 1 x 
TBS (50 mM Tris HC1, 150 mM NaCl, pH 7.4), spinning for 10 s in a microcentrifuge 
at 10 000 rpm, 4°C. FLAG-Pso2 was eluted from the washed resin by resuspending in 
100 pi 1 x TBS containing 150 pg 3 x FLAG peptide and 1 x protease inhibitors (Roche 
Diagnostics), and incubating for 1 h shaking at 4°C. The unbound agarose resin was 
then compacted by centrifuging for 10 s at 10 000 rpm, and the supernatant was 
transferred to a sterile eppendorf. The protein concentration of the supernatant was 
determined as described in Section 2.11.1.4.
Aliquots of the FLAG-Pso2 extract were further purified by centrifugation in a 
Vivascience Vivaspin 6 ml column (5- 50 000 MWCO) for 3 h at 4000 rpm, at 4°C.
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The concentrated fraction remaining in the column was transferred to a sterile 
eppendorf for storage at -70°C.
2.11.1.4 Quantification o f protein concentration
Protein concentrations were determined by spectrophotometer analysis using the Biorad 
DC Protein Assay reagents. Briefly, 2 pi of protein sample was diluted in 18 pi sterile 
water and combined with 100 pi of a 100:2 mix of Reagents A and S, respectively. 800 
pi reagent B was added and vortexed. Samples were incubated at room temperature for 
15 min before measuring absorption at 750 nm. Protein concentration (pg/pl) was 
calculated as A750 x 25.
2.11.2 Analysis of post-translation modifications
2.11.2.1 Phosphorylation
To determine whether Pso2 is modified by phosphorylated residues, extracted protein 
was treated with calf intestinal alkaline phosphatase (CIAP, NEB). Briefly, the eluate 
from an immunoprecipitation reaction (Section 2.11.1.2) was treated with 20 units 
CIAP or 20 units heat-inactivated CIAP (15 min, 80°C) in 1 x CIAP buffer for 1.5 h at 
37°C. Reactions were performed in the manufacturer’s buffer (100 mM NaCl, 50 mM 
Tris-HCl, 10 mM MgCl2, 1 mM dithiothreitol, pH 7.9). Samples were subsequently 
prepared by boiling in Laemmli buffer for loading on a PAGE gel (Section 2.11.3).
2.11.2.2 Glycosylation
To determine whether Pso2 is modified by glycosylation, extracted protein was treated 
with the glycosidase EndoH (NEB). Briefly, the eluate from an immunoprecipitation
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reaction (Section 2.11.1.2) was pre-treated in 1 x glycoprotein denaturing buffer (NEB) 
for 10 min at 100°C. 2500 units EndoH was then added in 1 x G5 buffer (NEB) and 
incubated for 1.5 h at 37°C. Samples were subsequently prepared by boiling in 
Laemmli buffer for loading on a PAGE gel (Section 2.11.3).
2.11.3 Polyacrylamide Gel Electrophoresis (PAGE)
Protein extracts were separated by Tris-glycine SDS-PAGE, according to standard 
protocols (Sambrook et al., 1989). The expected size of the FLAG-Pso2 fusion protein 
is 80 kDa, so PAGE was performed with an 8 % resolving gel topped with a 5 % 
stacking gel, prepared in single-use cassettes (Invitrogen). About 30 ng whole cell 
extract (or a single IP reaction) was prepared in 5 x Laemmli SDS sample buffer 
(Laemmli, 1970), boiled for 3 min at 100°C, and pulsed in a microcentrifuge. Standard 
protein suspensions (Biorad kaleidoscope) were loaded on each gel for reference 
purposes. The composition of the 1 x running buffer was as follows: 25 mM Tris-HCl 
pH 8.3, 200 mM glycine. Electrophoresis was carried out using the XCell SureLock 
Mini-Cell apparatus (Invitrogen), at 60 V until the samples had passed to the boundary 
of the stacking and resolving gels, followed by 100 V for a further 2 h. Gels were 
carefully removed from the cassette, and subsequently stained with Coomassie blue in 
methanol-acetic acid (Sambrook et al., 1989), or transferred by Western blotting, as 
appropriate.
2.11.4 Western blotting
The membrane (Millipore Immobilon-P) was prepared by cutting to the size of the 
PAGE gel, soaking in methanol for 15 min, rinsing in sterile water for 2 min, and
117
finally soaking in transblot buffer (1 x PAGE running buffer, 2 x methanol) for 5 min. 
The transfer apparatus (XCell II Blot Modul, Invitrogen) was arranged from the bottom 
of the tray upwards, as follows: two pre-soaked sponges; pre-soaked filter paper; PAGE 
gel; membrane; pre-soaked filter paper; and two further pre-soaked sponges. The 
transfer was carried out in transblot buffer for 1 h at 30 V.
2.11.5 Immunoblotting
Immunoblotting of western membranes was performed using one of two primary 
antibodies, both of which are polyclonal IgG raised in rabbit: anti-FLAG (Sigma), or 
anti-Sumol (Abeam, Cambridge, UK). Anti-FLAG antibody was prepared at a 
concentration of 2.5 p-g/ml in PBS with 1 % bovine serum albumin (BSA, Sigma). 
Anti-Sumol was used at a working dilution of 1:1000 in PBS with 1 % BSA. 
Antibodies were found to be effective at the manufacturers recommended 
concentration, and could be re-used 3-4 times without loss of activity (if stored at -  
20°C).
Membranes were blocked overnight at 4°C in a filtered solution of 5 % low-fat milk in
PBS. The membrane was subsequently washed 3 times in PBS/0.05 % Tween.
Membranes were incubated in the appropriate primary antibody on a roller for 3 h at
room temperature, and then washed three times in PSB/0.05 % Tween. The secondary
antibody, peroxidase-conjugated anti-rabbit IgG raised in goat (Rockland Inc., USA),
was diluted to 1:12000 in PBS/0.05 % Tween, and incubated with the membrane at
room temperature on a roller for 1 h. Membranes were washed a further 3 times in
PBS/0.05 % Tween, and blot-dried. Chemilluminescent detection of the peroxidase-
conjugated antibody-protein complexes was performed using ECL (Amersham),
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according to the manufacturers instructions. Briefly, the ECL solutions were mixed in a 
1:1 ratio, and incubated with the membrane at room temperature for 1 min. The 
membrane was then blot-dried, wrapped in Saran, and exposed to photographic film 
over a range of time points, typically 10 s, 30 s, 1 min, 3 min, and 5 min.
Membranes to be re-blotted were first stripped for 30 min at 50°C, in stripping buffer 
(100 mM 2-Mercaptoethanol, 2 % SDS, 62.5 mM Tris-HCl pH 6.7), and washed twice 
in PBS/0.05 % Tween at room temperature. Complete removal of the bound antibody 
complexes was confirmed by performing ECL detection, as above. The membranes 
were rinsed in PBS, and then blocked overnight at 4°C in a filtered solution of 5 % low- 
fat milk in PBS, ready for immunoblotting.
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CHAPTER 3 CHARACTERISATION OF YEAST
STRAINS DEFICIENT FOR PS02
The genetic characterisation of mutant S. cerevisiae strains is one of the few areas of 
research into the PS02  gene that has been actively pursued in the past. In particular, 
their specific sensitivity to a wide range of cross-linking agents, including the nitrogen 
mustards (Fleer and Brendel, 1979), psoralens (Henriques and Moustacchi, 1980), 
platinum-based compounds (Wilbom and Brendel, 1989), and mitomycin C (Pungartnik 
et a/., 2002), but not other forms of DNA damage, is well established. However, the 
genetic characterisation of pso2 strains is incomplete, and the results are in some cases 
ambiguous and contradictory. It is therefore desirable to revisit the fundamental aspects 
of this phenotype in order to present a definitive study.
The extent to which PS02  is involved in either the normal function of the cell cycle, or 
the response to DNA damage is not yet fully determined. It has been reported that loss 
of PS02  results in the induction of a G2 arrest after treatment with cisplatin, but a 
normal S-phase was observed (Grossmann et al., 2000). The question of whether PS02 
acts to repair ICL at a particular stage of the cell cycle is an important one as it holds 
many clues as to the mechanism of ICL repair in general. The DSBs that have been 
observed after treatment with ICL-inducing agents are believed to result from 
replication fork collapse and as such are obviously a cell cycle-dependent aspect of the 
repair of DNA cross-links.
Another paradox still to be resolved is the involvement of PS02  with the major yeast
repair pathways and how this relates to the current model of ICL repair. By analogy
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with the well-characterised pathway in E. coli (Section 1.3.1), the repair of cross-links 
in yeast is believed to involve three key stages. Firstly, incision at the site of an ICL by 
the NER apparatus, leading to the ‘unhooking’ of the cross-link from one strand of 
DNA. This is followed by resection in order for recombination to proceed into the 
gapped DNA. Previous studies of epistasis between pso2 disruptant cells and strains 
deficient in the main repair groups suggest that PS02 is involved with NER but not 
homologous recombination during the repair of ICLs (Henriques and Moustacchi, 1981; 
Siede and Brendel, 1982). This apparent contradiction between the activity of a cross­
link repair specific gene and the currently proposed mechanism of ICL repair remains to 
be resolved.
3.1 Disruption of the PS02 gene
The pso2 mutant strains used in this study were derived from the B356-7C (parent 
W303-1A) or DBY747 haploid parent strains by PCR based micro-homology targeted 
deletion, using the template plasmids derived by Longtine et al. (1998). This method 
involves PCR synthesis of a DNA cassette with terminal regions of homology to PS02 , 
from a plasmid bearing a selectable marker gene (Fig. 3.1 A). Two primers, each 
comprising 40 bp of homology to the PS02 gene and 20 bp of overlap with the 
KanMX4 cassette were used: 5’AGC ATA CGC ACT AGT GAC TAA TTT GGG TGG 
TCG GTT GAT Teg gat ccc egg gtt aat taa3’ (forward) and TCA TAC ATT CAT ATA 
ATA TCC ATT ACG TAC GTA CAT CTT Aga att cga get cgt tta aac3’ (reverse), 
where the region homologous to PS02 is in uppercase and to Kan MX4 in lowercase. 
In order to ensure complete disruption of the PS02  gene, these primers were designed 
to allow deletion of the coding sequence from upstream of the 5 ’ ATG, to downstream
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KanMX4
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Figure 3.1 PS02 gene disruption. A. Schematic of PCR based microhomology- 
targeted deletion. Plasmid DNA is depicted in black, and yeast DNA in red. B. 
Agarose gel comparing PCR products from a wild-type PS02 strain and an 
pso2::kanMX4 disruptant. PS02  gives a 2.2 kb PCR product, which when 
digested with EcoR I (RI) gives two fragments of 1.25 and 0.7 kb, and digested 
with Hind III (H III) gives two fragments of 1.5 and 0.5 kb. The pso2::kanMX4 
PCR product is 1.6 kb, reduced to 1.5 kb by EcoR I digestion, and fragmented to 
give 1.0 and 0.6 kb bands after Hind III digestion. M = 1 kb DNA marker.
pFA6aKanMX4
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of the 3’ termination site (primer locations as coordinates of the X64004 GenBank 
PS02  sequence: forward 156-195, reverse 2270-2231, CDS 196-2181). The resulting 
DNA fragment was transformed into the parent yeast strain by the lithium acetate 
method, and kanomycin resistant colonies were isolated by growth on YEPD-G418 
plates. Disruption of the PS02  gene was confirmed by PCR across the insertion region 
using two primers flanking the 5’ and 3’ deletion cassette primers, respectively (X64004 
coordinates: forward 131-150, reverse 2308-2286), producing a DNA fragment of 1.6 
kb in the pso2 disruptant, compared to 2.2 kb in the PS02  wild-type. Subsequent EcoR 
I and Hind III restriction enzyme analysis of the PCR product yields different patterns 
of DNA fragments in the wild-type and disrupted gene, hence providing conclusive 
evidence that PS02  was fully disrupted (Fig. 3.1 B).
3.2 PS02 is not required for normal growth and cell cycle 
kinetics
3.2.1 Loss of P S02  does not disrupt the normal pattern of cell division
One of the first avenues of research was to confirm that mutant pso2 cells are able to 
grow in the normal fashion. Simple analysis of the growth pattern was achieved by 
inoculating a fresh culture with exponential phase cells at 2 x 106 cells/ml, and 
observing the change in culture density at hourly intervals using a spectrophotometer. It 
is clear from figure 3.2 that the growth profile of the pso2 strain is indistinguishable 
from the wild-type parent B356-7C. The culture density was also analysed 
microscopically at 0 and 10 h, by performing cell counts using the haemocytometer 
method. Consistent with the spectrophotometer analysis, no significant difference was
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Figure 3.2 Analysis o f the growth profile ofpso2 deficient cells, relative to the 
wild-type parent B356-7C. Samples of a freshly inoculated YEPD culture (0 
h) were taken at hour intervals to determine cell density by spectrophotometer 
measurement at OD600. The analysis was repeated 3 times, and a typical 
result is shown.
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observed between the wild-type and pso2 strains (culture density at 10 h was 6.7 x 107 
and 6.4 x 107 cells/ml, respectively, relative to 0 h).
Exponential phase cells (cultured for 10 h) were also examined microscopically to 
ascertain the relative populations in each cell cycle phase: G1 (unbudded), S (small 
budded), and M (large budded, where the bud size is greater than 50 % of the volume of 
the mother cell). About 200 cells from each strain were counted. No significant 
difference was observed between the wild-type and pso2 defective strains, with both 
exhibiting equal proportions of cells in S and M phase (Table 3.1). As would be 
expected from an exponential phase culture, the majority of cells (70-80 %) have 
entered the replication and division phases of the cell cycle.
Table 3.1 Microscopic analysis of cell cycle phase.
Strain G1 (unbudded) S (small bud) M (large bud)
B356-7C 19.1 % 51.9% 29.0 %
pso2 28.1 % 47.7 % 24.2%
3.2.2 Loss of P S02  does not prevent or render cells sensitive to cell 
cycle arrest
In order to further discount a role for PS02 in the normal operation of the cell cycle, 
mutant pso2 strains were tested for sensitivity to a number of checkpoint-specific 
inhibitors. Hydroxyurea (HU) is a potent inhibitor of the enzyme ribonucleotide 
reductase, and blocks DNA synthesis by causing elongation arrest (Slater, 1973). 
Colony spotting assays were employed, in which defined numbers of cells are grown on
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YEPD plates supplemented with different concentrations of HU. It can be seen from 
figure 3.3 A that pso2 cells were as competent as the wild-type B356-7C strain to grow 
on YEPD supplemented with 40 mM HU. This contrasts with an m rell strain, which 
fails to survive even a concentration of 5 mM HU (data not shown). The anti-mitotic 
systemic benzimidazole fungicide, Benomyl, prevents spindle assembly by causing 
depolymerisation of microtubules. Colony spotting assays were again utilised to test 
the response to a range of different concentrations of Benomyl. As for HU, loss of 
PS02  does not lead to either a sensitive or a resistant phenotype to Benomyl, compared 
to the wild-type strain (Fig. 3.3 B). The pso2 and B356-7C strains are equally able to 
survive in the presence of Benomyl at a concentration of 25 pg/ml (Fig. 3.3 B), but fail 
to grow at all upon plates supplemented with 50 pg/ml (data not shown).
A further indication of proficiency in cell cycle progression is the ability to initiate G1 
arrest in the presence of alpha mating factor. Cells from an actively growing culture 
were transferred to YPAD containing 10 pM alpha mating factor, and incubated at 28 
°C. In the original exponential phase cultures, single unbudded cells were observed at a 
frequency of 13.1 % (27/206) and 20.9 % (49/235), for the wild-type and pso2 strains, 
respectively. However, after a 3 h incubation the presence of alpha mating factor, 92.3 
% (203/220) of pso2 deficient cells were observed microscopically as unbudded or 
“shmooed” (cells with a characteristic mating projection). This compares favourably 
with the parent DBY747 strain where 96.7 % (172/178) of cells were 
unbudded/shmooed after 3 h incubation. Hence it would seem that PS02 does not play 
a significant role in normal cell cycle kinetics, as cells are able to arrest normally in G1 
phase.
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Figure 3.3 Sensitivity to HU and Benomyl. A 10 fold serial dilution series 
(represented by the tapered grey bar) of B356-7C wild-type and pso2 deficient 
cells were spotted on YEPD containing A. 0 or 40 mM Hydroxyurea, B. 0 or 25 
p.g/ml Benomyl. Plates were spotted in duplicate, and incubated at 28°C for 3 
days.
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3.2.3 PS02  is not essential for mitochondrial function
In addition to the observed nuclear localisation of the Pso2 protein (Henriques et a l , 
1997; Dronkert et al., 2000; Richie et al., 2002), a systematic mass spectrometry screen 
of protein complexes identified using 10 % of the yeast genome as tagged bait, has 
suggested an interaction between FLAG-tagged-Pso2 and the mitochondrial proteins 
MgmlOl and YHR076W (Ho et al., 2002). MgmlOl has been shown to bind 
mitochondrial DNA as part of the nucleoid involved in the repair of oxidative damage 
(Meeusen et al., 1999). The biological function of YHR076W is as yet unknown, 
although it is known to exhibit protein phosphatase activity (Jiang et al., 2002).
Analysis of the Pso2 protein sequence using PSORTII (http://psortnibb.ac.jp, Gavel 
and von Heijne, 1990) reveals a potential mitochondrial targeting R-2 motif at residue 
77. The predictive software assigns a 34.8 % likelihood that the Pso2 protein will 
localise to the mitochondria, which, although a lesser probability than nuclear 
localisation (56.5 %), is significant, and contrasts with the negligible prospect of 
localisation to other cellular compartments (cytoplasm 4.3 %, endoplasmic reticulum
4.3 %). Hence it was important to determine whether functional PS02 was essential for 
normal mitochondrial metabolism. pso2 deficient cells were grown on YPG media, 
which contains the non-fermentable carbon sources glycerol and ethanol. Figure 3.4 
clearly shows a similar level of growth on YPG in the pso2 strain as for the parent 
B356-7C, which is indistinguishable from the capacity to grow on YEPD. It follows 
that PS02  is not essential for normal mitochondrial function, yet this does not preclude 
a role in some redundant mtDNA repair process.
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Figure 3.4 Analysis o f growth on non-fermentable media. A 10 fold serial 
dilution series (represented by the tapered grey bar) of B356-7C wild-type 
and pso2 deficient cells were spotted on either A. YEPD or B. YPG (non- 
fermentable) agar plates, and incubated for 3 days at 28°C.
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3.3 Confirmation that loss of PS02 results in specific 
sensitivity to DNA ICL, but not other forms of DNA 
damage
One of the considerations of previous research into PS02 has been the sensitivity of 
pso2 mutants to different DNA damaging agents. As already discussed (Section 1.4.1), 
initial interest in the PS02  gene was aroused following its identification from an 
unusual mutant strain sensitive to bifunctional, but not monofunctional, alkylating 
agents. To date, pso2 disruptant cells have been screened for sensitivity to many ICL- 
inducing agents, and this original observation stands unchallenged. It would not, 
therefore, be beneficial to conduct further examination of the pso2 mutant phenotype 
with regards to drug sensitivity. However, it was felt reasonable to utilise this 
knowledge to check the validity of the new pso2 disruptants produced by PCR-based 
micro-homology targeted gene deletion. The sensitivity to nitrogen mustard (HN2) 
resulting from a complete loss of the PS02 gene was investigated in three commonly 
used genetic backgrounds. A pso2 mutant in either the B356-7C (W303-IA) or 
DBY747 strains led to a 10,000-fold increase in sensitivity at the highest dose, 
compared to the respective parent (Fig. 3.5 A and B). Interestingly, the BY4741- 
derived pso2 strain from the EUROSCARF Yeast Deletion Project is considerably more
i
sensitive to HN2 (100-fold more than the DBY747 and B356-7C pso2 mutants at 1000 
p-M HN2), and this is not reflected in an increased susceptibility of the parent strain 
(Fig. 3.5 C).
These pso2 mutants were also tested for sensitivity to UVC and X-irradiation. Figure
3.6 A shows a mild increase (about 5-fold over the parent strain) in sensitivity to UV for
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Figure 3.5 Sensitivity to HN2. Exponential phase parental and pso2 cells 
were treated with 0 to 1000 pM HN2 for 1 h, and survival monitored by 
plating on YEPD. A. B356-7C background. B. DBY747 background. C. 
BY4741 background. All results are the mean of at least three independent
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Figure 3.6 Sensitivity to UVC and X-irradiation. Survival of parental and 
pso2 deficient cells following treatment with A UVC, or B and C X- 
irradiation, at the doses shown. Comparisons are made with mutants known 
to be highly sensitive to these treatments. All results are the mean of at least 
three independent experiments, and the error bars show the SEM.
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pso2, but only at the highest dose (50 J). This is extremely modest compared with the 
rad4 (NER) mutant, where survival could not be detected at doses greater than 10 J 
(Fig. 3.6 A). Additionally, it can be clearly seen from figure 3.6 B that loss of PS02 
does not lead to any sensitivity to X-irradiation, where a rad52 (homologous 
recombination mutant) strain is shown as a positive control. It is interesting to note that 
the BY4741 pso2 mutant also demonstrates a wild-type resistance to X-irradiation (Fig.
3.6 C), suggesting that should there be any other disrupted genes in this strain, they are 
not directly involved in the repair of DNA double-strand breaks.
3.4 The Schizosaccharomyces pombe pso2 mutant phenotype 
reflects that of S. cerevisiae pso2
Schizosaccharomyces pombe (fission yeast) is evolutionarily distinct from S. cerevisiae. 
A putative S. pombe PS02  gene was isolated by sequence analysis and the entire ORF 
was disrupted by KanMX6 insertion in collaboration with Professor Tony Carr (Genome 
Stability Centre, University of Sussex). This candidate gene gives rise to a protein with 
42 and 55 % similarity and 27 and 37 % identity across the complete protein sequence 
with S. cerevisiae Pso2 and human Pso2, respectively (Fig. 1.12; Lambert et al., 2003). 
The newly isolated pso2 mutant was tested for sensitivity to both HN2 and its 
monofunctional derivative mono-nitrogen mustard (2-dimethylaminoethylchloride 
hydrochloride, HN1) to determine whether this homologue is also involved in the 
specific processing of DNA ICL. It can be seen from figure 3.7 A that in S. pombe, loss 
of pso2 results in a moderate sensitivity to HN2 - approximately six-fold compared to 
the 501 parent strain at the highest dose used (1000 pM). Furthermore, in a serial 
dilution colony spotting assay the pso2 deficient strain demonstrates wild-type
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Figure 3.7 S. pombe pso2 sensitivity to HN2 and HN1. A. Survival following 
a 1 h treatment with 0 to 1000 HN2 in PBS. Results are the mean of at 
least three independent experiments, and the error bars show the SEM. B. 
Colony spotting assay in which 10 fold serial dilutions of cells (represented by 
the tapered grey bar) are spotted onto YEPD plates containing 0 to 10000 pM 
HN1. All plates were incubated for 3 days at 28°C before scoring.
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resistance to HN1, even at a dose of 10000 pM, 10 fold higher than the maximum HN2 
treatment applied (Fig. 3.7 B). It would therefore appear that although the degree of 
sensitivity of the S. pombe pso2 mutant to HN2 is less than in S. cerevisiae, the 
specificity of Pso2 activity does extend only to ICL-inducing agents and not 
monoadducts. Such a difference in the magnitude of drug sensitivity between these 
yeasts is not unusual, with S. pombe cells often demonstrating a far greater resistance to 
DNA damage.
3.5 Creation of a panel of single and multiple gene disruption 
strains in a defined isogenic background in S. cerevisiae
As discussed in section 1.4.6, previous research has been conducted regarding the 
genetic interactions of PS02  with the three key epistasis groups for DNA repair in yeast 
-  RAD3 (NER), RAD52 (homologous recombination), and RAD6 (post-replication 
repair/translesion synthesis). However, these investigations have involved the use of a 
spectrum of gene mutations, some of which may have retained hypomorphic (leaky) 
phenotypes. Furthermore, these studies have been carried out in non-isogenic genetic 
backgrounds. In the main part of this study, epistasis relationships for PS02 have been 
established using HN2 in the isogenic background B356-7C (Bai and Symington, 
1996). However, it has been necessary to use other strains for certain experimental 
techniques where B356-7C cannot be used, such as the CAN1 forward mutation assay. 
For the first time, a comprehensive panel of haploid single and multiple gene disruptant 
strains encompassing genes from the key yeast DNA repair pathways has been isolated 
in a defined genetic background (Table 2.1). In the creation of these strains, PCR-based 
micro-homology targeted deletion has been used employing combinations of selectable
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marker genes for kanamycin resistance, and histidine (HIS5) and uracil (URA3) 
metabolism. All gene deletions have been systematically checked by PCR across the 
insertion region, and by subsequent characteristic dual restriction enzyme analysis, as 
already described for the disruption of PS02  (Section 3.1).
3.5.1 PS02  is epistatic to the NER pathway for ICL repair
To elucidate any association of PS02 with established yeast epistasis groups for DNA 
repair, the sensitivity of haploid double disruptant strains to HN2 relative to their 
respective single mutants was determined using exponentially growing cultures. 
Previous studies have focussed on the use of RADI, RAD2, and RAD3 as markers for 
the NER epistasis group. In this study, the genetic interaction of PS02  with RAD4, an 
NER factor involved in damage recognition (Section 1.2.1), has been determined. 
Figure 3.8 shows the sensitivity of pso2, rad4 and rad4 pso2 strains to HN2 in two 
different parental backgrounds, DBY747 and B356-7C. Two defined genetic 
backgrounds were investigated as the sensitivity of this assay (survivors per 2 x 107 
cells) proved insufficient at the lOOOpM HN2 dose in the rad4 pso2 double mutant. In 
the case of DBY747 rad4 pso2, no colonies were obtained in any of 4 repeats, whereas 
in the B356-7C background, colonies were observed only once in 7 assays. By 
comparison, rad4 survivors were found at the highest dose in 1 in 4 (DBY747) and 4 in 
7 repeats (B356-7C), plating at the same concentration as for rad4 pso2. This reflects 
the fact that the DBY747 rad.4 strain demonstrates greater sensitivity to HN2 at the 
lower doses than in B356-7C (Fig. 3.8). In conclusion, the double mutant pso2 rad4 
does not exhibit significantly increased sensitivity to HN2 compared to the most 
sensitive corresponding single mutant (rad4), inferring an epistatic interaction of pso2 
with genes of the NER pathway.
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Figure 3.8 Comparison o f HN2 sensitivity in pso2 and rad4 (NER) deficient 
cells. A. DBY747 background. B. B356-7C background. Exponential phase 
cells were treated with 0 to 1000 pM HN2 for 1 h, and survival monitored by 
plating on YEPD. All results are the mean of at least three independent 
experiments, and the error bars show the SEM.
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3.5.2 Both P S02  and NER exhibit a non-epistatic relationship with 
homologous recombination for the repair of cross-links
The original examination of PS02 interaction with the homologous recombination 
epistasis group concentrated on RAD52 (Siede and Brendel, 1982). RAD52 is central to 
all pathways of homologous recombination, both conservative (involving gene 
conversion, cross-overs) and non-conservative (SSA, BIR and ectopic) (Symington, 
2002). Hence if PS02  was directly involved in one of these sub-pathways, but not 
others also relevant to ICL repair, it is possible that use of such a ubiquitous marker as 
RAD52 would prevent detection. In contrast, RAD51 is crucial only to conservative 
homologous recombination events (Symington, 2002). Therefore an epistatic 
association might be expected if PS02 interacted with RAD51, or a synergistic 
relationship should PS02  be involved in RAD5/-independent sub-pathways. The HN2 
sensitivity of pso2 rad51 and pso2 rad52, compared to the respective single mutants 
and B356-7C parental strain, is shown in figure 3.9. Consistent with a requirement for 
homologous recombination in ICL repair, both rad51 and rad52 cells demonstrate 
increased sensitivity to HN2 compared to the isogenic parent B356-7C, and this 
sensitivity is comparable to that of the pso2 single mutant strain. Interestingly, rad52 
deficient cells are only fractionally more sensitive to HN2 than rad51, suggesting that 
RAD57-dependent homologous recombination is the preferred repair mechanism for 
ICLs. Both pso2 rad51 and pso2 rad52 double disruptants are more sensitive to HN2 
than either single mutant alone. Loss of both rad51 and pso2 does not lead to as severe 
a phenotype as for the absence of rad52 and pso2. Certainly, it was never possible to
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Figure 3.9 Comparison o f HN2 sensitivity in pso2 and HR mutants. A. 
Comparison of pso2 with rad51 deficient cells. B. Comparison of pso2 with 
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detect pso2 rad52 survivors at the highest dose of 1000 \iM  HN2 (0/3 assays versus 3/5 
for pso2 rad51) and pso2 rad52 double disruptants are at least 10 fold more sensitive at 
the lower doses of 10 and 100 p,M HN2. It would seem that PS02  acts synergistically 
with RAD51-dependent pathways of recombination. Furthermore, an epistatic 
relationship with non-conservative pathways of recombination is unlikely, as a greater 
synergism is seen with RAD52 than with RAD51, presumably reflecting the spectrum of 
RAD52 activity. Hence it appears that pso2 does not exhibit any involvement with the 
homologous recombination pathways of DNA repair.
However, a synergistic relationship between PS02 and RAD51IRAD52 could also result 
from the additional occurrence of ICL-associated homologous recombination events 
that are totally independent of the epistatic NER-PS02 pathway. To address this 
hypothesis, the relationship between NER (rad4) and recombination (rad52) for ICL 
repair was determined. If prior processing of a cross-link by the NER apparatus is 
required for all ICL-associated recombination events, then rad4 should be epistatic to 
rad52 for sensitivity to HN2. It is clear from figure 3.9 C however, that the rad.4 rad52 
double mutant is significantly more sensitive to HN2 than either rad4 or rad52 alone. 
The magnitude of the sensitivity of the rad4 rad52 double mutant is identical to that for 
pso2 rad52, and again no colonies were recovered at the highest dose (cf. 3.9 B and C). 
It is clear therefore, that neitherpso2 nor NER is epistatic to homologous recombination 
for the repair of ICLs, but that this does not exclude the possibility that downstream 
recombination events may be required to reconstitute dsDNA from an ICL 
intermediates generated by the combined actions of NER factors and Pso2.
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3.5.3 PS02  acts synergistically with the tfADtf/post-replication repair 
pathway
It has been suggested that the PRR pathway is predominantly involved in the repair of 
ICLs in stationary phase cells where homologous DNA regions are not available for 
recombination (McHugh et al., 2000). Hence it is feasible that pso2 may be epistatic to 
the RAD6 pathway in stationary phase cells but not those that are exponentially 
growing. Figure 3.10 A and B contrast the genetic interactions between pso2 and rev3 
for HN2 treatment in exponential phase cells and after G1-arrest induced by a-mating 
factor, respectively. The rev3 mutant is sensitive to HN2 but only in stationary (Gl- 
arrested) cells. However, pso2 rev3 double disruptants exhibit greater HN2 sensitivity 
than the single mutants in either growth phase. This would suggest a role for PS02 in 
the repair of ICLs in stationary phase yeast that is distinct from the post-replication 
repair pathway.
Interestingly, pso2 appears to show epistasis with radl8 (Fig. 3.10 C) in exponential 
cells. This is not necessarily contradictory with the observation of synergism with 
REV3, as RAD18 acts upstream at the initial recognition phase of post-replication repair, 
before the pathway diverges into the mutagenic (REV3) and error-free (MMS2/RAD5) 
branches. It is entirely feasible that Pso2 may act in conjunction with Rad 18 for the 
recognition and repair of ICL by the error free pathway.
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3.5.4 Loss of PS02  leads to increased mutagenesis, dependent on 
REV3
The /MD6/post-replication repair pathway is known to be important for the efficient 
processing of ICLs, as already discussed (Section 1.3.2). If PS02 were involved in 
mechanisms of ICL repair distinct from the /?£V3/error-prone sub-pathway, then in the 
absence of PS02 , mutagenic repair would be expected to predominate. The CAN1 
forward mutation assay is a convenient method for the analysis of mutagenicity, as it 
measures the frequency of gain of function mutations (Grenson et al., 1966; Crouse,
2000). This contrasts with other assays of mutagenesis such as hom3-10 and lys2ABgl, 
which look for the reversal of an existing mutation, and as such can be compromised by 
the detection of suppressor mutations in addition to those in the original gene (Crouse,
2000). Briefly, CAN1 encodes an arginine permease that is equally able to transport the 
toxic arginine-analogue L-canavanine. It follows that to survive in the presence of L- 
canavanine, cells must acquire mutations in the CAN1 gene that prevent permease 
activity. It was necessary to conduct these experiments in the DBY747 genetic 
background that carries the CAN1 wild-type allele, as the B356-7C/W303-1A 
background is canl-100 and as such is already resistant to L-canavanine.
The frequency of CAN1 forward mutation after treatment with increasing doses of HN2 
was calculated as mutants per 108 survivors (Fig. 3.11). The pso2 deficient strain shows 
a spontaneous mutation frequency around 2-fold higher than in the wild type DBY747. 
After treatment with HN2, pso2 cells are hyper-mutagenic, with 4-times more mutations 
detected at 100 pM HN2 than for the parent strain. As expected, loss of REV3 results in
143
20000 -|
12r \ 18000-U.> 16000-
C 14000 -
CO
00q 12000-T“
l_ 10000-
CDQ. 8000-
COr" 6000-
CO 4000-
-J
E 2000 f
DBY747 wt
pso2 rev3
1 10 100 
HN2 dose (^M)
1000
B 20000£n 18000u> 16000
C
C/5
00
O
14000
12000
10000
CD
Q. 8000
CO 6000
B 4000
E 2000
0
■ DBY747 wt
pso2
rad18
■pso2 rad18
1 10 100 
HN2 dose (pM)
1000
20000 
g 18000 
|  16000 
|  14000 
12000 _ 10000 
§. 8000 
B  6000 
|  4000 |  2000 
0
— DBY747wt 
—Q—pso2 
♦  rad4 
—O—pso2 rad4
1 10 100 
HN2 dose (pM)
1000
Figure 3.11 Mutagenesis in pso2, PRR, and NER mutants. Analysis of HN2- 
induced CanR forward mutagenesis in pso2 cells, compared with A. rev3, B. 
ra d l8 , C. rad4, in the DBY747 background. Due to the logarithmic scale, 
spontaneous mutagenesis is plotted as 0.1 pM HN2. All results are the mean 
of at least 3 independent experiments, and the error bars represent the SEM.
144
a significantly lower mutation frequency, and no HN2-inducibile mutagenesis is seen 
(Fig. 3.11 A). The pso2 rev3 double mutant exhibits an equally low rate of mutagenesis 
(Fig. 3.11 A) indicating that the elevated mutation frequency seen in pso2 cells is 
entirely due to the activity of REV3. This implies that the R£V3/error-prone repair 
pathway is an important compensation mechanism in the absence of PS02.
Interestingly, mutation frequency in the radl8 mutant strain does not fall below the 
wild-type level until 100 pM HN2 (Fig. 3.11 B), at which dose survival is negligible 
(Fig. 3.10 C). This confirms the observations published by Liefshitz et al. where 
hypomutagenesis was only observed in the absence of both rad.18 and rad5 (Liefshitz et 
al., 1998). A similar mutation frequency is observed in the pso2 radl8 double 
disruptant (Fig. 3.11 B), confirming the role of the post replication repair pathway in the 
HN2-induced mutagenic phenotype of the pso2 strain.
Mutation frequency was also analysed in a rad4 pso2 double disruptant to observe 
whether the hyper-mutagenic phenotype was P5'02-specific. The rad4 single mutant 
elicits a greater frequency of mutation at the CAN1 locus than for pso2, even at a low 
dose of 1 pM HN2 where a 10-fold increase over the wild type mutation rate is seen 
(Fig. 3.11 C). This corresponds with the CAN1 forward mutation frequency observed 
previously for another NER factor, radl4  (McHugh et al., 1999). It is clear from figure
3.11 C that the epistatic relationship between PS02 and RAD4 for HN2 extends to 
induced mutagenesis, as no further increase in mutation frequency is seen in the double 
mutant compared to the rad4 single. This implies that a deficiency in NER1PS02- 
dependent ICL repair causes a diversion into the alternative RAD6/post-replication 
repair pathway, and in particular, the R£V3/error-prone mechanism.
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3.6 DSB repair is deficient in the absence of PS02
The occurrence of DSBs has frequently been observed in eukaryotic cells following 
treatment with ICL-forming drugs, particularly HN2 (Akkari et al., 2000; De Silva et 
al., 2000; McHugh et al., 2000). Furthermore, density gradient centrifugation 
experiments have suggested that repair of these breaks is deficient in the absence of 
pso2 (Magana-Schwencke et al., 1982; Wilbom and Brendel, 1989). A convenient 
technique for the visualisation of DSBs is contour-clamped homogeneous electric field 
(CHEF) pulsed field gel electrophoresis. In CHEF, yeast chromosomes appear as a 
distinct ladder of bands that are replaced by a smear of lower molecular weight material 
if DSBs are present. This procedure has been successfully used to study the occurrence 
of DSBs during the repair of ICLs (Averbeck and Dardalhon, 1990; Averbeck et al., 
1992; Dardalhon and Averbeck, 1995).
Here, CHEF is used to evaluate the formation and repair of DSBs after treatment with 
100 pM HN2 in cells deficient in the major pathway of ICL repair, namely pso2, rad4, 
and rad52. Exponentially growing cells were treated with HN2 and subsequently 
allowed to repair for 2, 4, or 24 h in drug-free minimal nutrient medium (MM) that 
prevents DNA replication (Dardalhon and Averbeck, 1995), before analysing the 
chromosomal preparations on CHEF gels. Samples were not investigated at 0 h repair, 
as DSBs have not been detected immediately after treatment (P. McHugh, unpublished 
observations). In the repair competent wild-type strain, DSBs are observed 2 h after 
HN2 treatment with initiation of repair by 4 h and completion after a 24 h period (Fig.
3.12 A). In contrast, an increased yield of DSBs is apparent in the absence of PS02 , 
and very little repair is evident after 24 h (Fig. 3.12 A).
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Figure 3.12 HN2-induced DSB repair in pso2, NER, and HR mutants. 
Exponential phase cells were treated with 100 pM HN2 for 3 h, and 
subsequently allowed to repair in minimal media for 2, 4, or 24 h. Mock 
treated (u) cells were allowed to repair for 24 h. Chromosomal preparations 
were analysed by CHEF, and typical gels are shown. A. DBY747 wt and pso2 
strains. B. rad4 and rad52 deficient cells.
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The appearance and subsequent repair of DSB arising from ICLs has previously been 
investigated to some extent in cells deficient in the major repair pathways (McHugh et 
al., 2000; Dardalhon and Averbeck, 1995). However, for completion, rad.4 and rad52 
disruptant strains representing NER and homologous recombination repair, respectively, 
were also considered here. It is clear from figure 3.12 B that the rad4 and rad52 strains 
are deficient in DSB repair. Strikingly, the rad4 mutant appears less able to repair ICL- 
associated DSBs than the recombination-defective rad52, as a small proportion of intact 
chromosomes have been recovered by 24 h in rad52 cells, whereas the rad4 
chromosomes remain completely degraded. Furthermore, the rad4 strain exhibits a 
greater accumulation of DSBs and a reduced capability for repair than pso2 (cf. Fig.
3.12 A).
3.7 Discussion
After decades of inconclusive investigation into the precise role of PS02 , it was prudent 
to revisit some of the published data using defined isogenic disruption strains and 
techniques, in order to unambiguously define the pso2 mutant phenotype. It is clear 
from the data accumulated from microscopy, culture density, and drug-induced arrest 
assays (Section 3.2) that loss of pso2 does not affect the normal progression of the cell 
cycle, compared to the wild-type parent strain. However, it was beyond the scope of 
this thesis to conduct a detailed study of the cell cycle response to ICL damage. Such 
an investigation has been performed concurrently in Oxford, using confocal microscopy 
and FACS (fluorescent activated cell sorting) analysis, with the conclusion that a 
deficiency in pso2 does not lead to irregular cell division or cell cycle arrest (S. Sarkar, 
J. Sidebotham and P. McHugh, personal communication). Hence the response to
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nitrogen mustard appears to differ to some extent from that observed with cisplatin, 
where cells have been reported to arrest in G2 (Grossmann et al., 2000).
Despite the putative interaction between Pso2 and MgmlOl identified in large-scale 
proteomic screens (Ho et al., 2002), the activity of Pso2 appears to be primarily nuclear 
rather than within the mitochondria (Section 3.2.3). This correlates with the PSORTII 
prediction of 56.5 % that Pso2 is localised to the nucleus, compared to a 34.8 % 
likelihood of localisation to the mitochondria. Furthermore, although assigned to the 
mitochondrion, the high-throughput mass spectrometry screen also detected an 
association of YHR076W with the nuclear factors Rad26 (DNA repair) and Drcl (a 
replication fork progression factor) (Ho et al., 2002). Likewise for MgmlOl, which 
was discovered in complexes with Mus81 (DNA repair) and Rfa2 (a subunit of 
replication factor A involved in replication, recombination, and repair) (Ho et al., 
2002), and in a similar independent screen with Msh6 (DNA repair) (Gavin et al., 
2002). Interestingly, some of these protein complexes were only detected after 
treatment of the cells with DNA damaging agents. The association of Pso2 with 
YHR076W was observed after exposure to 4-nitroquinoline 1-oxide, a UV radiation- 
like drug that produces bulky base damage and significant DNA strand breakage (Ho et 
al., 2002). Similarly, the interactions of MgmlOl with Mus81 and Rfa2, and 
YHR076W with Drcl, were found after treatment with the alkylating agent MMS (Ho 
et al., 2002). Hence it is equally possible that the involvement of Pso2 with MgmlOl 
and YHR076W occurs within the nucleus, or that a number of nuclear factors have as 
yet undefined additional roles within the mitochondrion. It is appreciated that such 
high-throughput screens are susceptible to spurious results, and that further research is 
necessary to elucidate any involvement of PS02 with these mitochondrial genes.
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Nevertheless, this research has concentrated on the known requirement for PS02 in the 
repair of cross-linked nuclear DNA.
As discussed in Chapter 1, the PS02  gene was originally isolated as a result of its novel 
mutant phenotype, namely a specific sensitivity to agents that induce DNA ICL, but no 
susceptibility to any other form of DNA damage. In the course of this work, new pso2 
deletion strains have been produced in 3 different yeast genetic backgrounds. Some 
variability was observed in the degree to which these strains are sensitive to HN2 
(Section 0), however, considerable strain differences have been reported previously for 
other gene deletants, such as rad26 strains irradiated with UVC (Gregory and Sweder,
2001). Furthermore, aneuploidy has been detected in a number of BY4743 (diploid) 
strains arising from the EUROSCARF project, not all of which could be explained as a 
result of the known gene deletion (Hughes et al., 2000). Hence the augmented HN2 
sensitivity of the BY4741 pso2 strain may be due to inappropriate expression of other 
genes responsible for repair of DNA ICL. As an additional confirmation of the 
reliability of these gene disruptants, a brief study was undertaken to determine 
sensitivity to the cross-linking drug HN2, as well as X-rays and UVC-irradiation. 
Consistent with published data, these pso2 mutants solely exhibited a significantly 
diminished degree of survival following treatment with HN2 (Section 3.2.4). The mild 
(5-fold) increase in sensitivity to high doses of UV in the pso2 mutant is comparable to 
that observed by Ruhland and co-workers (Ruhland et al., 1981 A).
PS02 has previously been assigned to the NER epistasis group on the basis of 
sensitivity to ICL-forming agents in strains disrupted for pso2 and radl/rad2/rad3. 
Early HN2-sensitivity analysis of the original pso2 isolates had shown that a pso2 radl
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rad2 triple mutant strain is epistatic to a radl rad2 double disruptant (Siede and 
Brendel, 1982). Concurrent studies relating to the ICL-inducing agent psoralen 
demonstrated an epistatic relationship between PS02 and the NER gene RAD3 
(Henriques, 1981). This relationship has been confirmed here for an additional NER 
factor, rad4 (Section 3.3.1). Furthermore, it has been shown that both PS02  and NER 
factors are required for the efficient repair of DSBs associated with cross-links (Section 
3.4). Hence PS02  and NER must act in a single pathway for the repair of ICL. 
However, Pso2 must act downstream of NER as pso2 mutants are proficient in the 
incision of ICL, whereas components of the NER apparatus are essential (Grossmann et 
al., 2000; Magana-Schwencke et al., 1982; Wilbom and Brendel, 1989; Meniel et al., 
1995). The prevailing theory for the mechanism of ICL repair in yeast, and indeed all 
eukaryotes, has been derived from the well-established system in E. coli, in which 
cross-links are incised by the NER apparatus (potentially a specialised XPF-ERCC1 
dependent reaction in mammals) and resected, with the subsequent intermediate 
targeted by recombination. It would seem that PS02 acts in concert with NER in the 
early stages of this pathway. However, if as proposed, the downstream events were 
accomplished by homologous recombination, an epistatic relationship would be 
expected between PS02 and key genes in this pathway. This is clearly not the case 
(Section 3.3.2; Siede and Brendel, 1982), and suggests that, in contrast to bacteria, the 
NER-PS02 system of ICL repair must be independent of recombination in yeast 
(Grossmann et al., 2001).
An alternative explanation for the increased sensitivity of p5o2-recombination double 
deficient cells to ICL-forming agents could be that some recombination events occur at 
cross-links independently of NER-P502. It is possible that such a mechanism may only
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act to tolerate lesions and hence salvage cells in the absence of an effective NER-PS02 
pathway. The observation that the NER genes rad4 (Section 3.3.2) and radl4 (P. 
McHugh, personal communication) also fail to exhibit an epistatic relationship with 
recombination for ICL repair supports this revised model. Furthermore, like rad52 
strains, both pso2 and NER defective cells have been shown to accumulate DSBs after 
treatment with HN2, and these fail to be repaired (Section 3.4). This corresponds with 
the findings of a recent report by Li and Moses (2003), and also corroborates the 
evidence from density gradient centrifugation experiments (Magana-Schwencke et al., 
1982; Wilbom and Brendel, 1989) for the persistence of ICL-associated DSBs in pso2 
mutant cells. The DSB repair deficiency in rad4 cells has been confirmed in a further 
NER mutant, radl4  (P. McHugh, unpublished data) that is also required for recognition 
and binding to damaged DNA. DSBs are known to be a potent trigger for 
recombination events. It is hard to imagine how NER factors and PS02 alone would be 
able to resolve these DSBs if recombination acted in a totally independent pathway of 
ICL repair. It is unlikely that ICL-associated DSBs are repaired by non-homologous 
mechanisms, as mutations in genes of the NHEJ pathway do not render cells sensitive to 
cross-links (McHugh et al., 2000).
There is yet further evidence to support the involvement of recombination with NER- 
PS02  in ICL repair. In repair proficient yeast cells, diploids exhibit an increased 
resistance to ICL compared to haploid cells. This ploidy-related resistance to cross­
links is believed to result from the greater potential for homologous recombination 
utilising the homologous chromosome. A loss of pso2 corresponds with a loss of 
ploidy-related resistance to 8-methoxypsoralen plus UVA, and an absence of the normal 
resistant fraction in G2 relative to stationary phase cells (Cassier et al., 1980; Henriques
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and Moustacchi, 1980). Given that no reduction in sporulation efficiency was observed, 
the authors concluded that PS02  was likely to be involved in a specific step in mitotic 
DNA repair. These characteristics reflect those seen in recombination-defective 
mutants in response to ionising radiation, where both diploid and haploid G2-associated 
resistance is absent (Bressan et al., 1990; Mortimer, 1958; Saeki et al., 1980). Together 
with the DSB repair deficiency observed here, this is strongly indicative of a 
requirement for homologous recombination in the PS02-dependent pathway of ICL 
repair.
Previous investigations into the relationship between PS02 and the RAD6Ipost- 
replication repair system have produced conflicting data. Siede and Brendel (1982) 
demonstrated a synergistic interaction between two independent pso2 mutant alleles and 
either rad6, or radl8 , in stationary phase yeast cells treated with HN2. Henriques and 
Moustacchi (1981) also found pso2 and rad6 to be synergistic for 8-methoxypsoralen 
(8-MOP) photoaddition in stationary phase cells, yet they observed an epistatic 
relationship between pso2 and rev3. More recently, Grossmann and co-workers have 
shown synergism for exponentially growing pso2 and rev3 cells exposed to cisplatin or 
8-MOP (Grossmann et al., 2001). Post-replication repair is believed to play a greater 
role in the response to ICL damage in stationary phase haploid cells, as no substrate is 
available for homologous recombination (McHugh et al.t 2000). Hence, the genetic 
interaction between PS02  and REV3 was considered in both exponential and stationary 
growth conditions. A synergistic relationship was observed in both cases, indicating 
that P5'02-dependent repair of ICL is distinct from DNA polymerase £ mediated post­
replication repair (Section 3.3.3). Further evidence to support this observation was 
obtained from the analysis of HN2-induced mutagenesis. If these two pathways were
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indeed distinct, then it would be assumed that in the absence of PS02, repair would be 
channelled into the post-replication pathway, leading to increased mutagenesis. This 
phenomenon was clearly observed (3.3.4), and suggests that the REV3-dependent error- 
prone repair branch of post-replication repair is required for ^502-independent repair 
oflCLs.
The novel observation that PS02  is epistatic to RAD18 in exponentially growing cells is 
particularly interesting with regards to published work suggesting an interaction 
between RAD18 and NER in the repair of minor groove adducts that prevent efficient 
DNA strand separation (Kiakos et al., 2002). It was proposed by the authors that Rad6- 
Radl8 and Rad5 might be required to target repair factors to lesions that are poorly 
displayed or prevent effective strand separation. Cross-links by definition prevent the 
separation of DNA strands, and so it is entirely conceivable that RAD18 may be 
required in the initial stages of ICL recognition and repair. One possibility is that as the 
cross-link is bound to both strands of DNA, ICL repair may require a combined 
recombination/bypass pathway, which is dependent upon both Rad 18 and Rad52, in 
addition to initial processing by NER-Pso2 (discussed in more detail in Chapter 6).
Homologues of PS02  have been identified throughout the eukaryotic kingdom from 
yeast to humans. However, complementation between these homologues has yet to be 
fully determined. Indeed, mouse embryonic stem cells null for the paralogue PS02  
only appear to be sensitive to mitomycin C (of the cross-linking agents tested) 
(Dronkert et al., 2000). It is possible that this may result from a functional redundancy 
between the multiple murine PS02 homologues, however this theory remains to be 
verified. Here, a pso2 deficient Schizosaccharomyces pombe strain is presented that is
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sensitive to HN2, but not the monofunctional derivative HN1. This study was 
performed in collaboration with Professor Tony Carr, who further confirmed the extent 
to which these two yeasts share an identical pso2 phenotype. In S. pombe, as for S. 
cerevisiae, pso2 defective cells were shown to be sensitive to the ICL-inducing agents 
cisplatin and MMC, but not UVC, gamma radiation, HU, and camptothecin (Lambert et 
al., 2003). This represents the first identification of an evolutionarily distinct PS02  
homologue with the same mutant phenotype as in S. cerevisiae, and provides an 
additional model organism through which the role of PS02/SNM1 in DNA repair may 
be elucidated.
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CHAPTER 4 INTERACTIONS OF PS02 WITH YEAST
REPAIR NUCLEASES
As discussed in Chapter 3, the nature of interaction of PS02 with genes of the NER and 
homologous recombination pathways suggests that Pso2 acts at some intermediate stage 
of repair, downstream of the initial incision event, but prior to reconstitution of high 
molecular weight DNA. It is plausible that the DNA product resulting from incision is 
unsuitable as a substrate for recombination, and so requires further processing before 
strand invasion can occur. Indeed, it is already established that the 5’ to 3’ exonuclease 
activity of DNA polymerase I is required to resect the incised strand during ICL repair 
in E. coli (Sladek et al. 1989), and that this is a prerequisite for subsequent strand- 
invasion mediated by RecA (van Houten et al., 1986). The classification of PS02 as a 
(3-CASP metallo-p-lactamase also supports the hypothesis that Pso2 may be involved in 
resection of the incised cross-link as to date, all other eukaryotic members of this family 
have been shown to act nucleolytically (Callebaut et al., 2002).
The relationship of PS02 with the known yeast repair nucleases EX01y MRE11, 
RAD27, and RADI was therefore investigated. Exol is a 5’-3’ exonuclease implicated 
in DNA replication, homologous recombination, and mismatch repair (Tishkoff et al., 
1997 A). M rell has been shown to possess 3’ to 5’ exonuclease and an endonuclease 
activity, and is involved in DSB resection and the S-phase checkpoint as a complex 
with Rad50 and Xrs2 (Usui et al., 1998; Haber, 1998). Rad27, the yeast homologue of 
mammalian FEN1 (Greene et al., 1999), has 5’-3’ exonuclease and flap endonuclease 
activity required for Okazaki fragment processing in DNA replication and also in BER
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(Reagan et al., 1995; Sommers et al., 1995). Radi forms a complex with RadlO to 
form a structure specific endonuclease that cuts 5’ to the lesion in NER (Bardwell et al., 
1992), and is also involved in cleavage of 3’ non-homologous tail structures during the 
single strand annealing recombination pathway (Fishmann-Lobell and Haber, 1992; 
Schiestl and Prakash, 1988; Tomkinson et al., 1993). A panel of single and multiple 
gene deletions encompassing these factors and PS02 was established in the isogenic 
background B356-7C, as described in Section 3.5.
4.1 Repair of nitrogen mustard-induced DNA ICL
4.1.1 PS02  exhibits significant synergism with EXO l
In the first instance, S. cerevisiae strains deficient for nuclease activities and PS02 were 
treated with HN2, and sensitivity was compared to their respective single mutant 
parents (Fig. 4.1). Given that RADI belongs to the NER repair group, an epistatic 
relationship with PS02 would be expected, as has already been established for RAD4 
(Section 3.5.1). As can be seen from figure 4.1 A, radl cells are more sensitive to HN2 
than pso2 mutants, and the double disruptant exhibits a moderate (less than 10 fold) 
increase in sensitivity. The magnitude of this increase is not sufficiently large to 
indicate additivity, but presumably reflects the involvement of RADI in a minor, 
recombination-dependent repair pathway, that acts on ICL lesions in the absence of 
PS02. It is noteworthy, however, that radl is equally sensitive to HN2 as rad4 (Fig.
4.1 A, E), exhibiting 2.1 and 3.5 x 105 % survival, respectively, at 1000 p,M HN2. This
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Figure 4.1 Comparison o f HN2 sensitivity in pso2 and nuclease mutants. 
Exponential phase parental B356-7C, single and double mutant cells were 
treated with 0 to 1000 pM HN2 for 1 h, and survival monitored by plating on 
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suggests that RADI-dependent recombination is not significant for ICL repair in the 
presence of functional PS02. A loss of RAD27 leads to a mild sensitivity to HN2 (Fig.
4.1 B), indicating some involvement in ICL repair, as has been reported previously 
(McHugh et al., 2000). The sensitivity of the pso2 rad27 double mutant to HN2 is 
approximately equivalent to the sum of the individual mutant sensitivities, particularly 
at the highest dose (Fig. 4.1 B). Hence, PS02  shows an additive association with 
RAD27, as would be expected for genes operating in different repair capacities.
In contrast, PS02  acts synergistically with both MRE11 and EXOl for HN2 sensitivity 
(Fig. 4.1 C, D). At 100 pM HN2, the pso2 exol and pso2 m rell double mutants exhibit 
10,000-fold greater sensitivity than the pso2 strain alone, and no survivors were 
obtained from 2 x 107 double-disruptant cells treated with 1000 pM HN2. This 
relationship is most striking for EXO l, as unlike m re ll , the exol single mutant 
demonstrates wild-type resistance to HN2 (Fig. 4.1 D). Indeed, the m rell strain is as 
sensitive to HN2 as other recombination defective mutants such as rad51 and rad52, 
and the corresponding double disruptants with pso2 give similar phenotypes for HN2 
sensitivity (cf. Fig. 3.9 A, B). It follows that the synergism existing between PS02  and 
MRE11 is more likely to reflect the involvement of M rell in recombination events, 
rather than specifically its nuclease activity. The synergism with EXOl is interesting as 
it intimates that, although Exol does not play an essential role in the repair of ICL, as 
some degree of sensitivity would be expected for exol, it may be able to compensate for 
the loss of Pso2 to some extent, and therefore may have a similar mode of activity, 
potentially a nuclease function.
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As PS02  is generally assigned to the NER epistasis group, the relationship between 
EXOl and RAD4 was investigated to determine whether the overlap of activity with 
Exol is specific to Pso2 rather than NER as a whole. It is clear from figure 4.1 E that 
the rad4 exol double disruptant does not exhibit increased sensitivity to HN2, and 
hence synergism with EXOl is not observed with the NER repair group in general. 
Hence, for the first time, separation of function is presented genetically for PS02 and 
genes of the NER pathway during ICL repair.
4.1.2 PS02  also acts synergistically with MSH2
Exol has been shown to interact physically with Msh2 and Mlhl by co- 
immunoprecipitation and two-hybrid analysis (Tishkoff et al., 1997 A; Tran et al.,
2001). A recent study has shown that Msh2, as part of the MutSa complex, acts to 
regulate the 5’-3’ exonucleolytic activity of Exol during mismatch repair (Genschel and 
Modrich, 2003). Exol is known to be required for the processing of DSBs (Tsubouchi 
and Ogawa, 2000), and it has also been suggested that the Msh2-Msh3 (MutSP) 
heterodimer is recruited to DSBs and branched DNA structures, with a possible role in 
the promotion of cleavage by the Radl-RadlO endonuclease (Sugawara et al., 1997; 
Evans et al., 2000). Consequently, the relationship of PS02  with MSH2 was 
investigated, to determine whether a pso2 msh2 double mutant would phenocopy pso2 
exol cells for sensitivity to HN2. Figure 4.2 A shows a similar pattern of interaction 
between PS02  and MSH2 as with EXOl. The single msh2 mutant demonstrates an 
almost wild-type level of resistance to HN2, similar to the exol mutant (Fig. 4.1 D). 
The double disruptant pso2 msh2 is significantly more sensitive than the pso2 strain
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(Fig. 4.2 A), exhibiting a 10,000-fold increase in sensitivity at 100 pM HN2, equal to 
that observed for pso2 exol cells.
An exol msh2 double mutant demonstrates near wild-type resistance to HN2 (Fig. 4.2 
B), consistent with epistasis amongst these genes in the response to ICLs. A triple 
mutant, pso2 exol msh2 was also tested for sensitivity to HN2 (Fig. 4.2 C). Although a 
very slight increase in sensitivity was seen, this probably only reflects the variability in 
this experimental system, especially given the moderate differences between the pso2 
exol and pso2 msh2 sensitivities to HN2 at the intermediate doses. Furthermore, this 
increase is not significant enough to be considered as non-epistatic. Hence, it would 
seem that Exol and Msh2 are jointly involved in the repair of DNA cross-links in a 
mode that overlaps with the activity of Pso2.
4.2 Sensitivity to other DNA damaging agents
Given the well-established pso2 mutant phenotype of specific sensitivity to DNA cross­
links, yet the apparent non-essential role of Exol-Msh2 in ICL repair, it was important 
to establish whether the observed overlap of activity between PS02 and EX01/MSH2 
was exclusive to the repair of ICL. A range of cytotoxic agents was considered, 
including other DNA damaging agents (X-irradiation and UVC) and also inhibitors of 
cell cycle progression (Hydroxyurea and Benomyl).
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4.2.1 Loss of both P S02  and EX01IMSH2 causes increased sensitivity 
to ionising radiation
The pso2 exol and pso2 msh2 double disruptants, and corresponding single gene 
mutants, were exposed to X-irradiation. As demonstrated in Section 3.3 for pso2 
mutants, the phenotypes of exol and msh2 deficient cells also resemble that of the wild- 
type parent strain (Fig. 4.3 A, B). Hence, neither gene is required for the repair of DNA 
lesions arising from ionising radiation. Yet it is clear from figure 4.3 A and B that both 
the pso2 exol and pso2 msh2 double mutants are sensitive to X-irradiation. This 
increased sensitivity is more pronounced in the case of pso2 msh2 than pso2 exol (5 x 
and 2 x more sensitive, respectively). It is clear that, although significant, these 
increases in sensitivity are mild compared to the extreme sensitivity of the 
recombination-defective rad52 strain (Fig. 4.3 C). Interestingly, PS02  appears epistatic 
to RAD52 for the repair of ionising radiation, as a pso2 rad52 double mutant does not 
further impair the rad52 strain. Therefore, any involvement of PS02  in the repair of X- 
irradiation-induced DNA damage must be co-operative with homologous 
recombination.
It is well established that the cytotoxicity of ionising radiation primarily results from the 
induction of DSBs, and that homologous recombination is the principal DSB repair 
pathway in yeast (van Gent et al., 2001). To confirm the important finding that the 
overlap of activity between PS02 and EX01/MSH2 extends to the repair of lesions 
arising from ionising radiation, the analyses of sensitivity to X-irradiation were repeated 
in a different S. cerevisiae genetic background, BY4741. It can be seen from figure 4.3
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D and E that an identical result was obtained in this strain, implying that the increased 
sensitivity observed in the pso2 exol and pso2 msh2 double mutants is solely related to 
these genetic factors. The discovery that PS02 appears to have an overlap of activity 
with EX01/MSH2 for the repair of ionising radiation-induced DNA damage is 
suggestive of a more fundamental, possibly DSB-associated, repair defect in the 
absence of both pathways.
4.2.2 PS02  and EX01IMSH2 are not synergistic for the repair of DNA 
damage associated with UVC
It has already been ascertained that loss of PS02 results in a mild sensitivity to high 
doses of UVC (Fig. 3.6 A). It was therefore prudent to determine whether a further 
deficiency in EX01/MSH2 would exacerbate this condition. The double disruptants 
pso2 exol and pso2 msh2 were exposed to UVC and the resulting sensitivities were 
compared to those of the respective single mutants. It is clear from figure 4.4 that 
neither exol nor msh2 single mutants are sensitive to UVC. The exol strain appears 
indistinguishable from the wild-type, whereas msh.2 cells show a slight resistance over 
this UVC dose range. This result is contrary to the report published by Qiu and co­
workers (1998) in which exol and msh2 deficient yeast strains exhibited a mild 
sensitivity to UV, however, this was primarily observed at high doses (in excess of 100 
J/m2), and not in the range presented here. No increase in sensitivity to UVC is 
observed in either the pso2 exol or pso2 msh2 double disruptant strains, compared to 
the respective single mutants (Fig. 4.4). Hence neither PS02 nor EX01/MSH2 play a 
role in the repair of UVC-induced DNA damage. Although it remains possible that a
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non-epistatic interaction may be manifest at doses of UV greater than 50 J/m2, it is 
debatable whether this would represent a true physiological relationship, given the loss 
of viability of NER deficient yeast exposed to UVC in excess of 10 J/m2 (Fig. 3.6 A).
4.2.3 PS02  and EX01/MSH2 do not function in the S-phase or mitotic 
checkpoints
As already discussed (Section 3.2.2), HU and benomyl are potent inhibitors of cell cycle 
progression, affecting DNA synthesis and mitosis, respectively. Single and double 
mutant combinations of pso2, exol, and msh2 were grown on YAPD plates 
supplemented with HU (0, 2.5, 5, 10, 20, 40 mM) or benomyl (0, 10, 25, 50 p-g/ml). An 
m rell mutant was used as a positive control for HU sensitivity, as previous studies 
have shown it to be hypersensitive to replicative stress, with no viability detected on 
YPAD supplemented with 10 mM HU (D’Amours and Jackson, 2001). In the case of 
HU, viability of the pso2, exol, msh2, and pso2 exol, pso2 msh2 double disruptants was 
indistinguishable from the wild-type parent B356-7C in that all were able to grow 
unhindered at the maximum dose of 40 mM HU (Fig. 4.5 A). This contrasts with the 
m rell strain, which exhibited negligible growth when treated with 10 mM HU, and not 
at all at doses above 20 mM HU (data not shown).
A similar result was achieved upon treatment with benomyl (Fig. 4.5 B). Both the pso2 
exol and pso2 msh2 double mutants were able to survive as competently as the wild- 
type and pso2 strains, exhibiting good growth at a dose of 25 p-g/ml (Fig. 4.5 B), but 
negligible survival at 50 (ig/ml benomyl (data not shown). The exol and msh2 strains 
appeared to be slightly more sensitive at 25 p-g/ml, but not to any significant degree, and
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their growth in the presence of benomyl was not as affected as the m rell deficient cells 
(Fig. 4.5 B). Together this suggests that PS02 and EX01/MSH2 do not play a major 
role in either the maintenance of replication forks stalled by dNTP depletion, or the S- 
phase or mitotic checkpoints.
4.3 Analysis of DSB repair by CHEF
The discovery of sensitivity to ionising radiation in cells doubly disrupted for pso2 and 
exol/msh2 (Section 4.2.1), suggests the possibility of a more general defect in DSB 
repair in the absence of both of these factors, than just ICL-associated DSBs. The 
application of CHEF for the study of DSB repair has already been introduced in Chapter 
3. Here it has been utilised to further investigate the role of PS02 and EX01-MSH2 in 
DSB repair, following treatment with HN2 and also after ionising radiation. Given the 
observed sensitivity to X-irradiation, it was expected that pso2 exol/msh2 gene 
disruptants would demonstrate a reduced capacity to repair DSBs. However, the precise 
sequence of events surrounding the formation of a DSB at a cross-link has not yet been 
determined. One intriguing possibility is that if Pso2 and Exol-Msh2 were redundantly 
involved in incision events at a cross-link that resulted in the formation of a DSB, then 
loss of both activities may manifest as a failure to produce DSBs. If the DSB was an 
important stimulus for recombination, then the overall efficiency of the repair pathway 
would be reduced, and sensitivity would increase, as observed.
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4.3.1 DSB repair intermediates fail to be repaired and accumulate 
after HN2 treatment
Exponentially growing cells were treated with HN2 and subsequently allowed to repair 
for 2, 4, or 24 h in drug-free minimal nutrient medium that permits efficient repair but 
prohibits cell division1 before analysing the chromosomal preparations on CHEF gels. 
Figure 4.6 shows typical CHEF gels obtained from B356-7C (wild type), pso2, exol, 
pso2 exo l, msh2, pso2 msh2, and pso2 exol msh2 mutant cells, treated with 50 pM 
HN2. Consistent with the results obtained using 100 pM HN2 (3.4), repair is evident 
by 2 h, and intact chromosomes are significantly restored by 24 h in the wild-type strain 
(Fig. 4.6 A). Also, pso2 mutant cells are proficient in the formation of DSB, but these 
fail to be repaired to the same extent as in the parental strain, as degraded chromosomes 
(smear) are still observed after 24 h (Fig. 4.6). The exol strain has a repair profile 
indistinguishable from the wild-type (Fig. 4.6 A), as expected from the lack of 
sensitivity to HN2 (Fig. 4.1 D). Although the msh2 mutant exhibits significant DSBs at 
2 h, the proportion of the chromosomes recovered by 24 h is comparable to the wild- 
type and exol strains (Fig. 4.6 B, Table 4.1). In contrast, the double disruptants, pso2 
exol and pso2 msh2, accumulate a higher proportion of DSBs than the pso2 strain, as 
can be seen from the complete degradation of the largest yeast chromosomes in the 
double disruptants (Fig. 4.6 A, B). Despite the large differences in cell survival 
between the strains at 50 pM HN2 (Fig. 4.2), the considerable chromosomal 
degradation observed in the double mutants is not thought to be due to cell death.
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Figure 4.6 HN2-induced DSB repair in pso2, exol, and msh2 mutants. 
Exponential phase cells were treated with 50 pM HN2 for 3 h with subsequent 
repair in MM for 2, 4, or 24 h. Mock treated cells = (u). Position of the plugs 
(P), chromosomes IV and XV are marked with arrows. Typical CHEF gels 
comparing A. B356-1C,pso2, exol, andpso2 exol, and B. pso2 and msh2.
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Indeed, little smearing is observed in rad52 cells treated with 200 Gy ionising radiation 
(Figs. 4.7, 4.8), even though the surviving cell population is just 0.01 % (Fig. 4.3 C). 
Furthermore, the double mutants show an even greater deficiency in DSB repair, as 
indicated by the persistence of a smear rather than recovery of clear defined 
chromosomal bands. This is most clearly observed in the larger yeast chromosomes, 
such as chromosome IV, which by virtue of their size will receive more cross-links and 
therefore DSBs. The triple gene disruptant, pso2 exol msh2, demonstrates a complete 
deficiency in DSB repair (Fig. 4.6 B). It is apparent from figure 4.6, that partial 
recovery of chromosome IV is achieved in the absence of PS02 , but that an additional 
deficiency in EXOl and MSH2 renders cells unable to reconstitute any detectable high 
molecular weight DNA. Hence disruption of both PS02 and EX01/MSH2 amplifies the 
deficiency in repair of ICL-induced DSB.
Attempts were made to quantify this deficiency by Southern blotting of the CHEF gels 
and subsequent probing with a radioactive marker for chromosome XV, which exhibits 
the second slowest migration (Fig. 4.6). A good level of detection was achieved in the 
untreated samples of all strains. However, this technique did not prove sensitive 
enough to differentiate between the repair capacities of the pso2, pso2 exol, and pso2 
msh2 strains (data not shown). An indication of the repair capacities of each strain was 
instead obtained by computational Gel-Pro analysis (Media Cybergenetics) of the 
images of the ethidium bromide-stained CHEF gels taken under UV light. As a result 
of the highly stained smear of fragmented DNA, it was impossible to quantify the extent 
to which the smaller chromosomes could be reconstituted. Therefore it was decided to 
base the quantification of repair solely upon the largest chromosome, IV, which runs 
considerably slower than the smear in any of the strains investigated. Using Gel-Pro,
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the maximum optical density (OD) was calculated for this chromosome band in the 
untreated and 24 h repair lanes. From this data, the DSB repair capacity of each strain 
could be estimated from the percentage of untreated chromosome IV recovered at 24 h 
(Table 4.1).
Table 4.1 DSB repair efficiencies. The maximum OD was calculated by Gel-Pro 
analysis of chromosome IV in the untreated (u) and 24 h repair samples. The extent of 
DSB repair at 24 h is expressed as a percentage of the untreated chromosomal 
preparation for each strain, and this figure is also given relative to the wild-type strain.
Strain Repair after 24 h (% of u) Repair after 24 h (rel. to wt)
B356-7C wt 44.9 100
pso2 14.8 33.0
exol 38.1 84.9
pso2 exol 1.7 3.9
msh2 30.2 67.3
pso2 msh2 3.4 7.6
pso2 exol msh2 0.3 0.7
These semi-quantitative results confirm the observations already made by visual 
inspection of the gels. The wild-type strain is able to repair 45 % of the DSBs in the 
largest chromosome population after 24 h. Both the exol and msh2 strains exhibit a 
slight deficiency in repair, reconstituting chromosome IV to 70-80 % of the wild-type 
level. In contrast, repair in pso2 deficient cells is significantly reduced, to only 30 % of 
the wild-type capacity. This deficiency in DSB repair is further reduced in both the 
pso2 exol and pso2 msh2 double mutants, which recover just 4-8 % of the largest 
chromosomes, relative to the wild-type. Less than 1 % of the parental capacity for DSB 
repair is observed in the absence of all three genes.
4.3.2 CHEF analysis of X- and y -irradiated cells
The moderate sensitivity of pso2 exol/msh2 double mutant cells to X-irradiation 
suggests an underlying deficiency in the general repair of DSBs, rather than specifically 
those associated with ICL. Hence CHEF was also used to investigate the repair of 
DSBs arising from ionising radiation. Cells were irradiated with 200 Gy X-rays, and 
then allowed to repair for 2, 4, or 24 hours in minimal media, as for HN2 treatments. 
Samples were also taken immediately following the irradiation, as contrary to HN2, 
where DSBs occur as an intermediate of repair, ionising radiation-induced DSBs are a 
direct DNA lesion. Figure 4.7 shows a typical set of CHEF gels. It is apparent that 200 
Gy X-irradiation does not induce the same extent of detectable DSBs, compared to HN2 
(Fig. 4.6). This is surprising, as at 200 Gy, ionising radiation might be expected to 
produce a significant number of DSBs. Nevertheless, some DSBs are observed, most 
clearly at the level of the largest chromosome (Fig. 4.7).
It has been suggested that the frequency of DSB induction is proportional to the dose 
rate (Dardalhon et al., 1994). Therefore, in order to obtain a higher yield of DSBs, and 
to facilitate greater strain comparison, yeast cells were irradiated using a Co-60 y-ray 
source with a higher dose rate of 9 Gy/min. Figure 4.8 shows a typical CHEF gel of 
chromosome preparations from cells irradiated at 200 Gy y-rays. A smear of degraded 
DNA is not apparent for any of the strains at any of the time-points. Hence, despite an 
almost four-fold increase in dose rate, fewer DSBs were observed than for X- 
irradiation. Detectable levels of DSBs have been observed in yeast using the CHEF 
method after treatment at 200 Gy y-ray from comparable Co-60 sources (Geigl and 
Eckardt-Schupp, 1990; Dardalhon et al., 1994; Moore et al., 2000). However the dose 
rates used in these published studies were greater than 20 Gy/min, and experiments
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Figure 4.7 X-irradiation-induced DSB repair. Exponential phase cells were 
treated with 200 Gy X-rays with repair in MM for 0 ,2 ,4 , or 24 h. Mock treated 
cells (u) were allowed to repair for 24 h. Typical CHEF gels comparing B356- 
7C parental, pso2, exol ,pso2 exol, and rad52 strains. The plug, P, and largest 
chromosome, IV, are marked with arrows.
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were performed on stationary phase diploid cells, rather than the exponential phase 
haploid cells utilised here. It is feasible that these conditions could significantly affect 
the yield of DSBs.
The lack of detectable DSBs induced by y-irradiation, as compared to X-rays, suggests 
that the incidence of frank DSBs is very rare under these conditions. It is possible that a 
proportion of the DSBs observed after X-irradiation may have occurred indirectly, as a 
result of replication forks meeting SSBs caused by reactive oxygen species. The 
apparent delay in the accumulation of DSBs in the repair-defective rad52 strain 
supports this notion (Fig. 4.7), as these cells are extremely slow growing, and arrest for 
extended periods in G2. Hence, the potential for DSB formation at a replication fork is 
greatly reduced in rad52 cells, compared to the wild-type. It is conceivable that the low 
initial yield of DSBs in the pso2 exol strain (Fig. 4.7) is also due to growth arrest, 
especially as this strain exhibits a mild sensitivity to ionising radiation (Fig. 4.3).
By calculating the ratio of chromosomal band intensities between treated and untreated 
cells (q), an estimate can be made of the number of DSB breaks per molecule, in terms 
of the negative natural logarithm of q (Table 4.2) (Geigl and Eckardt-Schupp, 1990). 
The results of this analysis are within the range of 0.23-0.65 DSB per Mb DNA, 
presented by Geigl and Eckardt-Schupp for wild-type cells irradiated with Co-60 y- 
radiation (1990). Evaluation of this data using a Poisson distribution, gives an 
estimation that the likelihood of at least one DSB within a region of DNA comparable 
to the largest yeast chromosome (Ch. IV, 1531 kb) is 37 %, whereas for the smallest 
chromosome (Ch. I, 230 kb), the probability is only 7 %. It is therefore likely that the 
level of DSBs detected here represents the limits of detection using CHEF, and as such,
pso2 exo l pso2exo1
B356-7C wt rad52
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Figure 4.8 y-irradiation-induced DSB repair. Exponential phase cells were 
treated 200 Gy y-irradiation with subsequent repair in MM for 0, 2, 4, or 24 h. 
Mock treated cells = (u). Typical CHEF gels comparing B356-7C parental, pso2, 
exol,pso2 exol, and rad52 strains.
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Table 4.2 Number of DSBs per 1 Mb DNA induced by 200 Gy X-irradiation, as
given by n=-ln(q), where q has been determined experimentally using Gel-Pro analysis 
of the CHEF gel image. The intensity of each band in treated (0, 24 h) lanes was 
calculated as a fraction of the equivalent band in the untreated lane, to give a value of q 
for each chromosome. Data is presented as the mean DSBs observed for the 7 largest 
chromosomes (giving an average length of ~1 Mb), and standard deviations are stated.
Strain DSB /Mb at 0 h (+/- SD) DSB /Mb at 24 h (+/- SD)
B356-7C wt 0.47 (+/- 0.32) 0.26 (+/- 0.08)
pso2 0.24 (+/- 0.21) 0.22 (+/- 0.08)
exol 0.20 (+/- 0.22) 0.20 (+/- 0.15)
pso2 exol 0.02 (+/- 0.08) 0.17 (+/-0.12)
rad52 0.07 (+/-0.11) 0.57 (+/- 0.18)
the variation in DSB yield observed in the wild-type and pso2/exol single mutants is 
probably not significant. Hence an alternative procedure will be required to reliably 
determine whether the sensitivity of the pso2 exol and pso2 msh2 double mutant strains 
is due to a deficiency in DSB repair.
4.4 Recombination at an inverted repeat substrate
Homologous recombination is known to be the major pathway by which DSBs 
generated at ICLs are repaired (McHugh et al., 2000). The parent strain selected for this 
study was developed by L. Symington to contain a novel construct for the analysis of 
mitotic recombination events, integrated at the HIS3 locus on chromosome XV (Rattray 
and Symington, 1994). This well-characterised recombination substrate is comprised of 
an intrachromosomal inverted duplication of the ade2 gene, separated by TRP1 (Fig. 4.9 
A). Both ade2 alleles are non-functional: one has a deletion of the 5’ coding region and
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upstream DNA extending beyond the region of homology (hence may only act as the 
donor), and the other full-length allele bears a 3’ frame-shift mutation at an Nde I site. 
It follows that, in haploid cells, it is possible to compare the frequency of 
intrachromosomal recombination in different genetic backgrounds by measuring 
reversion to ADE? prototrophy, quantified in terms of the proportion of a population 
arising from a single cell that is able to grow in the absence of adenine. Furthermore, 
this system has the additional benefit that the nature of the recombination event (gene 
conversion and/or crossover) can be established through physical analysis of the 
resultant orientation of the ADE2 construct.
4.4.1 Spontaneous intrachromosomal recombination
Rates of spontaneous mitotic intrachromosomal recombination at the ade2 inverted 
repeat construct were determined for the same panel of repair-defective strains as 
considered for HN2 sensitivity (Section 4.1). The results presented here represent the 
mean of at least 10 independent analyses of ADE2+ prototrophs arising spontaneously 
from a founder ade2- cell, upon a switch to solid SC media lacking adenine. Rates 
(events per cell per generation) were calculated from the recombination frequency 
(ADE+ cells/TRP* cells), according to the formula first described by Drake (1970) to 
account for fluctuations in the population size (Section 2.8.1).
In the parental, recombination-proficient strain, the rate of Ade+ recombination was 
observed as 564 (+/- 133) x 10'6 events/cell/generation (Fig. 4.9 B). Spontaneous 
recombination was reduced to 23 % of the wild-type rate in a recombination defective 
rad51 strain, and 0.01 % in a rad52 strain (Table 4.3). These relative rates correspond 
with the original results published by Rattray and Symington for these strains (1994). A
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Figure 4.9 Spontaneous recombination at an inverted repeat substrate. A. 
Representation of the mutant ade2 alleles arranged in an inverted repeat about 
the TRP1 gene. One ade2 allele has a 5’ deletion, the other has a 3’ frameshift at 
an Nde I site (marked n with a blue arrow). B. Comparison of spontaneous 
recombination rates in various single and multiple gene disruptants. Rates are 
the mean of 10-20 independent assays, and error bars represent the SEM.
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Table 4.3 Spontaneous recombination rates at an inverted repeat substrate.
Mean rates are calculated as events/cell/generation from 10-20 independent analyses 
(SEM as represented in Fig. 4.9 B), and relative rates are expressed as a percentage of 
the wild-type.
Strain Mean rates (x 10'6) Relative rates (% wt)
B356-7C wt 564 100.0
pso2 585 103.6
exol 400 70.9
pso2 exol 64 11.3
msh2 386 68.4
pso2 msh2 55 9.8
pso2 exol msh2 45 7.9
exol msh2 425 75.4
rad.27 771 136.7
pso2 rad27 769 136.4
radl 358 63.5
pso2 radl 361 64.0
rad4 525 93.0
pso2 rad4 435 77.1
rad4 exol 283 50.1
m rell 160 28.3
pso2 m rell 116 20.6
pso2 exol m rell 36 6.4
rad51 126 22.3
pso2 radSl 94 16.7
rad52 0.030 0.0052
pso2 rad52 0.020 0.0036
wild-type level of spontaneous recombination was observed in the pso2 mutant cells 
(Fig. 4.9 B), whereas both exol and msh2 single disruptants exhibit a moderate 
reduction in recombination rate (70 % of the wild type rate, Table 4.3). In contrast,
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spontaneous recombination was reduced 9 fold in the pso2 exol double disruptant, 
comparative to the 10 fold decrease in recombination seen in a pso2 msh2 defective 
strain (11 and 10 % of the wild type rate, respectively, Fig. 4.9 B, Table 4.3). Each of 
these results was confirmed in two independently obtained pso2 exol or pso2 msh2 
double disruptants.
The reduced rates of spontaneous recombination in the absence of both PS02 and 
EXOl or MSH2 are greater than in the rad51 strain, suggesting that these factors play a 
considerable role. Furthermore, control studies were performed in a rad4 exol double 
mutant to determine whether the reduced capacity for spontaneous recombination is 
unique to pso2 exol and pso2 msh2. It can be seen from figure 4.9 B that an additive 
relationship, rather than a significant reduction in recombination rate is observed for 
rad4 exol. This is indicative of independent roles for Rad4 and Exol in spontaneous 
recombination events. In addition, EXOl and MSH2 appear epistatic as the capacity for 
spontaneous recombination was not diminished further in either the exol msh2 
(compared to the respective single mutants) or pso2 exol msh2 disruptants (relative to 
the pso2 exol and pso2 msh2 strains) (Fig. 4.9 B). In contrast to the pso2 exol and 
pso2 msh2 double disruptants, no significant differences were observed for the 
frequency of spontaneous recombination in the pso2 m re ll , pso2 radl, pso2 rad27, or 
pso2 rad51 strains compared to their respective single mutants (Fig. 4.9 B).
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4.4.2 Analysis of spontaneous recombination events in the absence of 
PS02
Further investigation of the nature of the recombination events occurring in the absence 
of P S02 , EXOl, and MSH2 can be achieved through physical analysis of the ADE2 
construct. The primary advantage of using this inverted-repeat substrate rather than a 
direct-repeat system is that only DNA crossovers occurring via a fully reciprocal 
mechanism are viable, as incomplete exchanges result in fragmentation of the 
chromosome, which is obviously lethal in a haploid cell. Such reciprocal crossovers 
can be identified as a consequence of the inversion of the DNA between the two ADE2 
alleles (Class II, Fig. 4.10). In contrast, if recombination has occurred by gene 
conversion, the intervening DNA remains in its original orientation, but the unique Nde 
I restriction site in the full-length allele is restored (Class I, Fig. 4.10). Further, if a 
crossover has been accompanied by a gene conversion event, then both inversion of the 
connecting DNA and recovery of the Nde I site are observed (Class III, Fig. 4.10). It 
would be expected that a double crossover event would result in the transfer of the Nde 
I mutation to the ade2-5’A allele (Class IV, Fig. 4.10), yet this class of event has not 
been recovered to date (Rattray and Symington, 1995).
The original approach, adopted by Rattray and Symington (1994), was to use Southern 
blot for the physical analysis of the ADE2 construct arrangement. A combination of 
probes homologous to the ADE2 and TRP1 genes, and restriction digest by Nde I and 
Pst I, enabled the four classes of recombination events to be distinguished. A new 
PCR-based method is presented here, which can differentiate between the first three 
classes of recombination event, but not between Class 1/ gene conversion and Class IV/
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Figure 4.10 Representation o f the classes o f recombination event at the ADE2 
inverted repeat construct. The Nde I frameshift is marked n with a blue arrow and 
boxed cross, a and b show the orientation of the intervening TRP1 gene.
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double crossover. Given the lack of detectable Class IV/ double crossover events in 
previous analyses, it was deemed satisfactory to use this approach. This PCR-based 
protocol takes advantage of the fragments of vector sequence arising from molecular 
cloning that have been retained within the ADE2 construct after integration into the host 
genome (Rattray and Symington, 1994, and refs therein). The ADE2 alleles are flanked 
on the outside by DNA from the pBluescript II KS(-) plasmid, containing the 
recognition sequences for the T7 and T3 standard primers, upstream of the ade2-n and 
ade2-5’A alleles, respectively (Fig. 4.11 A). A short region of the pBluescript II KS(-) 
multiple cloning site sequence remains between the ade2-5*A and TRP1 genes, to which 
a novel primer, int, has been designed: 5’-GAT CTC GAA TTC CTG CAG CC-3’. 
PCR analysis of DNA extracted from individual ADE+ prototrophs was carried out 
using all 3 primers in the same reaction. In the original orientation of the ADE2 
construct, this int primer will only generate a DNA fragment with the T7 primer, 
whereas an inversion of the intervening DNA results in a product from the int and T3 
primer pair. The conditions of the PCR reaction were optimised to exclude the longer 
T7-T3 product. Products were digested with Nde 1 and visualised by agarose gel 
electrophoresis (Fig. 4.11 B).
Confirmation of the reliability of this new PCR-based analysis of spontaneous 
recombination events can be achieved through comparison of the data for the B356-7C 
recombination-proficient strain with that obtained by Rattray and Symington using 
Southern blots. A spectrum of 75 % Class 1/ gene conversions, 16.7 % Class II/ 
crossovers, and 8.3 % Class III/ crossovers associated with gene conversions, was 
identified by PCR (Table 4.4). This compares favourably with the previously published 
event ratios: 50, 35, 15 % Class I, II, III, respectively (Rattray and Symington, 1994).
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Figure 4.11 Analysis o f spontaneous recombination events occurring at the 
ADE2 inverted repeat construct. A. Schematic to show the location and 
orientation of the primers (T3, int, T7) used in the PCR-based analysis of the 
classes of recombination event. Only two primers (T3-int or T7-int) are 
compatible with each substrate, depending on the DNA orientation between the 
ade2 alleles (a, b), as the longer T3-T7 product is largely excluded by the PCR 
conditions. The Nde I frameshift is marked n with a blue arrow and boxed 
cross. B. Typical agarose gel showing Nde I digested PCR products from 
independent recombinants. The expected band sizes for each recombination 
class are approximately: I - 2.1 and 1.7 kb, II - 3.6 and 2.1 kb, III - 2.1,1.2, and 
1.0 kb. The recombination class is marked above each lane as I, II, or III. M = 
DNA ladder (kHind III digest).
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The wild-type predominance of gene conversion events over crossovers is also observed 
in the pso2 mutant (Table 4.4). This contrasts greatly with the significantly increased 
preference for crossovers in the absence of exol or msh2 (70 % crossovers versus 20 % 
gene conversion). In both the pso2 exol and pso2 msh2 double mutants, crossover 
events predominate to a similar degree as in the exol and msh2 strains (Table 4.4). 
Hence, it would appear that the influence of PS02 on the outcome of recombination 
reactions is epistatic to EX01-MSH2.
Table 4,4 Classification of recombination events. Percentage of recombinant 
colonies exhibiting a Class I, II, or III recombination event at the ADE2 inverted repeat 
construct, as detected by PCR and subsequent Nde I digestion. A total of 10-25 
colonies were examined per strain.
Strain Recombination Class (% events)
I II III
B356-7C 75.0 16.7 8.3
pso2 50.0 25.0 25.0
exol 20.0 70.0 10.0
pso2 exol 19.2 61.5 19.2
msh2 20.0 70.0 10.0
pso2 msh2 11.1 77.8 11.1
4.4.3 HN2-induced recombination at the inverted repeat construct
It is apparent that PS02, EXO l, and MSH2 act synergistically in both the repair of 
HN2-induced ICL and spontaneous homologous recombination. However, the question 
remains as to whether these factors are involved in the processing of recombination
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intermediates at the ICL. Intrachromosomal recombination rates at the inverted repeat 
construct were determined following HN2 treatment of the B356-7C-derived strains. 
Individual pink colonies were cultured overnight in adenine-rich (YPAD) media in 
order to provide sufficient cells to be tested against a range of HN2 doses. The 
recombination rate calculation was adjusted to account for this culture step, with an 
estimation of the number of cells in the inoculum determined from samples plated on 
media lacking tryptophan. Cultured cells were resuspended in PBS and treated with 0, 
1, 10 or 100 pM HN2 for 1 hour, before plating at appropriate dilutions on solid media 
lacking adenine or tryptophan. Recombination rates were calculated as events per cell 
per generation, with due consideration given to variations in the number of cells 
produced in the overnight culture (Section 2.8.2).
Overall, a similar pattern was observed as for spontaneous recombination (Fig. 4.12). 
The untreated B356-7C wild-type cells exhibit a mean recombination rate of 410 x 106 
events/cell/generation, comparable to that observed in the absence of a culture step (Fig. 
4.9). This suggests that growth in liquid culture does not adversely affect the rate of 
spontaneous recombination. Neither the pso2 and exol single mutants, nor the exol 
msh2 strain, showed any deficiency in recombination rate at the inverted repeat 
construct (Fig. 4.12). In contrast, both the pso2 exol and pso2 msh2 double disruptant 
strains are as defective as the rad51 recombination-deficient strain (Fig. 4.12). The 
extent of this deficiency does not appear to be as severe as observed for spontaneous 
recombination, as all three strains have a recombination capacity at 40 % of the wild- 
type rate. The reduced recombination rates in pso2 exol and pso2 msh2 strains at the 
highest dose of 100 pM HN2 are due to the severely limited cell survival at this dose 
(Fig. 4.1 E, 4.2 A). It is interesting to note that even the rate of recombination in the
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Figure 4.12 HN2-induced recombination at an ADE2 inverted repeat 
construct. Exponential phase cells were treated with 0, 1, 10, or 100 pM 
HN2 prior to plating on SC-ade and SC-trp media to determine recombination 
rate. All results are the mean of 5-10 independent experiments, and error bars 
represent the SEM.
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rad52 strain is 10 fold higher after growth in liquid culture (0.26 x 106 
events/cell/generation in the untreated cells), compared to the conditions of the 
spontaneous recombination assay. Hence it is possible that although recombination in 
the wild-type parent does not appear to be affected by the overnight culture step, these 
conditions are biased where recombination events are limited, likely as a result of the 
increased capacity for cell division in ADE+ prototrophs (Rattray and Symington, 
1994). The observation that neither the exol nor exol msh.2 strains show the mild 
recombination deficiency seen in the spontaneous recombination assay also supports 
this hypothesis. Nevertheless, it is clear that induction of intrachromosomal 
recombination above the spontaneous rate was not observed in any strain following 
treatment with HN2.
4.5 Non-homologous End Joining
Non-homologous end joining (NHEJ) is not believed to play an important role in the 
repair of ICL in yeast, as no significant sensitivity to agents such as HN2 and psoralen 
has been observed in cells deficient for the key genes in this repair pathway, such as 
KU70 (McHugh et al., 2000). Nevertheless, one of the human PS02 homologues, 
Artemis (hPS02C)y has been identified as a component of the V(D)J recombination 
apparatus, which is a specific NHEJ event at the immunoglobulin loci. Furthermore, in 
mice, both EXOl and MSH2 seem to be required for immunoglobulin class-switch 
recombination, in addition to the role of MMR in somatic hypermutation of the V 
region (Bardwell et al., 2004). Consequently, a plasmid-based assay in which cell 
survival depends upon NHEJ competence was used to determine whether the yeast 
PS02  is involved in this pathway. Comparison is made between the transformation
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efficiency of cut versus supercoiled plasmid DNA to provide a simple quantitation of 
NHEJ incidence. This assay has been widely utilised, and was key in establishing the 
roles of the NHEJ factors Yku70, Yku80, and Lig4 (Boulton and Jackson, 1996; Teo 
and Jackson, 1997).
Strains were transformed with YEplacl81 plasmid DNA that had been linearised with 
restriction enzymes to give 5’ (EcoR I), 3’ (Pst I) overhang, or incompatible ends (EcoR 
I and Pst I) in a region that bears no homology to the yeast genome. Preliminary 
titration experiments were conducted to ensure that DNA quantity was in the linear 
range of transformation efficiency per pg to facilitate comparisons across strains. The 
wild-type BY4741 strain demonstrates good recovery of plasmids digested with either 
EcoR I or Pst I, but a reduced efficiency to rejoin fragments with non-homologous ends 
(Fig. 4.13). In contrast, the NHEJ-deficient strain lig4 is only able to recircularise up to 
20 % of DNA fragments, regardless of the nature of the ends. The pso2 mutant 
demonstrates a wild-type pattern of transformant recovery (Fig. 4.13), and loss of EXOl 
does not significantly affect the efficiency of NHEJ (Fig. 4.13), consistent with 
published reports (Wu and Lieber, 1999). The pso2 exol double disruptant strain also 
shows no quantitative defect in joining of compatible or incompatible substrates relative 
to the wild-type, and especially compared to the considerably greater reduction in 
transformant recovery in the lig4 strain (Fig. 4.13). Similarly, neither msh2 nor pso2 
msh2 are defective in NHEJ of the range of substrates considered here (Fig. 4.13). In 
conclusion, PS02  does not appear to be required for NHEJ, even in the absence of 
either EXOl or MSH2.
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Figure 4.13 Non-homologous end joining assay. The plasmid YEplacl81 was 
digested with EcoR I, Pst I, or both enzymes, and transformed into S. cerevisiae 
strains defective for one or more repair genes, as shown. The percentage 
transformant recovery relative to a parallel transformation with uncut plasmid 
was used as a determinant of the cells ability to rejoin DNA in the absence of a 
homologous template. Assays were repeated at least 3 times, and error bars 
represent the SEM.
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4.6 Complementation studies
In cases of genetic redundancy where a cellular process can be carried out by more than 
one gene product, overexpression of one gene can often compensate for the phenotype 
associated with loss of another. There are several examples of complementation 
involving the nucleolytic function of EXOL For example, overexpression of EXOl has 
been shown to suppress a number of rad27 mutation phenotypes, including temperature 
sensitivity, Okazaki fragment accumulation, elevated mutation frequency, and the rate 
of mini chromosome loss (Sun et al., 2003). Similarly, EXOl overexpression has been 
found to complement other phenotypes associated with rad50y m re ll, msh2, and mlhl 
mutants (Sokolsky and Alani, 2000; Lewis et al., 2002; Argueso et al., 2002). If the 
activity of Pso2 is truly redundant with that of Exol and Msh2 for ICL and DSB repair, 
it is possible that overexpression of EXOl or MSH2 would rescue the HN2-sensitivity 
of the pso2 deficient strain.
4.6.1 Overexpression of EXOl or MSH2 does not compensate for loss 
of PS02
EXOl was constitutively expressed under the control of the ADC1 (ADH1) promoter 
from the 2p plasmid pDB20 (here designated pDB-EXOl; Qiu et al., 1999, published as 
PDB-ScE). It is clear from figure 4.14 A that constitutive expression of EXOl in pso2 
defective cells could not reverse the increased HN2 sensitivity to any extent. However, 
it is known that the ADC1 promoter drives high levels of expression in yeast and it is 
possible that the constitutive upregulation of such a fundamental cellular nuclease as 
Exol may be toxic to general metabolic processes such as replication.
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Figure 4.14 Complementation analysis of a pso2 mutant. A. Constitutive 
expression of EXOl. B. Galactose-induced (overnight) expression of EXOl. C. 
Galactose-induced expression of MSH2. Cells were treated with 0 to 1000 pM 
HN2, and survival determined by plating on YEPD. Comparisons are made with 
empty vector controls. Error bars show SEM.
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In order to account for possible interference with other cellular processes, EXOl was 
also expressed in an inducible fashion using the GAL1 promoter (pYES2-EXOl). The 
plasmid pYES2-EX01 was cloned for the purposes of this study using standard 
molecular techniques. Briefly, a 2.6 kb fragment incorporating the complete CDS of S. 
cerevisiae EXOl was amplified by PCR using primers designed to incorporate a unique 
Hind III restriction site at the 5’ end, and a Not I site at the 3* end. This facilitated 
cloning of the fragment into pYES2 in an orientation-specific manner, and this was 
subsequently confirmed by sequencing across the insert. The effect of EXOl 
upregulation on the HN2 sensitivity of pso2 disruptant cells was investigated across a 
range of induction periods using galactose and raffinose (which neither activates nor 
represses the GAL1 promoter) as carbon source. Cells were found to be more viable if 
treatment with HN2 followed an overnight incubation in the induction media, although 
the experimental outcome was no different after 2 to 5 hours induction. In all cases, the 
overexpression of EXOl did not suppress the HN2 sensitivity of the pso2 mutant, as 
compared to the native vector (Fig. 4.14 B). Similarly, upregulation of MSH2 from the 
galactose-inducible episomal plasmid pRS425 (here designated pRS-MSH2\ Sokolsky 
and Alani, 2000, published as pEAE127) did not complement the pso2 mutant (Fig. 
4.14C).
The lack of an observable phenotype for sensitivity to HN2 in either the exol or msh2 
mutant strains prevents additional control experiments for the efficiency of 
complementation from these plasmids. However, both pDB-EXOl and pRS-MSH2 
have been used to successfully express the cloned gene according to published reports, 
and the integrity of the EXOl coding sequence was confirmed for pYES-EXOL 
Furthermore, RT-PCR was carried out to investigate the extent of overexpression above
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the level of the endogenous gene. Figure 4.15 compares MSH2 expression (520 bp 
fragment) in a pso2 deficient cell line carrying either the empty vector pRS425, or pRS- 
MSH2. It is clear that in cells carrying the pRS-MS7/2 plasmid, MSH2 is expressed at a 
considerably greater extent than the endogenous background, particularly after 24 h 
galactose induction but even in the uninduced state. The PCR reactions also contained 
a control primer pair for ACT1 expression (300 bp fragment). Other appropriate 
controls included: an msh2 deficient strain, omission of the reverse transcriptase 
enzyme (designated *-*), and an RT-PCR reaction containing no RNA/DNA template. 
Unfortunately, the EXOl transcript has not yet been successfully identified by RT-PCR, 
despite the use of a range of different primers.
One possible explanation for the lack of complementation by EXOl or MSH2 for pso2 
sensitivity to HN2 could be that both components of the Exol-Msh2 complex need to 
be overexpressed, otherwise one factor will be limiting. This was investigated by co­
transforming pso2 deficient cells with both the pYES-EXOl and pRS-MSH2 plasmids 
(facilitated by the different selectable marker genes URA3 and LEU2, respectively). 
The HN2 sensitivity of pso2 strains bearing both empty vectors or pYES-£X07 and 
pRS-MSH2 was assessed following an overnight induction in galactose-raffmose media. 
No rescue of the pso2 mutant phenotype was observed after the combined 
overexpression of both genes (Fig. 4.16). It is unlikely that this is a result of the 
effective drug concentration being diminished by the significantly increased DNA 
content of the cells (pYES-7sX07 is 8.5 kb, pRS-MSH2 is 10.6 kb) as in all cases, the 
pso2 cells are more sensitive to HN2 than in the absence of any vector (Fig. 4.1 A). 
Given that this increase is more substantial for the larger pRS vector, it is plausible that 
the reduced tolerance of HN2 is due to the extra replicative stress imposed in
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Figure 4.15 Confirmation o f MSH2 gene expression by RT-PCR. The 
extent of MSH2 expression is compared across four different strains: 
pso2, msh2, and pso2 bearing either the empty vector pRSY25, or pRS- 
MSH2. RNA was extracted from uninduced cells (u), or after 24 h 
galactose induction (i). RNA preparations were treated with RNase-free 
DNase before RT-PCR, to prevent contamination by cellular DNA, and 
this is confirmed by the omission of reverse transcriptase enzyme in the 
RT reaction (+/- RT). The 520 bp fragment is MSH2, and the 300 bp 
fragment is the ACT1 loading control, c = water control (no template). 
M = 100 bp marker.
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Figure 4.16 Simultaneous complementation analysis of a pso2 mutant by EXOl 
and MSH2. Cells were incubated in galactose media overnight to induce 
expression of EXOl and MSH2, then treated with 0 to 1000 pM HN2, and 
survival determined by plating on YEPD. A comparison is made with the 
empty vector controls. Results are the mean of two independent experiments, 
and error bars show the SEM.
maintaining the plasmid. Indeed, subsequent replica plating to selective media revealed 
that few cells retain either plasmid after treatment with HN2 (data not shown).
4.6.2 The HN2 sensitivity of pso2 exol and pso2 nish2 can be rescued 
by plasmid expression of the disrupted genes
Given the lack of complementation of pso2 mutants by EXOl or MSH2, it was crucial 
to confirm that the HN2 sensitivity observed in the pso2 exol and pso2 msh2 double 
mutants is solely due to the loss of these genes. The pso2 exol and pso2 msh2 strains 
were transformed with plasmids expressing wild type copies of one of the disrupted 
genes (pYES-/}5'02, pYES-EXOi, and pRS-MS/72, respectively). If the phenotype of 
the double disruptant were true, it would be expected that pso2 exol pYES-PS02 
should resemble a single exol mutant, and pso2 exol pYES-EXOl should resemble the 
pso2 single mutant. Likewise for pso2 msh2\ replacing the PS02 gene should recover 
the phenotype back to that of the msh2 mutant, and overexpression of MSH2 should 
give a phenotype resembling pso2. As has been already observed, strains carrying a 
plasmid are sometimes more sensitive to HN2, and so comparisons were made with 
empty vector controls. It is clear from the graphs in figure 4.17 that both double 
mutants can be rescued as predicted by the respective wild type genes. Although it 
appears that expression of MSH2 in the pso2 msh.2 double disruptant strain provides 
more resistance to HN2 than is expected from the vector control pso2 pYES, the 
observed cell survival is identical to that of the pso2 strain without a plasmid (Fig. 4.1). 
Hence, it is the pso2 pYES strain that is hyper-sensitive to HN2 rather than an increased 
resistance in pso2 msh2 pRS-MSH2. Conclusively, the significant sensitivity to HN2
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Figure 4.17 Complementation analysis in the pso2 exol and pso2 msh2 double 
disruptants. Cells were incubated in galactose media overnight to induce 
expression of PS02 , EXOl or MSH2, then treated with 0 to 1000 pM HN2, and 
survival determined by plating on YEPD. A. pso2 exol and B. pso2 msh2. 
Comparisons are made with the double disruptants and respective single mutant 
strains bearing empty vector controls. Results are the mean of two independent 
experiments, and error bars show the SEM.
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observed in the pso2 exol and pso2 msh2 double disruptants is exclusively due to the 
synergism between these genes.
4.7 Further analysis of the relationship between PS02 and 
Mismatch Repair
One of the possible explanations for the absence of complementation of the pso2 
phenotype by EXOl and MSH2 could be a requirement for the entire MMR pathway in 
ICL and DSB repair. Indeed, it is possible that in the absence of Pso2, the role played 
by Exol and Msh2 is not specific for their nuclease and DNA recognition activity, but 
simply part of a compensatory mechanism provided by the combined activity of MMR. 
It is well established that MMR is not a predominant mechanism in ICL repair, as the 
disruption of genes involved in MMR does not render a cell sensitive to interstrand 
cross-linking agents (Fig. 4.1.2; McHugh et al., 2000). However, the observations of 
synergism between PS02 and MSH2 suggest that MMR may act in some reserve 
capacity in the absence of PS02. Previous research into the involvement of MMR 
proteins in recombination have shown that in some pathways, Msh2 may act without the 
cooperation of the full MMR family. Msh2 acts in a complex with Msh3 in the removal 
of 3’ non-homologous tails in RADI-dependent single-strand annealing reactions, yet 
Msh6, Mlhl, and Pmsl are not required (Sugawara et al., 1997). It is therefore 
important to elucidate whether it is MMR in general, or specific activities attributed to 
Exol and Msh2 that are able to compensate for Pso2, as this will clarify the function of 
Pso2 in ICL repair.
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4.7.1 Other MMR factors show an intermediate phenotype for the 
modification of pso2 sensitivity to HN2
A panel of single and double (with pso2) disruptant strains encompassing the major 
MMR factors MSH3, MSH6, and MLH1 were created in the B356-7C S. cerevisiae 
background. All known examples of DNA repair involving Msh2 have been found to 
require interaction with either Msh3 or Msh6. Hence a role for either of these factors is 
plausible in the EX07/MS7f2-dependent ICL repair mechanism. Mlhl acts downstream 
of Msh2 in MMR, but has also been found to interact with Exol, and so is another 
candidate factor for this reserve ICL repair pathway. PMS1 was not investigated, as it 
is not required in all MMR reactions. The disruptant strains were examined for 
sensitivity to nitrogen mustard, as for exol and msh2 (Section 4.1).
Consistent with the accepted view that MMR is not involved in the repair of ICL and 
the results already presented here for msh2, loss of msh3, msh6, or mlhl alone did not 
significantly increase sensitivity to HN2 compared to the wild-type parent strain (Fig. 
4.18 A-C). However, disruption of any of these MMR factors combined with a 
deficiency in pso2 results in a synergistic increase in HN2 sensitivity (Fig. 4.18). The 
response to HN2 in the pso2 msh3, msh6, and mlhl double mutants varies slightly from 
that observed for either pso2 exol or pso2 msh2. The latter strains demonstrated a very 
severe reduction (10,000-fold) in cell survival after treatment at 100 pM HN2, whereas 
the pso2 msh3, msh6, and mlhl double disruptants all exhibit a normal shoulder of 
resistance at this dose, with only 100-fold lower survival than the wild-type strain. At 
the highest dose, all double mutant strains are equally sensitive to HN2. Hence it would 
seem that while loss of any of the major MMR repair genes in conjunction with pso2 
leads to a synergistic increase in sensitivity to HN2, only a deficiency in msh2
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Figure 4.18 Comparison of HN2 sensitivity in pso2 and MMR mutants. 
Exponential phase cells were treated with 0 to 1000 pM HN2 for 1 h, and 
survival monitored by plating on YEPD. Comparisons of pso2 with: A. msh3, 
B. msh6, C. mlhl. All results are the mean of at least three independent 
experiments, and the error bars show the SEM.
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resembles the phenotype of an pso2 exol strain, with the other strains (pso2 msh3, pso2 
msh6, pso2 mlhl) exhibiting an intermediate response. However, this notion is 
dependent upon the set of data at one single dose, and should be more thoroughly 
investigated using a range of doses between 50 and 500 pM HN2.
4.7.2 An intermediate phenotype is also observed for sensitivity to 
ionising radiation in pso2-MMR double disruptants
The same panel of MMR-deficient strains (msh3, msh6, mlhl) was subjected to X- 
irradiation, as already described for exol and msh2 (Section 4.2.1). As anticipated, 
none of the single MMR mutants responded differently to ionising radiation, compared 
to the wild-type parent strain (Fig. 4.19 A-C). The three double disruptant strains pso2 
msh3, pso2 msh6, and pso2 mlhl display a range of sensitivity to X-irradiation (Fig.
4.19), yet none are as susceptible as the pso2 msh2 strain (Fig. 4.3 B). The response to 
X-rays in pso2 msh3 and pso2 msh6 cells is of a similar magnitude as in pso2 exol 
cells, being approximately 2-fold more sensitive than the wild-type at 300 Gy (Fig. 4.19 
A, B). In contrast, pso2 mlhl double disruptants are only negligibly more sensitive 
(1.3-fold) than the respective single mutants (Fig. 4.19 C). Hence it would seem that 
loss of the MMR factors MSH3, MSH6, and MLH1 in a pso2 deficient background leads 
to an intermediate sensitivity to X-irradiation.
4.7.3 No deficiency in recombination is observed for other MMR 
factors in combination with pso2
Further investigation of the effects of incomplete MMR in cells deficient for PS02 
activity utilised the inverted repeat recombination substrate introduced into the B356-
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Figure 4.19 Comparison of X-irradiation sensitivity in pso2 and MMR mutants. 
Exponential phase cells were treated with 0 to 300 Gy X-irradiation, and 
survival monitored by plating on YEPD. Comparisons of pso2 with : A. msh3, 
B. msh6, C. mlhl. All results are the mean of at least three independent 
experiments, and the error bars show the SEM.
208
7C strain background. As can be seen from figure 4.20, the msh3 and mlhl single 
mutants exhibit a 50 % reduction in recombination at the inverted repeat substrate, 
compared to the wild-type parent, B356-7C. This represents a slightly more 
recombination-deficient phenotype than observed for msh2 cells. However, the most 
significant difference between these MMR mutants and msh2 is that there is no 
synergism with pso2 for recombination. It is clear that pso2 msh3 and pso2 mlhl 
demonstrate no further reduction in recombination capacity compared to the respective 
single mutants (Fig. 4.20, Table 4.5). Recombination rates were not calculated for the 
MMR factor MSH6, as to date, only white (ADE+) pso2 msh6 colonies have been 
isolated.
Table 4.5 Spontaneous recombination rates in /we>2-MMR defective strains.
Mean rates at the ADE2 inverted repeat construct are calculated as 
events/cell/generation from 10-20 independent analyses (SEM as represented in Fig.
4.20), and relative rates are expressed as a percentage of the wild-type.
Strain Mean rates (x 10 6) Relative rate (% wt)
B356-7C wt 564 100.0
msh2 386 68.4
pso2 msh2 55 9.8
msh3 261 46.3
pso2 msh3 258 45.7
mlhl 306 54.2
pso2 mlhl 328 58.1
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4.7.4 Increased spontaneous mutation is not further affected in exol 
and msh2 mutants by the loss of PS02
Both exol and msh.2 disruptant cells are deficient in mismatch repair, and have been 
shown to cause an increased rate of mutation in the CAN1 gene, particularly 
frameshifts, after growth in the presence of canavanine (Marsischky et al., 1996). 
Consequently, the CAN1 forward mutation assay was used to determine whether the 
overlap of activity between PS02 and EX01-MSH2 extends to MMR as well as 
recombination. Given that neither exol nor msh2 deficient cells are sensitive to HN2, 
and that HN2-induced mutagenesis is not observed in either strain (data not shown), the 
relationship between PS02 and EX01-MSH2 was investigated for spontaneous 
mutagenesis at the CAN1 locus. As already discussed in Chapter 3, the B356-7C 
parental strain is derived from the W303 background which is CAN*, and hence not 
compatible with this assay. In the wild-type strain, forward mutation to canavanine 
resistance was observed at a rate of 126 mean mutants per 108 survivors, and loss of 
PS02 did not result in any significant deviation from the wild-type (Fig. 4.21 A). Both 
the exol and msh2 mutants demonstrate an elevated rate of spontaneous mutation, 14 
and 22 fold higher than the wild-type, respectively. It is clear from figure 4.21 A that 
PS02 behaves epistatically with both EXOl and MSH2 for forward mutation at the 
CAN1 locus, as the mutator phenotypes of the pso2 exol and pso2 msh2 double 
disruptants are no more pronounced than in the exol or msh2 single mutants.
To examine whether the additional deletion of PS02 altered the type of mutagenic 
event occurring in the exol or msh2 background, the PCR-based screen designed by Xie 
and co-workers (2001) for the investigation of rad27 mutagenesis was employed. This 
strategy involves PCR amplification of the CAN1 gene and subsequent Hph I
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restriction, with the products visualised by agarose gel electrophoresis. It is possible to 
distinguish between the single nucleotide deletions and small frameshifts or base 
substitutions that are characteristic of mismatch repair mutants, and gross 
rearrangements such as large duplications that predominate in the absence of rad27 
(Tishkoff et al., 1997 B). Examination of the Hph I digestion pattern indicated that 
there is no difference between the wild-type, and pso2, exol, msh2 single and double 
disruptant strains (Fig. 4.21 B). Hence PS02 behaves epistatically to both EXOl and 
MSH2 for spontaneous mutagenesis, and a loss of PS02 does not further influence the 
spectrum of mutation events. No insertion-deletion mutations were observed, and the 
low frequency occurrence of variant Hph I fragments (starred lanes, Fig. 4.21 B) can be 
explained by the loss of an Hph I restriction site in all cases. The absence of 
frequentgross alterations of the CAN1 gene in these mutants is consistent with a defect 
in single base and small-tract MMR (Xie et al., 2001; Tran et al., 2001).
4.8 Discussion
Conclusions drawn from the studies presented in Chapter 3 endorsed a model of ICL 
repair requiring initial processing of the cross-link by both NER and Pso2, and 
subsequent repair of the resulting DSB by homologous recombination. In this chapter, 
consideration was given to elucidating the role of Pso2 at this early-intermediate stage 
of ICL repair. On the basis of its metallo-P-lactamase hydrolytic domain and putative 
events expected to coincide with the period of Pso2 activity in ICL repair, a hypothesis 
was drawn that Pso2 is involved in the nucleolytic processing of repair intermediates. 
The preliminary approach was to evaluate whether PS02 interacts genetically with any 
of the known DNA repair nucleases. Synergism was identified between PS02 and
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EXOl in the repair of HN2-induced cross-links, which is particularly significant 
considering that a loss of EXOl alone does not affect a cells capacity to repair ICL 
(Section 4.1.1). This appears to represent a novel relationship for PS02 that is not 
shared with other NER factors, and is specific for EXOl of the yeast repair nucleases 
tested. Exol is a member of the Rad2 nuclease family, of which the nuclear members 
are Rad2, Exol and Rad27 in yeast. These nucleases appear to be redundant in some 
processes, such as DNA replication where Rad27, and Exol collaborate in Okazaki 
fragment maturation (Tishkoff et al., 1997; Qiu et al., 1999; Sun et al., 2003). 
However, it is clear that the overlap of activity between Pso2 and Exol in ICL repair 
does not extend to the other members of this family. An additive relationship is 
observed for RAD27 and PS02 (Section 4.1.1), suggesting independent roles in the 
repair of cross-linked DNA, and consistent with the involvement of Rad27 in the BER 
of mono-alkylation damage produced by nitrogen mustards (McHugh et al., 1999, 
2000). Furthermore, PS02 consistently exhibits an epistatic relationship with NER, 
even for factors such as RADI, which have additional nucleolytic roles in 
recombination (Section 4.1.1).
In contrast to the other repair nucleases, an identical synergistic effect to that seen with 
EXOl was observed upon the disruption of MSH2 in a pso2 deficient background 
(Section 4.1.2). Given that the Exol and Msh2 proteins are known to associate 
(Tishkoff et al., 1997 A; Sokolsky and Alani, 2000) and the observation that exol and 
msh2 are epistatic, it would seem that their combined activity compensates for a loss of 
Pso2 in the repair of ICL.
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Further to the overlapping role for PS02 with MSH2 and EXOl in the repair of DNA 
interstrand cross-links, a synergistic relationship was also observed for spontaneous 
homologous recombination and DSB repair. It has already been observed that loss of 
pso2 is associated with a deficiency in the repair ICL-associated DSBs (Section 3.6). 
This has been further investigated using CHEF-PFGE for the pso2 exol and pso2 msh2 
double mutants, with the discovery that DSBs accumulate to a greater extent and fail to 
be repaired (Section 4.3.1). The apparent requirement for Pso2, Exol, and Msh2 in the 
repair of DSBs associated with ICL also extends to the lesions arising from ionising 
radiation, although only to a modest degree (Section 4.2.1). None of these factors were 
required in the repair of UVC-induced DNA damage, nor were they involved in the 
response to cell cycle inhibition by benomyl and hydroxyurea. However, the 
combination of a pso2 mutation with the disruption of msh2 or exol leads to a 
significant defect in spontaneous inverted repeat homologous recombination (Section
4.4.1). The recombination defect observed in the exol and msh2 single mutants 
correlates with published data, although a greater degree of deficiency has been 
observed using alternative direct repeat recombination substrates (Saparbaev et al., 
1996; Fiorentini et al., 1997; P. McHugh, unpublished data).
It was appropriate to investigate the complete panel of B356-7C gene disruptants in the 
analysis of spontaneous recombination as each is known to affect recombination to 
some extent. RAD51, RAD52, and MRE11 are all key factors in homologous 
recombination. However, this inverted repeat substrate highlights differences in the 
relative involvement of these genes in recombination, with RAD52 having a more 
fundamental role in multiple pathways (Section 4.4.1; Rattray and Symington, 1994). 
The extent of the recombination deficiency observed in the absence of both PS02 and
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EX01IMSH2 is not as severe as the complete abrogation of recombination in the rad52 
mutant, yet it is more pronounced than that seen in the rad51 or m rell strains. RADI 
removes 3’ flaps and heterologies during single strand annealing and DSB repair 
pathways (Ivanov and Haber, 1995). Loss of RADI has resulted in variable effects on 
spontaneous recombination in direct repeat substrates (Thomas and Rothstein, 1989; 
Klein, 1998; Schiestl and Prakash, 1998), but none at an inverted repeat (Rattray and 
Symington, 1995), although a mild defect is observed here (Section 4.4.1). 
Furthermore, mutations in the RAD27 gene have previously been associated with a 
hyper-recombinant phenotype (Vallen and Cross, 1995; Tishkoff et al., 1997; 
Symington, 1998; Debrauwere et al., 2001), which is confirmed by this study (Section
4.4.1). The observation that deletion of PS02 in these backgrounds does not further 
affect the recombination phenotype (Section 4.4.1), indicates that PS02 either behaves 
epistatically or does not affect the pathways of spontaneous recombination represented 
by these genes. However, the interaction with RAD52 is less easily defined, as accurate 
and quantifiable detection of recombination events in the absence of RAD52 is beyond 
the scope of this assay. Unfortunately, the ADE2 inverted repeat construct also proved 
unsuitable for the investigation of HN2-induced recombination events, probably as a 
result of the infrequent occurrence of a cross-link within the substrate DNA (Section 
4.4.3).
In the pso2 exol and pso2 msh2 double mutants the defect in spontaneous 
recombination is associated with a reduction in gene conversion and compensatory 
increase in the occurrence of cross-overs (Section 4.4.2). That only a subset of 
recombination events are blocked in pso2 exol and pso2 msh.2 cells likely explains their 
only moderate sensitivity to ionising radiation and partial defect in spontaneous
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recombination. Presumably some intermediate structure arising from the repair of both 
endogenous and ionising radiation-induced damage needs to be processed by Pso2 
and/or Exol-Msh2 prior to recombinational repair. It is possible that these factors are 
recruited in the presence of an irreversibly collapsed replication fork, such as that 
occurring in the presence of an ICL. Indeed, the current models of fork restart are based 
upon the replication machinery encountering an adduct that afflicts a single DNA 
strand, and so it is plausible that additional factors or alternative mechanisms may be 
required in cases where both strands are affected (McGlynn and Lloyd, 2002).
The diverse nature of DSBs arising from different genotoxic agents is highlighted by 
the fact that mammalian cells often repair radiation-induced DSBs by NHEJ (Lieber et 
al., 2003), whereas ICL-associated DSBs are almost exclusively processed by 
homologous recombination (De Silva et al., 2000; Caldecott and Jeggo, 1991). For 
example CHO cells deficient in XRCC5 (ku80) show a near wild-type sensitivity to 
cross-linking drugs but are highly sensitive to ionising radiation. This contrasts with 
cells lacking XRCC2 and XRCC3 (Rad51-paralogs), which are sensitive to both 
ionising radiation and cross-linking drugs, and also show a profound defect in the repair 
of ICL-associated DSBs (De Silva et a l, 2000). A greater understanding of the 
structures of replication forks inhibited by ICLs and other DSBs would help in 
elucidating the DNA structures acted upon by Pso2 and Exol-Msh2.
Several mechanisms have been proposed to account for the spectrum of recombination 
events that can contribute to the recovery of ADE prototrophs following recombination 
events at the inverted repeat construct used here. The original models of simple 
intrachromatid gene conversions, with or without associated crossovers (Rattray and
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Symington, 1994, 1995) have more recently been extended to include mis-aligned sister 
chromatid exchanges mediated by long conversion tracts, and break-induced 
recombination followed by single-strand annealing (Symington, 2002). An increased 
frequency of crossovers during spontaneous recombination has been observed 
previously for an exol strain, although with a different substrate, used to determine 
plasmid gap repair (Symington et al., 2000). It was suggested that the increase in 
crossovers may result from the elimination of MMR-mediated constraints on the 
recombination process, which would be consistent with increased occurrence of 
crossovers seen in the msh2 mutant in this study (Section 4.4.2). However, the absence 
of an associated rise in the Class III events (gene conversions associated with cross­
overs) is unexpected. This may reflect a general loss of cells attempting gene 
conversion in the exollmsh2 defective strains, due to a defect in the processing of an 
intermediate structure, such as the removal of ssDNA tails generated during 
recombination. As the spectrum of recombination events is not further modified by the 
loss of PS02 in either an exol or msh2 background despite the decreased incidence of 
recombination, it would seem that the activities of Pso2 and Exol-Msh2 are redundant 
in the initial processing of spontaneous lesions, but Pso2 does not directly influence the 
final recombination outcome. It is likely that Exol and Msh2 have two roles: one that 
overlaps with Pso2 for the recognition and processing of damaged sites prior to 
commitment to a recombination-based repair pathway, and a second role during the 
recombination reaction that is involved with the suppression of crossovers, probably 
due to rejection of pairing in homeologous regions of DNA (Evans et al. 2000).
Unlike the human homologue Artemis, PS02 does not appear to play a role in NHEJ. 
This is not surprising, as of the three known human homologues of PS02, Artemis is
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the least conserved (30 % identity by Blast, but only within 132 residues of the metallo- 
p-lactamase and |3-CASP motifs; Fig. 1.13). Also, it is well known that gene 
duplications enable the evolution of proteins with novel functions. Normal frequencies 
of plasmid rejoining have been observed in pso2 cells regardless of the nature of the 
DNA ends, and this was not affected by the further deletion of exol or msh2 (Section 
4.5). The absolute values are slightly higher than those observed by Teo and Jackson 
for the BY4741 wild-type and lig4 strains (1997), however, the trend is the same, and 
the variance probably reflects the use of a different S. cerevisiae strain and plasmid. A 
minor, qualitative role for Pso2 in the fidelity of NHEJ cannot be excluded, as this can 
only be examined by sequencing the rejoined plasmids recovered from this assay. 
Nevertheless, a recent report by Yu and co-workers (Yu J. et al., 2004) also failed to 
detect any deficiency in the NHEJ of restriction endonuclease-linearised plasmids or 
HO endonuclease-cleaved chromosomal DNA, in the absence of PS02. This suggests 
that Pso2 induces a homologous recombination-based pathway of DSB repair, 
especially given that NHEJ does not play a significant role in ICL repair in yeast 
(McHugh et al., 2000).
Although Artemis has been associated with the NHEJ pathway of repair, its function is 
primarily involved with the opening of DNA hairpin structures, such as those formed 
during vertebrate immunoglobulin gene (V(D)J) rearrangement (Ma et al., 2002). The 
study by Yu and co-workers (Yu J. et al., 2004) also investigated the involvement of 
yeast PS02 in the transposition and repair of maize Ac/Ds transposon excision sites 
introduced into S. cerevisiae (thought to be similar to V(D)J rearrangement: Kunze and 
Weil, 2002). In contrast to the major NHEJ factors (which are completely deficient in 
this assay), pso2 mutants retained 10 % of the wild-type capacity for reversion of the
219
ade2::Ac-l allele, and this was associated with an increased incidence of transposase 
mis-cutting. The authors suggest that Pso2 may act in the recognition of the DNA 
hairpin structures that arise during transposition, and subsequently assist binding of the 
transposase. It is plausible that the DNA confirmation adopted following the excision 
of the first transposon end resembles that of a partially incised ICL-repair intermediate. 
Indeed, where suitable DNA regions are accessible in the absence of the transposition 
complex, this structure will be resolved by homologous recombination. Furthermore, it 
has been suggested that Msh2 recognises and binds sites of DNA damage, and that 
human MutSa activates mismatch excision by Exol (Genschel and Modrich, 2003), 
which would seem to resemble the profile of Pso2 and transposase. If this were the 
case, it may explain the nominal increase in sensitivity to HN2 seen in the triple gene 
disruptant, pso2 exol msh2 (Section 4.1.2), as there may be alternative, less efficient 
nucleolytic partners that can be recruited by Msh2. High throughput proteomic screens 
have as yet failed to detect any association of nuclear proteins with Pso2 (Ho et al., 
2002). However, it is entirely possible that Pso2 may only interact with its relevant 
partner after binding to ICLs, especially given the variations in protein complexes 
identified after treatment with other DNA damaging agents (Ho et al., 2002), and this 
scenario has not yet been investigated. Alternatively, Pso2 may act independently to 
process some DNA lesions by means of its hydrolytic metallo-(3-lactamase domain.
The synergism between PS02 and EXOl or MSH2 for sensitivity to HN2, DSB repair, 
and spontaneous recombination suggests that these factors act in independent pathways 
that can perform the same function. In the case of cross-link repair, the lack of HN2 
sensitivity in the exol and msh2 single mutants strains indicates that these factors do not 
make a significant contribution in the presence of functional Pso2. Hence, any
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involvement of Exol and Msh2 in ICL repair transpires purely as a backup mechanism 
in the absence of Pso2. This may partially explain the inability of Exol and Msh2 to 
complement the pso2 mutant, as it is possible that the obtained level of overexpression 
was not sufficient to allow for further repair activity. It is possible that Exol and Msh2 
are only able to recognise and process certain types of intermediate structures that occur 
during ICL repair. There may even exist other factors that can substitute to some extent 
for Pso2. Alternatively, the population of these proteins may be so tightly regulated that 
no significant increase in enzymatic activity was achieved despite the apparent increase 
in mRNA. Although overexpression of Exol has been reported to complement a 
number of other nuclease deficiencies, closer inspection of the data shows that often 
only partial complementation was achieved (Sokolsky and Alani, 2000; Lee S.E. et al.y
2002), and others have been unable to overexpress Exol in S. cerevisiae for protein 
purification (Tran et al., 2001; P. McHugh, personal communication). Interestingly, 
sufficient expression is achieved from the pYES-£X07 vector to restore the phenotype 
of the pso2 exol double disruptant back to that of the pso2 single mutant (Section
4.6.2), although this would obviously be achievable within any post-transcriptional 
regulation existing for the endogenous gene. A further explanation for the absence of 
complementation between PS02 and EX01IMSH2 may be that the full complement of 
MutS genes (i.e. MSH3 and MSH6 as well), are required to facilitate the function of 
Msh2. Investigation of such a requirement for these Msh2-dimerisation partners in the 
complementation of a pso2 mutant strain is obviously beyond the scope of this plasmid- 
based assay.
Given the overlap in activity of PS02 and MSH2-EX01 it was also clearly important to 
determine if this extended to mismatch repair itself. The predominant phenotypes
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associated with this relationship, namely, hypersensitivity to HN2, moderate sensitivity 
to ionising radiation, and a deficiency in spontaneous recombination, were considered. 
It is clear from the results presented in section 4.7 that PS02 does not interact with all 
MMR factors to the same extent. In the case of ICL repair, it would seem that at lower 
doses of HN2, Msh3, Msh6, and Mlhl cannot compensate for a loss of Pso2 activity to 
quite the same extent as Msh2 and Exol (Section 4.7.1). However, at the maximum 
dose, all /?s<?2-MMR double mutants are equally sensitive to HN2, regardless of which 
MMR factor is absent. This suggests that either the Exol-Msh2 complex recruits other 
MMR factors as part of the repair process, perhaps with redundancy between Msh3 and 
Msh6, or that the function of Pso2 in ICL repair can only be substituted by the complete 
MMR pathway. If the data for HN2 survival is considered alongside that of the ionising 
radiation and recombination assays, the former hypothesis seems more tenable. Clearly 
the overlap of activity of PS02 with EXOl and MSH2 is not related to the role of MMR 
in the maintenance of genetic fidelity, as an epistatic relationship is observed for 
mutagenesis at the CAN1 locus (Section 4.7.4). The elevated rates of mutagenesis 
observed in the exol and msh2 strains are consistent with previously published data 
(Reenan and Kolodner, 1992; Tran et al., 2001), however, these are not modified by the 
additional loss of PS02. Most strikingly, none of these other MMR factors are 
absolutely required for spontaneous recombination in the absence of PS02 (Section
4.7.3). Furthermore, neither MSH6 nor MLH1 has any significant effect on cell survival 
after treatment with ionising radiation, yet MSH3 exhibits a moderate effect, 
comparable to EXOl (Section 4.7.2). It is possible that a preference for Msh3 as the 
binding partner for Msh2 reflects the type of lesion arising from ionising radiation 
damage that can be acted on by Pso2, Exol, and Msh2. In MMR, Msh2 preferentially 
complexes with Msh3 for the repair of heteroduplex DNA loops, rather than Msh6.
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Additionally, it has been suggested that the Msh2-Msh3 complex may be involved in 
the recognition of branched DNA structures incorporating a free 3’ tail (Sugawara et al., 
1997). Hence, in the absence of Pso2, Msh2 may recognise and bind some of the 
intermediate DNA structures arising from the repair of ICL and other DSBs, 
subsequently recruiting Exol and other MMR factors as required to resume repair. 
Recent analysis of the HN2 sensitivity of a pso2 msh3 msh6 triple disruptant strain has 
shown that it phenocopies the pso2 msh2 strain (T. Ward and P. McHugh, personal 
communication). This indicates that the intermediate phenotypes seen in the pso2 msh3 
and pso2 msh6 double deficient cells are due to redundancy between the MutS 
complexes. Furthermore, it is clear that Msh2 must be associated with either Msh3 or 
Msh6 in order to function in ICL repair.
In conclusion, it appears that Pso2 plays an overlapping role specifically with Exol and 
Msh2 (MutS) in the processing of ICL repair intermediates, as well as some 
spontaneous and ionising radiation-induced damage. In the presence of EXOl and 
MSH2 the recombination defective phenotype of pso2 cells is not apparent, except 
during interstrand cross-link repair. This presumably reflects the unusual nature of the 
intermediates produced at this form of damage, which are preferentially acted upon by 
Pso2, with Exol-MutS acting in reserve. In contrast, both PS02  and EX01/MSH2 are 
redundantly important during the repair of spontaneous and ionising radiation-induced 
damage, since no single disruptant demonstrates any reduction in repair efficiency, yet 
in combination, a significant increase in ionising radiation sensitivity and a reduction in 
homologous recombination events were observed.
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CHAPTER 5 BIOCHEMICAL ANALYSIS
To further elucidate the role of Pso2 in ICL repair, it is necessary to employ 
biochemical techniques. The genetic studies in yeast that have been described in 
Chapters 3 and 4 have given a good insight into the relationship between PS02  and the 
DNA repair epistasis groups of NER, homologous recombination, and MMR. 
However, conclusive evidence relating to the putative nucleolytic activity of Pso2 is 
only likely to be resolved by producing purified protein for use in in vitro assays. This 
chapter details the procedures used in the first purification of the ScPso2 protein direct 
from S. cerevisiae. Preliminary analysis of the Pso2 protein has been made, providing 
the foundations for a comprehensive in vitro investigation of the function of Pso2 in 
ICL repair.
A yeast expression vector bearing S. cerevisiae PS02  modified with the small antigenic 
FLAG® epitope at the C-terminus (pGAL-c-FLAG PS02, here abbreviated to pFLAG- 
PS02 ) was obtained from Dr M. Tyers (Samuel Lunenfeld Research Institute, Toronto, 
Canada) (Ho et al., 2002). It was deemed preferable to use a C-terminal tag to 
investigate the function of Pso2, as although the valine belonging to the final (3-CASP 
motif C has been predicted to lie close to the C-terminal, it remains separated from the 
FLAG tag by a buffer of 29 residues (Fig. 1.12). Furthermore, the critical HXHXDX 
motif of the putative catalytic site is positioned more than 200 residues from the C- 
terminus. It was felt that the application of an N-terminal tag would be more likely to 
interfere with the nuclear localisation of the Pso2 protein. The FLAG tag is an 
octapeptide (N-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Leu-C), which has been designed to be 
hydrophilic in nature in order to increase the probability of localisation to the surface of
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the fusion protein (Sigma product information; Einhauer and Jungbauer, 2001). This is 
obviously a prerequisite for affinity purification and immunogenic identification of the 
tagged protein, as the epitope must be accessible to its specific antibody. Previous 
research suggests that modification with FLAG rarely affects the original conformation 
and function of the native protein (Molloy et al., 1994; Lee and Altenberg, 2003; Terpe,
2003).
Given the existence of a yeast expression vector bearing the PS02  gene, it seemed 
prudent to attempt to purify Pso2 direct from yeast, rather than using an alternative host 
organism such as E. coli. Considerable effort has recently been made in the use of E. 
coli for the production of yeast Pso2 protein, but without success (P. McHugh, personal 
communication). Purification of proteins from S. cerevisiae is not without limitations, 
particularly related to complications arising from the need to break down the cell wall. 
However, extraction from bacterial cells can also prove difficult as a result of the lack 
of relevant, targeted post-translational modification processes such as phosphorylation 
and glycosylation, and the frequent production of denatured or inappropriately folded 
proteins.
5.1 Verification of FLAG-Pso2 activity
The pFLAG-PS02 plasmid was initially transformed into pso2 deficient cells in two 
different genetic backgrounds (B356-7C and BY4741) to confirm the complete 
functionality of the FLAG-Pso2 protein in ICL repair. Expression of FLAG-PS02 from 
the GAL1 promoter was induced by incubation for 5 h in galactose-raffinose media. It 
was found that cell viability was improved by the inclusion of a pre-induction step, in
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which cells were grown to exponential phase in the presence of glucose. Induced cells 
were subsequently treated with 1, 10, 100, and 1000 pM doses of HN2 (as in previous 
chapters), and plated to determine the extent of survival. Unfortunately, the empty 
parent plasmid, pMT2250 was not available as a control. Parallel control experiments 
were performed instead, in which the pso2 pFLAG-PS02 strains were treated with HN2 
in the absence of galactose induction.
It is clear from figures 5.1 A and B that expression of YLAG-PS02 completely 
complements the HN2 sensitivity of the pso2 disruptant strain. A very slight increase in 
survival is observed in the uninduced cells carrying the FLAG-PS02 plasmid, 
compared to the parent pso2 strain. This may result from a residual level of expression 
from the GAL1 promoter, even in the absence of galactose, as in some cases this 
promoter has been reported to be leaky.
Therefore, the presence of the FLAG epitope at the C-terminus of Pso2 does not appear 
to affect the activity of the Pso2 protein in the repair of ICL. It is notable that 
analogous results are obtained in both genetic backgrounds, despite the variance in HN2 
sensitivity of the two independent pso2 strains.
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Figure 5.1 Complementation o f a pso2 mutant by FLAG-PS02 expression. 
pso2  deficient cells carrying the pFLAG-PS02  vector were treated with 0, 1, 
10, 100, or 1000 p,M HN2, either after a 5 h induction in galactose media 
(induced) or directly following normal culture in glucose media (uninduced). 
Survival was monitored by plating on YEPD. A. B356-7C genetic 
background. B. BY7471 background. Error bars show the SEM.
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5.2 Optimisation of protein extraction
Having established that FLAG-Pso2 is fully active in the repair of HN2-induced DNA 
ICL, it was necessary to optimise both the galactose induction conditions and the 
protocol for protein extraction, in order to maximise the protein yield. Initially these 
extractions were performed on a small scale. A protease-deficient yeast strain, JEL1 
(Lindsley and Wang, 1993, gift of Professor Ian Hickson), was exploited for the 
expression and extraction of Pso2, in order to overcome the normal processes of protein 
degradation once the cell is disrupted. This is an important consideration for the overall 
protein yield, as yeast contains a large number of different proteases located within 
various cellular compartments and membranes. Two of the most problematic proteases 
for protein purification, the luminal vacuolar endoproteinases PrA and PrB (encoded by 
PEP4 and PRB1 respectively), have been disrupted in the JEL1 strain. PrB in particular 
is activated by the typical extraction conditions of neutral pH and SDS, and gene 
disruption has been shown to be far more effective than the use of pepstatin as an 
inhibitor (Guthrie and Fink, 1991). A further advantage of using the JEL1 strain is that 
GAL4 expression has been modified to be under the control of the galactose-inducible 
GAL1 promoter (Lindsley and Wang, 1993). As the Gal4 protein is also a 
transcriptional activator of the GAL1 promoter, a positive feedback loop is initiated 
upon exposure to galactose, ensuring a greater efficiency of expression of the target 
gene from the GAL1 promoter, in this case PS02.
5.2.1 Protein extraction techniques
To determine the most favourable conditions for extraction of the total cellular protein 
content, a number of different buffers and cell disruption methods were tested. These
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procedures were rated by the resulting protein yield, as determined 
spectrophotometrically using the Biorad DC reagents.
Three buffers were investigated: Breaking buffer (Invitrogen pYES2 manual) consisting 
of 50 mM sodium phosphate pH7.4, 1 mM EDTA, 5 % glycerol, 1 mM PMSF, plus 
protease inhibitor cocktail; RIP A buffer (widely used for extraction and 
immunoprecipitation; P. Kaiser, University of California, USA) consisting of 50 mM 
Tris-HCl, 250 mM NaCl, 1 % deoxycholic acid, 1 % Triton X-100, 0.1% SDS, plus 
protease inhibitors; and the commercial buffer, CelLytic-Y (Sigma), which has been 
optimised for efficient yeast protein extraction with minimal interference with protein 
immunoreactivity and biological function. An EDTA-free cocktail of broad-spectrum 
serine and cysteine protease inhibitors (Roche Diagnostics) was used in conjunction 
with all three buffers. These buffers were chosen for their diverse spectrum of 
components, and as they have been used successfully in, or are marketed for, the 
extraction of proteins from yeast. Both the RIPA and CelLytic buffers were found have 
a superior performance (3 to 4-fold greater protein yield) compared to the Breaking 
buffer (Table 5.1).
Two different methods for mechanical disruption of the yeast cell wall were analysed: 
vortexing in the presence of glass beads, and grinding cells frozen in liquid nitrogen. 
Both of these procedures are widely used (Ausubel et al.y 1993), with glass beads 
perhaps being the more popular, although usually only where there is access to a bead 
beater machine. A bead beater was not available during this study, and consequently, 
the grinding of cells in liquid nitrogen using a pestle and mortar, was found to be twice 
as efficient than regular vortexing with glass beads (Table 5.1).
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Table 5.1 Comparison of protein yields obtained using different extraction 
techniques. Different combinations of extraction buffer and mechanical disruption 
mechanisms were investigated. Data are the means of at least 6 independent protein 
extractions.
Method of protein extraction Mean protein yield (+/- SEM) ng/jxl
RIPA buffer/ Liquid Nitrogen 3.88 (+/- 0.72)
Breaking buffer/ Liquid Nitrogen 1.32 (+/- 0.19)
CelLytic-Y/ Liquid Nitrogen 4.63 (+/- 0.34)
CelLytic-Y/Glass beads 2.40 (+/- 1.02)
5.2.2 Galactose inducibility
Given that expression of the endogenous PS02  gene appears to be strictly regulated in 
yeast, and that it is maintained at a low constitutive expression in the absence of DNA 
damage (Richter et al., 1992), it is likely that an excess of the Pso2 protein could be 
toxic to the cell. Indeed, overexpression of hSNMl has been shown to correlate with 
the symptoms of apoptosis (Dronkert 2000). Therefore, it could not be assumed that an 
increase in the period of exposure to galactose would result in a higher concentration of 
Pso2 protein within the cell. It was therefore possible that excessive induction of PS02  
expression would either result in cell death, or that the protein would be subject to 
stringent regulation by proteolytic degradation.
Exponentially growing cells were transferred to a fresh culture containing galactose 
(plus the neutral carbon source, raffinose), and 50 ml samples were taken at the 
following time points: 0, 2, 3, 4, 6, and 24 h. Cells were pelleted and washed, before 
immediately freezing at -80°C. Protein was subsequently extracted from each of these 
samples by resuspending in RIPA buffer and grinding in liquid nitrogen. 30 p,g of each
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whole cell extract was separated by SDS-Polyacrylamide gel electrophoresis, and 
subjected to Western blotting using the optimised conditions described in Chapter 2. 
The primary antibody utilised was a rabbit polyclonal IgG aFLAG (Sigma), 
recommended by the manufacturer for the recognition of C-terminal FLAG-tagged 
proteins. A horseradish peroxidase-conjugated secondary antibody was selected to 
facilitate analysis of the blot by commercial ECL detection reagents. It is clear from 
figure 5.2 that a band representing a protein of about 100 kDa (estimated from the 
standard size markers) is first detected after 4 h galactose induction, and is maximal at 
the longest incubation time of 24 h. This band is not seen in either the JEL1 parent 
strain, or the uninduced cells carrying the pFLAG-PS02 vector. Although this protein 
migrates at a slower rate than would be expected for Pso2 (sequence-based prediction of 
Pso2 size is 76 kDa, plus 3 kDa FLAG epitope), it is the only band that does not appear 
in the control extracts. There is a band at 85 kDa, which is closer to the expected size, 
but this is seen in all extracts, including the vector-free control (Fig. 5.2). Even though 
the JEL1 strain is wild-type for PS02 , this cannot account for the presence of the 85 
kDa band, as the immunodetection is for the FLAG epitope, and not Pso2 directly. 
Furthermore, repetition of the Western blot analysis using a number of independent 
extracts has shown that this 85 kDa protein is consistently expressed (data not shown). 
This protein is likely to display a naturally occurring FLAG-like epitope that is 
recognised under the immunoblotting conditions used here.
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Figure 5.2 Analysis o f galactose-inducible FLAG-PS02 expression. Western 
blot of whole cell extracts (30 pg) from JEL1 cells carrying the pFLAG-P502 
vector , with anti-FLAG primary antibody. Cells were cultured in galctose 
induction media for 0, 2, 3, 4, 6, or 24 h. The JEL1 control (c, no vector) was 
incubated for 24 h. The probable location of the Pso2 protein band is marked 
with an arrow (~ 100 kDa).
232
5.3 Isolation of FLAG-Pso2 by immunoprecipitation
To further enrich the putative FLAG-Pso2 from the whole cell protein extract, 
immunoprecipitation reactions were implemented. The basic principle is that the 
desired protein is recognised by a specific antibody, which in turn is bound by a protein- 
agarose conjugate, forming large complexes that can be precipitated by centrifugation. 
Standard procedures (such as those described in the Sigma Procedures publication) 
were tested under different conditions in order to find an optimal method. The variable 
conditions that were considered included the period and temperature of incubation with 
the anti-FLAG antibody, and the order of mixing the antibody, protein A sepharose, and 
total cell lysate. The efficiency of any one system was determined by calculation of 
protein concentration. The optimal conditions for isolation of FLAG-Pso2 using the 
polyclonal anti-FLAG antibody were deemed to involve sequential incubations in RIPA 
buffer: firstly, the total protein extract and anti-FLAG antibody were mixed on a rotary 
wheel overnight at 4°C, with subsequent addition of the protein A sepharose and a 
further 1 h incubation prior to thorough washing. Both the antibody and protein A 
sepharose were found to be effective at the manufacturers recommended concentration.
A set of immunoprecipitations prepared from JEL1 pFLAG-PS02 cells, either induced 
in galactose for 5 or 24 h, or uninduced, were analysed by Western blotting (Fig. 5.3). 
Compared to the respective total cell protein extracts, the immunoprecipitations are 
relatively clean, with only one dominant protein band of about 100 kDa, detected in the 
galactose-induced samples. This protein is the same as that observed previously, 
appearing only after 4 h galactose induction, and not in the control sample that lacks the
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Figure 5.3 FLAG-PS02 immunoprecipitation. Western blot of whole cell 
extracts (X, 100 pg) and aFLAG immunoprecipitates (IP, each from 200 pg 
crude extract) from JEL1 cells carrying the pFLAG-P5'02 vector, with anti- 
FLAG as the primary immunoblot antibody. Cells were cultured in galactose 
induction media for 0, 5, or 24 h. The location of the putative Pso2 protein 
band and the IgG (released from the sepharose due to the pre-PAGE 
preparative step of boiling in SDS) band is marked with an arrow.
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pFLAG-PS02 vector (Figs. 5.2, 5.3). Hence, if this protein proves to be FLAG-tagged 
Pso2, it appears that it can be isolated from the other cellular proteins by immunological 
means. However, further optimisation is necessary, as the resulting yield of putative 
FLAG-Pso2 is low. It is apparent from figure 5.3 that considerably less 100 kDa 
protein is present in the immunoprecipitate, compared to the whole cell extract, despite 
the use of twice as much crude extract in the immunoprecipitation reaction.
5.4 Large-scale purification of Pso2
Suitable conditions for FLAG-PS02 expression and subsequent protein extraction have 
been determined from the small-scale reactions. The experience of these analyses has 
also highlighted aspects for improvement. In particular, in order to scale up these 
reactions by at least 40-fold, it would be preferable to use a commercially prepared 
agarose-conjugated anti-FLAG antibody, rather than using the sequential antibody and 
protein A sepharose method. This should ensure a greater yield as the protein A 
sepharose is particularly difficult to prepare accurately and manipulate efficiently. 
Furthermore, antibody-agarose conjugates can be more easily recycled for repeated use.
One-litre galactose induction cultures of JEL1 pFLAG-F5'02 were initiated from 
exponentially growing cells and incubated for 24 hours, before washing and freezing 
the resultant cell pellet at -70°C. Crude cellular protein extracts were performed using 
a combination of CelLytic-Y buffer and grinding in liquid nitrogen to fully disrupt the 
cell walls. To account for the larger volumes of extract (on average 5 ml per litre of 
culture), the protein fraction was separated from cellular debris by two 
ultracentrifugation steps at 30,000 rpm, initially for 1.5 h, and subsequently for 45 min.
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The yield of total cellular protein (as determined spectrophotometrically using Biorad 
DC reagents) was usually in the region of 50 mg per litre of cell culture.
Two methods were tested for the isolation of FLAG-Pso2 from the total cellular protein 
complement, both utilising anti-FLAG-M2 affinity gel agarose (Sigma). This gel 
consists of a murine IgG monoclonal antibody (with specificity for C-terminal FLAG 
epitopes) covalently attached to agarose by hydrazide linkage. The use of a monoclonal 
antibody should also assist in reducing the cross-reactivity with endogenous proteins, as 
observed with the polyclonal antibody. One of the reasons for opting to use the 
CelLytic-Y buffer for the crude cellular extracts, rather than the equally well performing 
RIPA buffer, is that the M2 affinity gel is sensitive to the detergent components of the 
RIPA buffer. SDS causes denaturation of the M2 antibody on the resin, and 
deoxycholate inhibits the interaction between the M2 antibody and the FLAG fusion 
protein (Sigma technical bulletin).
The total cellular protein extract was either introduced to the freshly prepared M2 
affinity gel by column chromatography, or incubated in smaller aliquots on a rotary 
wheel (akin to the small scale immunoprecipitations). In both cases, samples were 
agitated at 4°C overnight, to ensure complete formation of the protein-antibody/resin 
conjugates. Subsequent washing was performed by gravity flow (column) or 
centrifugation (eppendorf aliquots), as appropriate. Despite the extra care needed to 
avoid disrupting the resin after centrifugation, this method was found to be more 
satisfactory, both in terms of time and protein yield (3-fold greater yield from 
centrifugation compared to column chromatography). The conjugated protein was 
eluted from the affinity gel by competition with 3 x FLAG peptide for 1 h at 4°C. After
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centrifugation, the FLAG-Pso2 supernatant fraction (XI) was removed and stored at -  
70°C (with protease inhibitors). The yield was typically in the region of 200 pg protein 
per litre of original culture (aliquot/centrifuge method).
It can be seen from the PAGE analysis in figure 5.4 that the XI fraction exhibits a 
number of protein components additional to the suspected FLAG-Pso2 (100 kDa) band, 
although this is the predominant constituent. Further purification of the extract was 
achieved by centrifugation in a Vivascience Vivaspin column with a molecular weight 
cut-off of 5- 50 000 kDa. Clearly, the resulting fraction (X2) contains just two major 
proteins (at 80 and 100 kDa), the larger of which is prevalent (Fig. 5.4). These two 
proteins were excised from the PAGE gel, and sent for analysis by peptide mass 
fingerprint (Cancer Research UK Protein Analysis Laboratory, London Research 
Centre). This analysis involves in-gel protease digestion of the protein band, and 
measurement of the peptide masses using an ABI 4700 TOF-TOF machine (Applied 
Biosystems), which uses high-energy fragmentation to generate characteristic patterns 
for accurate protein identification through comparison with an extensive database. The 
100 kDa protein was indeed found to correspond to Pso2, whereas the 80 kDa 
contaminant is the yeast metabolic protein Leul.
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Figure 5.4 Purification o f FLAG-PS02. PAGE gel resolution of the large 
scale Pso2 extracts, visualised by Coomassie Blue staining. XI is the protein 
fraction resulting from immunopurification with anti-FLAG M2 agarose 
affinity gel. X2 is the protein fraction after further purification of XI by 
centrifugation in a Vivascience Vivaspin column for 3 h at 4000 rpm. Gel one 
contains 20 pg X I, whereas gel two contains a third of the purified X2 fraction 
resulting from a total of 40 pg X I. The location of the Pso2 protein band is 
marked with an arrow (~ 100 kDa).
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5.5 Analysis of post-translational modifications of the Pso2 
protein
After translation of the mRNA, nascent proteins are often modified by the addition of 
small groups to the amino acid side chains (phosphorylation, glycosylation, 
methylation, acetylation), and by the binding of small proteins (ubiquitin, SUMO/small 
ubiquitin-like modifier). These reversible modifications are crucial for protein 
regulation, and enable rapid alterations in protein function, complex specificity, and 
subcellular localisation. Post-translational modification is an important mechanism that 
enables the cell to respond to changes in both its internal and external environment. 
Observations have already been made of transcriptional upregulation of PS02  in 
response to DNA damage (Wolter R et al.t 1996), however this is a relatively slow 
mechanism of protein regulation. Hence it is quite possible that the cell employs post- 
translational mechanisms as well, perhaps to ensure the rapid mobilisation of Pso2 to 
the sites of damage, or to facilitate interactions with other repair and signal transduction 
proteins. Given that purified FLAG-Pso2 migrates significantly more slowly during 
SDS-PAGE than would be expected for a protein of 79 kDa (Fig. 5.4), it is reasonable 
to hypothesize that the protein is modified in some way. The magnitude of this 
migration retardation corresponds to a modification of around 20 kDa. This could be 
consistent with multiple phosphorylated sites (as each corresponds with a shift of 1-5 
kDa, depending on the nature of the protein and of the PAGE gel), multiple 
glycosylation events (for example, the N-linked oligosaccharide Man8GlcNAc2 
contributes about 2 kDa to the molecular weight; Guthrie and Fink, 1991) or the 
addition of at least one ubiquitin/SUMO moiety (8.5 and 12 kDa respectively; 
Saccharomyces Genome Database www.yeastgenome.org).
5.5.1 Phosphorylation
The phosphorylation of proteins, most often at serine, threonine, tyrosine and histidine 
residues, is an important regulatory mechanism that can have a variety of effects, 
including activation, repression or altered function/substrate specificity. 
Phosphorylation of the human Pso2 paralogue, Artemis, by DNA-PKcs has been shown 
to change the substrate specificity of Artemis to include the endonucleolytic cleavage of 
ssDNA overhangs and hairpins (Ma et al., 2002). Furthermore, the phosphorylation of 
tyrosine residues is a key aspect of signal transduction pathways. For example, the 
DNA damage checkpoint consists of a cascade of protein kinase events to amplify the 
signal arising from the detection of the damaged DNA in order to stimulate the 
numerous effector pathways (Toh and Lowndes, 2003). It has been suggested that the 
induction of PS02  expression in response to DNA damage is dependent upon the Dunl 
kinase, which is one of the substrates for the Rad53 checkpoint kinase (Wolter R et al., 
1996; de la Torre Ruiz and Lowndes, 2000). It is not known whether the involvement 
of Pso2 in ICL repair extends to a role in the detection and signalling of DNA damage.
The Pso2 protein sequence was screened for the existence of potential phosphorylation 
sites using two freely available internet databases: Prosite (www.expasy.org/prosite), a 
general database of biologically significant sites and protein motifs, and NetPhos 2.0 
(www.cbs.dtu.dk/services/NetPhos), which specifically produces neural network 
predictions for serine, threonine and tyrosine phosphorylation sites in eukaryotic 
proteins Blom et al., 1999). The Prosite database returned a number of putative 
phosphorylation sites, such as those recognised by protein kinase C and tyrosine kinase. 
However, it should be noted that these predictions are subject to a high frequency of 
false positive associations. Nevertheless, the more refined NetPhos database
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highlighted a total of 28 serine, 13 threonine, and 9 tyrosine residues that could 
represent potential phosphorylation sites (score above a 50 % likelihood threshold). 
Five of these residues (4 serine and 1 tyrosine) correlated with sites specified in the 
Prosite scan, as well as returning a NetPhos prediction score of 99 % (only 88 % for the 
tyrosine residue) (Fig. 5.5, Table 5.2).
Table 5.2 Putative Pso2 phosphorylation sites. The NetPhos predictive scores 
(probabilities) are presented for the Pso2 serine and tyrosine residues that are most 
likely to be targeted by phosphorylation.
Residue S19 S26 S38 S204 Y529
Predictive Score 0.988 0.991 0.996 0.997 0.875
These sequence-based predictive screens, although purely speculative, provided 
reasonable justification to investigate the phosphorylation status of the purified FLAG- 
Pso2 protein. The alkaline phosphatase, CIAP (extracted from calf intestinal mucosa), 
is known to dephosphorylate serine, threonine and tyrosine residues in proteins, in 
addition to its activities on nucleic acids. Immunoprecipitated Pso2 was treated with 20 
units of CIAP for 1.5 h at 37°C, with subsequent electrophoretic mobility shift analysis 
performed by PAGE. Two control reactions were also performed, namely, a mock- 
treatment, and incubation with 20 units of heat-inactivated CIAP enzyme. It is clear 
from figure 5.6 that no change is observed in the migration of the Pso2 protein after
241
1 msrksivqir rsevkrkrSs tasstSegkt lhknthtSsk rqrtltefni ptssnlpvrs
61 ssysfsrfsc stsnkntepv iindddhnsi cledtaKvei tidtdeeelv slhdnevsai
121 eNrtedrivt eleeqvnvkv steviqcpic leNlshlely erethcdtci gsdpsnmgtp
181 kknirsfisn psspaktkrd iatskkptrv klvlpsfkii kfnngheiw dgfnykaset
241 isqyflshfh sdhyiglkks wnnpdenpik ktlycskita ilvnlkfKip mdeiqilpmn
301 krfwitdtis wtldanhcp gaiimlfqef lansydkpir qilhtgdfrs nakmietiqk
361 wlaetaNeti dqvyldttym tmgynfpsqh svcetvadft lrliKhgkNk tfgdsqrnlf
421 hfqrkktltt hryrvlflvg tytigkekla ikiceflktk lfvmpnsvkf smmltvlqnn
481 enqndmwdes lltsnlhess vhlvpirvlk sqetieaylk slkeletdYv kdiedwgfi
541 ptgwshnfgl kyqkknddde nemsgnteyc lelmKndrdn ddengfeiss ilrqykkynk
601
661
fqvfnvpyse
k
hssfndlvKf gcklkcsevi ptvnlnnlwk vrymtnwfqc wenvrktraa
Figure 5.5 Sequence-based prediction o f post-translational modifications. 
Predictive analysis of three types of post-translational modification in the Pso2 
protein (Genbank sequence NP_013857). Putative phosphorylation sites 
identified by both the NetPhos and Prosite databases are highlighted in red. 
Putative glycosylation sites identified in the Prosite screen are hihglighted in 
green. Putative Sumoylation motifs, as predicted by SUMOplot, are 
highlighted in blue.
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treatment with CIAP, suggesting that phosphorylation of the FLAG-Pso2 protein does 
not account for the mobility shift observed. The CIAP used in this assay was a fresh 
stock, and so its activity is not in question. However, it is possible that the conditions 
used were not optimal for protein dephosphorylation, and so it would be good practise 
to confirm the activity of CIAP for a protein known to be in a phosphorylated state.
5.5.2 Glycosylation
Yeast proteins can be modified by the addition of carbohydrate moieties, either attached 
to asparagine (N-linked) or to serine/threonine (O-linked) residues. N-linked structures 
consist predominantly of mannose sugars, whereas O-linked mono- or oligosaccharides 
are more varied (Guthrie and Fink, 1991). Glycosylation used to be considered as a 
specific adaptation of extracellular proteins, particularly those destined for the cell wall. 
However, glycosylation (particularly O-linked N-acetylglucosamine, O-GlcNAc) has 
been found to play an important role in the regulation of intracellular (nuclear and 
cytoplasmic) proteins in higher eukaryotic cells, sometimes even acting antagonistically 
with phosphorylation (Vosseller et al., 2002; Kamemura et al., 2002).
Analysis of the Pso2 protein sequence using the Prosite database identifies four 
asparagine residues as potential N-glycosylation sites, although these are motifs with a 
disproportionately high probability of occurrence (Fig. 5.5). A simple assay for the 
presence of N-glycosylation is to treat the protein with Endoglycosidase H (Endo H), 
and determine whether there is a reduction in protein size by electrophoretic mobility 
shift analysis. Endo H is a recombinant glycosidase that cleaves high mannose 
structures and some hybrid oligosaccharides (such as mannose combined with AcNeu-
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Fig. 5.6 Biochemical analysis o f post-translational modifications. Western 
blot of aFLAG immunoprecipitates (performed on 200 pg crude extract), 
subsequently treated with either calf intestinal alkaline phosphatase (CIAP, 0, 
20 units, or heat inactivated, HI) or EndoH (0 or 5000 units) for 1.5 h at 37 
°C. Due to volume restrictions, only half of the EndoH reactions were 
electrophoresed. The position of bands corresponding to Pso2 and IgG are 
marked with an arrow.
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Gal-GlcNAc) (Maley et al., 1989). The Western blot in figure 5.6 shows that a shift in 
the mobility of immunoprecipitated FLAG-Pso2 is not observed following exposure to 
Endo H (5000 units, 1.5 h at 37°C). Hence it is doubtful that the post-translational 
modification of Pso2 by N-glycosylation accounts for its decreased mobility.
5.5.3 Sumoylation
SUMO (small, ubiquitin-like modifier) is a small polypeptide that can be covalently, 
yet reversibly attached by specific cellular machinery to the lysine residues of other 
proteins, in order to regulate their function. As the name suggests, it is related to the 
well-characterised modifier, ubiquitin, which is essential for the targeting and correct 
degradation of proteins by the proteasome, as well as regulating other processes such as 
endocytosis and meiosis. It is thought that sumoylation is required for protein transport 
into the nucleus (Muller et al., 2001, Schwartz and Hochstrasser, 2003), and 
accordingly, protein modification by Smt3 in S. cerevisiae (homologue of human 
Sumol) is thought to regulate a number of nuclear processes G2-M cell cycle 
progression (Meluh and Koshland, 1995; Li and Hochstrasser, 1999). Crucially, 
sumoylation also appears to regulate some DNA repair pathways, such as RAD6/PRR 
(Hoege et al., 2002).
Many sumoylated proteins exhibit the tetrapeptide motif W-K-x-D/E, where W is a 
hydrophobic residue, K is the conjugated lysine, and D/E is an acidic residue 
(Rodriguez et al., 2001). SUMOplot (www.abgent.com/sumoplot.html) is an internet 
database designed to determine the probability that sequences matching this consensus 
motif are likely to be sumoylated. Analysis of the ScPso2 sequence highlights 5
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potential motifs (at K97, K288, K405, K575, and K619), all of which are assigned a 
likelihood probability between 75 and 80 % (Fig. 5.5, Table 5.3).
Table 5.3 Putative Pso2 sumoylation sites. The SUMOplot predictive scores 
(probabilities) are presented for the lysine residues in Pso2 that could potentially be 
sumoylated.
Residue K97 K288 K405 K575 K619
Predictive Score 0.794 0.744 0.772 0.800 0.756
Consequently, a Western blot of 20 pg purified (X2) Pso2 protein was sequentially 
immunoblotted with the polyclonal anti-FLAG antibody, stripped, and reprobed with a 
polyclonal anti-hSumol antibody (anti-Smt3 is not yet available). It is clear from figure 
5.7 that both antibodies identify a band of equal magnitude. Given that the Pso2 protein 
fraction is relatively pure, it seems likely that Pso2 may be modified by the covalent 
attachment of one or more SUMO polypeptides.
5.6 Discussion
Attaching a FLAG epitope to Pso2 provides a very convenient way of extracting the 
protein directly from yeast, without having to identify Pso2 directly. Both monoclonal 
and polyclonal antibodies to the FLAG peptide are readily available, which provide the 
means to specifically isolate FLAG-tagged proteins from the total cellular extract. 
These antibodies have been well characterised, with respect to both their 
immunoprecipitation capabilities and spectrum of cross-reactivity with non-specific
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Fig. 5.7 Putative sumoylation o f FLAG-Pso2. Further analysis of post- 
translational modifications. Western blot of large scale Pso2 preparation (20 
p.g). The membrane was first immunoblotted with anti-FLAG primary 
antibody, and subsequently stripped and reblotted with anti-SUMO primary 
antibody.
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proteins. Subsequent incubation with excess FLAG peptide facilitates elution of the 
desired protein from the immunocomplexes, at physiological pH, and without the need 
to use stringent salt conditions that can result in loss of protein integrity (Einhauer and 
Jungbauer, 2001). In addition, affinity gel systems are commercially available for 
larger scale protein preparations.
The use of such a peptide tag-based approach to protein purification can cause problems 
if functional protein is required for downstream assays, as is the case with Pso2. It is 
obviously essential to confirm that the presence of the epitope does not alter the normal 
cellular localisation and activity of the protein. In cases where the tagged protein does 
not appear to function in the natural way, steps must be taken to incorporate a cleavage 
site between the protein and the epitope, so that it can be efficiently removed after the 
extraction procedure. In the case of Pso2, it can be assumed that cellular localization 
and activity is normal if Pso2-FLAG is proficient in the repair of HN2-induced ICL, as 
this is the identifying feature of this protein. Since the expression vector utilised here is 
for yeast, the most straightforward means to test functionality is to assay for 
complementation in a S. cerevisiae pso2 defective strain. It is evident from the data 
presented in figure 5.1 that expression of the Pso2-FLAG protein can completely 
compensate for the absence of the endogenous gene, as the extent of HN2 survival is 
indistinguishable from the wild-type strain. Having established that the Pso2-FLAG 
protein is completely functional in the repair of HN2-induced DNA damage, it was not 
deemed necessary to check the extent of activity in other processes such as 
recombination and DSB repair.
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Once the use of a FLAG epitope was confirmed as suitable for the identification of 
Pso2, the next phase was to optimise the procedure for small-scale protein extractions. 
One of the advantages of the FLAG system is that the available anti-FLAG antibodies 
are sufficiently specific to produce a relatively homogeneous preparation of the fusion 
protein direct from the whole-cell protein extract (Einhauer and Jungbauer, 2001). 
Exploitation of either the polyclonal anti-FLAG antibody in small-scale 
immunoprecipitations, or the monoclonal anti-FLAG-M2 affinity gel in larger 
preparations, has proved successful in isolating the FLAG-Pso2 protein from the crude 
cell extract (Sections 5.3 and 5.4). The yield of Pso2 protein was higher under the 
conditions of the larger preparations, probably as a consequence of the reduced 
handling inaccuracies achievable with the antibody-conjugated affinity gel. It is also 
possible that the interaction of the monoclonal M2 antibody with the FLAG epitope is 
more efficient than the polyclonal antibody, in the case of FLAG-tagged Pso2. 
Subsequent purification through a size exclusion column was found to significantly 
improve the quality of the FLAG-Pso2 immunoprecipitate fraction (Fig. 5.4).
The conditions of protein extraction have been optimised, in terms of incubation times, 
buffer compositions, and the mechanism employed to disrupt the yeast cell wall 
(Sections 0 and 5.4). The final preference for the commercial CelLytic-Y buffer 
resulted predominantly from consideration of the need for efficient downstream 
immunopurification (inhibited by some detergent constituents of other extraction 
buffers), and also for the maintenance of Pso2 biological activity. For example, the 
presence of high levels of EDTA in the Breaking buffer may have affected the stability 
of Pso2 zinc coordination at the metallo-|3-lactamase site, possibly to the extent where 
the purified protein is rendered inactive. Significantly, a relatively pure fraction of
ScPso2 protein has been isolated, directly from yeast, for the first time (Section 5.4). 
There now exists a sufficient stock (approximately 0.5 mg) of Pso2 protein for 
biochemical analysis, and a simple protocol has been elucidated for its replenishment.
Attempts have been made to start to characterise the purified Pso2 protein, initially in 
terms of post-translational modifications that could be responsible for the observed 
retardation of about 20 kDa in the migration of FLAG-Pso2. Multiple phosphorylation 
was considered to be one of the most likely putative modifications, especially 
considering the number of candidate residues (Section 5.5.1). However, incubation 
with the phosphatase CIAP failed to induce a change in the pattern of FLAG-Pso2 
migration, at least under the conditions employed here (Fig. 5.7). Furthermore, a 
detailed analysis of the phosphorylation status of Pso2, perhaps considering various 
stages during the repair of ICLs, should be performed in the future, even if only to 
confirm that it is not a regulatory mechanism. Modification by multiple glycosylation 
was also investigated, as this could account for the considerable size difference between 
the sequence-based prediction and that observed by PAGE (Section 5.5.2). However, 
this was a less likely hypothesis, given that glycosylation has not yet been observed for 
any yeast nuclear protein (Guthrie and Fink, 1991; Vosseller et al.t 2002). Accordingly, 
no change in protein size was identified after exposure to Endoglycosidase H (Fig. 5.6).
Nevertheless, these speculative analyses of the state of the Pso2 protein have resulted in 
a novel and significant discovery. A polyclonal antibody raised against a prokaryotic 
recombinant protein corresponding to human Sumol appears to cross-react with the 
purified FLAG-Pso2 protein (Fig. 5.7). The 101 amino acid yeast homologue, Smt3, 
exhibits 48 % identity (as determined by BLAST, NCBI) with the human Sumol
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protein, and so it is entirely feasible that the polyclonal antibody could recognise a 
common epitope. Furthermore, the size of Smt3 is predicted to be 12 kDa, which 
(singularly, or at two sites) could well account for the retarded migration of FLAG- 
Pso2. Analysis of the sequence of Pso2 suggests five different lysine residues that lie 
within putative sumoylation motifs (Section 5.5.3). Nevertheless, it should be noted 
that the SUMOplot predictive database also identifies a number of suitable lysine 
residues (7 with a probability of greater than 70 %) in the sequence of Leul, the major 
contaminant found in the Pso2 preparation. Whether the cytosolic protein Leul is a 
likely substrate for sumoylation is debatable, as in higher eukaryotes at least, the 
majority of the modified proteins are nuclear (Muller c'a/,2001). Correspondingly, most of 
the known functions of Sumo are related to the regulation of nuclear processes, 
including transcription, chromosome segregation, and DNA repair (Muller et al., 2001; 
Schwartz and Hochstrasser, 2003).
Interestingly, a recent report has shown that the enzyme responsible for conjugation of 
SUMO to its target proteins, Ubc9, is required for damage induced homologous 
recombination in yeast, and that loss of this gene renders cell sensitive to a range of 
genotoxic agents, including the ICL-inducing compounds mitomycin C and cisplatin 
(Maeda et al., 2004). Hence, the observation that the Pso2 protein may be sumoylated 
is an important one, and warrants detailed investigation, including an analysis of protein 
extracted from cells exposed to ICL-inducing agents. In particular, Pso2 protein should 
be purified from a ubc9 deficient strain, to conclusively demonstrate whether the 
protein is sumoylated.
251
It is notable that none of the Pso2 preparation migrates at the expected, lower molecular 
weight of 76 kDa. One possibility is that the unmodified form is less stable, and is 
more difficult to purify. By analogy with other sumoylated proteins, it is unlikely that 
all Pso2 is quantitatively modified by SUMO (Hoege et al., 2002). However, recent 
studies have suggested that proteins involved in DNA repair, such as PCNA, can be 
alternately regulated by mono/poly-ubiquitination and sumoylation of the same residue 
(Hoege et al., 2002). Such a phenomenon should be investigated for Pso2, as if Pso2 
always existed in some kind of a modified state, it could explain the homogeneous 
preparation of higher molecular weight protein. Nevertheless, the migration of FLAG- 
tagged Pso2 protein as a single band precludes the existence of a range of differently 
sized modifications, unless the presence of the FLAG epitope causes aberrant post- 
translational modification. It has already been shown that Pso2 functions normally with 
respect to the repair of ICLs (Section 5.1), but for clarification, future studies of post- 
translational modification could be performed after the removal of the FLAG tag from 
the purified protein.
It is tempting to speculate upon the possible role of SUMO modification in the function 
of Pso2. Perhaps it is required for the localisation of Pso2 to the nucleus, or even, more 
specifically, to sites of DNA damage. An alternative is that sumoylation may repress 
Pso2 activity in the absence of DNA damage, perhaps by altering confirmation or 
substrate/ligand specificity. Indeed, the putative sumoylation of Pso2 has been 
observed in undamaged cells where PS02 is expressed at an elevated level (from the 
GAL1 promoter), and a similar case of SUMO modification has previously been 
observed for overproduced Rad22 (homologue of ScRad52) in S. pombe (Ho et al.,
2001). It should be noted that the apparent sumoylation of Pso2 might simply be a
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cellular response to the artificially high expression levels used in this study. If Pso2 
does in fact have a nuclease activity, as predicted from its p-CASP domain, it is likely 
that the protein would be subject to stringent cellular controls to prevent inappropriate 
DNA digestion.
The successful purification of Pso2 direct from its native yeast provides the foundations 
for detailed future analysis of Pso2 function in vitro. One of the first applications of 
this protein is to be the investigation of the role of its metallo-P-lactamase hydrolytic 
domain. A crude assay for nuclease activity has already been performed, in which the 
purified (X2) Pso2 fraction was incubated with a radioactive 5’ end-labelled DNA 
oligonucleotide in either magnesium or manganese based nuclease buffers, and 
subsequently resolved by denaturing PAGE (based on the in vitro studies of M rell- 
Rad50 nuclease activity by Trujillo and Sung, 2001, and of hExol activity by Lee and 
Wilson, 1999). The initial attempt has proved inconclusive, however, there are 
numerous possible substrates and buffer conditions to be analysed. Given the apparent 
specificity of Pso2 for cross-link associated DNA structures, it is likely that such an 
assay will need to be highly refined to detect any activity of Pso2.
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CHAPTER 6 GENERAL DISCUSSION
It has been established for some time that Pso2 is a crucial component of the cellular 
response to DNA interstrand cross-links, yet the exact nature of its function has 
remained elusive. This investigation sought to elucidate the role of Pso2, and, 
accordingly, to refine the current models of ICL repair, using the cross-linking agent 
nitrogen mustard as a paradigm. In concordance with previous genetic studies of pso2 
mutant cells (Henriques and Moustacchi, 1981), the data presented here shows pso2 is 
epistatic to the NER pathway {RADI, RAD2, RAD3, RAD4). However, in contrast to 
the defined ICL incision defect in NER mutants, pso2 disruptant cells are proficient in 
the unhooking (incision) step of interstrand cross-link repair (Magana-Schwencke et al., 
1982; Wilbom and Brendel, 1989; Meniel et al., 1995). Pso2 must therefore be 
involved in a stage of ICL repair that is downstream of the initial excision events.
Loss of PS02 results in an accumulation of DSBs that fail to be repaired (Ch. 3; 
Magana-Schwencke et al., 1982; Wilborn and Brendel, 1989), implying a diminished 
capacity to repair cross-links by recombination (McHugh et al., 2000). Hence, Pso2 is 
involved in the processing of an uncoupled cross-link intermediate structure, prior to 
further repair by the homologous recombination pathway. However, both pso2 and 
NER mutants demonstrate a synergistic relationship with homologous recombination 
CRAD51, RAD52, MRE11) (Chapter 3). Although these genetic relationships seem to 
contradict the perceived mechanism of ICL repair by the sequential action of NER and 
homologous recombination, it is suggested that they are rather a reflection of the non­
exclusivity of this mechanism, and that other repair pathways exist that are dependent 
upon NER or recombination. Indeed, NER factors have been implicated in some
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mechanisms of ICL repair by damage bypass/PRR (Barre et al., 1999; Beljanski et al., 
2004; Saffran et al., 2004). It is also feasible that some cross-link associated DSBs may 
be repaired by recombination alone.
The analyses presented in Chapter 4 suggest that there is a secondary system of ICL 
repair, alternative to the PS02-NER pathway, which is also resolved by recombination. 
This secondary mechanism requires the activity of both Exol and the MutS complexes 
(Msh2:Msh3 and Msh2:Msh6). It is clear that Pso2 provides a key route for ICL repair, 
as loss of Exol and MutS activity only affects viability in cells lacking Pso2 (Chapter 
4). These two branches of repair must represent the only means to process a cross-link 
for subsequent repair by recombination, as a pso2 msh.2 double disruptant is epistatic to 
rad52.
Recent work conducted in parallel with this thesis and using the same panel of B356- 
7C-derived strains has provided further evidence to support an absolute requirement for 
homologous recombination in Pso2-dependent ICL repair (T. Ward and P. McHugh, 
personal communication). Cells were arrested in G1 with a-mating factor, treated with 
HN2, and plated on YEPD to score survival. The single mutants pso2, exol, and msh2 
all behaved as the wild-type parent, in that stationary/Gl phase cells exhibit greater 
sensitivity to HN2 than in exponential phase. This growth-related resistance to HN2 is 
likely to result from the presence of a sister chromatid, which enables repair by 
homologous recombination. In contrast, the pso2 exol and pso2 msh2 strains exhibit an 
equivalent level of sensitivity in both growth phases, suggesting that repair by 
homologous recombination is totally eliminated in the absence of the Pso2- and 
Exol/MutS-dependent repair sub-pathways. Furthermore, these factors are important in
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the recombinational repair of non-ICL-associated DSBs, as pso2 exol and pso2 msh2 
double mutant cells demonstrate an increased sensitivity to ionising radiation, and a 
reduced capacity for spontaneous recombination at an inverted repeat substrate (Chapter 
4). This sensitivity to ionising radiation is epistatic with rad52, since elimination of 
both pso2 and msh2 in a rad52 background produces an indistinguishable level of 
sensitivity to the rad52 single disruptant (Chapter 4; T. Ward and P. McHugh, personal 
communication). Presumably, a subset of the lesions arising either spontaneously, or 
after exposure to ionising radiation, resemble intermediates encountered in the repair of 
an ICL, perhaps involving an irreversibly collapsed replication fork, or break sites 
associated with base damage or other modified/unusual terminal structures.
It is clear that Pso2 is involved at an intermediate stage of ICL repair, after the initial 
incision and unhooking of the cross-link by the NER apparatus, but prior to 
reconstitution of dsDNA by recombination. It is plausible that such an intermediate 
stage of repair may involve nucleolytic processing of the region around the unhooked 
cross-link in order to produce a suitable substrate for the initiation of recombination by 
strand invasion. Given the identification of a highly conserved hydrolytic (3-lactamase 
domain and a DNA-specific (3-CASP motif within the PS02 sequence (Callebaut et al.,
2002), and the recent demonstration that the human /\S02-paralogue Artemis has 
nuclease activity in vitro (Ma et a l,  2002), it is not inconceivable that Pso2 may act in 
some nucleolytic capacity in ICL repair. Furthermore, the results presented here have 
identified a parallel repair mechanism involving the exonuclease Exol, and the MutS 
heterodimer, which is known to bind to branched DNA structures and facilitate the 
endonuclease activity of Radl-RadlO (Alani et al., 1997; Sugawara et al., 1997). By 
analogy, Pso2 may recognise and bind to the complex branched intermediate structures
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arising from the NER-dependent unhooking of the cross-link, and instigate the 
subsequent nucleolytic processing of the gap to provide a suitable ssDNA substrate for 
strand invasion. This exonuclease activity may resemble that of DNA polymerase I in 
E. coli ICL repair, which proceeds in a 5’-3’ direction, equivalent to S. cerevisiae Exol 
(Sladek et al., 1989). Alternatively, Pso2 may act as a flap endonuclease, analogous to 
the DNA-PKcs-complexed form of human Artemis (Ma et al., 2002), or the MutS- 
associated Radi-Rad 10 heterodimer (Sugawara et al., 1997). Indeed, hairpin structures, 
similar to those acted upon by human Artemis, may be formed as an intermediate 
structure in ICL repair.
The confirmation here that NER, Pso2, and recombination act sequentially upon a DNA 
cross-link represents an important advance in the understanding of ICL repair in 
actively growing cells. Figure 6.1 outlines a putative model for ICL repair, which 
encompasses these new discoveries. It is proposed that Pso2 or Exol-MutS acts upon 
the DNA structures arising from NER-dependent incision events, which occur 
throughout the cell cycle (Meniel et al., 1997). However, to account for both the lack of 
epistasis between NER and recombination, and the complete inhibition of 
recombination and DSB repair in the pso2 exol and pso2 msh2 strains, it is suggested 
that Pso2 and Exol-MutS can also process alternative substrates arising directly from a 
replication fork-associated DSB. It is not known whether these branches are co­
ordinated, but the epistasis of PS02 with NER, and the partial DSB repair deficiency in
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Figure 6.1 A revised model of ICL repair in yeast, demonstrating 
the proposed functions of Pso2 and MutS-Exol in exo- and 
endonucleolytic cleavage of intermediate DNA repair structures.
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pso2 mutants, implies that NER-PS02  processing of ICLs may precede DSB repair. 
Furthermore, Pso2 is expected to act as the predominant factor in the processing of 
intermediate DNA structures, due to the absence of an increased sensitivity to ICLs in 
exol msh2 deficient cells. In both cases, where a homologous template is available, the 
resulting intermediates are resolved by strand invasion and recombination across the 
uncoupled cross-link, with a second round of incision reactions to repair the 
complementary DNA strand (Fig. 6.1). The analyses of multiple gene disruptants have 
for the first time facilitated clarification of the complicated relationships between these 
different repair components, resolving the previous ambiguities which yielded 
predictions that NER-Pso2 and recombination represented distinct pathways of ICL 
repair (Grossmann et al., 2001). Pso2 or MutS-Exol could conceivably also digest 
DNA 3’ to the ICL, by first incising endonucleolytically (Fig. 6.1). In the absence of a 
suitable homologous template, it may be possible to replicate past this intermediate 
structure using translesion polymerases.
The conclusions drawn from this investigation regarding the mechanisms involved in 
ICL repair have recently been verified by two other studies in S. cerevisiae using a 
range of cross-linking agents, including cisplatin, mitomycin C, and psoralen (Beljanski 
et al., 2004; Saffran et al., 2004). Beljanski et al. also suggest that the relative 
importance of the different repair pathways in the response to cross-link damage can 
vary, depending on the nature of the ICL-agent. This has important implications for the 
elucidation of ICL repair in mammalian cells, where subtle diversions from the yeast 
system have already been observed, such as the enhanced involvement of XPF-ERCC1 
compared to the other NER factors (Collins 1993; de Silva et al. 2000).
259
One of the remaining questions for ICL-associated DSB repair concerns the mechanism 
by which recombination restart can occur. Obviously, the nature of a cross-link 
attached to both DNA strands precludes simple recombinational bypass. However, the 
observation that ICL repair is more mutagenic in rapidly growing cells than in G1 
phase, suggests an involvement for error-prone repair, even where substrates exist for 
homologous recombination (P. McHugh, unpublished observations). Furthermore, it 
has recently been suggested that a Rad52-dependent replication restart may occur in 
conjunction with damage bypass mechanisms (Schurer et al.y 2004). Such a system 
may well be suited to the bypass of an incised cross-link, hence facilitating DSB- 
initiated replication restart It is hoped that further analysis of the relationship between 
PS02 and PRR, in particular the apparent epistasis with RAD 18 for nitrogen mustard 
sensitivity (Chapter 3), may help to elucidate this pathway of ICL repair.
Future investigation of the explicit function of Pso2 and the elucidation of ICL repair in 
more detail can only be achieved through biochemical analysis. The availability of 
yeast Pso2 protein, as produced here (Chapter 5), now enables a thorough study of its 
potential nuclease activity. These in vitro analyses should incorporate the determination 
of the DNA substrates acted upon by Pso2 and the manner of the nucleolytic activity 
(i.e. endo or exo, and directionality), as well as any protein interactions required for 
efficient cross-link processing. A further tool will be the use of the Pso2 purification 
process to provide a number of mutant Pso2 proteins, deficient in one of the conserved 
motifs, such as the metallo-p-lactamase and p-CASP domains. Such analysis should 
assist in determining the role of Pso2 in ICL repair. Ultimately, it may be possible to 
reconstitute in vitro repair at a defined ICL, and hence formulate a convincing model 
for the repair of DNA interstrand cross-links.
260
The sequence conservation of PS02, especially within the putative catalytic domains, 
from yeast throughout higher eukaryotes implies that this is an important gene. New 
additions to the PS02 family have recently been identified in three other model 
organisms, namely the fission yeast S. pombe (Chapter 3), the fruit fly Drosophila 
melanogaster (Laurencon et al., 2004), and Chicken DT40 cells (M. Takata, Kawasaki 
Medical University, Kurashiki, Japan, personal communication). These will no doubt 
prove to be essential for the extrapolation of the results observed in S. cerevisiae, in 
order to determine the extent of the functional conservation of Pso2. It is hoped that the 
investigation of Pso2 in model organisms will help further the understanding of human 
Snml in the repair of DNA ICL, and ultimately lead to new therapeutic strategies for 
the treatment of cancer.
261
REFERENCES
Abuin A, Zhang H, and Bradley A. 2000. Genetic analysis of mouse embryonic stem 
cells bearing Msh3 and Msh2 single and compound mutations. Mol. Cell. Biol. 20: 149- 
157
Adachi N, Ishino T, Ishii Y, Takeda S, and Koyama H. 2001. DNA ligase IV-deficient 
cells are more resistant to ionizing radiation in the absence of Ku70: Implications for 
DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 98: 12109-12113
Akkari YM, Bateman RL, Reifsteck CA, Olson SB, and Grompe M. 2000. DNA 
replication is required to elicit cellular responses to psoralen-induced DNA interstrand 
cross-links. Mol. Cell Biol. 20: 8283-8289
Alani E, Lee S, Kane MF, Griffith J, and Kolodner RD. 1997. Saccharomyces 
cerevisiae MSH2, a mispaired base recognition protein, also recognizes Holliday 
junctions in DNA. /. Mol. Biol. 265: 289-301
Allers T and Lichten M. 2001. Differential timing and control of noncrossover and 
crossover recombination during meiosis. Cell 106: 47-57
Ammerer G. 1983. Expression of genes in yeast using the ADCI promoter. Methods 
Enzymol. 101: 192-201
Anderson DG and Kowalczykowski SC. 1997. The translocating RecBCD enzyme 
stimulates recombination by directing RecA protein onto ssDNA in a chi-regulated 
manner. Cell. 90: 77-86
Aravind L. 1999. An evolutionary classification of the metallo-|3-lactamase fold 
proteins. In Silico Biol. 1:69-91
262
Argueso JL, Smith D, Yi J, Waase M, Sarin S, and Alani E. 2002. Analysis of 
conditional mutations in the Saccharomyces cerevisiae MLH1 gene in mismatch repair 
and in meiotic crossing over. Genetics 160: 909-921
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, and Struhl K 
(Eds.). 1993. Unit 13.13, Preparation of Protein Extracts from Yeast. In: Current 
Protocols in Molecular Biology, John Wiley & Sons, Inc.
Averbeck D, Dardalhon M, Magana-Schwencke N, Meira LB, Meniel V, Boiteux S, 
and Sage E. 1992. New aspects of the repair and genotoxicity of psoralen 
photoinduced lesions in DNA. J. Photochem. Photobiol. B Biol. 14: 47-63
Averbeck D and Dardalhon M. 1990. Pulsed-field electrophoresis analysis of the 
repair of DNA interstrand cross-links induced in Saccharomyces cerevisiae. Yeast 6: 
S114
Bai Y and Symington LS. 1996. A Rad52 homologue is required for RAD51- 
independent mitotic recombination in Saccharomyces cerevisiae. Genes Dev. 10: 2025- 
2037
Bailly V, Lamb J, Sung P, Prakash S, and Prakash L. 1994. Specific complex 
formation between yeast RAD6 and RAD18 proteins: a potential mechanism for 
targeting RAD6 ubiquitin-conjugating activity to DNA damage sites. Genes Dev. 8: 
811-820
Balajee AS and Bohr VA. 2000. Genomic heterogeneity of nucleotide excision repair. 
Gene 250: 15-30. Review.
263
Bardwell AJ, Bardwell L, Tomkinson AE, and Friedberg EC. 1994. Specific cleavage 
of model recombination and repair intermediates by the yeast Radi-Rad 10 DNA 
endonuclease. Science 265: 2082-2085
Bardwell L, Cooper AJ, and Friedberg EC. 1992. Stable and specific association 
between the yeast recombination and DNA repair proteins RADI and RADIO in vitro. 
Mol. Cell Biol. 12: 3041-3049
Bardwell PD, Woo CJ, Wei K, Li Z, Martin A, Sack SZ, Parris T, Edelmann W, and 
Scharff MD. 2004. Altered somatic hypermutation and reduced class-switch 
recombination in exonuclease 1-mutant mice. Nat. Immunol. 5: 224-229
Barre FX, Asseline U, and Harel-Bellan A. 1999 A. Asymmetric recognition of 
psoralen interstrand cross-links by the nucleotide excision repair and the error-prone 
pathways. J. Mol. Biol. 286: 1379-1387
Barre FX, Giovannangeli C, Helene C, and Harel-Bellan A. 1999 B. Covalent 
crosslinks introduced via a triple helix-forming oligonucleotide coupled to psoralen are 
inefficiently repaired. Nucleic Acids Res. 27: 743-749
Batty DP and Wood RD. 2000. Damage recognition in nucleotide excision repair of 
DNA. Gene 241: 193-204. Review.
Becker DM, Fikes JD, and Guarente L. 1991. A cDNA encoding a human CCAAT- 
binding protein cloned by functional complementation in yeast. Proc. Natl. Acad. Sci. 
USA 88: 1968-1972
264
Beljanski V, Marzilli LG, and Doetsch PW. 2004. DNA damage-processing pathways 
involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs. 
Mol Pharmacol. 65: 1496-1506
Berardini M, Foster PL, and Loechler EL. 1999. DNA polymerase II (polB) is 
involved in a new DNA repair pathway for DNA interstrand cross-links in Escherichia 
coli. J. Bacteriol. 181: 2878-82
Bessho T. 2003. Induction of DNA replication-mediated double strand breaks by 
psoralen DNA interstrand cross-links. J. Biol. Chem. 278: 5250-5254
Bessho T, Mu D, and Sancar A. 1997. Initiation of DNA interstrand cross-link repair 
in humans: the nucleotide excision repair system makes dual incisions 5' to the cross- 
linked base and removes a 22- to 28-nucleotide-long damage-free strand. Mol. Cell. 
Biol. 17: 6822-30
Bhatia PK, Verhage RA, Brouwer J, and Friedberg EC. 1996. Molecular cloning and 
characterization of Saccharomyces cerevisiae RAD28, the yeast homolog of the human 
Cockayne syndrome A (CSA) gene. J. Bacteriol. 178: 5977-5988
Bishop DK, Ear U, Bhattacharyya A, Calderone C, Beckett M, Weichselbaum RR and 
Shinohara A. 1998. Xrcc3 is required for assembly of Rad51 complexes in vivo. J. 
Biol. Chem. 273: 21482-21488
Blom N, Gammeltoft S, and Brunak S. 1999. Sequence- and structure-based prediction 
of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294: 1351-1362
265
Bodell WJ. 1990. Molecular dosimetry for sister-chromatid exchange induction and 
cytotoxicity by monofunctional and bifunctional alkylating agents. Mutat Res. 233: 
203-210
Boulton SJ and Jackson SP. 1996. Saccharomyces cerevisiae Ku70 potentiates 
illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA 
repair pathways. EMBOJ. 15:5093-5103
Brendel M and Ruhland A. 1984. Relationships between functionality and genetic 
toxicology of selected DNA-damaging agents. Mutat. Res. 133: 51-85
Bressan DA, Baxter BK, and Petrini JH. 1999. The Mrell-Rad50-Xrs2 protein 
complex facilitates homologous recombination-based double-strand break repair in 
Saccharomyces cerevisiae. Mol. Cell. Biol. 19: 7681-7687
Broomfield S and Xiao W. 2002. Suppression of genetic defects within the RAD6 
pathway by srs2 is specific for error-free post-replication repair but not for damage- 
induced mutagenesis. Nucl. Acids Res. 30: 732-739
Broomfield S, Hryciw T, and Xiao W. 2001. DNA postreplication repair and 
mutagenesis in Saccharomyces cerevisiae. Mutat. Res. 486: 167-184. Review.
Caldecott K and Jeggo P. 1991. Cross-sensitivity of gamma-ray-sensitive hamster 
mutants to cross-linking agents. Mutat. Res. 255: 111-121
Callebaut I, Moshous D, Mornon JP, and de Villartay JP. 2002. Metallo-beta- 
lactamase fold within nucleic acids processing enzymes: the beta-CASP family. 
Nucleic Acids Res. 30: 3592-3601
266
Carfi A, Pares S, Duee E, Galleni M, Duez C, Frere JM, and Dideberg O. 1995. The 3- 
D structure of a zinc metallo-P-lactamase from Bacillus cereus reveals a new type of 
protein fold. EMBOJ. 14:4914-4921
Cassier C, Chanet R, Henriques JA, and Moustacchi E. 1980. The effects of three PSO 
genes on induced mutagenesis: a novel class of mutationally defective yeast. Genetics 
96: 841-857
Cassier-Chauvat C and Moustacchi E. 1988. Allelism between psol-1 and rev3-l 
mutants and between pso2-l and snml mutants in Saccharomyces cerevisiae. Curr. 
Genet. 13:37-40
Chanet R, Cassier C, and Moustacchi E. 1985. Genetic control of the bypass of mono- 
adducts and of the repair of cross-links photoinduced by 8-methoxypsoralen in yeast. 
Mutat. Res. 145: 145-155
Chaney SG and Sancar A. 1996. DNA repair: enzymatic mechanisms and relevance to 
drug response. J. Natl. Cancer Inst. 88: 1346-1360. Review.
Chen C and Kolodner RD. 1999. Gross chromosomal rearrangements in
Saccharomyces cerevisiae replication and recombination defective mutants. Nat. 
Genet. 23: 81-85
Christmann M, Tomicic MT, Roos WP, and Kaina B. 2003. Mechanisms of human
DNA repair: an update. Toxicology 193: 3-34 Review.
Chu G and Gunderson K. 1991. Separation of large DNA by a variable-angle contour- 
clamped homogeneous electric field apparatus. Anal. Biochem. 194:439-446
267
Clark AB, Cook ME, Tran HT, Gordenin DA, Resnick MA and Kunkel TA. 1999. 
Functional analysis of human MutSalpha and MutSbeta complexes in yeast. Nucleic 
Acids Res. 27: 736-742
Cole RS, Levitan D, and Sinden RR. 1976. Removal of psoralen interstrand cross-links 
from DNA of Escherichia coli: mechanism and genetic control. J. Mol. Biol. 103: 39- 
59
Cole RS. 1973. Repair of DNA containing interstrand crosslinks in Escherichia coli: 
sequential excision and recombination. Proc. Natl. Acad. Sci. USA 70: 1064-1068
Collins AR. 1993. Mutant rodent cell lines sensitive to ultraviolet light, ionizing 
radiation and cross-linking agents: a comprehensive survey of genetic and biochemical 
characteristics. Mutat Res. 293: 99-118
Comess KM and Lippard SJ. 1993. Molecular aspects of platinum-DNA interactions. 
In: Molecular Aspects of Anticancer Drug-DNA interactions, (Eds. Neidle S and 
Waring MJ), Macmillan Press, Houndmills, Basingstoke, UK, pp 134-168.
Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, and Marians KJ. 2000. 
The importance of repairing stalled replication forks. Nature 404: 37-41
Crouse GF. 2000. Mutagenesis assays in yeast. Methods 22: 116-119. Review.
Damia G, Imperatori L, Stefanini M, D'Incalci M. 1996. Sensitivity of CHO mutant 
cell lines with specific defects in nucleotide excision repair to different anti-cancer 
agents. Int. J. Cancer 66: 779-83
D’Amours D and Jackson SP. 2001. The yeast Xrs2 complex functions in S phase 
checkpoint regulation. Genes Dev. 15: 2238-2249
268
D'Andrea AD and Grompe M. 2003. The Fanconi anaemia/BRCA pathway. Nat Rev 
Cancer. 3: 23-34. Review.
Dardalhon M and Averbeck D. 1995. Pulsed-field gel electrophoresis analysis of the 
repair of psoralen plus UVA induced DNA photoproducts in Saccharomyces cerevisiae. 
Mutat. Res. 336: 49-60
Dardalhon M, Nohturfft A, Menial V and Averbeck D. 1994. Repair of DNA double- 
strand breaks induced in Saccharomyces cerevisiae using different y-ray dose rates: a 
pulsed-field electrophoresis analysis. Int. J. Radiat. Biol. 65: 307-314
de Jager M, Wyman C, van Gent DC, and Kanaar R. 2002. DNA end-binding 
specificity of human Rad50/Mrell is influenced by ATP. Nucl. Acids Res. 30: 4425- 
4431
de Jager M, van Noort J, van Gent DC, Dekker C, Kanaar R, and Wyman C. 2001. 
Human Rad50/Mrell is a flexible complex that can tether DNA ends. Mol. Cell. 8: 
1129-1135
de la Torre Ruiz MA and Lowndes NF. 2000. DUN1 defines one branch downstream 
of RAD53 for transcription and DNA damage repair in Saccharomyces cerevisiae. 
FEBS Lett. 485: 205-206
De Silva IU, McHugh PJ, Clingen PH, and Hartley JA. 2002. Defects in interstrand 
cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF 
cells to cisplatin. Nucleic Acids Res. 30: 3848-3856
269
De Silva IU, McHugh PJ, Clingen PH, and Hartley JA. 2000. Defining the roles of 
nucleotide excision repair and recombination in the repair of DNA interstrand cross­
links in mammalian cells. Mol. Cell. Biol. 20: 7980-7990
Debrauwere H, Loeillet S, Lin W, Lopes J, and Nicolas A. 2001. Links between 
replication and recombination in Saccharomyces cerevisiae: a hypersensitive 
requirement for homologous recombination in the absence of Rad27 activity. Proc. 
Natl. Acad. Sci. USA 98: 8263-8269
Demuth I and Digweed M. 1998. Genomic organization of a potential human DNA- 
crosslink repair gene, KIAA0086. Mutat. Res. 409:11-16
Doetsch PW, Morey NJ, Swanson RL, and Jinks-Robertson S. 2001. Yeast base 
excision repair: interconnections and networks. Prog. Nucleic Acid Res. Mol. Biol. 68: 
29-39. Review.
Drake JW. 1970. The Molecular Basis of Mutation. Holden-Day, San Francisco, USA.
Dronkert ML and Kanaar R. 2001. Repair of DNA interstrand cross-links. Mutat. Res. 
486: 217-247. Review.
Dronkert ML, de Wit J, Boeve M, Vasconcelos ML, van Steeg H, Tan TL, Hoeijmakers 
JH, and Kanaar R. 2000. Disruption of mouse SNM1 causes increased sensitivity to the 
DNA interstrand cross-linking agent mitomycin C. Mol. Cell. Biol. 20: 4553-4561
Eggleston AK and West SC. 1996. Exchanging partners: recombination in E. coli. 
Trends Genet. 12: 20-26. Review.
270
Einhauer A and Jungbauer A. 2001. The FLAG peptide, a versatile fusion tag for the 
purification of recombinant proteins. J. Biochem. Biophys. Methods. 49: 455-465. 
Review.
Evans E, Sugawara N, Haber JE, and Alani E. 2000. The Saccharomyces cerevisiae 
Msh2 mismatch repair protein localises to recombination intermediates in vivo. Mol. 
Cell 5: 789-799
Evans E, Moggs JG, Hwang JR, Egly JM, and Wood RD. 1997. Mechanism of dpen 
complex and dual incision formation by human nucleotide excision repair factors. 
EMBOJ. 16: 6559-6573
Fichtinger-Schepman AM, van Dijk-Knijnenburg HC, van der Velde-Visser SD, 
Berends F, and Baan RA. 1995. Cisplatin- and carboplatin-DNA adducts: is PT-AG 
the cytotoxic lesion? Carcinogenesis 16: 2447-2453
Fichtinger-Schepman AMJ, van der Veer JL, den Hartog JHJ, Lohman PHM, and 
Reedijk J. 1985. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with 
DNA: formation, identification, and quantitation. Biochemistry 24: 707-713
Fink D, Aebi S, and Howell SB. 1998. The role of DNA mismatch repair in drug 
resistance. Clin Cancer Res. 4: 1-6. Review.
Fiorentini P, Huang KN, Tishkoff DX, Kolodner RD, and Symington LS. 1997. 
Exonuclease I of Saccharomyces cerevisiae functions in mitotic recombination in vivo 
and in vitro. Mol. Cell. Biol. 17: 2764-2773
271
Fishman-Lobell J and Haber JE. 1992. Removal of nonhomologous DNA ends in 
double-strand break recombination: the role of the yeast ultraviolet repair gene RADI. 
Science 258: 480-484
Fishman-Lobell J, Rudin N, and Haber JE. 1992. Two alternative pathways of double­
strand break repair that are kinetically separable and independently modulated. Mol. 
Cell. Biol. 12: 1292-303
Fleer R and Brendel M. 1979. Formation and fate of cross-links induced by 
polyfunctional anticancer drugs in yeast. Mol. Gen. Genet. 176: 41-52
Frank-Vaillant M and Marcand S. 2001. NHEJ regulation by mating type is exercised 
through a novel protein, Lif2p, essential to the ligase IV pathway. Genes Dev. 15: 
3005-12
Friedberg EC, Walker GC, and Siede W. 1995. DNA repair and Mutagenesis. 
American Society for Microbiology, Washington, DC.
Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, 
and D'Andrea AD. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a 
common pathway. Mol. Cell. 7: 249-262
Gavel Y and von Heijne G. 1990. Cleavage-site motifs in mitochondrial targeting 
peptides. Protein Eng. 4: 33-37
Gavin A-C, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, 
Michon AM, Cruciat CM, Remor M, Hofert C, Schelder M, Brajenovic M, Ruffner H, 
Merino A, Klein K, Hudak M, Dickson D, Rudi T, Gnau V, Bauch A, Bastuck S, Huhse 
B, Leutwein C, Heurtier MA, Copley RR, Edelmann A, Querfurth E, Rybin V, Drewes
272
G, Raida M, Bouwmeester T, Bork P, Seraphin B, Kuster B, Neubauer G, and Superti- 
Furga G. 2002. Functional organization of the yeast proteome by systematic analysis 
of protein complexes. Nature 415: 141-147
Geigl EM and Eckardt-Schupp F. 1990. Chromosome-specific identification and 
quantification of SI nuclease-sensitive sites in yeast chromatin by pulsed-field gel 
electrophoresis. Mol. Microbiol. 4: 801-810
Genschel J and Modrich P. 2003. Mechanism of 5’-directed excision in human 
mismatch repair. Mol. Cell 12: 1077-1086
Genschel J, Littman SJ, Drummond JT, and Modrich P. 1998. Isolation of MutSbeta 
from human cells and comparison of the mismatch repair specificities of MutSbeta and 
MutSalpha. J. Biol. Chem. 273: 19895-901
Godthelp BC, Wiegant WW, van Duijn-Goedhart A, Scharer OD, van Buul PP, Kanaar 
R, and Zdzienicka MZ. 2002. Mammalian Rad51C contributes to DNA cross-link 
resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res. 30: 
2172-2182
Goldstein AL and McCusker JH. 1999. Three new dominant drug resistance cassettes 
for gene disruption in Saccharomyces cerevisiae. Yeast. 15: 1541-1553
Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A, and McLennan 
MT. 1946. Nitrogen Mustard Therapy. Journal of the American Medical Association, 
September 21, pp. 126-132.
273
Greenberg RB, Alberti M, Hearst JE, Chua MA, and Saffran WA. 2001.
Recombinational and mutagenic repair of psoralen interstrand cross-links in
Saccharomyces cerevisiae. J. Biol. Chem. 276: 31551-31560
Greene AL, Snipe JR, Gordenin DA, and Resnick MA. 1999. Functional analysis of 
human FEN1 in Saccharomyces cerevisiae and its role in genome stability. Hum. Mol. 
Genet. 8: 2263-2273
Gregory SM and Sweder K. 2001. Deletion of the CSB homolog, RAD26, yields Spt- 
strains with proficient transcription-coupled repair. Nucleic Acids Res. 29: 3080-3086
Grenson M, Mousset M, Wiame JM, and Bechet J. 1966. Multiplicity of the amino acid 
permeases in Saccharomyces cerevisiae. I. Evidence for a specific arginine-transporting 
system. Biochim. Biophys. Acta 127: 325-338
Grompe M and D'Andrea A. 2001. Fanconi anemia and DNA repair. Hum. Mol. 
Genet. 10: 2253-2259. Review.
Grossmann KF, Ward AM, Matkovic ME, Folias AE, and Moses RE. 2001. S. 
cerevisiae has three pathways for DNA interstrand crosslink repair. Mutat Res. 487: 
73-83
Grossmann KF, Ward AM, and Moses RE. 2000. Saccharomyces cerevisiae lacking 
Snml, Rev3 or Rad51 have a normal S phase but arrest permanently in G2 after 
cisplatin treatment. Mutat. Res. 461: 1-13
Guthrie C and Fink GR. 1991. Guide to yeast genetics and molecular biology.
Academic Press, San Diego, California.
274
Guzder SN, Sung P, Prakash L, and Prakash S. 1999. Synergistic interaction between 
yeast nucleotide excision repair factors NEF2 and NEF4 in the binding of ultraviolet- 
damaged DNA. J. Biol. Chem. 274: 24257-24262
Guzder SN, Sung P, Prakash L, and Prakash S. 1996. Nucleotide excision repair in 
yeast is mediated by sequential assembly of repair factors and not by a pre-assembled 
repairosome. J. Biol. Chem. 271: 8903-10
Guzder SN, Habraken Y, Sung P, Prakash L, and Prakash S. 1995. Reconstitution of 
yeast nucleotide excision repair with purified Rad proteins, replication protein A, and 
transcription factor TFIIH. J. Biol. Chem. 270: 12973-12976
Haber JE, Ira G, Maikova A, and Sugawara N. 2004. Repairing a double-strand 
chromosome break by homologous recombination: revisiting Robin Holliday's model. 
Philos Trans R Soc Lond B Biol Sci. 359: 79-86. Review.
Haber JE. 2000. Partners and pathwaysrepairing a double-strand break. Trends. Genet. 
16: 259-64 Review.
Haber JE. 1998. The many interfaces of Mrell. Cell. 95: 583-586. Review.
Habraken Y, Sung P, Prakash L, and Prakash S. 1995. Structure-specific nuclease 
activity in yeast nucleotide excision repair protein Rad2. J. Biol. Chem. 270: 30194-8
Hansen WK and Kelley MR. 2000. Review of mammalian DNA repair and 
translational implications. J. Pharmacol. Exp. Ther. 295: 1-9. Review.
Haracska L, Torres-Ramos CA, Johnson RE, Prakash S, and Prakash L. 2004. 
Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on
275
replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol. Cell. Biol. 24: 
4267-4274
Haracska L, Prakash S, and Prakash L. 2000. Replication past 0(6)-methylguanine by 
yeast and human DNA polymerase eta. Mol. Cell. Biol. 20: 8001-8007
Harfe BD and Jinks-Robertson S. 2000. Mismatch repair proteins and mitotic genome 
stability. Mut. Res. 451: 151-167. Review.
Hartley JA. 2001. Alkylating agents. In: Oxford Textbook of Oncology, (Eds.
Souhami RL, Tannock IF, Hohenberger P, and Horiot JC), pp. 639-654
Hartley JA, Souhami RL, and Berardini MD. 1993. Electrophoretic and
chromatographic separation methods used to reveal interstrand crosslinking of nucleic 
acids. J. Chromatogr. 618: 277-88. Review.
Henriques JA, Brozmanova J, and Brendel M. 1997. Role of PSO genes in the repair 
of photoinduced interstrand cross-links and photooxidative damage in the DNA of the 
yeast Saccharomyces cerevisiae. J. Photochem. Photobiol. B 39: 185-196
Henriques JA and Moustacchi B. 1981. Interactions between mutations for sensitivity 
to psoralen photoaddition (pso) and to radiation (rad) in Saccharomyces cerevisiae. J. 
Bacteriol. 148: 248-256
Henriques JA and Moustacchi E. 1980. Isolation and characterization of pso mutants 
sensitive to photo-addition of psoralen derivatives in Saccharomyces cerevisiae. 
Genetics 95: 273-288
276
Ho JC, Warr NJ, Shimizu H, and Watts FZ. 2001. SUMO modification of Rad22, the 
Schizosaccharomyces pombe homologue of the recombination protein Rad52. Nucleic 
Acids Res. 29: 4179-4186
Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, Millar A, Taylor P, 
Bennett K, Boutilier K, Yang L, Wolting C, Donaldson I, Schandorff S, Shewnarane J, 
Vo M, Taggart J, Goudreault M, Muskat B, Alfarano C, Dewar D, Lin Z, Michalickova 
K, Willems AR, Sassi H, Nielsen PA, Rasmussen KJ, Andersen JR, Johansen LE, 
Hansen LH, Jespersen H, Podtelejnikov A, Nielsen E, Crawford J, Poulsen V, Sorensen 
BD, Matthiesen J, Hendrickson RC, Gleeson F, Pawson T, Moran MF, Durocher D, 
Mann M, Hogue CW, Figeys D, and Tyers M. 2002. Systematic identification of 
protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature. 415: 
180-183, with supplementary information available at
http://www.mdsproteomics.com/yeast/
Ho YP, Au-Yeung SC, and To KK. 2003. Platinum-based anticancer agents: 
innovative design strategies and biological perspectives. Med. Res. Rev. 23: 633-55. 
Review.
Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, and Jentsch S. 2002. RAD6- 
dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. 
Nature. 419: 135-41
Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer. 
Nature 411: 366-374. Review.
277
Hollingsworth NM, Ponte L, and Halsey C. 1995. MSH5, a novel MutS homologue 
facilitates meiotic reciprocal recombination between homologues in Saccharomyces 
cerevisiae but not mismatch repair. Genes Dev. 9: 1728-1739
Hopfner KP, Craig L, Moncalian G, Zinkel RA, Usui T, Owen BA, Karcher A, 
Henderson B, Bodmer JL, McMurray CT, Carney JP, Petrini JH, and Tainer JA. 2002. 
The Rad50 zinc-hook is a structure joining Mrell complexes in DNA recombination 
and repair. Nature 418: 562-6
Huang W, Feaver WJ, Tomkinson AE, and Friedberg EC. 1998. The N-degron protein 
degradation strategy for investigating the function of essential genes: requirement for 
replication protein A and proliferating cell nuclear antigen proteins for nucleotide 
excision repair in yeast extracts. Mutat. Res. 408: 183-94
Hughes TR, Roberts CJ, Dai H, Jones AR, Meyer MR, Slade D, Burchard J, Dow S, 
Ward TR, Kidd MJ, Friend SH, and Marton MJ. 2000. Widespread aneuploidy 
revealed by DNA microarray expression profiling. Nat. Genet. 25: 333-337
Ira G, Maikova A, Liberi G, Foiani M, and Haber JE. 2003. Srs2 and Sgsl-Top3 
suppress crossovers during double-strand break repair in yeast. Cell 115: 401-11
Ira G and Haber JE. 2002. Characterization of RAD51-independent break-induced 
replication that acts preferentially with short homologous sequences. Mol. Cell. Biol. 
22: 6384-92
Ivanov EL, Sugawara N, Fishman-Lobell J, and Haber JE. 1996. Genetic requirements 
for the single-strand annealing pathway of double-strand break repair in Saccharomyces 
cerevisiae. Genetics 142: 693-704
278
Ivanov E and Haber JE. 1995. RADI and RADIO, but not other excision repair genes 
are required for double-strand break-induced recombination in Saccharomyces 
cerevisiae. Mol. Cell. Biol. 15:2245-2251
Ivanov EL, Sugawara N, White Cl, Fabre F, and Haber JE. 1994. Mutations in XRS2 
and RAD50 delay but do not prevent mating-type switching in Saccharomyces 
cerevisiae. Mol. Cell. Biol. 14: 3414-25
Jachymczyk WJ, von Borstel RC, Mowat MR, and Hastings PJ. 1981. Repair of 
interstrand cross-links in DNA of Saccharomyces cerevisiae requires two systems for 
DNA repair: the RAD3 system and the RAD51 system. Mol. Gen. Genet. 182: 196-205
Jacobson LO, Spurr CL, Barron ESG, Smith T, Lushbaugh C, and Dick GF. 1946. 
Nitrogen mustard therapy. Studies on the effect of methyl-bis (Beta-chloroethyl) amine 
hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system. J. 
Am. Med. Assoc. 132: 263-71
Jakupec MA, Galanski M, and Keppler BK. 2003. Tumour-inhibiting platinum 
complexes—state of the art and future perspectives. Rev Physiol Biochem Pharmacol. 
146: 1-54. Review.
Jeggo PA. 1998. Identification of genes involved in repair of DNA double-strand 
breaks in mammalian cells. Radiat. Res. 150: S80-91. Review
Jiang L, Whiteway M, Ramos C, Rodriguez-Medina JR, and Shen SH. 2002. The 
YHR076w gene encodes a type 2C protein phosphatase and represents the seventh 
PP2C gene in budding yeast. FEBS Lett. 527: 323-325
279
Johnson RE, Wahington MT, Prakash S, and Prakash L. 1999. Bridging the gap: a 
family of novel DNA polymerases that replicate faulty DNA. Proc. Natl. Acad. Sci. 
USA96: 12224-12226
Jones NJ, Cox R, and Thacker J. 1987. Isolation and cross-sensitivity of X-ray- 
sensitive mutants of V79-4 hamster cells. Mutat. Res. 183: 279-286
Kamemura K, Hayes BK, Comer FI, and Hart GW. 2002. Dynamic interplay between 
O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative 
glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in 
lymphomas, is regulated by mitogens. J. Biol. Chem. 277: 19229-19235
Karanjawala ZE, Adachi N, Irvine RA, Oh EK, Shibata D, Schwarz K, Hsieh CL, and 
Lieber MR. 2002. The embryonic lethality in DNA ligase IV-deficient mice is rescued 
by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ 
mutants. DNA Repair 1: 1017-26
Karran P. 2000. DNA double strand break repair in mammalian cells. Curr. Opin. 
Genet. Dev. 10: 144-150. Review.
Kaye J, Smith CA, and Hanawalt PC. 1980. DNA repair in human cells containing 
photoadducts of 8-methoxypsoralen or angelicin. Cancer Res. 40: 696-702
Kiakos K, Howard TT, Lee M, Hartley JA, McHugh PJ. 2002. Saccharomyces 
cerevisiae RADS influences the excision repair of DNA minor groove adducts. J. Biol. 
Chem. 277: 44576-44581
Klein HL. 1998. Different types of recombination events are controlled by the RADI 
and RAD52 genes of Saccharomyces cerevisiae. Genetics 120: 367-377
280
Kobayashi J, Antoccia A, Tauchi H, Matsuura S, and Komatsu K. 2004. NBS1 and its 
functional role in the DNA damage response. DNA Repair 3: 855-61
Kraakman-van der Zwet M, Overkamp WJI, van Lange REE, Essers J, van Duijn- 
Goedhart A, Wiggers I, Swaminathan S, van Buul PPW, Errami A, Tan RTL, Jaspers 
NGJ, Sharan SK, Kanaar R and Zdzienicka MZ. 2002.' Brca2 (XRCC11) deficiency 
results in radioresistent DNA synthesis and a higher frequency of spontaneous 
deletions. Mol. Cell. Biol. 22: 669-679
Kumaresan KR, Hwang M, Thelen MP, and Lambert MW. 2002. Contribution of XPF 
functional domains to the 5’ and 3’ incisions produced at the site of a psoralen 
interstrand cross-link. Biochemistry. 41: 890-896
Kunze R and Weil CF. 2002. The hAT and CACTA superfamilies o f plant transposons. 
p565-610. In Craig N, Craigie R, Gellert M, and Lambowitz A (ed.), Mobile DNA II. 
American Society for Microbiology, Washington, D.C.
Kuraoka I, Kobertz WR, Ariza RR, Biggerstaff M, Essigmann JM, Wood RD. 2000. 
Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination 
nuclease. J Biol Chem. 275: 26632-6
Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature. 227: 680-5
Lage C, de Padula M, de Alencar TA, da Fonseca Goncalves SR, da Silva Vidal L, 
Cabral-Neto J, Leitao AC. 2003. New insights on how nucleotide excision repair could 
remove DNA adducts induced by chemotherapeutic agents and psoralens plus UV-A 
(PUVA) in Escherichia coli cells. MutatRes. 544: 143-57
281
Lambert S, Mason SJ, Barber LJ, Hartley JA, Pearce JA, Carr AM, and McHugh PJ. 
2003. Schizosaecharomyces pombe checkpoint response to DNA interstrand cross­
links. Mol. Cell. Biol. 23: 4728-4737
Laurencon A, Orme CM, Peters HK, Boulton CL, Vladar EK, Langley SA, Bakis EP, 
Harris DT, Harris NJ, Wayson SM, Hawley RS, Burtis KC. 2004. A large-scale screen 
for mutagen-sensitive loci in Drosophila. Genetics. 167: 217-31
Lawrence CW and Hinkle DC. 1996. DNA polymerase zeta and the control of DNA 
damage induced mutagenesis in eukaryotes. Cancer Surv. 28: 21-31
Le S, Moore JK, Haber JE, and Greider CW. 1999. RAD50 and RAD51 define two 
pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics 
152: 143-52
Lee BI, Wilson DM 3rd. 1999. The RAD2 domain of human exonuclease 1 exhibits 51 
to 3' exonuclease and flap structure-specific endonuclease activities. J Biol Chem. 274: 
37763-9
Lee KJ, Huang J, Takeda Y, and Dynan WS. 2000. DNA ligase IV and XRCC4 form a 
stable mixed tetramer that functions synergistically with other repair factors in a cell- 
free end-joining system. J. Biol. Chem. 275: 34787-96
Lee SE, Bressan DA, Petrini JH, Haber JE. 2002. Complementation between N- 
terminal Saccharomyces cerevisiae m rell alleles in DNA repair and telomere length 
maintenance. DNA Repair (Amst). 1: 27-40
282
Lee SH, Altenberg GA. 2003. Expression of functional multidrug-resistance protein 1 
in Saccharomyces cerevisiae: effects of N- and C-terminal affinity tags. Biochem. 
Biophys. Res. Commun. 306: 644-9
Lee SK, Yu SL, Prakash L, Prakash S. 2002. Requirement of yeast RAD2, a homolog 
of human XPG gene, for efficient RNA polymerase II transcription: implications for 
Cockayne syndrome. Cell 109: 823-34
Lewis LK, Karthikeyan G, Westmoreland JW, Resnick MA. 2002. Differential 
suppression of DNA repair deficiencies of Yeast rad50, m rell and xrs2 mutants by 
EXOl and TLC1 (the RNA component of telomerase). Genetics 160: 49-62
Lewis LK and Resnick MA. 2000. Tying up loose ends: non-homologous end-joining 
in Saccharomyces cerevisiae. Mut. Res. 451: 71-89
Li L, Moshous D, Zhou Y, Wang J, Xie G, Salido E, Hu D, de Villartay JP, and Cowan 
MJ. 2002. A founder mutation in Artemis, an SNM1-like protein, causes SCID in 
Athabascan-speaking Native Americans. J. Immunol. 186:6323-6329
Li L, Peterson CA, Lu X, Wei P, Legerski RJ. 1999. Interstrand cross-links induce 
DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol 
Cell Biol. 19: 5619-30
Li SJ, Hochstrasser M. 1999. A new protease required for cell-cycle progression in 
yeast. Nature. 398: 246-51
Li X and Moses RE. 2003. The beta-lactamase motif in Snml is required for repair of 
DNA double-strand breaks caused by interstrand crosslinks in S. cerevisiae. DNA 
Repair 2:121-129
283
Lieber MR, Ma Y, Pannicke U, and Schwarz K. 2003. Mechanism and regulation of 
human non-homologous DNA end-joining. Nat. Rev. Mol. Cell. Biol. 4: 712-20. 
Review.
Liefshitz B, Steinlauf R, Friedl A, Eckardt-Schupp F, and Kupiec M. 1998. Genetic 
interactions between mutants of the 'error-prone' repair group of Saccharomyces 
cerevisiae and their effect on recombination and mutagenesis. MutatRes. 407: 135-45.
Lindsley, J. E., and J. C. Wang. 1993. On the coupling between ATP usage and DNA 
transport by yeast DNA topoisomerase II. J. Biol. Chem. 268: 8096-8104
Lisby M, Rothstein R. 2004. DNA damage checkpoint and repair centers. Curr. Opin. 
Cell. Biol. 16: 328-34. Review.
Liu Y, Masson JY, Shah R, O'Regan P, and West SC. 2004. RAD51C is required for 
Holliday junction processing in mammalian cells. Science 303: 243-6
Loehrer PJ and Einhorn LH. 1984. Drugs five years later. Cisplatin. Ann Intern Med. 
100: 704-13. Review.
Longtine MS, McKenzie A 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, 
Philippsen P, and Pringle JR. 1998. Additional modules for versatile and economical 
PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14: 
953-61
Ma Y, Pannicke U, Schwarz K, and Lieber MR. 2002. Hairpin opening and overhang 
processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous 
end joining and V(D)J recombination. Cell 108:781-794
284
Maeda D, Seki M, Onoda F, Branzei D, Kawabe Y, and Enomoto T. 2004. Ubc9 is 
required for damage-tolerance and damage-induced interchromosomal homologous 
recombination in S. cerevisiae. DNA Repair (Amst). 3: 335-41
Magana-Schwencke N and Averbeck D. 1991. Repair of exogenous (plasmid) DNA 
damaged by photoaddition of 8-methoxypsoralen in the yeast Saccharomyces 
cerevisiae. Mutat. Res. 251: 123-131
Magana-Schwencke N, Henriques JA, Chanet R, and Moustacchi E. 1982. The fate of 
8-methoxypsoralen photoinduced crosslinks in nuclear and mitochondrial yeast DNA: 
comparison of wild-type and repair-deficient strains. Proc. Natl. Acad. Sci. USA 79: 
1722-1726
Maley F, Trimble RB, Tarentino AL, and Plummer TH Jr. 1989. Characterization of 
glycoproteins and their associated oligosaccharides through the use of 
endoglycosidases. Anal Biochem. 180: 195-204. Review.
Maikova A, Ivanov EL, and Haber JE. 1996. Double-strand break repair in the absence 
of RAD51 in yeast: a possible role for break-induced DNA replication. Proc. Natl. 
Acad. Sci. USA 93: 7131-6
Manivasakam P, Weber SC, McElver J, and Schiestl RH. 1995. Micro-homology 
mediated PCR targeting in Saccharomyces cerevisiae. Nucleic Acids Res. 23: 2799-800
Marsischky GT, T, Lee S, Griffith J, and Kolodner RD. 1999. Saccharomyces 
cerevisiae MSH2-6 complex interacts with Holliday junctions and facilitates their 
cleavage by phage resolution enzymes. J. Biol. Chem. 274: 7200-7206
285
Marsischky GT, Filosi N, Kane MF, and Kolodner R. 1996. Redundancy of 
Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. 
Genes Dev. 10: 407-420
Marti TM, Kunz C, and Fleck O. 2002. DNA mismatch repair and mutation avoidance 
pathways. J. Cell. Physiol. 191: 28-41. Review.
Martin SG, Laroche T, Suka N, Grunstein M, and Gasser SM. 1999. Relocalization of 
telomeric Ku and SIR proteins in response to DNA strand breaks in yeast. Cell 97: 621- 
33.
Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai 
S, Takio K, and Hanaoka F. 1999. The XPV (xeroderma pigmentosum variant) gene 
encodes human DNA polymerase eta. Nature 399: 700-704
McGlynn P and Lloyd RG. 2002. Recombinational repair and restart of damaged 
replication forks. Nat Rev Mol Cell Biol. 3: 859-70. Review.
McHugh PJ, Spanswick VJ, and Hartley JA. 2001. Repair of DNA interstrand 
crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2: 483-90. 
Review
McHugh PJ, Sones WR, and Hartley JA. 2000. Repair of intermediate structures 
produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol. Cell. Biol. 
20: 3425-3433
McHugh PJ, Gill RD, Waters R, and Hartley JA. 1999. Excision repair of nitrogen 
mustard-DNA adducts in Saccharomyces cerevisiae. Nucl. Acids Res. 27: 3259-3266
286
Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, 
Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, and Wang W. 2003. A 
novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35: 165-70
Meeusen S, Tieu Q, Wong E, Weiss E, Schieltz D, Yates JR, and Nunnari J. 1999. 
MgmlOlp is a novel component of the mitochondrial nucleoid that binds DNA and is 
required for the repair of oxidatively damaged mitochondrial DNA. J. Cell. Biol. 145: 
291-304
Mello JA, Acharya S, Fishel R, and Essigmann JM. 1996. The mismatch repair protein 
hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 
3: 579-589
Meluh PB and Koshland D. 1995. Evidence that the MIF2 gene of Saccharomyces 
cerevisiae encodes a centromere protein with homology to the mammalian centromere 
protein CENP-C. Mol. Biol. Cell. 6: 793-807
Memisoglu A and Samson L. 2000. Base excision repair in yeast and mammals. 
Mutat. Res. 451: 39-51. Review.
Meniel V, Magana-Schwencke, Averbeck D, and Waters R. 1997. Preferential incision 
of interstrand crosss-links induced by 8-methoxypsoralen plus UVA in yeast during the 
cell cycle. Mutat. Res. 384: 23-32
Meniel V, Magana-Schwencke N, and Averbeck D. 1995. Preferential repair in 
Saccharomyces cerevisiae rad mutants after induction of interstrand cross-links by 8- 
methoxypsoralen plus UVA. Mutagenesis 10: 543-548
287
Metzler M. 1986. DNA adducts of medicinal drugs: some selected examples. J. 
Cancer Res. Clin. Oncol. 112: 210-215. Review.
Miller RD, Prakash L, and Prakash S. 1982. Genetic control of excision of 
Saccharomyces cerevisiae interstrand DNA cross-links induced by psoralen plus near- 
UV light. Mol. Cell. Biol. 2:939-948
Misra RR and Vos JM. 1993. Defective replication of psoralen adducts detected at the 
gene-specific level in xeroderma pigmentosum variant cells. Mol Cell Biol. 13: 1002- 
12
Moggs JG, Szymkowski DE, Yamada M, Karran P, and Wood RD. 1997. Differential 
human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucl. 
Acids Res. 25: 480-490
Molloy SS, Thomas L, VanSlyke JK, Stenberg PE, and Thomas G. 1994. Intracellular 
trafficking and activation of the furin proprotein convertase: localization to the TGN 
and recycling from the cell surface. EMBO J. 13: 18-33
Moncalian G, Lengsfeld B, Bhaskara V, Hopfner KP, Karcher A, Alden E, Tainer JA, 
and Pauli TT. 2004. The rad50 signature motif: essential to ATP binding and 
biological function. J. Mol. Biol. 335: 937-51
Moore CW, McKoy J, Dardalhon M, Davermann D, Martinez M, and Averbeck D. 
2000. DNA damage-inducible and RAD52-independent repair of DNA double-strand 
breaks in Saccharomyces cerevisiae. Genetics 154: 1085-1099
Mortimer RK. 1958. Radiobiological and genetic studies on a polyploidy series 
(haploid to hexaploid) of Saccharomyces cerevisiae. Radiat. Res. 9: 312-326
288
Moshous D, Callebaut I, de Chasseval R, Comeo B, Cavazzana-Calvo M, Le Deist F, 
Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, and de Villartay JP. 2001. 
Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is 
mutated in human Severe Combined Immune Deficiency. Cell 105:177-186
Mu D, Bessho T, Nechev LV, Chen DJ, Harris TM, Hearst JE, and Sancar A. 2000. 
DNA interstrand cross-links induce futile repair synthesis in mammalian cell extracts. 
Mol. Cell B iol 20: 2446-54
Muller A and Fishel R. 2002. Mismatch repair and the hereditary non-polyposis 
colorectal cancer syndrome (HNPCC). Cancer Invest. 20: 102-109. Review.
Muller S, Hoege C, Pyrowolakis G, and Jentsch S. 2001. SUMO, ubiquitin's 
mysterious cousin. Nat Rev Mol Cell Biol 2: 202-10. Review.
Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew 
CG, Kastan MB, Weaver DT, and DAndrea AD. 2002. Interaction of FANCD2 and 
NBS1 in the DNA damage response. Nat. Cell. Biol. 4: 913-20
Nelson JR, Lawrence CW, and Hinkle DC. 1996 A. Thymine-thymine dimer bypass 
by yeast DNA polymerase zeta. Science. 272: 1646-9
Nelson JR, Lawrence CW, and Hinkle DC. 1996 B. Deoxycytidyl transferase activity 
of yeast REV1 protein. Nature. 382: 729-31
Niedemhofer U , Odijk H, Budzowska M, van Drunen E, Maas A, Theil AF, de Wit J, 
Jaspers NG, Beverloo HB, Hoeijmakers JH, and Kanaar R. 2004. The structure- 
specific endonuclease Erccl-Xpf is required to resolve DNA interstrand cross-link- 
induced double-strand breaks. Mol Cell Biol. 24: 5776-87
289
Niegemann E and Brendel M. 1994. A single amino acid change in SNM1-encoded 
protein leads to thermoconditional deficiency for DNA cross-link repair in 
Saccharomyces cerevisiae. Mutat. Res. 315:275-279
O’Connor PM and Kohn KW. 1990. Comparative pharmacokinetics of DNA lesion 
formation and removal following treatment of L1210 cells with nitrogen mustards. 
Cancer Comm. 2: 387-394
O'Driscoll M and Jeggo P. 2002. Immunological disorders and DNA repair. Mutat 
Res. 509: 109-26. Review.
Ojwang JO, Grueneberg DA, and Loechler EL. 1989. Synthesis of a duplex 
oligonucleotide containing a nitrogen mustard interstrand DNA-DNA cross-link. 
Cancer Res. 49: 6529-37
Palom Y, Suresh Kumar G, Tang LQ, Paz MM, Musser SM, Rockwell S, and Tomasz 
*
M. 2002. Relative toxicities of DNA cross-links and monoadducts: new insights from 
studies of decarbamoyl mitomycin C and mitomycin C. Chem. Res. Toxicol. 15: 1398- 
1406
Paques F and Haber JE. 1999. Multiple pathways of recombination induced by double­
strand breaks in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 63: 349-404. 
Review.
Pastink A and Lohman PH. 1999. Repair and consequences of double-strand breaks in 
DNA. Mutat. Res. 428: 141-56. Review.
290
Pathak MA and Fitzpatrick TB. 1992. The evolution of photochemotherapy with 
psoralens and UVA (PUVA): 2000 BC to 1992 AD. J. Photochem. Photobiol. B. 14: 3- 
22
Pauli TT and Gellert M. 1998. The 3' to 5' exonuclease activity of Mre 11 facilitates 
repair of DNA double-strand breaks. Mol. Cell. 1: 969-79
Petukhova G, Van Komen S, Vergano S, Klein H, and Sung P. 1999. Yeast Rad54 
promotes Rad51-dependent homologous DNA pairing via ATP hydrolysis-driven 
change in DNA double helix conformation. J. Biol. Chem 274: 29453-29456
Pichierri P, Averbeck D, and Rosselli F. 2002. DNA cross-link-dependent 
RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. 
Hum. Mol. Genet. 11: 2531-2546
Piette J, Gamper HB, van de Vorst A, and Hearst JE. 1988. Mutagenesis induced by 
site specifically placed 4'-hydroxymethyl-4,5l,8-trimethylpsoralen adducts. Nucl. Acids 
Res. 16: 9961-77.
Pinto AL and Lippard SJ. 1985. Binding of the antitumor drug cis- 
diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta. 780: 167-80. 
Review.
Prakash S and Prakash L. 2000. Nucleotide excision repair in yeast. Mut. Res. 451: 
13-24. Review.
Prolla TA, Christie DM, and Liskay RM. 1994. Dual requirement in yeast mismatch 
repair for MLH1 and PMS1> two homologues of the bacterial mutL gene. Mol. Cell. 
Biol. 14: 407-415
291
Pungartnik C, Picada J, Brendel M, and Henriques JA. 2002. Further phenotypic 
characterisation of pso mutants of Saccharomyces cerevisiae with respect to DNA 
repair and response to oxidative stress. Genet. Mol. Res. 1: 79-89
Qiu J, Qian Y, Chen V, Guan MX, and Shen B. 1999. Human exonuclease 1 
functionally complements its yeast homologues in DNA recombination, RNA primer 
removal, and mutation avoidance. J. Biol. Chem. 274:17893-17900
Qiu J, Guan MX, Bailis AM, and Shen B. 1998. Saccharomyces cerevisiae 
exonuclease-1 plays a role in UV resistance that is distinct from nucleotide excision 
repair. Nuc. Acids Res. 26: 3077-3083
Rahn R and Patrick M. 1976. Photochemistry of DNA: secondary structure, 
photosensitisation, base substitution, and exogenous molecules, in: Wang S (Ed.) 
Photochemistry and Photobiology o f nucleic acids. Biology, Vol II, Academic Press, 
New York, 97-145
Rattray AJ and Symington LS. 1995. Multiple pathways for homologous 
recombination in Saccharomyces cerevisiae. Genetics 139: 45-56
Rattray AJ and Symington LS. 1994. Use of a chromosomal inverted repeat to 
demonstrate that the RAD51 and RAD52 genes of Saccharomyces cerevisiae have 
different roles in mitotic recombination. Genes Dev. 10: 2025-2037
Reagan MS, Pittenger C, Siede W, and Friedberg EC. 1995. Characterization of a 
mutant strain of Saccharomyces cerevisiae with a deletion of the RAD27 gene, a 
structural homologue of the RAD2 nucleotide excision repair gene. J. Bacteriol. 
177:364-371
292
Reed E, Yuspa SH, Zwelling LA, Ozols RF, and Poirier MC. 1986. Quantitation of 
ds-diamminedichloroplatinum(II)(cisplatin)-DNA-intrastrand adducts in testicular and 
ovarian cancer patients receiving cisplatin chemotherapy. /. Clin. Invest. 77: 545-550
Reenan RAG and Kolodner RD. 1992. Characterization of insertion mutations in the 
Saccharomyces cerevisiae MSH1 and MSH2 genes: evidence for separate mitochondrial 
and nuclear functions. Genetics 132: 975-985
Resnick MA. 1976. The repair of double-strand breaks in DNA: a model involving 
recombination. J. Theor. Biol. 59: 97-106
Richardson C and Jasin M. 2000. Coupled homologous and nonhomologous repair of a 
double-strand break preserves genomic integrity in mammalian cells. Mol. Cell. Biol. 
20: 9068-75
Richie CT, Peterson C, Lu T, Hittelman WN, Carpenter PB, and Legerski RJ. 2002. 
hSnml colocalizes and physically associates with 53BP1 before and after DNA 
damage. Mol. Cell. Biol. 22:8635-8647
Richter D, Niegemann E, and Brendel M. 1992. Molecular structure of the DNA cross­
link repair gene SNM1 (PS02) of the yeast Saccharomyces cerevisiae. Mol. Gen. 
Genet. 231:194-200
Rink SM, Lipman R, Alley SC, Hopkins PB, and Tomasz M. 1996. Bending of DNA 
by the mitomycin C-induced, GpG intrastrand cross-link. Chem. Res. Toxicol. 9: 382- 
389
293
Rodriguez MS, Dargemont C, and Hay RT. 2001. SUMO-1 conjugation in vivo 
requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276: 
12654-12659
Rosenberg B, Van Camp L, Grimley EB, and Thomson AJ. 1967. The inhibition of 
growth or cell division in Eschericia coli by different ionic species of platinum(IV) 
complexes. J. Biol. Chem. 242: 1347-1352
Ross-Macdonald P and Roeder GS. 1994. Mutation of a meiosis specific MutS 
homologue decreases crossing over but not mismatch correction. Cell 79: 1069-1080
Rothfuss A and Grompe M. 2004. Repair kinetics of genomic interstrand DNA cross­
links: evidence for DNA double-strand break-dependent activation of the Fanconi 
anemia/BRCA pathway. Mol. Cell. Biol. 24: 123-34
Ruhland A, Haase E, Siede W, and Brendel M. 1981 A. Isolation of yeast mutants 
sensitive to the bifunctional alkylating agent nitrogen mustard. Mol. Gen. Genet. 181: 
346-51
Ruhland A, Kircher M, Wilborn F, and Brendel M. 1981 B. A yeast mutant 
specifically sensitive to bifunctional alkylation. Mutat. Res. 91:457-462
Ruhland A and Brendel M. 1979. Mutagenesis by cytostatic alkylating agents in yeast 
strains of differing repair capacities. Genetics 92:83-97
Saeki T, Machida I, and Nakai S. 1980. Genetic control of diploid recovery after y- 
irradiation in the yeast Saccharomyces cerevisiae. Mutat. Res. 73: 251-265
Saffran WA, Ahmed S, Bellevue S, Pereira G, Patrick T, Sanchez W, Thomas S, Alberti 
M, and Hearst JE. 2004. DNA Repair Defects Channel Interstrand DNA Cross-links
294
into Alternate Recombinational and Error-prone Repair Pathways. J. Biol. Chem. 279: 
36462-9
Sambrook J, Fritsch EF and Maniatis T. 1989. Molecular cloning: a laboratory 
manual. 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
SancarA. 1996. DNA excision repair. Annu Rev Biochem. 65: 43-81. Review.
Saparbaev M, Prakash L, and Prakash S. 1996. Requirement of mismatch repair genes 
MSH2 and MSH3 in the RAD1-RAD10 pathway of mitotic recombination in 
Saccharomyces cerevisiae. Genetics 142: 727-736
Schiestl RH and Prakash S. 1988. RADI, an excision repair gene of Saccharomyces 
cerevisiae, is also involved in recombination. Mol. Cell. Biol. 8:3619-3626
Schurer KA, Rudolph C, Ulrich HD, and Kramer W. 2004. Yeast MPH1 gene 
functions in an error-free DNA damage bypass pathway that requires genes from 
Homologous recombination, but not from postreplicative repair. Genetics 166: 1673-86
Schwartz DC and Hochstrasser M. 2003. A superfamily of protein tags: ubiquitin, 
SUMO and related modifiers. Trends Biochem Sci. 28: 321-8. Review.
Shinohara A, Shinohara M, Ohta T, Matsuda S, and Ogawa T. 1998. Rad52 forms ring 
structures and co-operates with RPA in single-strand DNA annealing. Genes Cells. 3: 
145-56
Siede W and Brendel M. 1982. Interactions among genes controlling sensitivity to 
radiation (RAD) and to alkylation by nitrogen mustard (SNM) in yeast. Curr. Genet. 5: 
33-38
295
Signon L, Maikova A, Naylor ML, Klein H, and Haber JE. 2001. Genetic 
requirements for RAD51- and RAD54-independent break-induced replication repair of 
a chromosomal double-strand break. Mol. Cell. Biol. 21: 2048-56
Sladek FM, Munn MM, Rupp WD, Howard-Flanders P. 1989. In vitro repair of 
psoralen-DNA cross-links by RecA, UvrABC, and the 5’-exonuclease of DNA 
polymerase I. J  Biol Chem. 264: 6755-65
Slater M.L. 1973. Effect of reversible inhibition of deoxyribonucleic acid synthesis on 
the yeast cell cycle. J. Bacteriol. 113: 263-270
Sokol sky and Alani E. 2000. EXOl and MSH6 are high copy suppressors of 
conditional mutations in the MSH2 mismatch repair gene of Saccharomyces cerevisiae. 
Genetics 155: 589-599
Sommers CH, Miller EJ, Dujon B, Prakash S, and Prakash L. 1995. Conditional 
lethality of null mutations of RTH1 that encodes the yeast counterpart of a mammalian 
5’- to 3’-exonuclease required for lagging strand DNA synthesis in reconstituted 
systems. J. Biol. Chem. 270: 4193-4196
Spanswick VJ, Craddock C, Sekhar M, Mahendra P, Shankaranarayana P, Hughes RG, 
Hochhauser D, and Hartley JA. 2002. Repair of DNA interstrand crosslinks as a 
mechanism of clinical resistance to melphalan in multiple myeloma. Blood. 100: 224-9
Stelter P and Ulrich HD. 2003. Control of spontaneous and damage-induced 
mutagenesis by SUMO and ubiquitin conjugation. Nature 425: 188-91
296
Strathdee G, MacKean MJ, Illand M, and Brown R. 1999. A role for methylation of 
the hMLHl promoter in loss of hMLHl expression and drug resistance in ovarian 
cancer. Oncogene 18: 2335-41
Sugawara N, Goldfarb T, Studamire B, Alani E, and Haber JE. 2004. Heteroduplex 
rejection during single-strand annealing requires Sgsl helicase and mismatch repair 
proteins Msh2 and Msh6 but not Pmsl. Proc. Natl. Acad. Sci. USA 101: 9315-9320
Sugawara N, Wang X, and Haber JE. 2003. In vivo roles of Rad52, Rad54, and Rad55 
proteins in Rad51-mediated recombination. Mol. Cell. 12: 209-19
Sugawara N, Paques F, Colaiacovo M, and Haber JE. 1997. Role of Saccharomyces 
cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced 
recombination. Proc. Natl. Acad. Sci. USA 94: 9214-9.
Sugawara N and Haber JE. 1992. Characterization of double-strand break-induced 
recombination: homology requirements and single-stranded DNA formation. Mol. Cell. 
Biol. 12: 563-75
Sun X, Thrower D, Qiu J, Wu P, Zheng L, Zhou M, Bachant J, Wilson DM, and Shen 
B. 2003. Complementary functions of the Saccharomyces cerevisiae Rad2 family 
nucleases in Okazaki fragment maturation, mutation avoidance, and chromosome 
stability. DNA Repair 2: 925-40
Sung P, Guzder SN, Prakash L, and Prakash S. 1996. Reconstitution of TFIIH and 
requirement of its DNA helicase subunits, Rad3 and Rad25, in the incision step of 
nucleotide excision repair. J. Biol. Chem. 271: 10821-6
297
Sung P. 1994. Catalysis of ATP-dependent homologous DNA pairing and strand 
exchange by yeast RAD51 protein. Science 265: 1241-3
Sunters A, Springer CJ, Bagshawe KD, Souhami RL, and Hartley JA. 1992. The 
cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline 
mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid. 
Biochem. Pharmacol. 44: 59-64
Symington LS. 2002. Role of RAD52 epistasis group genes in homologous 
recombination and double-strand break repair. Microbiol. Mol. Biol. Rev. 66: 630-670
Symington LS, Kang LE, and Moreau S. 2000. Alteration of gene conversion tract 
length and associated crossing over during plasmid gap repair in nuclease-deficient 
strains of Saccharomyces cerevisiae. Nucl. Acids Res. 28: 4649-4656
Symington LS. 1998. Homologous recombination is required for the viability of rad27 
mutants. Nucl. Acids Res. 26:5589-5595
Szostak JW, Orr-Weaver TL, Rothstein RJ, and Stahl FW. 1983. The double-strand- 
break repair model for recombination. Cell 33: 25-35
Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi- 
Iwai Y, Shinohara A, and Takeda S. 1998. Homologous recombination and non- 
homologous end-joining pathways of DNA double-strand break repair have overlapping 
roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17: 
5497-508
298
Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok 
SC, and D'Andrea AD. 2003. Disruption of the Fanconi anemia-BRCA pathway in 
cisplatin-sensitive ovarian tumors. Nat. Med. 9: 568-574
Tateishi S, Sakuraba Y, Masuyama S, Inoue H, and Yamaizumi M. 2000. Dysfunction 
of human Rad 18 results in defective postreplication repair and hypersensitivity to 
multiple mutagens. Proc. Natl. Acad. Sci. USA 97: 7927-32
Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo 
AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Famham JM, Frank D, Frye C, 
Ghaffari S, Gupte JS, Hu R, Uiev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc 
G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, 
Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, 
Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, and Cannon- 
Albright LA. 2001. A candidate prostrate cancer susceptibility gene at chromosome 
17p. Nat. Genet. 27:172-180
Teo SH and Jackson SP. 1997. Identification of Saccharomyces cerevisiae DNA ligase 
IV: involvement in DNA double-strand break repair. EMBO J. 16:4788-95.
Terpe K. 2003. Overview of tag protein fusions: from molecular and biochemical 
fundamentals to commercial systems. Appl Microbiol Biotechnol. 60: 523-33. Review.
Thomas BJ and Rothstein R. 1989. The genetic control of direct-repeat recombination 
in Saccharomyces'. the effect of rad52 and radl on mitotic recombination at GAL10, a 
transcriptionally regulated gene. Genetics 123: 725-738
Tishkoff DX, Boerger AL, Bertrand P, Filosi N, Gaida GM, Kane MF, and Kolodner
RD. 1997 A. Identification and characterization of Saccharomyces cerevisiae EXO l, a
299
gene encoding an exonuclease that interacts with MSH2. Proc. Natl. Acad. Sci. USA 
94: 7487-7492
Tishkoff DX, Filosi N, Gaida GM, and Kolodner RD. 1997 B. A novel mutation 
avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA 
mismatch repair. Cell 88: 253-263
Toh GW and Lowndes NF. 2003. Role of the Saccharomyces cerevisiae Rad9 protein 
in sensing and responding to DNA damage. Biochem Soc Trans. 31: 242-6. Review.
Tomasz M. 1995. Mitomycin C: small, fast and deadly (but very selective). Chem 
Biol. 2: 575-9. Review.
Tomkinson AE, Bardwell AJ, Bardwell L, Tappe NJ, and Friedberg EC. 1993. Yeast 
DNA repair and recombination proteins Radi and RadlO constitute a single-stranded- 
DNA endonuclease. Nature 362:860-862
Torres-Ramos CA, Prakash S, and Prakash L. 2002. Requirement of RADS and MMS2 
for postreplication repair of UV-damaged DNA in Saccharomyces cerevisiae. Mol. 
Cell. Biol. 22: 2419-2426
Tran PT, Simon JA and Liskay RM. 2001. Interactions of Exolp with components of 
MutLalpha in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 98: 9760-9765
Trujillo KM, Roh DH, Chen L, Van Komen S, Tomkinson A, and Sung P. 2003. Yeast 
xrs2 binds DNA and helps target rad50 and m rell to DNA ends. J. Biol. Chem. 278: 
48957-48964
Trujillo KM and Sung P. 2001. DNA structure-specific nuclease activities in the 
Saccharomyces cerevisiae Rad50*Mrell complex. J. Biol. Chem. 276: 35458-35464.
300
Tsubouchi H and Ogawa H. 2000. Exol roles for repair of DNA double-strand breaks 
and meiotic crossing over in Saccharomyces cerevisiae. Mol. Biol. Cell 11: 2221-2233
Tsubouchi H and Ogawa H. 1998. A novel m rell mutation impairs processing of 
double-strand breaks of DNA during both mitosis and meiosis. Mol. Cell. Biol. 18: 
260-268
Ulrich HD and Jentsch S. 2000. Two RING finger proteins mediate cooperation 
between ubiquitin-conjugating enzymes in DNA repair. EMBO J. 19: 3388-3397
Usui T, Ohta T, Oshiumi H, Tomizawa J, Ogawa H, and Ogawa T. 1998. Complex 
formation and functional versatility of M rell of budding yeast in recombination. Cell 
95: 705-716
Valencia M, Bentele M, Vaze MB, Herrmann G, Kraus E, Lee SE, Schar P, and Haber 
JE. 2001. NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae. 
Nature 414: 666-669
Vallen EA and Cross FR. 1995. Mutations in RAD27 define a potential link between 
G1 cyclins and DNA replication. Mol. Cell. Biol. 15: 4291-4302
Van Gent DC, Hoeijmakers JH, and Kanaar R. 2001. Chromosomal stability and the 
DNA double-stranded break connection. Nat. Rev. Genet. 2: 196-206. Review.
van Gool AJ, Verhage R, Swagemakers SM, van de Putte P, Brouwer J, Troelstra C, 
Bootsma D, and Hoeijmakers JH. 1994. RAD26, the functional S. cerevisiae homolog 
of the Cockayne syndrome B gene ERCC6. EMBO J. 13: 5361-5369
301
Van Houten B, Gamper H, Holbrook SR, Hearst JE, and Sancar A. 1986. Action 
mechanism of ABC excision nuclease on a DNA substrate containing a psoralen 
crosslink at a defined position. Proc. Natl. Acad. Sci. USA 83: 8077-8081
Van Houten B, Eisen JA, and Hanawalt PC. 2002. A cut above: discovery of an 
alternative excision repair pathway in bacteria. Proc. Natl. Acad. Sci. USA. 99: 2581- 
2583
Volker M, Mone MJ, Karmakar P, van Hoffen A, Schul W, Vermeulen W, Hoeijmakers 
JH, van Driel R, van Zeeland AA, and Mullenders LH. 2001. Sequential assembly of 
the nucleotide excision repair factors in vivo. Mol. Cell. 8: 213-224
Vosseller K, Sakabe K, Wells L, and Hart GW. 2002. Diverse regulation of protein 
function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational 
modification. Curr. Opin. Chem. Biol. 6: 851-857. Review.
Vuksanovic L and Cleaver JE. 1987. Unique cross-link and monoadduct repair 
characteristics of a xeroderma pigmentosum revertant cell line. Mutat. Res. 184: 255- 
263
Wakasugi M and Sancar A. 1998. Assembly, subunit composition, and footprint of 
human DNA repair excision nuclease. Proc. Natl. Acad. Sci. USA 95: 6669-6674
Wang H, Yang Y, Schofield MJ, Du C, Fridman Y, Lee SD, Larson ED, Drummond JT, 
Alani E, Hsieh P, and Erie DA. 2003. DNA bending and unbending by MutS governs 
mismatch recognition and specificity. Proc. Natl. Acad. Sci. USA 100: 14822-14827
302
Wang X, Peterson CA, Zheng H, Nairn RS, Legerski RJ, and Li L. 2001. Involvement 
of nucleotide excision repair in a recombination-independent and error-prone pathway 
of DNA interstrand cross-link repair. Mol. Cell. Biol. 21: 713-720
Webb BL, Cox MM, Inman RB. 1997. Recombinational DNA repair: the RecF and 
RecR proteins limit the extension of RecA filaments beyond single-strand DNA gaps. 
Cell. 91: 347-356
Weng, YS, and Nickoloff JA. 1998. Evidence for independent mismatch repair 
processing on opposite sides of a double-strand break in Saccharomyces cerevisiae. 
Genetics 148: 59-70
Wilbom F and Brendel M. 1989. Formation and stability of interstrand cross-links 
induced by cis- and trans-diamminedichloroplatinum (II) in the DNA of Saccharomyces 
cerevisiae strains differing in repair capacity. Curr. Genet. 16: 331-338
Wolter R, Siede W, and Brendel M. 1996. Regulation of SNM1, an inducible 
Saccharomyces cerevisiae gene required for repair of DNA cross-links. Mol. Gen. 
Genet. 250: 162-168
Woodgate R. 1999. A plethora of lesion-replicating DNA polymerases. Genes Dev. 
13: 2191-5. Review.
Wu HI, Brown JA, Dorie MJ, Lazzeroni L, and Brown JM. 2004. Genome-wide 
identification of genes conferring resistance to the anticancer agents cisplatin, 
oxaliplatin, and mitomycin C. Cancer Res. 64: 3940-8
Wu L and Hickson ID. 2003. The Bloom's syndrome helicase suppresses crossing over 
during homologous recombination. Nature 426: 870-874
303
Wu X, Wilson TE, Lieber MR. 1999. A role for FEN-1 in nonhomologous DNA end 
joining: the order of strand annealing and nucleolytic processing events. Proc. Natl. 
Acad. Sci. USA 96: 1303-1308
Xiao W and Chow BL. 1998. Synergism between yeast nucleotide and base excision 
repair pathways in the protection against DNA methylation damage. Curr. Genet. 33: 
92-99
Xiao W, Chow BL, and Rathgeber L. 1996. The repair of DNA methylation damage in 
Saccharomyces cerevisiae. Curr. Genet. 30: 461-468
Xie Y, Liu Y, Argueso JL, Henricksen LA, Kao HI, Bambara RA, and Alani E. 2001. 
Identification of rad27 mutations that confer differential defects in mutation avoidance, 
repeat tract instability, and flap cleavage. Mol. Cell. Biol. 21: 4889-4899
Yu J, Marshall K, Yamaguchi M, Haber JE, and Weil CF. 2004. Microhomology- 
dependent end joining and repair of transposon-induced DNA hairpins by host factors in 
Saccharomyces cerevisiae. Mol. Cell. Biol. 24: 1351-1364.
Yu S, Owen-Hughes T, Friedberg EC, Waters R, and Reed SH. 2004. The yeast 
Rad7/Radl6/Abfl complex generates superhelical torsion in DNA that is required for 
nucleotide excision repair. DNA Repair 3: 277-87
Zamble DB, Mu D, Reardon JT, Sancar A, and Lippard SJ. 1996. Repair of cisplatin- 
DNA adducts by the mammalian excision nuclease. Biochemistry 35: 10004-10013
Zdraveski ZZ, Mello JA, Marinus MG, and Essigmann JM. 2000. Multiple pathways 
of recombination define cellular responses to cisplatin. Chem. Biol. 7: 39-50
304
Zhang N, Lu X, and Legerski RJ. 2003. Partial reconstitution of human interstrand 
cross-link repair in vitro: characterization of the roles of RPA and PCNA. Biochem. 
Biophys. Res. Commun. 309: 71-78
Zhang N, Lu X, Zhang X, Peterson CA, and Legerski RJ. 2002. hMutSbeta is required 
for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol. 
Cell. Biol. 22: 2388-97
Zhang X, Richie C, and Legerski RJ. 2002. Translation of hSNMl is mediated by an 
internal ribosome entry site that upregulates expression during mitosis. DNA Repair 
(Amst). 1: 379-90
Zwelling LA, Anderson T, and Kohn KW. 1979. DNA-protein and DNA interstrand 
cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse 
leukaemia cells and relation to cytotoxicity. Cancer Res. 39: 365-369
305
APPENDIX
The gene-specific sequences of primers used in the PCR-based micro-homology 
targeted gene deletion of S. cerevisiae, are detailed below. The co-ordinates given are 
the 5’ end of each primer, according to the sequence deposited in the Genbank database. 
Where further sequence was required upstream of the CDS, primers were designed from
the sequence deposited in the Saccharomyces Genome Database (SGD).
Primer Gene-specific sequence 
(5’-3’)
Co-ordinates 
(Genbank accession)
PS02-DEL5’ AGC ATA CGC ACT AGT GAC TAA 
TTT GGG TGG TCG GTT GAT T
131
PS02-DEL3’ TCA TAC ATT CAT ATA ATA TCC 
ATT ACG TAC GTA CAT CTT A
2270
(X64004)
RAD4-DEL5’ GGA CGA CAA GCA GAG ACA TAA 
CGA CAC TAT TTT TCC GCT AAA 
ATG
345
RAD4-DEL3’ AAA ACA TAC TTT CCT AAT TAT 
TCA AAC CGT TTC AGC CTC ATT 
TCA
2693
(M24928)
RAD51-DEL5’ ACG TAG TTA TTT GTT AAA GGC 
CTA CTA ATT TGT TAT CGT CAT 
ATG
1315
RAD51-DEL3’ AAG TAA ACC TGT GTA AAT AAA 
TAG AGA CAA GAG ACC AAA TAC 
CTA
2600
(M88470)
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RAD52-DEL5’
RAD52-DEL3’
EX01-DEL5’
EX01-DEL3’
MRE11-DEL5’
MRE11-DEL3’
RAD1-DEL5’
RAD1-DEL3’
RAD27-DEL5’
RAD27-DEL3’
AAA AGA CGA AAA ATA TAG CGG 
CGG GCG GGT TAC GCG ACC G 
TGA TGC AAA TTT TTT ATT TGT 
TTC GGC CAG GAA GCG TTT C
GCG TAG AAA GGA ATG GGT ATC 
CAA GGT CTT CTT CCT CAG T 
TCC GAT ATG AAA CGT GCA GTA 
CTT AAC TTT TAT TTA CCT T
CTC CAC TAT GGA CTA TCC TGA 
TCC AGA CAC AAT AAG GAT T 
TCG ACC ATT AAG TAA ACC ATA 
ACT AGC GTC CTC TTC GTC A
AGA GCA TTT GCT AAA TGT GTA 
AAA ATA ATA TTG CAC TAT C 
TCA CCA AAT GAA TAT TGT TAT 
TTT CAC TAT AGT TAA TCG C
TAC ATT GGA AAG AAA TAG GAA 
ACG GAC ACC GGA AGA AAA AAT 
ATG
CAA GGT GAA GGA CCA AAA GAA 
GAA AGT GGA AAA AGA ACC CCC 
TCA
921
2520 
(M10249)
521
2670
(U86134)
161
2120
(U60829)
381
3830
(M15435)
-2
1050
(SGD YKL113C)
307
MSH2-DEL5’ CTT TAT CTG CTG ACC TAA CAT 
CAA AAT CCT CAG ATT AAA AGT 
ATG
1193
MSH2-DEL3’ ATT ATC TAT CGA TTC TCA CTT 
AAG ATG TCG TTG TAA TAT TAA 
TTA
4172
(M84170)
MSH3-DEL5’ TGA ATT TTC AAT GAT AAA TAA 
GCT GGA ACA ATG GTG ATA G
8
MSH3-DEL3’ TGG ATA TCC AAT GAT AGT AAT 
TTC GCG AGT TTA TCC GTT G
3177
(M96250)
MSH6-DEL5’ AAT TTT GAC AAA GCC AAT TTG 
AAC TCC AAA ATG GCC CCA G
-100
MSH6-DEL3’ AAA ATC TTA CAT ACA TCG TAA 
ATG AAA ATA CTT AGG ATT G
4761
(SGD YDR097C)
MLH1-DEL5’ GTA AAA ATA ACA TAG ACC TAT 
CAA TAA CGA ATG TCT CTC A
211
MLH1-DEL3' CTT TGG TAT TAC AGC CAA AAC 
GTT TTA AAG TTA ACA CCT C
2580
(U07187)
The following adapter sequences were added to the 3’ end of the gene-specific
sequences to form the complete primer for gene targeting. FI (5’ deletion primer) and
R1 (3’ deletion primer) sequences were used to amplify the KanMX4 and HIS3MX6
cassettes. URA573’ were used to amplify URA3 from the pYES2 vector.
FI CGG ATC CCC GGG TTA ATT AA
R1 GAA TTC GAG CTC GTT TAA AC
URA5’ CCT GAG CGG AAG TGT ATC GT
URA3 ’ AAT AAG GGC GAC ACG GAA AT
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